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Abstract 
 
For  all  living  organisms,  macromolecular  interactions  facilitate  most  of  their 
natural functions. Alterations to macromolecular structures through mutations, 
can  affect  the  stability  of  their  interactions,  which  may  lead  to  unfavourable 
phenotypes  and  disease.  Presented  here,  are  a  number  of  computational 
methods  aimed  at  uncovering  the  principles  behind  complex  stability  -  as 
described by binding affinity and dissociation rate constants. Several factors are 
known to govern the stability of protein-protein interactions, however, no one 
factor dominates, and it is the synergistic effect of a number of contributions, 
which amount to the affinity, and stability of a complex. The characterization of 
complex stability can thus be presented as a two-fold problem; modelling the 
individual factors and modelling the synergistic effect of the combination of such 
individual  factors.  Using  machine  learning  as  a  central  framework,  empirical 
functions are designed for estimating affinity, dissociation rates and the effects of 
mutations  on  these  properties.  The  performance  of  all  models  is  in  turn 
benchmarked on experimental data available from the literature and carefully 
curated  datasets.  Firstly,  a  wild-type  binding  free  energy  prediction  model  is 
designed, composed of a diverse set of stability descriptors, which account for 
flexibility and conformational changes undergone by the  complex in question. 
Similarly, models for estimating the effects of mutations on binding affinity are 
also designed and benchmarked in a community-wide blind trial. Emphasis here 
is on the detection of a small subset of mutations that are able to enhance the 
stability  of  two  de novo  protein  drugs  targeting  the  flu  virus  hemagglutinin. 
Probing  further  the  determinants  of  stability,  a  set  of  descriptors  that  link 
hotspot  residues  with  the  off-rate  of  a  complex  are  designed,  and  applied  to 
models predicting changes in off-rate upon mutation. Finally, the relationship 
between  the  distribution  of  hotspots  at  protein  interfaces,  and  the  rate  of 
dissociation of such interfaces, is investigated.   
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Chapter 1 
1 Introduction 
 
These  days  more  than  ever,  we  live  in  a  world  of  networks.  At  its  roots,  a 
network is defined as a set of ‘nodes’ and a related set of ‘links’. A link between 
two nodes indicates some connection or relationship between these nodes.  More 
interestingly, a link between two nodes may indicate a transfer of information. 
Be it a transfer of information as a result of a simple conversation between two 
friends on a social network, a flip of polarity at the output of a logic gate in an 
electronic circuit network, or, and what concerns this thesis mostly, the binding 
of two molecules in a biological network. Such binding events are at the core of 
all cellular processes, and networks of molecular interactions enable each cell to 
sense its external environment, propagate the necessary information inwards, 
and  make  decisions  concerning  its  cellular  state  or  even  the  states  of  its 
neighbouring cells. With this, it then becomes clear that, not only do we live in a 
world  of  networks,  but  our  health  too  is  the  result  of  numerous 
intercommunicating biological networks. 
This thesis is concerned with the link between two nodes, that very interaction 
between two molecules; in this case that between two proteins. The emphasis is 
placed on  understanding what constitutes a  stable  interaction  between  them. Chapter 1: Introduction 
17 
 
The  stability  of  such  interactions  plays  an  important  role  in  both  our 
understanding of disease and that of designing better drugs; these aspects are 
detailed below in the thesis justification section, 1.4. First, as an introduction to 
this work, the signalling behaviour of T cells will be described. This case study is 
a prime example of both the centrality of protein-protein interactions, and how 
the change in stability of one of these interactions can affect the activity and 
response of the T cell itself. 
 
1.1  Information Processing in the Cell: A Key Example, T Cell 
Receptor Signalling 
 
The importance of understanding the factors controlling the binding affinities of 
proteins within a complex cellular information processing system can be well 
exemplified by the T cell receptor-signalling network. T cells (T lymphocytes) are 
a subset of white blood cells which form an integral part of our immune system 
fighting against virus infected or malignant cells. These include, T-Helper Cells, 
T-Suppressor and T-Killer Cells (cytotoxic T cells). Effectively, their function is to 
elicit a distinct and specific response depending on the foreign antigen detected. 
T cells work by a cascade of signalling events initiated from the T-cell receptor 
(TCR).  The  TCR  recognizes  peptides  presented  by  Major  Histocompatibility 
Complex  (MHC)  molecules  from  antigen  presenting  cells  (APC).  The  peptides 
themselves are usually cleaved parts of cellular proteins. If the cell is infected 
with  a  virus,  then  some  of  these  peptides  will  be  from  foreign  proteins  (See 
Figure 1.1a). The ability for T cells to make this distinction is therefore critical 
and defects in the normal T cell response lead to several autoimmune (Dejaco et 
al., 2006) or immunodeficiency related diseases (Edgar, 2008), some of which 
may have severe health consequences. Besides the binding of the TCR and pep-
MHC,  (MHC  with  antigenic  peptide)  simultaneous  binding  of  specific  co-
receptors, CD4 on T helper cells, and CD8 on cytotoxic T cells, with the MHC 
molecule initiates a myriad of signalling events. Some of these interactions are 
depicted in Figure 1.1b.   
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Figure 1.1: T cell Receptor Signalling. 
(A)  Pictorial  depiction  of  viral  infection,  viral  protein  expression,  peptide 
fragmentation  and the presentation of the  viral protein peptide on the Major 
Histocompatibility  Complex  (MHC).  A  neighbouring  T  Cell  detects  the  foreign 
peptide  using  its  T  cell  receptor  (TCR).  (B)  Some  of  the  interactions  and 
signalling triggered by the formation of the TCR/pepMHC complex. Figure taken 
from Miller et al. (2007). (C) the structure the complex between human TCR b7, 
viral peptide (TAX) and MHC Class I molecular HLA-A 0201. (PDBid: 1BD2). This 
structure includes the extracellular portions of a T-cell receptor and class I MHC. 
TCR chains are in red and yellow. MHC chains are in green and orange. Peptide is 
shown in white. Of much debate is how the affinity and kinetic of this interaction 
affects T cell activity. 
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Upon  TCR/pep-MHC  binding,  LCK  (an  Src  family  kinase)  is  recruited  and 
phosphorylates the immune-receptor tyrosine-based activation motifs (ITAMS) 
which form part of the intracellular subunits of the TCR itself(Lin and Weiss, 
2001). After phosphorylation of ITAMS, ZAP-70 is activated which binds to two 
adapter molecules LAT and SLP-76 and their subsequent phosphorylation of LAT 
and SLP-76 triggers the Ras pathway (Lin and Weiss, 2001). The signal continues 
further downstream until several transcription factors are activated. This in turn 
elicits a number of responses related to T cell activation which include cytokine 
release, proliferation and apoptosis amongst others. 
Sensitivity of T Cell response signalling to TCR/pep-MHC affinity and kinetics: 
The centrality of the interaction between TCR and pep-MHC (see Figure 1.1c), 
has led to many different models of T cell activation. Initial models propose the 
TCR as simple on-off switch where TCR/pep-MHC binding elicits a full T cell 
activation  (Jameson,  1998).  Experiments  presenting  different  pep-MHC 
molecules however show that different TCR ligands trigger none or only some of 
the T cell activation responses (Kersh and Allen, 1996). These have been termed 
as TCR antagonists and partial agonists respectively. The fact that some but not 
all T cell activity responses may be activated led to development of the ‘kinetic 
proofreading’ model. In this model, the affinity (or off-rates) of the pep-MHC 
molecule with the TCR is proportional to the magnitude of the T cell response (!!! 
INVALID CITATION !!!). For low residence times (fast off-rates), early activation 
events, without the presence of late T cell activation events, are elicited. Slower 
off-rates on the other hand, enable a full T cell activation response. Evidence not 
supporting this model, such as the activation of late T cell signals with fast off-
rates (Rosette et al., 2001), and the discovery that a small number of peptide-
MHC can serially engage and trigger up to approximately 200 TCRs, instigated an 
alternative ‘serial triggering ‘ hypothesis (Valitutti et al., 1995). In this case, the 
interaction’s  off-rate  must  be  sufficiently  low  for  initial  signalling  to  be 
completed, but high enough to allow different TCRs to bind the same pep-MHC 
molecule. This suggest that there is an ‘optimal dwell time’ which elicits T cell 
activation and anything outside this optimal range results in reduced activity. A 
model of consensus is however still hindered by several challenges (Stone et al., Chapter 1: Introduction 
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2009). For example; outlier observations have been made that contradict both 
hypothesis;  experimental  binding measurements  are generally  made  at lower 
temperatures than those of in vivo activity; and the effects of co-receptors CD4 
and CD8 should complicate the story even further (Stone et al., 2009). 
The overview of TCR signalling presented above is a crude one at most, and can 
only be refined once our theoretical knowledge of just how binding affinities are 
controlled at the atomic level improves. Moreover, there are a vast amount of 
molecular interactions and interplays between multiple pathways (Huse, 2009). 
Therefore,  this  example  serves  as  a  reminder  of    the  complexity  of  protein 
interactions in cellular networks, and how the response of such a system may be 
affected  by  the  stability  of  just  one  of  those  interactions.  The  information 
processing  mechanisms  of  the  T  cell  receptor  network,  as  with  many  other 
signalling  networks,  can  only  be  truly  appreciated  and  understood  when 
considering the dynamics and stability of its molecular interactions.  
1.2  Thesis Outline 
 
In this thesis, a number of computational investigations are performed aimed at 
understanding  the  stability  of  protein-protein  complexes.  The  investigations 
revolve around the design of a number of predictive models that correlate with 
experimental measurements for stability. Therefore, in the following section, 1.3, 
a brief overview is given of the different terms that relate to complex stability, 
and  those  that  form  part  of  this  study;  these  include  binding  affinities, 
dissociation rates and hotspots. In section 0, justification for this thesis is further 
underlined  by  showing  that  the  study  of  the  stability  of  protein-protein 
interactions (PPIs), has a direct impact on recent trends in drug design. This 
includes  the  growing  interest  in  PPIs  as  drug  targets  (section  1.4.1),  protein 
engineering and protein drugs (section 1.4.2) and the importance of considering 
off-rates for the enhancement of in vivo drug activity. In section 1.4.4 it will also 
be described how the functional interpretation of missense SNPs is dependent on 
our  ability  to  characterise  the  changes  in  stability  resulting  from  these 
mutations.  In  section  1.5  the  equations  governing  the  kinetics  and 
thermodynamics  of  binding  are  presented  the  energetic  terms  used  for Chapter 1: Introduction 
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modelling of binding free energies detailed. In section 1.6.7 an overview of the 
current  models  for  the  prediction  of  binding  affinities  is  given  and  their 
limitations highlighted. A number of machine learning algorithms are employed 
throughout this thesis of which an overview is given in section 1.6. 
Finally, in section 1.7, I present some of my personal motivations and themes 
that drive the studies presented in this thesis. This chapter then concludes with 
an overview of each of the remaining thesis chapters. In summary, models for the 
prediction of binding affinities and their change upon mutation are presented in 
Chapters  3  and  4.  In  Chapter  5,  models  for  the  prediction  of  hotspots  are 
presented and benchmarked. In Chapter 6, a set of descriptors that link hotspot 
residues with the off-rate of a complex are designed. Chapter 7 extends on this 
idea by building prediction models for off-rate changes upon mutation. Finally in 
Chapter 8, the relationship between the distribution of hotspots on an interface, 
and the rate of dissociation, is investigated.  
1.3  Facets of Complex Stability in a Nutshell: Binding Affinities, Off-
Rates and Hotspots 
 
The pathways shown in diagrams similar to Figure 1.1b, provide a very sparse 
and static picture of the nature of the environment of protein interactions. In 
reality,  proteins  exist  in  a  highly  dense  ‘soup-like’  environment  in  the  cell 
(Lewitzky et al., 2012). For example, the intracellular concentration of proteins 
for  mammalian  cells  is  estimated  at  200-300mg/ml  (Luby-Phelps,  2000)  and 
macromolecules themselves occupy 40% of the total cell volume (Fulton, 1982). 
For an interaction to take place, proteins must therefore rummage through this 
crowded environment, i) find their partner, ii) find the binding site and iii) form 
a  complex  for  an  indefinite  amount  of  time.  For  those  protein-protein 
interactions that are sufficiently long-lived, the strength of the interaction can be 
determined by the binding affinity. This means that for a pair of proteins, being 
able to predict their binding affinity, should in theory determine whether two 
such  proteins  make  a  biologically  significant  interaction.  In  kinetic  terms  (as 
derived in section 1.5.1), the binding affinity of an interaction  
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Figure 1.2: The relationship between the different facets at which complex 
stability may be characterised and those which are studied in this thesis.  
(A)  The  off-rate  (koff)  represents  the  intrinsic  disposition  of  a  complex  to 
dissociate  once  it  has  formed.  The  higher  the  time  for  which  the  complex  is 
bound, the  lower   the  off-rate.  (B)  Adding to  this, knowledge  of the intrinsic 
disposition for the complex to associate (kon), the binding affinity (ΔG) may also 
be calculated. (C) Characterisation of the effects of mutations on both the off-
rate,  koff,  and  on  the  binding  affinity,  ΔΔG,  is  central  to  the  functional 
interpretation of disease and for computational drug design. Alanine scanning 
experiments have shown that only a few mutations cause significant disruption 
to  complex  stability.  These  are  known  as  hotspots  and  are  the  residues 
responsible for most of the binding affinity of a protein-protein interaction. 
 
is related to how easy it is for the two partners to reach the bound state (kon), 
and how easy it is for the two partners to unbind back into separate protein 
conformations (koff). Prediction of the koff of a complex effectively determines the 
length of time (residence time = 1/koff) for which the complex is bound. From 
alanine scanning experiments on protein-protein interfaces, only a small subset 
of interface ‘hotspot’ residues is found to be responsible for the binding affinity 
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of the complex (Bogan and Thorn, 1998, Clackson et al., 1998). These hotspot 
residues may in turn affect binding through a change in koff independently of kon 
and vice versa (Moal and Fernandez-Recio, 2012). In this view, complex stability, 
as  in fact explored in  this  thesis, may be  approached  at different  yet related 
levels (See Figure 1.2).  
 
1.4  A Thesis Justified  
 
In this section it will be described how the characterisation of protein-protein 
binding affinities and off-rates has direct relevance to the current trends and 
difficulties  of  drug-design.  In  a  similar  vein,  the  functional  interpretation  of 
mutations involved in disease necessitates that we are able to accurately predict 
changes in affinities upon mutation. 
1.4.1  Protein-Protein Interactions as Drug Targets 
 
Despite their therapeutic relevance and major involvement in cellular signalling, 
PPIs have traditionally received less attention as drug targets, or attempts to 
target them have shown few success stories. For example, Bcl-2 family proteins 
are  key  regulators  of  programmed  cell  death  and  Bcl-XL  and  Bcl-2  are 
overexpressed  in  many  cancers.  Bcl-XL  expression  is  correlated  with  chemo-
resistance and reduction in Bcl-2 expression increases sensitivity to anticancer 
drugs  and  in vivo  survival.  Several  drugs  targeting  these  proteins  have  been 
explored  but  resultant  affinities  have  not  been  found  to  be  sufficiently  high 
(Oltersdorf et al., 2005). The main difficulty in achieving high-affinity binding is 
that  the  structural  properties  of  PPIs  do  not  have  common  drug-like  site 
properties. The large surface area of the PPI binding site is typically much larger 
than  that  covered  by  the  small-molecule  drug.  In  addition,  PPIs  have 
characteristically flat interfaces and no well-defined binding pockets; this limits 
the  contact  surface  area  the  small-molecule  drug  can  make  with  the  protein 
(Mullard, 2012, Jin et al., 2014). The ‘undruggable’ view started to change in the 
1990s  after  studies  on  protein-protein  interactions  identified  certain  hotspot 
residues  responsible  for  most  of  the  binding  free  energy  (Bogan  and  Thorn, Chapter 1: Introduction 
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1998, Clackson et al., 1998). This shows that, even though large in surface area, 
binding energy is not distributed homogenously across the interface and it is 
therefore potentially sufficient to design drugs which target only these hotspot 
residues (Hajduk et al., 2005). The recent interest in inhibiting PPIs is reflected 
by several pharmaceutical firms which are now in the process of extending drug 
discovery  programs  aimed  at  identifying  PPI  inhibitors  and  expanding  their 
libraries to account for this class of targets (Mullard, 2012). In the light of this 
new interest for PPI inhibitors, a number of companies have also moved past the 
preclinical stage. Lifitegrast (SAR1118), a small molecular inhibitor for treatment 
of  dry  eye  is  in  phase  III  trials.  It  works  by  reducing  T  cell-mediated 
inflammation,  blocking  the  PPI  between  ICAM-1  and  LFA-1.  Two  anti-cancer 
agents blocking the PPI of p53 and MDM2 are under phase 1b trials (Vassilev et 
al., 2004, Mullard, 2012) and key PPIs inhibiting the function of the pro-survival 
BCL-2 family proteins are in phase-II development as anticancer agents (Mullard, 
2012, Oltersdorf et al., 2005). 
Two main challenges are therefore present in targeting PPIs with small-molecule 
drugs; knowing where to target on the protein interface, and doing so with high 
affinity. For competitive drug binding, the affinity of the protein-drug complex on 
its  own  gives  no  indication  to  its  inhibitory  effect.  Rather,  this  protein-drug 
affinity becomes relevant only when higher than the affinity of wild-type protein-
protein interaction i.e. that which it is competing against. Therefore, knowledge 
of the wild-type protein-protein binding affinities, as presented in Chapter 2, is a 
critical piece of information in competitive inhibitor design. As mentioned above, 
for  small-molecule  drugs  targeting  PPIs,  only  a  small  portion  of  the  protein-
protein interface can be targeted; therefore, knowing where at the interface to do 
so is imperative. Although hotspots are indeed good targets, unappreciated is the 
fact that hotspots can occur at disjointed parts of an interface or within  clusters 
called  hotregions  (Keskin  et  al.,  2005).  Therefore,  whereas  the  presence  of 
hotspots  greatly reduces  the  druggable  search space  of an interface, multiple 
potentially  druggable  sites  are  still  present.  In  Chapter  8,  an  investigation  is 
reported on which hotspot sites are contributing the most towards stability. Such Chapter 1: Introduction 
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investigations should further guide the design of small-molecule drugs targeting 
PPIs. 
1.4.2  Protein Engineering and Protein Drugs 
 
In  the  previous  section  it  was  described  how  knowledge  of  the  affinity  and 
determinants of complex stability for protein-protein interactions, is important 
to  the  design  of  small-molecule  drugs  inhibiting  PPIs.  Here  a  more  direct 
application of the methods developed in this thesis, that of protein engineering 
and  protein  drug  design  is  presented.    Protein  engineering  refers  to  the 
reengineering  of  proteins  to  enhance  the  affinity  of  existing  interactions  or 
develop  new  ones.  In  theory,  the  applications  are  numerous  and  include  the 
rewiring of cellular networks by redesigning specificities; the design of proteins 
mimicking  antigenic  epitopes  for  potent  vaccines  and  the  design  of  protein 
probes for dissection of cellular protein networks and protein drug inhibitors 
(Mandell  and  Kortemme,  2009).  Though  applications  are  still  exploratory  in 
nature, proofs of concept have already started to surface. Recent work in the 
computational design of protein interactions includes the redesign of specificity 
at  a  protein-protein  interface  which  was  applied  to  model  novel  interacting 
DNase-inhibitor  protein  pairs  (Kortemme  et  al.,  2004);  the  use  of  positive 
(affinity  increasing)  and  negative  (affinity  decreasing)  design  strategies  to 
convert a homodimer into a heterodimer (Bolon et al., 2005); the redesign of a 
micromolar affinity human hyperplastic disc protein binding the kinase domain 
of PAK1 (Jha et al., 2010); the design of a high affinity interaction by grafting 
known key residues onto an unrelated protein scaffold  (Liu et al., 2007) and 
more  recently,  (Fleishman  et  al.,  2011)  designed  two  proteins  that  bind  a 
conserved surface patch on the stem of the influenza hemagglutinin (HA) from 
the 1918 H1N1 pandemic virus with low nanomolar affinity.  
The methods mentioned above employ a variety of computational approaches, 
including conformational sampling mechanisms, docking algorithms and scoring 
functions. The latter function should be capable of identifying designs (generally 
through  interface  mutations),  which  increase  the  affinity  of  the  desired 
interaction. In Chapter 4, the design of computational models capable of rank Chapter 1: Introduction 
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ordering mutations on a protein-protein interface according to their change in 
affinity (ΔΔG) is reported upon. The models are benchmarked on two protein 
drugs  where  affinity-increasing  mutations  formed  less  than  5%  of  all  the 
mutations to be tested.  
1.4.3  Off-Rates in Drug design 
 
Traditionally, early stage drug development is characterised by the optimization 
of the binding affinity or its other forms, IC50, or EC50 that calculate the drug 
concentration needed to achieve half-maximal inhibition. This is based on the 
assumption that binding affinity in closed in vitro systems is a good indicator of 
in vivo drug efficacy (Pan et al., 2013). In vivo systems, where the concentration 
of  a  drug-like  ligand  exposed  to  its  target  receptor  is  not  constant,  the  drug 
efficacy  is  no  longer  well  described  by  the  in  vitro  measured  dissociation 
constant. Rather, it depends on the association (kon) and dissociation (koff) rate 
constants (Copeland et al., 2006). The enhancement of the on-rate is limited in 
several ways, which highlights the reduction of the off-rate as the more favoured 
route.  For  example,  the  diffusion-rate  remains  an  upper-bound  restricting 
further  optimisation  of  the  on-rate.  Modulating  receptor  desolvation  and 
molecular  orientation  in  a  systematic  way,  is  not  trivial.  Also,  the  rate  of 
association depends not only on the kon, but also on the concentration of ligand, 
which in turn is affected by multiple steps in vivo;  as absorption, distribution 
and clearance all have an effect on ligand concentration (Copeland et al., 2006). 
Off-rate  optimization  on  the  other  hand,  is  independent  of  such  factors  and 
entirely  dependent  on  the  short-range  interactions  between  the  bound 
monomers  in  question.  Swinney  (2004)  hypothesizes  that  the  most  effective 
drugs  utilize  non-equilibrium  transitions  to  enhance  activity,  and  therefore 
methodologies that measure kinetics (most notably off-rates), non-equilibrium 
binding  events  and  conformational  diversity  might  have  more  potential  than 
previously thought. Similar recent opinions can be found in (Holdgate and Gill, 
2011), where surrogates of the off-rate, i.e. residence time (1/koff) and kinetic 
efficiency  are  proposed  as  additional  optimization  targets  to  improve  drug 
potency.  A case in point is the management of Chronic Obstructive Pulmonary 
Disease (COPD). COPD encompasses a number of pulmonary diseases including Chapter 1: Introduction 
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chronic  bronchitis,  emphysema  and  chronic  obstructive  airways  disease. 
Ipratropium  bromide  (Baigelman  and  Chodosh,  1977)  the  drug  commonly 
administered for the treatment of COPD has now been replaced by Tiotropium 
bromide (Kato et al., 2006) as the drug of choice. Both of the drugs have similar 
drug mechanism of action; namely by binding to the M3 muscarinic receptor, 
leading to a reduction in smooth muscle contraction which in turn opens up the 
airways.  Both  drugs  also  have  similar  structures  and  pharmokinetic  profiles; 
however,  the  duration  of  action  of  Tiotropium  (24hrs)  is  four  times  that  of 
Ipratropium, which can be administered daily. Studies (Disse et al., 1999) show 
that the difference in the duration of action between the drugs lies in their rates 
of  dissociation  from  the  M3  muscarinic  receptor.  Namely  Tiotropium  has  a 
residence time of 34.7 hours compared to 0.26 hours for Ipratropium. 
In contrast to studies on binding affinities and on-rates, work on off-rates is still 
very  limited  (Moal  and  Bates,  2012).  Up  until  this  work,  no  models  for  the 
prediction of changes in off-rate upon mutation were reported. The release of the 
SKEMPI dataset (Moal and Fernandez-Recio, 2012) which contained a set of 713 
off-rate  mutations,  enabled  for  the  first  time  the  modelling  of  off-rates  on  a 
diverse set of PPIs. In chapter 5-8 work is presented on the design of descriptors 
and models for characterising changes in off-rate upon mutation using SKEMPI. 
1.4.4  Changes in Protein-Protein Stability and Disease 
 
In  the  previous  sections,  it  is  argued  that  understanding  and  predicting  the 
stability of protein-protein complexes is at the core of applications related to 
drug design. Presented in this section is, the other side of the spectrum, namely 
that  predicting  the  change  in  stability  of  mutations  on  protein-protein 
interactions, is central to the understanding of disease mutations, such as those 
driving cancer. 
Single Nucleotides polymorphisms (SNPs) are variations in the DNA sequence 
that  have  a  direct  effect  on  our  susceptibility  to  disease  and  response  to 
treatment. For those SNPs that occur in the coding regions, the SNPs can either 
be synonymous (not affecting protein amino-acid sequence), or non-synonymous Chapter 1: Introduction 
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(affecting the protein amino-acid sequence). For the latter category, the SNPs can 
either  by  nonsense,  where  the  protein  amino-acid  sequence  is  truncated,  or 
missense where amino-acid substitutions take place. Nonsense non-synonymous 
(nsSNPs) generally result in a non-functional protein as a result of the truncation 
(Gregersen  et  al.,  2000),  missense  nsSNPS  are  however  more  diverse  and 
depending  on  where  the  variation  occurs,  effect  on  protein  function  can  be 
anything from disease related to indiscernible (Haber and Settleman, 2007).  
A major goal is therefore linking nsSNPs to phenotype through structure and 
function. For example, missense nsSNPs which translate to a mutation at the core 
of  a  protein  generally  destabilizes  the  protein-fold  (Yue  et  al.,  2005). 
Consequently all of the protein’s interactions are lost. A study on nsSNPs on a 
number of protein-protein interactions show that disease causing nsSNPs not 
found at the core of a protein, tend to frequent the interface more than the non-
interacting  surface  (David  et  al.,  2012).  Missense  nsSNPs  resulting  in  surface 
mutations may affect PPIs in a number of ways; they may destabilise existing 
interactions by disrupting favourable intermolecular contacts at the interface, 
affect post-translational-modifications, or even modulate the intrinsic disorder 
of the protein. In some cases it may also lead to the creation of new interactions 
consequently re-wiring the PPI network (Yates and Sternberg, 2013).  
Being  able  to  predict  the  consequence  of  a  mutation  at  a  protein-protein 
interface  is  therefore  vital  to  uncovering  the  mechanism  of  action  of  disease 
causing  nsSNPs.  For  example,  depending  on  its  sign  and  magnitude,  the 
prediction of the ΔΔG may tell us whether the mutation has no effect on the given 
interaction, whether it leads to its loss or whether it helps stabilise a potential 
novel interaction. Models for the prediction of ΔΔGs are designed and presented 
in Chapter 4. 
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1.5  Modelling the Binding Free Energy 
 
1.5.1  The Kinetics of Binding 
 
The derivation of the binding free energy of an interaction may be approached 
from two perspectives; from a kinetic and from a thermodynamic standpoint. 
Take a non-covalent interaction between a receptor R and a ligand L and their 
complex form RL, where [R] and [L] is the concentration of the free molecules 
and [RL] is the concentration of their bound form. Then 
  R L RL        1.1 
Two  processes  exist;  an  association  process  of  the  two  molecules  into  their 
bound form RL; and a dissociation process back to free molecular R and L. The 
rate  at  which  association  or  dissociation  takes  place,  depends  on  the 
concentrations of each molecular species as: 
  rate of association [R][L] on k    1.2 
  rate of dissociation [RL] off k    1.3 
kon and koff represent the intrinsic disposition of R and L to associate or RL to 
dissociate respectively. The rate of change of concentration of R, L and RL is as 
follows: 
  [ ] [L]
[ ] [ ][ ] off on
d R d
k RL k R L
dt dt
     1.4 
  []
[ ][ ] [ ] on off
d RL
k R L k RL
dt
   1.5 
For this system to be in equilibrium (i.e. constant concentrations of R, L and RL), 
the rate of association must equal the rate of dissociation and using equation 1.4 
and 1.5: 
  [ ][ ] [ ] on off k R L k RL    1.6 
  [ ][ ]
[]
off
D
on
k RL
K
k RL
  
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where KD is the dissociation constant that is related to the binding affinity of the 
interaction.  
1.5.2  The Thermodynamics of Binding 
 
A  second  route  towards  characterising  binding  affinity  is  that  based  on  the 
standard free energy of binding (Gilson et al., 1997). The free energy of binding is 
the change in free energy when one receptor and one ligand react to form a 
complex. The free energy of binding can therefore be expressed as 
  ΔG=URL-UL-UR  1.8 
Where URL is the change in free energy of a solution when the complex RL is 
added to the system, and -UL and -UR are the change in free energy of a solution 
when  one  ligand  L,  and  one  receptor  R,  are  removed  from  the  system, 
respectively (Gilson and Zhou, 2007). The chemical potential UP of a protein can 
be expressed as 
 
( ) (r )
2
( )/ 8
ln( )
rpp U W RT
pp
p
u RT e dr
C
 
   
1.9 
where  R  is  the  gas  constant  and  T  the  absolute  temperature,  C p  is  the 
concentration of the protein p, U(rp) is the potential energy of the protein at the 
conformation rp and W(rp) is the solvation energy at the conformation rp (Gilson 
and Zhou, 2007). Substituting equation 1.8 into 1.9 for each species, the free 
energy of binding can be obtained as: 
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1.10 
The system is in equilibrium when the free energy of binding ΔG=0. Therefore 
equation 1.10 becomes 
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Multiplying both sides of equation 1.11 by the standard concentration Co gives Chapter 1: Introduction 
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1.12 
and replacing the concentration in equation 1.10 by the standard concentration 
Co, the standard free energy of binding is 
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1.13 
Substituting equation 1.12 in 1.13 gives 
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and from the kinetics approach and equation 1.7  
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This equation links both the kinetics and the thermodynamics of the binding 
process. 
Equation 1.13 can be decomposed into 
  oo
RL R L RL R L config G U U U W W W T S            1.17 
The  standard  free  energy  of  binding  can  be  decomposed  into  the  enthalpic 
contribution to binding 
o H  and the entropic contribution to binding 
o TS  as 
 
o o o G H T S       1.18 
In  1.17,  RL U and  RL W  are  Boltzmann-average  potentials  for  the  potential 
energy and solvation energy respectively. As seen in equation 1.13, in this form, 
though the integral is taken over all conformations of the species in question, 
only  the  low  energy  contributions  contribute  significantly  to  the  potential. 
o
config TS  represents the change in entropy when the receptor and ligand move 
from the unbound to the bound form, this includes, a loss in translational, and 
rotational entropy, and change in side-chain entropies. The solvation energiesChapter 1: Introduction 
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RL r L W W W  also include an entropic component related to the freedom 
of  water  molecules.  Equation  1.17  forms  the  basis  of  many  binding  affinity 
predictive  models  (see  section  1.5.7),  where  a  number  of  physics-based 
descriptors  representative  of  the  energetic  terms  in  equation  1.17,  are 
calculated. The modelling of the three main components of equation 1.17, the 
potential energy, solvation energy and entropy are discussed below in sections 
1.5.3, 1.5.4, and 1.5.5 respectively. Further, in section 1.5.6, the use of statistical 
potentials  and  the  role  of  miscellaneous  descriptors  for  affinity  are  also 
mentioned. 
1.5.3  Potential Energy 
 
The potential energy of a macromolecule can be thought of as an energy surface, 
which is a function of the atomic, nuclear, and electron positions in space. The 
parameter  space  covering  the  positions  and  motions  of  electrons  for  large 
macromolecules  is  still  too  large  to  be  dealt  with  using  quantum  mechanical 
methods. A more accessible alternative is the use of empirical force-fields, where 
the energy of a system is a function of the nuclear positions only (Leach, 2009). 
In general most of the molecular modelling force-fields describe both the intra- 
and intermolecular forces within a system. An example of which is the potential 
energy function U(rN) shown in Figure 1.3.   
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Figure  1.3:  Representation  of  the  main  energetic  terms  involved  in  a 
molecular  mechanics  force  field  describing  the  potential  energy  of  a 
molecule or system.  
These  are  bond  stretching,  angle  bending,  torsional  terms  and  non-bonded 
interactions. Figure derived  from (Leach, 2009). 
 
The intramolecular forces are described by terms which represent an energetic 
penalty associated with some deviation of bond lengths, angles or rotations from 
a reference state (Leach, 2009). The intermolecular forces may include energetic 
terms such as the Lennard-Jones 12-6 Van der Waals potential and the Columbic 
energy.  The  rij-12  term  in  the  Lennard-Jones  potential  is  based  on  the  Pauli 
exclusion  principle,  which  states  that  no  two  particles  can  occupy  the  same 
region of space. Computationally, this prevents the generation of clashes that 
may arise from two interacting molecules. The rij-6 term is related to correlated 
motions  of  electrons  known  as  London  dispersion  forces,  which  give  rise  to 
spontaneous  dipoles  or  higher  multipoles.  In  turn  these  dipoles  may  induce 
Bond Stretching 
Angle Bending 
Bond Rotation 
(torsion) 
Non-bonded interactions 
(Electrostatic)  Non-bonded interactions 
(van der Waals) Chapter 1: Introduction 
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electrostatic  complementarity,  which  decreases  the  potential  energy  of  the 
system.  The  Coulombic  energy  represents  the  favourable  electrostatic 
complementarity arising from charged particles within an electric field. Charged 
particles  arise  when  electrons  concentrate  around  atoms  with  large 
electronegativities, and deplete elsewhere. This leads to partial atomic charges, 
leading  to  polar  atoms  for  those  atomic  charges  that  are  large  enough  in 
magnitude. The potential describing this non-bonded interaction between partial 
atomic charges is represented by the product of the two-point charges qi and qj, 
separated by a distance rij, where  o   represents the permittivity of free space. All 
terms in the empirical force-field shown in Figure 1.3 are a function of N atoms 
and  their  positions  in  space  (r). Each  term  can  be  computed  separately  and 
therefore varying levels of sophistication can be added as required. 
1.5.4  Solvation Energy 
 
Protein interactions are surrounded by salt-water, which in turn has a significant 
effect on binding. The solvation energy represents the proteins’ interactions with 
water and its effect can be summarized into the dielectric screening of water and 
the  hydrophobic  effect.  Dielectric  screening  results  from  the  different 
permittivities of different mediums. Water has a high dielectric constant, which 
makes the interaction between charged, and polar atoms in water favourable. 
Atoms in areas of low solvent accessibility, those forming part of the interface 
when a complex is bound, have a lower effective dielectric constant. There may 
therefore  be  an energetic  penalty associated with moving polar atoms out  of 
water  and  into  a  binding  site  (Gilson  and  Zhou,  2007).  In  simple  solvation 
screening models, the dielectric constant is directly proportional to the inter-
atomic distance of two particles. Methods such as the Poisson-Boltzmann (PB) 
(Honig et al., 1993), apart from other considerations, account for the fact that the 
solvent  accessibility  surrounding  an  atom,  is  also  a  function  of  the  atoms 
surrounding it. A second effect of water on the formation of protein interactions 
is the tendency of non-polar atoms to be brought together and away from water 
(Kauzmann, 1959, Hildebrand, 1979). This is known as the hydrophobic effect, 
and is a major driving force in protein folding (Lins and Brasseur, 1995, Dill, Chapter 1: Introduction 
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1990) and also an important aspect of protein binding (Tsai et al., 1997). The 
non-polar parts of the protein exposed to water, restricts the movement of water 
molecules resulting in the formation of ordered ‘water cages’. Bringing non-polar 
atoms  from  a  solvent  exposed  site,  to  a  solvent  inaccessible  site  such  as  the 
binding interface, results in an increase in the system entropy that decreases the 
binding free energy (equation 1.18). A common method employed to model the 
hydrophobic effect implicitly, is to calculate the change in the solvent accessible 
area of non-polar atoms upon going from the unbound to the bound state (Chen 
et al., 2004). The addition of surface area terms accounting for the hydrophobic 
effect  in  Poisson-Boltzmann  implicit  solvation  methods  are  known  as  PBSA 
(Sitkoff et al., 1994). Faster approximations to the PBSA also exist such as the 
Generalized Born model with Surface Area (GBSA) (Qiu et al., 1997). 
1.5.5  Configurational and Side-Chain Entropy  
 
The binding free energy of complex formation, as presented in equation 1.18, 
shows  that  complex  formation  may  be  either  enthalpy  or  entropy  driven. 
Therefore, the correct modelling of the potential and solvent energies involved in 
the  binding  process  (ΔH  in  equation  1.18)  still  does  not  give  an  accurate 
estimation of the binding free energy. To do so, the change in entropy (ΔS) of the 
system also has to be characterised. One entropic aspect important for binding is 
the  change  in  entropy  experienced  by  water  molecules  described  by  the 
hydrophobic effect. This is generally accounted for in solvation energy models 
such as those described in the previous section. The formation of a complex also 
involves changes in the configurational (rotational and translational) entropy of 
the  receptor  and  ligand.  In  general  it  is  widely  assumed  that  the  changes  in 
rotational and translational entropy have negligible contribution to the binding 
free energy in aqueous solutions at 1 M standard state (Yu et al., 2001) or that 
they are constant across different interactions. However, it has been shown that 
for  complexes,  which  are  not  tightly  bound,  the  change  in  configurational 
entropy is not the same as that of a tightly bound complex (Chen et al., 2004). 
Upon  binding,  the  side-chains  of  the  receptor  and  ligand  become 
conformationally restricted if they form part of the binding interface. This results Chapter 1: Introduction 
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in a reduction in entropy upon binding. Traditional methods of accounting for 
the change in side-chain entropies make use of rotamer libraries (Dunbrack and 
Cohen, 1997, Chandrasekaran and Ramachandran, 1970, Dunbrack and Karplus, 
1993, Dunbrack and Karplus, 1994) or simply the number of rotatable bonds 
affected upon binding (Finkelstein and Janin, 1989). 
1.5.6  Knowledge-Based-Potentials and Miscellaneous Descriptors 
 
The  approaches  discussed  in  previous  sections,  1.5.3,  1.5.4  and  1.5.5,  in 
modelling the terms of the binding free energy function presented in equation 
1.17,  are  derived  from  the  underlying  physical  processes  driving  complex 
formation. An alternative method is to use knowledge-based potentials. In this 
approach, rather than enumerating all potential physical processes responsible 
for complex formation and affinity, the relative positions of atoms or residues 
are used as an indication of the validity (in the case of protein folding or docking) 
or strength (in the case of binding affinity prediction) of the complex in question.  
The central hypothesis made by knowledge-based potentials (also referred to as 
statistical potentials throughout this work), is that the frequency of two specific 
atoms/residues  at  a  specific  distance  is  an  indication  of  how  favourable  the 
contact  between  the  pair  of  atoms/residues  is.  More  frequently  occurring 
contacts are considered to be favourable and likely the result of capturing some 
underlying physical process.  Chapter 1: Introduction 
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Figure 1.4: Example of Atom-Types and Contact Frequency-Distance plots 
of a typical knowledge-based potential.  
Top of figure shows the atoms considered in the statistical potential, and bottom 
of figure shows the potentials (frequency-distance plots) generated for three of 
the  contacts.  These  include  a  backbone-backbone  contact  potential  (1-1),  a 
backbone-side-chain contact potential (7-4) and a side-chain-side-chain contact 
potential (8-6). The figures are taken from the work of (Su et al., 2009). 
 
For example, the contact frequency-distance plots of the Potential-Mean-Force 
(PMF)  potential  from  Su  et  al.  (2009),  show  functions  very  similar  to  the 
Lennard-Jones  potential  (See  Figure  1.4).  This  is  characterised  by  strong 
repulsions at very short distances, followed by a global minimum on increasing 
distance, which approaches zero at larger distances. An important aspect which 
affects the success of statistical potentials, is the reference state taken. Namely, 
the reference state must account for frequency and volume, and many potentials 
do in fact differ by their reference state (Zhang et al., 2004, Su et al., 2009, Shen 
and Sali, 2006). Besides differences in the reference state, different statistical 
potentials include; atom-based  and coarse-grained (Lu et al., 2008, Rykunov and 
Fiser, 2010) (residue level through centroid or Cα, Cβ distances) potentials; pair 
potentials and multi-body potentials (Feng et al., 2010); those derived on protein 
structures for protein folding and stability (Zhou and Skolnick, 2011), and those Chapter 1: Introduction 
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derived on protein-protein complexes for docking and binding affinity prediction 
(Liu and Vakser, 2011). One drawback of knowledge-based potentials is that they 
do not  account for solvation  or entropy terms and only recently for protein-
ligand  interactions  has  this  consideration  been  attempted  (Huang  and  Zou, 
2010).  Therefore,  one  way  of  thinking  about  statistical  potentials  in  binding 
affinity  prediction  is  as  an  alternative  or  addition  to  terms  related  to  the 
potential energy. 
Another  class  of  descriptors  termed  as  ‘miscellaneous’  descriptors,  are  again 
those that do not model a particular physical process, but their presence may 
capture some underlying physical property that favours complex stability. These 
include;  secondary  structure  elements,  such  as  the  proportion  of  interface 
resides which are in alpha helices, or beta sheets; geometrical properties such as 
interface planarity, volume of empty space at the interface and interface surface 
complementarity. With this in mind, the inclusion of such descriptors in binding 
affinity models is primarily exploratory in nature and must be interpreted with 
caution. 
1.5.7  Binding Affinity Prediction (BAP) Methods 
 
Between  1989  and  2011,  19  publications  have  specifically  dealt  with  the 
prediction of binding affinities for protein-protein complex formation. Most of 
these  Binding  Affinity  Prediction  (BAP)  models  contain  empirical  functions 
where the terms include relevant enthalpic and entropic contributions to binding 
(as the terms described in sections 1.5.3, 1.5.4 and 1.5.5); most commonly, terms 
for  the  contribution  of  electrostatics,  hydrophobic  burial,  hydrogen  bonding, 
side-chain entropy etc. (Novotny et al., 1989, Horton and Lewis, 1992, Krystek et 
al., 1993, Vajda et al., 1994, Nauchitel et al., 1995, Xu et al., 1997, Weng et al., 
1997,  Noskov  and  Lim,  2001,  Ma  et  al.,  2002,  Jiang  et  al.,  2005,  Audie  and 
Scarlata, 2007, Bougouffa and Warwicker, 2008, Bai et al., 2011). The second 
category of BAP models is model's that consist of statistical potentials (Zhang et 
al., 1997, Jiang et al., 2002, Liu et al., 2004, Su et al., 2009). Here the relative 
positions of atoms or residues observed in experimental structures are used to Chapter 1: Introduction 
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infer a potential of mean force that is then correlated to binding affinity (see 
section 1.5.6). 
On analysis of the aforementioned BAP models, the following limitations were 
identified: 
I.  Models  restricted  to  complexes  for  which  the  component  parts 
undergo little to no conformational changes upon complex formation. 
II.  Assumed  that  complexes  and  component  parts  exist  as  static 
structures (assumed all proteins are rigid entities)  
III.  Routine use of Linear Regression. 
 
1.5.7.1  Models Restricted to Proteins that Undergo Little to No Conformational 
Changes Upon Complex Formation. 
 
Most of the BAP models are designed under the assumption that minimal to no 
conformational  changes  take  place  upon  complex  formation.  To  satisfy  this 
assumption, the complexes used to test the models are specifically selected to be 
rigid-body complexes. The descriptor calculations therefore generally take the 
form of:  
  Complex - (ReceptorBound + LigandBound)  1.19 
where  the  monomers  are  assumed  to  be  pre-organised  in  their  bound 
conformation when in their free state. Moreover, up until the work of Liu et al. 
(2004),  careful  analysis  of  the  complexes  used  for  training  and  testing  were 
limited to protease-inhibitor pairs (Krystek et al., 1993, Nauchitel et al., 1995, 
Vajda et al., 1994, Wallqvist et al., 1995, Zhang et al., 1997) with the addition of a 
few  other  high-affinity  rigid  complexes  such  as  such  as  Barnase-barstar,  the 
insulin dimer, the α and β chains of deoxyhaemoglobin and lysozyme-antibody 
complexes (Ma et al., 2002, Horton and Lewis, 1992, Audie and Scarlata, 2007, 
Bougouffa and Warwicker, 2008, Jiang et al., 2002, Weng et al., 1997, Xu et al., 
1997).  For  some  of  these  models,  the  correlation  with  experimental  binding 
affinities  is  exceptionally  high.  However,  as  seen  from  the  restrictions  on Chapter 1: Introduction 
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conformational changes and on the diversity of structures used, the models are 
highly  biased,  and  the  final  correlation  coefficients  should  be  treated  with 
caution. This bias was confirmed in the work of (Kastritis and Bonvin, 2010; 
Kastritis  et  al.,  2011)  where  the  top  performing  BAP  energy  functions  were 
tested on two recent benchmark datasets, with no restrictions on conformational 
changes. Correlations with experimental binding affinities were only as high as 
0.53 and as low as 0.17 (Kastritis and Bonvin, 2010; Kastritis et al., 2011). 
After the introduction of a larger (ranging from 52 to 86 complex structures) and 
a more diverse set structures by Liu et al. (2004), subsequent work on BAP was 
characterised by less accurate predictive models. Moreover, the bias was still 
towards  rigid  structures  and  conformational  changes  were  never  explicitly 
accounted for. It is also worth to note, that in a recent affinity benchmark dataset 
with 144 protein-protein complexes (Kastritis et al., 2011), when considering 
complexes with limited conformational changes (rmsd <1 Å), a ∆G prediction 
scheme that only uses the interface area achieves performance similar to more 
elaborate empirical models. 
1.5.7.2  Conformational Flexibility  
 
Proteins, and even protein complexes, do not exist as static structures but as an 
ensemble of conformations. As shown in equation 1.13, the binding free energy 
of  a  protein  complex  depends  on  the  Boltzmann  weighted  average  of  the 
energies  of  the  conformational  states  accessible  by  the  complex,  and  those 
accessible by the free monomers.  With this in mind, none of the BAP models 
mentioned above (with one exception (Vajda et al., 1994)) explicitly account for 
this. Rather all energetic calculations are calculated on a single static structure. 
In  the  case  of  the  work  of  (Vajda  et  al.,  1994),  the  static  restriction  is  not 
employed. However, flexibility is still only accounted for the ligands, which in 
this  case  are flexible  peptides  binding  an  MHC receptor. For these cases, the 
authors also show that ligand flexibility contributes 30-50% of the free energy 
change.  A  recent  study  (Yang  et  al.,  2009)  shows  how  the  inclusion  of  an 
ensemble  of  protein-ligand  conformations,  obtained  from  MD  simulations, 
improves  the  prediction  accuracy  of  affinity  scoring  functions.  Though Chapter 1: Introduction 
41 
 
promising,  this  work  is  again  limited  to  ligand  flexibility,  which  has  a 
significantly lower conformational space than the two components of a binary 
protein complex.  
1.5.7.3  Routine use of Linear Regression 
 
The  diversity  in  macromolecular  interactions  and  their  structural  properties 
(Nooren and Thornton, 2003) suggests that an energetic contribution dominant 
in a given interaction is not necessarily the dominant contribution in another. 
For example it is known that protein-protein interfaces tend to be hydrophobic 
(Young et al., 1994, Chothia and Janin, 1975) and planar (Baker and Der, 2013). 
However,  hydrophilic  interfaces  are  also  common  (Ben-Naim,  2006)  and 
interfaces can also be protruding (Yura and Hayward, 2009). Moreover,  Cho et 
al. (2006) show that there are specific interaction types based on the functional 
category  of  the  protein  complex,  and  such  interaction  types  are  conserved 
through  the  common  binding  mechanism,  rather  than  through  sequence  or 
structure conservation. Effectively, this indicates that generalizations concerning 
the  determinants  of  protein-protein  binding  affinity  may  be  limited  in  the 
context of a large and diverse dataset of protein complex families. Hence, a model 
such as Linear Regression (LR), which can only exploit globally well-rounded 
descriptors, might not be adept for a set of diverse complexes, such as the one 
used in this work. 
 
All BAP models developed until the work reported in this thesis (those reported 
in  section  1.5.7),  that  are  not  statistical  potentials,  use  LR  to  combine  the 
energetic factors deemed responsible for complex affinity. Effectively, LR seeks a 
set of descriptors which best describe the dataset as a whole, which means that 
certain  intricacies  of  a  dataset,  perhaps  represented  by  a  particular  set  of 
descriptors  that  are  each  specific  to  different  cases,  are  overridden  by 
descriptors which achieve higher overall, but limited, correlations. For example, 
electrostatics  is  a  major  driving  force  for  small  interface  formation  whereas 
hydrophobic burial tends to be more significant in larger interface formation 
(Sheinerman and Honig, 2002). Hence, for a dataset where small interfaces are 
underrepresented the effect of electrostatics may be underestimated as opposed Chapter 1: Introduction 
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to the hydrophobic burial effect. Namely, as datasets become diverse, LR is not a 
sufficient model to represent such diversity. Rather, feature space-partitioning 
methods, which can encompass logical reasoning such as: ‘if interface is small 
use these descriptors, if the interface is larger use these other descriptors’, is 
more  appropriate;  these  models  are  able  to  subset  the  feature  space  so  that 
different features  can contribute  in different situations. The  topic of machine 
learning is detailed the following section 1.6. 
1.5.8  Hotspot Prediction 
 
The binding free energy of a complex may also be understood through alanine 
scanning of residues at its interface. From such scans, it is understood that not all 
interface  residues  have  marked  effects  on  binding.  Rather,  only  a  subset  of 
residues termed ‘hotspots’ contribute significantly to the binding energy of the 
complex (Clackson and Wells, 1995, Bogan and Thorn, 1998). Traditionally, a 
residue is a hotspot, if upon its substitution into alanine, is causes a reduction in 
binding  free  energy  of  2kcal/mol  or  higher.  Analysis  on  protein-protein 
interfaces and hotspot residues has shown that: hotspots tend to occur in regions 
of low solvent accessibility (Bogan and Thorn, 1998); Tyr, Trp and Arg are the 
most frequent hotspots (Ma and Nussinov, 2007, Bogan and Thorn, 1998); and 
hotspot tend to cluster into densely packed regions known as hotregions (Keskin 
et  al.,  2005).  As  mentioned  in  section  1.4.1,  the  major  attraction  of  hotspot 
residues is that they are crucial for targeting of protein-protein interfaces with 
small drug-like molecules (Fry, 2012, Thangudu et al., 2012, Arkin and Wells, 
2004).  This  has  led  to  the  development  of  several  computational  hotspot 
prediction algorithms (Kortemme and Baker, 2002, Cho et al., 2009, Lise et al., 
2009, Lise et al., 2011, Tuncbag et al., 2010, Tuncbag et al., 2009, Xia et al., 2010, 
Zhu  and  Mitchell,  2011,  Grosdidier  and  Fernandez-Recio,  2012,  Morrow  and 
Zhang, 2012, Wang et al., 2012). The predictors generally use a combination of 
solvent  accessibility  and  physiochemical  descriptors,  which  are  then  fed  into 
machine  learning  algorithms  trained on  experimental datasets  such as  ASEdb 
(Bogan and Thorn, 1998)and BID (Fischer et al., 2003). For example, Robetta 
(Kortemme and Baker, 2002) uses an empirical energy function using potential, 
solvation and entropic energy terms. These include, the Lennard-Jones potential, Chapter 1: Introduction 
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orientation dependant hydrogen bonding, shape complimentarity and an implicit 
solvation model. KFC2 (Zhu and Mitchell, 2011) consists of two support vector 
machine models (KFC2a and KFC2b). Besides standard energy terms such as van 
der  Waals  terms  and  hydrogen  bonding,  the  solvent  accessibility  and  local 
flexibility  surrounding  the  target  residue,  were  also  included  as  features. 
Hotpoint (Tuncbag et al., 2010) takes a more efficient approach by basing the 
hotspot prediction only on solvent accessibility and a pair potential. The authors 
claim that even with such minimal features, the method still outperforms Robetta 
and KFC2. One major limitation of the aforementioned algorithms is that they 
have been trained and tested on very limited alanine scanning databases, namely 
the ASEdb (Thorn and Bogan 2001) and BID (Fischer, Arunachalam et al. 2003). 
The shortcoming of these datasets as benchmarks has been highlighted in (Xia, 
Zhao et al. 2010; Moal and Fernandez-Recio 2012).  
In Chapter 5, two hotspot prediction algorithms (RFSpot and RFSpot_KFC2) are 
designed and their performance compared to a number of hotspot predictors. 
The hotspot predictors are then used in scheme which involves alanine scanning 
for the prediction of off-rate changes upon mutation, as described in Chapter 6. 
1.6  Machine Learning 
 
Machine  Learning  (ML)  is  a  subfield  of  computer  science  that  deals  with 
frameworks  for  identifying  and  exploiting  patterns  in  data  (Bishop,  2007). 
Nowadays, in all its forms, ML has become an enabling technology in a number of 
fields and industries, and even if it is not immediately obvious, your first guess 
should be that at any moment, you are making use of something where ML has 
been implemented in. This includes machine vision algorithms for your camera’s 
face recognition feature (Turk and Pentland, 1991); your e-mail spam filter and 
virus  software  on  your  computer  (Bishop,  2007);  or  even  your  movie 
recommendations on Netflix (Ricci et al., 2011). The search of patterns from data 
is  neither  a  novel  idea  nor  limited  to  artificial  systems.  Rather,  throughout 
history, most of what we know today about the world around us, is based on 
observers uncovering regularities and patterns in some physical phenomena. For 
example, Johannes Kepler only developed the empirical laws of planetary motion Chapter 1: Introduction 
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by discovering consistencies in the astronomical observations of Tycho Brahe in 
the 16th century. Pattern recognition (not necessarily learnt recognition) is an 
inherent  characteristic  of  even  the  simplest  forms  of  living  organisms  (Bray, 
2009).  In  addition,  associative  learning  is  one  of  the  main  characteristics  of 
organisms  with  nervous  systems  and  evidence  also  shows  that  organisms 
without such a dedicated system are capable of advanced learning behaviour, 
such as the anticipation of environmental stimuli (Mitchell et al., 2009). The first 
computational learning algorithms, most commonly, Artificial Neural Networks 
(ANNs), (the earliest example of which being the perceptron (Rosenblatt, 1958)), 
are  in  fact  inspired  from  the  human’s  central  nervous  systems.  ANNs  use  a 
number  of  artificial  neurons  connected  together  to  learn  the  appropriate 
response from a given input pattern. ANNs and other similar supervised machine 
learning algorithms are concerned with the automatic discovery of regularities in 
data using computer algorithms (Bishop, 2007). Their aim is to make predictions 
(apply the appropriate response) on some unseen data based on the regularities 
they have discovered and based on the comparison of these regularities to those 
observed in the new data. 
Setting up a problem in a ML framework, for instance that of supervised learning, 
invariably  requires  three  main  elements;  a  training  dataset  of  target  output 
values,  a  set  of  input  features  and  a  learning  algorithm.  The  aim  is  to  make 
predictions on some unseen data after having learnt a model from the training 
dataset. The model effectively learns a mapping between the input features and 
the target output values. Once this mapping is learnt, the model can be invoked 
to make new predictions on input features calculated on  data with unknown 
target  output  values.  Apart  from  supervised  learning,  other  ML  frameworks, 
which are not necessarily distinct from each other, include unsupervised learning 
which involves the clustering of data into distinct regions without target values 
to  learn  on;  Anomaly  detection  (both  supervised  and  unsupervised)  which 
involves the identification of irregularities which do not conform to the expected 
pattern  of  data  and  Reinforcement  Learning  where  an  optimal  sequence  of 
decisions are to be made in an environment which is largely unknown. All ML Chapter 1: Introduction 
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methods  implemented  in  this  thesis  are  either  supervised  classification  or 
regression methods. 
1.6.1  Machine Learning in this Thesis 
 
The ML framework is used consistently throughout this thesis for modelling the 
stability of protein-protein complexes at various levels. This includes wild-type 
binding affinity (ΔG) prediction, ΔΔG and hotspot prediction; and Δkoff prediction. 
It is important to highlight that highly ML specific investigations are beyond the 
scope of this thesis. For example, there is no motivation to compare and contrast 
different learning algorithms for the same problem. The general belief employed 
is that the largest gains in prediction accuracy are best made with better feature 
design  and  careful  analysis  of  the  dataset.  Consequently,  in  seeking  better 
predictions,  an  exhaustive  evaluation  of  a  number  of  learning  algorithms  or 
parameters in hope of increasing accuracy, is not employed. With this in mind, a 
conscious effort  is  made  throughout, firstly to  validate  the  choice of learning 
algorithms in relation to the datasets and features available and secondly, not to 
use machine learning in a black-box fashion. Figure 1.5 shows the dependencies 
between different elements of a supervised machine-learning framework. These 
dependencies are not an exhaustive list, but rather highlight those dependencies 
that are given careful consideration in this work. These include dependencies 
considered prior to the learning phase, and those discovered subsequent to it 
upon analysis of the results. 
1.6.2  Dependencies in a Supervised Machine Learning Framework 
 
The dataset is the main source of training and benchmarking and its biases and 
diversity have a direct effect on both the choice of learning model and features 
employed. Bias in the context of this work is not limited to a class distribution 
bias  (commonly  referred  to  as  dataset  imbalance).  The  datasets  used  in  this 
thesis (see Methods section 2.1) contain PPIs, which in turn come in many forms; 
different  structural,  physiochemical  and  conformational  properties  (Moal  and 
Fernandez-Recio,  2012,  Kastritis  et  al.,  2011).  A  dataset  which  is  not  a 
representative sample of this diversity is therefore, also biased. For example, in Chapter 1: Introduction 
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section 1.5.7.1 it is shown that previous binding affinity prediction (BAP) models 
use datasets without conformational and complex-family diversity. In this case, 
simple learning algorithms such as linear regression are sufficient to produce 
accurate results (‘Dataset->Choice of Learner’ in Figure 1.5). 
 
Figure 1.5: Dependencies in a supervised machine learning framework.  
White boxes highlight dependencies that must be considered prior to learning; 
blue  boxes  highlight  dependencies  affecting  the  interpretation  of  results 
subsequent to learning. Though not an exhaustive list of dependencies, the ones 
shown  here  are  those  that  are  discussed  in  this  thesis.  Some  of  these 
dependencies  were  considered  pre-emptively;  for  example  when  selecting 
descriptors  or  learning  algorithms,  whereas  others  were  discovered  upon 
analysis  of  the  results;  for  example  when  assessing  the  results  of  feature 
importance measures for different learning algorithms. 
 
 The BAP model developed in Chapter 3 made use of a larger and more diverse 
set  of  structures.  To account  for  this  diversity,  new  descriptors  (for  example 
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those accounting for unbound to bound transitions) and non-linear ML models 
were introduced (‘Dataset->Choice  of Learner/ Choice  of Features’   in  Figure 
1.5). The choice of the learning algorithm should be an informed one taking into 
consideration both the domain knowledge of the problem at hand and the nature 
of the features available for learning (‘Choice of Features/Domain Knowledge-
>Choice  of  Learner’  in  Figure  1.5).  For  instance,  features  also  come  in  many 
forms, particularly those for modelling complex stability (See sections 1.5 and 
2.2).  Some  might  be  good  global  estimators,  whereas  others  might  only  hold 
predictive value within certain ranges. For the latter, a learning algorithm like 
linear regression cannot exploit these locally predictive regions. Therefore, it is 
imperative  that  the  choice  of  learner  matches  this  information.  Domain 
knowledge refers to the prior beliefs we have about the problem at hand. This in 
turn again affects the learner choice.  
An informed interpretation of the results and analysis (through benchmarking 
and descriptor importance) must also consider the relevant dependencies (see 
Figure 1.5). For example in Chapter 3 it is observed that descriptors identified as 
being important for modelling affinity are not only a function of the dataset at 
hand, but also a function of the learning algorithm employed and other features 
available to the learning algorithm. Moreover, in in section 7.3.3 it is shown that 
certain descriptors are highly important to the characterization of certain off-
rate  mutations  in  the  dataset  but  not  for  others.  Therefore,  global  feature 
importance measures are not necessarily the appropriate choice, particularly in 
diverse datasets. In summary, this shows that any tentative conclusions on the 
importance  of a  particular descriptor must also be  made  in light of all of its 
dependencies.  
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1.7  Outline of Thesis 
 
1.7.1  Motivations Behind this Work 
 
This work deals directly with computational experiments investigating protein-
protein complex stability at various levels. These include prediction models for 
binding  affinity,  dissociation  rates  and  hotspots.  Characterising  the  effect  of 
mutations on complex stability forms a major part of this thesis, and emphasis is 
given on the detection of rare mutations that can further enhance the stability of 
protein-protein interactions. The understanding is that being able to do so, is 
central to future computational drug design algorithms (See section 1.4). Though 
ultimately,  the  central  motivation  is  to  design  accurate  predictive  models, 
parallel  to  this,  an  equal  goal  is  that  of  uncovering  determinants  of  complex 
stability. 
The intention is that this thesis asks the questions which have not been asked 
before, or for those which have been, improvements are made which directly 
address the deficiencies of current methods. In some instances, this work might 
take unconventional approaches, be it the use of the uncommon Radial Basis 
Function learner in Chapter 3; the position-specific models designed in Chapter 
4; or even, the design of descriptors derived from hotspots for characterising 
changes in dissociation rates in Chapter 6. The thesis attempts to answer most of 
the questions that come to mind, but for those that remain answered, the hope is 
that the questions raised are worthy of further investigation. The aim for this 
thesis was also to be in line with what we do know about complex stability. For 
instance,  building  a  large  and  diverse  set  of  descriptors  (not  limited  to 
biophysical  descriptors)  and  using  them  for  characterizing  the  stability  of 
protein-protein  interactions  may  seem  as  a  naïve  or  ungrounded  pursuit  to 
some. On the other hand what best way forward than to make use of, otherwise 
forgotten, descriptors that have been carefully designed by other researchers in 
the field in these last years. With this in mind, this methodology is not to be 
confused with one where a ‘bunch’ of descriptors are thrown blindly, in hope of 
finding something that correlates with our target. Firstly, the works of authors Chapter 1: Introduction 
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that do so are reported for their deficiencies, and all models developed in this 
work  are  analysed  for  their  biophysical  plausibility.  Recent  publications 
(Kastritis and Bonvin, 2013) also put forward the argument that a simple model 
of buried surface area or simple biophysical models can still achieve reasonable 
correlations  for  binding  affinity.  The  implication  being,  usually  explicitly 
mentioned, that more complex binding affinity models (where complexity refers 
to large sets of descriptors and machine learning models), improve very little. 
These arguments I feel, fail to make a distinction between good correlation and 
high correlation. For uncovering a relationship, good correlations are acceptable, 
as  they  are  for  proofs  of  concept.  A  predictive  algorithm  with  reasonable 
correlation  is  however  unusable  in  most  practical  situations.  Any  predictive 
algorithm designed in this work, and others’, remain purely explorative in nature 
until  significantly  high  accuracies  are  achieved.  Only  until  then  may  such 
algorithms become standard protocol. Predictive performance is thus one of the 
major  motivations  behind  this  work.  It  should  be  noted  that  the  algorithms 
designed here are part of an on-going pipeline of algorithms that came before 
and will come after. Attention is therefore given to highlighting clearly where the 
algorithms  fail,  which  structures  we  still  cannot  characterise  well,  which 
mutations are harder to predict and how we might improve. In a similar vein of 
reasoning,  all  publications  resulting  from  these  investigations  contain  model 
prediction  lists  for  direct  comparison  analysis  by  other  researchers.  Careful 
benchmarking is also employed, be it with the use of alternative cross-validation 
folds, or diverse and validated datasets.  
1.7.2  Chapter Summaries and Themes 
 
Chapter 2: The datasets, stability descriptors and machine learning models used 
throughout this thesis are summarized and described here. Following this, the 
hotspot prediction algorithm developed in this work (RFSpot), is described and 
benchmarked against other hotspot predictor algorithms. In addition a number 
of descriptors generated using the predicted hotspots are presented. These are 
termed as hotspot descriptors and subsequently used for the prediction of off-
rate changes upon mutation in Chapters 6-8. Chapter 1: Introduction 
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Chapter 3:  In  this  chapter  the  prediction  of  wild-type  binding  affinities  on  a 
diverse set of protein-protein interactions is investigated. In contrast to previous 
related  work,  the  structures  cover  a  wide  range  of  complex  families  and 
conformational  changes  upon  complex  formation;  thereby  addressing  the 
limitations associated with the BAP methods up until this work. Moreover, non-
linear  machine  learning  algorithms  were  used  for  modelling  and  the  use  of 
unbound structures and conformational ensembles was also introduced into the 
descriptor  calculations.  A  number  of  molecular  descriptors  were  calculated 
which  include,  biophysical,  statistical  and  miscellaneous  descriptors.  The 
prediction model (a consensus of four machine learning algorithms) achieves a 
cross-validated  correlation  coefficient  with  experimental  affinities  of  R=0.77. 
Significant  reduction  in  accuracy  is  observed  for  complexes  undergoing 
conformational changes and those for which their experimental affinities have 
not been corroborated.  
Chapter 4:  In  this  chapter  the  prediction  of  changes  in  binding  affinity  upon 
mutation (ΔΔG) is studied. The models are benchmarked in CAPRI round 26 on a 
blind set of circa 1800 mutations on two different protein drugs each binding the 
stem of the flu virus hemagglutinin. For the first round, a ΔΔG predictor based on 
similar  principles  as  those  presented  in  Chapter  3  are  used.  For  the  second 
round, a ΔΔG model that exploits correlations between similar mutations at a 
given  mutation  site,  is  designed.  For  both  rounds,  the  predictions  compared 
favourable to other competing groups, and also ranked as the top predictor for 
one of the protein drug targets. The difficulty in such scenarios, is that datasets 
available for training are mostly dominated with alanine mutations, which tend 
to be neutral or destabilizing (affinity decreasing). On the other hand, stabilizing 
mutations (affinity increasing) are rarely alanine mutations and only form ~2-
5% of all the 1800 mutations considered. In turn, the detection of these affinity 
increasing mutations is central for high affinity drug binding. 
Chapter  5:  In  this  chapter,  two  hotspot  prediction  algorithms  (RFSpot  and 
RFSpot_KFC2)  are  designed  and  benchmarked  against  a  number  of  hotspots 
predictors. The  results confirm the  importance  of  having  solvent-accessibility 
related descriptors and more comprehensive ΔΔG datasets. Chapter 1: Introduction 
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Chapter 6: This chapter approaches complex stability from a more specific facet, 
that of the dissociation rate. The question here shifts to that of understanding 
what makes a complex remain bound once the complex has formed. A dataset of 
50  complexes  with  713  mutations  for  which  their  Δkoff  was  measured 
experimentally was extracted from the SKEMPI database (Moal and Fernandez-
Recio, 2012). Computational alanine scans, using a number of hotspot prediction 
algorithms,  were  performed  on  the  wild-type  and  mutated  interfaces.  The 
hotspots  predicted from these scans are used to  design  a  number of hotspot 
related  descriptors,  which  are  correlated  with  Δkoff..  When  compared  to 
molecular  descriptors,  the  hotspot  descriptors  achieve  consistently  higher 
correlations. The ‘averaging out effect’ of energetics across an interface when 
using molecular descriptors and the synergy of hotspot residues are proposed as 
the two main contributors to the success of the hotspot descriptors.   
Chapter  7:  In  the  previous  chapter,  hotspot  descriptors  are  introduced  and 
benchmarked against molecular descriptors, as estimators of Δkoff. This chapter 
goes one step further and feeds both sets of hotspot and molecular descriptors 
into  ML  regression  and  classification  algorithms.  Besides  the  numerical 
prediction of Δkoff, emphasis is also put on the detection of the rare, residence 
time increasing (koff increasing) mutations which amount to < 5% of the off-rate 
dataset. ML models with hotspot descriptors show consistently better predictive 
performance  both  in  the  numerical  prediction  and  for  the  detection  of  koff 
increasing mutations. In order to see whether certain classes of mutations are 
harder  to  characterise,  the  713  off-rate  mutation  dataset  is  subset  into  data 
regions,  and  results  analysed  separately  for  each.  Predictions  for  mutations 
occurring at the rim region of protein complex interfaces for example are less 
accurate to those at the core of region of interfaces. The relationships between 
different  descriptors  and  different  regions  of  the  dataset  are  studied  using 
descriptor-data  region  networks.  These  networks  uncovered  highly  specific 
relationships  between  descriptors  and  certain  classes  of  mutations,  and 
conversely, descriptors that are broadly predictive over a number of mutation 
classes. The effects of conformational changes and alternative cross-validation 
routines, on predictive accuracy, are also reported. Chapter 1: Introduction 
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Chapter 8: In chapters 7 and 8 it is shown how counting the energies of hotspot 
energies, pre- and post-mutation provides an accurate description of changes in 
koff. Here, the focus shifts towards understanding to which extent the off-rate of a 
complex is affected by the distribution of hotspots. For example, studies have 
shown that hotspots are likely to occur at the core regions of an interface and 
tend to cluster into hotregions. Though these two properties are observed on 
protein-protein  interfaces,  their  link  to  stability  is  only  implicated.  The  main 
motivation  behind  this  chapter  is  to  uncover  advantages,  if  any,  of  hotspot 
distributional properties, by assessing the effect they have on the dissociation 
rate. As a result of the investigations, it is found that hotspots in the core region 
are solely critical for the stability of large complexes. For small complexes, rim 
hotspots  become  as  important  and  their  role  is  no  longer  secondary.  The 
intention of introducing distribution into the equation of stability is to be able to 
make  more  informed  decisions  on  ‘where’  to  mutate  when  designing 
computational interactions.  
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Chapter 2 
2 Materials & Methods 
 
In this chapter, the datasets (section 2.1), stability descriptors (section 2.2) and 
machine  learning  models  (section  0)  used  in  this  thesis  are  presented.  The 
performance  measures  applied  for  the  assessment  of  model  predictions  and 
descriptors are also detailed in section 2.4.  
2.1  Datasets 
 
2.1.1  Dataset for Binding Affinity (ΔG)  
 
The  structures  and  experimental  affinities  for  the  recently  published  binding 
affinity  benchmark  (Kastritis  et  al.,  2011)  were  used  as  the  main  source  for 
training and testing the BAP described in Chapter 3. As listed in the appendices 
Table 10.2, this dataset consists of a total of 144 complex structures for which 
the  crystal  structures  of  each  complex, Chapter 2: Methods 
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along with each of its unbound components at high resolution (< 3.25Å), are 
available. To avoid redundancy and the potential for over training, complexes 
with high sequence identity are not included; this facilitates the use of cross-
validation routines such as leave-one-out for benchmarking test predictions. A 
key aspect of this dataset, which improves upon previous datasets used in BAP, is 
its diversity: 
  Several  receptor/ligand  protein-binding  partners  undergo  significant 
conformational change upon complex formation, of which some exhibit 
disorder to order transitions.  
  Complexes,  within  different  protein  families,  cover  a  wide  range  of 
functions;  a  total  of  19  Antibody/Antigen,  40  Enzyme/Inhibitor,  21 
Enzyme-regulatory/accessory chains, 17 G-protein binding proteins, 13 
Receptor containing complexes and 34 Miscellaneous. 
  Wide  range  of  affinities.  A  total  of  20  high  affinity  (KD  <  10-10M),  90 
medium affinity (10-10M <KD<10-6M) and 34 low affinity (KD > 10-6M). 
2.1.1.1  Validated Set 
 
The  affinities  available  for  the  protein  complexes  in  the  binding  affinity 
benchmark come from a number of experimental methods including isothermal 
titration calorimetry, surface plasmon resonance, stopped flow fluorimetry and 
other  spectroscopic  techniques.  For  a  number  of  complexes,  more  than  one 
group measured the KD values or an additional experimental technique was used. 
For such measures that are within 1 kcal mol-1 of each other, the complexes were 
said to form part of the ‘validated set’. This high-quality subset is used to assess 
to which extent experimental error in affinities affects the model predictions. 
One should note that in this validate set the diversity in affinity and complex 
families  is  still  present.  Affinities  range  between  13  kcal  mol-1  and  complex 
families include; 3 antibody/antigen complexes, 16 enzyme/inhibitor complexes, 
5  enzyme  substrate  complexes,  5  enzyme  complexes,  8  G-protein  binding 
complexes,  7  receptor-ligand  complexes  and  a  remaining  13  miscellaneous 
complexes. Chapter 2: Methods 
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2.1.2  Dataset for Off-Rate (Δkoff) 
 
The structures and experimental off-rates from the SKEMPI database (Moal and 
Fernandez-Recio,  2012)  were  used  as  the  main  source  of  benchmarking 
descriptors, training and testing models for Δkoff  prediction in Chapter 6, 7 and 8. 
Wild-type and mutant koff values were transformed into Δlog10(koff) using  
  Δlog10(koff) = log10(koff)Mut - log10(koff)WT  2.1 
 
Where  the  value  range  is,  -8.6  <  Δlog10(koff)    <  6.5  with  a  mean  of  0.7 
(destabilizing). The 713 off-rate mutations from SKEMPI are also subdivided into 
the following data regions for analysis: Single-Point (SP) alanine mutations, 361; 
SP non-alanine mutations, 155; SP mutations, 516; Multi-Point (MP) mutations, 
197; SP mutations to polar (Q, N, H, S, T, Y, C, M, W) residues, 39; SP mutations to 
hydrophobic (A, I, L, F, V, P, G) residues, 309; SP mutations to charged (R, K, D, E) 
residues,  68;  mutations  exclusively  on  core  regions,  272;  rim  regions,  79; 
support regions, 114; mutations on complexes of Large-Interface-Area (>1600 
Å2) , 355 and Small-Interface-Area (<1600 Å2), 358. The off-rate dataset is listed 
in appendices Table 10.3. 
An assessment of how severely variations in experimental temperature, ionic 
strength and pH can introduce noise into log10(koff) and Δlog10(koff) was also 
performed. Firstly, 635 of the 713 values come from experiments reported to be 
performed  in  the  295–298K  range,  and  72  values  either  did  not  have  their 
temperature  reported,  or  were  reported  as  ‘room  temperature’  or  ‘standard 
conditions’,  corresponding  to  the  293–298K  range.  The  remaining  six 
experiments were performed at 323K. Thus, only 0.8% of the data lies outside of 
a 5K temperature range. Although not reported in the SKEMPI database, most of 
the  rate  constants  were  determined  using  surface  plasmon  resonance  or 
stopped-flow  fluorescence  in  a  relatively  narrow  range  of  standard  buffer 
conditions.  Further,  ionic  strength  and  pH  predominantly  affect  the  rate  of 
association  rather  than  the  rate  of  dissociation;  electrostatic  shielding  and 
changes in protonation state influence the long-range forces which drive protein Chapter 2: Methods 
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association, rather than the short-range forces which keep the buried surfaces of 
the binding partners together. For instance, in the M3-XCL1 complex, in which 
ionic  strengths  in  the 0.2  to  1.5  M  NaCl  range  were  investigated,  the  rate  of 
association varied by over 70-fold, while the rate of dissociation varied by less 
than 3 fold (Figure 2C and Table III of  Alexander-Brett and Fremont (2007)). 
Similarly, in a study of a VEGF-antibody interaction, varying pH in the 6.5–8.5 
range resulted in around 30% variation in dissociation rate, while varying the 
ionic  strength  in  the  10–1000  mM  range  produced  a  two-fold  change 
in koff (Moore  et  al.,  1999).  Even  assuming  a  large  three-fold  standard  error 
in koff, this would result in a standard error of 3/ln10≈1.3 in logkoff  (Moore et al., 
1999).  Lastly  and  most  importantly,  the  assumption  was  made  that  though 
reference states may change across experimental methods and studies, within a 
given  experiment  the  reference  state  is  constant  for  the  experimental 
determination  of  the wild-type and  its  mutants,  which  tend  to  be  generated 
within  the  same  experimental  work.  Given  that  we  training  is  performed  on 
values  for  Δlog10(koff)  as  shown  in  equation  2.1,  any  systematic  variations 
associated with experimental conditions are eliminated, this issue is less likely to 
be prominent for mutation prediction as it is for wild-type.  
2.1.3  Off-rate Classification Data Sets (CDS1 and CDS2) 
 
The 713 off-rate mutations in the previous section of 2.1.2 are partitioned into 
(Δlog10(koff)<−1),  representing  the  stabilizing  portion  of  the  dataset,  and 
(Δlog10(koff)>0), representing the neutral to destabilizing portion of the dataset 
(referred  to  as  CDS1  –Classification  Dataset  1).  The  motivations  behind  the 
thresholds  of  CDS1  are  two-fold.  Firstly,  previous  error  estimates  show  that 
experimental noise in the data can be as high as 2kcal/mol (Moal et al., 2011, 
Moal and Fernandez-Recio, 2012). Experimental noise causes miscategorization 
errors when converting Δlog10(koff) from continuous values to categorical bins, 
and  therefore,  the  exclusion  of  data-points  within  [−1,  0]  should  reduce 
sufficiently  the  number  of  miscategorization  errors  between  stabilizing  and 
neutral/de-stabilizing  mutations.  Secondly,  being  able  to  detect  stabilizing 
mutations  from  neutral  ones  is  an  important  aspect  of  interface  design  (see 
section 1.4.3). A total  of 43% of the mutations lie within the range of [0, 1]. Chapter 2: Methods 
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Therefore,  the  removal  of  Δlog10(koff)  within  the  range  [−1,0]  still  allows  a 
sufficient amount of neutral mutations. This data subset, results in a dataset of 
501 neutral to destabilizing mutations (referred to as non-stabilizing mutations) 
and 31 stabilizing mutations. To further investigate the discrimination ability of 
the  descriptors,  an  additional  threshold  satisfying  |Δlog10(koff)|  >1  is  also 
investigated.  This  dataset  which  removes  most  of  the  neutrals  is  referred  to 
CDS2 – Classification Dataset 2. 
 
2.1.4  Dataset for Hotspot (ΔΔGALA) 
 
All  single-point  alanine  mutations,  limited  to  the  complex  interfaces,  were 
extracted from the SKEMPI database. This totals to a set of 635 non-redundant 
mutations  with experimental  ΔΔG in 59 different complexes and 154 hotspot 
residues with ΔΔG >= 2 kcal/mol. All hotspots represent the positive training 
examples and anything, which is not a hotspot (ΔΔG < 2 kcal/mol) as negative 
training examples. The hotspot dataset is listed in the appendices Table 10.4. 
 
2.2  Stability Related Descriptors 
 
A number of stability related descriptors are calculated and listed in Table 2.1. 
These include descriptors related to the potential and solvation energy, entropy 
related  descriptors,  statistical  potentials  and  a  number  of  miscellaneous 
descriptors. These different classes of descriptors have been described in the 
introductory section of 1.5. 
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Table 2.1: Stability Related Descriptors. 
A list of stability related descriptors calculated in this thesis. The descriptors are 
categorized  under  four  sections;  Potential  /  Total  Energy,  Solvation  Energy, 
Entropy, Statistical Potentials and Miscellaneous Descriptors. It should be noted 
that some of the descriptors are not exclusive to one type of category, but are 
only included one for ease of reference. The entries in the columns ΔG (Chapter 
3),  ΔΔG  (Chapter  4),  Δkoff (Chapter 7) and  HS  -  Hotspots  (Chapter  5),  indicate 
whether the descriptor was used in the respective predictive models. Note that 
this is only an indication of a descriptor being available to the learning models, 
and  not  necessarily  the  case  that  the  descriptor  formed  part  of  the  final 
prediction model. Those which do, are reported at the respective chapters. Not 
included in the table are all FoldX energy terms which are used for ΔΔG, Δkoff and 
HS prediction models (Schymkowitz et al., 2005). 
Potential / Total Energy 
Descriptor Type  Description  Note / Package  Reference  ΔG  ΔΔG  Δkoff  HS 
ROS_HBOND  Directional H-Bonding 
Potential  PyRosetta  (Chaudhury et al., 
2010)  Y       
H_BOND  12_10 Hydrogen Bonding 
Potential 
Firedock  (Andrusier et al., 
2007) 
Y 
     
PI_PI  Orientation Independent pi-pi  Firedock  (Misura et al., 
2004)  Y       
CATION_PI  Orientation Independent 
catian-pi  Firedock  Misura, Morozov et 
al. 2004)  Y       
ALIPHATIC  Orientation Independent 
aliphatic-aliphatic  Firedock  Misura, Morozov et 
al. 2004)  Y       
ROS_TOTAL  Total Energy  PyRosetta 
(Chaudhury et al., 
2010)  Y       
ACE22_ALL  Total energy  CHARMM 22 Forcefield  (Schaefer and 
Karplus, 1996) 
Y 
     
STC_H  STC Enthalpy  STC package  (Lavigne et al., 
2000)  Y       
STC_G  STC free energy  STC package  (Lavigne et al., 
2000)  Y       
ROS_FA_ATR / 
PY_fa_atr  Lennard-jones attractive 
PyRosetta 
 
(Chaudhury et al., 
2010)  Y  Y  Y  Y 
ROS_FA_REP 
PY_fa_rep 
Lennard-jones repulsive  PyRosetta  (Chaudhury et al., 
2010) 
Y  Y  Y  Y 
PY_fa_dun 
Internal energy of side-chain 
rotamers as derived from 
Dunbrack's statistics based 
pair term 
PyRosetta 
(Chaudhury et al., 
2010)    Y  Y  Y 
PY_fa_pair  Favors salt bridges  PyRosetta  (Chaudhury et al., 
2010)    Y  Y  Y 
PY_hbond_lr_bb 
Backbone-backbone H-bonds 
distant in primary sequence  PyRosetta 
(Chaudhury et al., 
2010)    Y  Y  Y 
PY_hbond_sr_bb  Backbone-backbone H-bonds 
close in primary sequence 
PyRosetta  (Chaudhury et al., 
2010) 
  Y  Y  Y 
PY_fa_Intra_rep 
Lennard-jones repulsive 
between atoms in the same 
residue 
PyRosetta  (Chaudhury et al., 
2010) 
  Y  Y  Y 
PY_hbond_bb_sc  H-bond energy sidechain-
backbone  PyRosetta  (Chaudhury et al., 
2010)    Y  Y  Y 
PY_hbond_sc  H-bond energy sidechain-
sidechain  PyRosetta  (Chaudhury et al., 
2010)    Y  Y  Y 
PY_pro_close  Proline ring closure energy  PyRosetta  (Chaudhury et al., 
2010)    Y  Y  Y 
ROS_CG_VDW  Coarse grained VDW  PyRosetta 
(Chaudhury et al., 
2010)  Y       
ACE22_COUL / 
ACE19_COUL 
Coulombic Energy  CHARMM 22/19 
Forcefield 
(Schaefer and 
Karplus, 1996) 
Y  Y  Y  Y 
ACE22_ELEC / 
ACE19_ELEC 
Total Electrostatic (ACE_INTE 
+ SELF) 
CHARMM 22/19 
Forcefield 
(Schaefer and 
Karplus, 1996)  Y  Y  Y  Y 
ACE22_INTE / 
ACE19_INTE  COUL+SELF  CHARMM 22/19 
Forcefield 
(Schaefer and 
Karplus, 1996)  Y  Y  Y  Y 
CHARM_total  Total Energy  CHARMM 19 Forcefield  Schaefer and 
Karplus 1996)    Y  Y  Y 
CHARM_elec  Electrostatic Energy  CHARMM 19 Forcefield  Schaefer and 
Karplus 1996) 
  Y  Y  Y 
CHARM_vdwaals  VDW potential  CHARMM 19 Forcefield  Schaefer and 
Karplus 1996)    Y  Y  Y Chapter 2: Methods 
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NUM_HB  Number of interfacial 
Hydrogen Bonds  HBPlus  (McDonald and 
Thornton, 1994)  Y       
NUM_SB  Number of interfacial Salt 
Bridges  HBPlus  (McDonald and 
Thornton, 1994)  Y       
NUM_WB  Number of interfacial Water 
Bridges  HBPlus  (McDonald and 
Thornton, 1994)  Y       
Solvation Energy 
Descriptor Type  Description  Note  Reference  ΔG  ΔΔG  Δkoff  HS 
DELISI_SOLV  Atomic Desolvation Energies  ACE – Atomic Contact 
Energies 
(Zhang et al., 1997)  Y 
     
LK_SOLV /  
PY_fa_sol 
The Lazaridis-Karplus effective 
energy function  PyRosetta  (Lazaridis and 
Karplus, 1999)  Y  Y  Y  Y 
SASA  SASA model  Ferrara et al. 2002  Ferrara et al. 2002  Y       
ROS_CG_ENV  Rossetta Cbeta Potential  PyRosetta  (Chaudhury et al., 
2010)  Y       
ROS_CG_BETA  Rosetta Environment Potential  PyRosetta  (Chaudhury et al., 
2010)  Y       
ACE22_SCRE / 
ACE19_SCRE  Electrostatic Screening  CHARMM 22/19 
Forcefield 
(Schaefer and 
Karplus, 1996)  Y  Y  Y  Y 
ACE22_SELF / 
ACE19_SELF  Electrostatic Self Energy 
CHARMM 22/19 
Forcefield 
(Schaefer and 
Karplus, 1996)  Y  Y  Y  Y 
ACE22_SOLV / 
ACE19_SOLV 
Sum of SELF and SCREEN  CHARMM 22/19 
Forcefield 
(Schaefer and 
Karplus, 1996) 
Y  Y  Y  Y 
ACE22_HYDR / 
ACE19_HYDR  Hydrophobic Burial  CHARMM 22/19 
Forcefield 
(Schaefer and 
Karplus, 1996)  Y  Y  Y  Y 
ACE19_SASL  SASA Solvation Energy  CHARMM 19 Forcefield  (Schaefer and 
Karplus, 1996)    Y  Y  Y 
CHARM_gb 
Generalized Born Implicit 
Solvation Energy  CHARMM 19 Forcefield 
(Schaefer and 
Karplus, 1996)    Y  Y  Y 
CHARM_sasa  Hydrophobic Solvation Energy  CHARMM 19 Forcefield  (Schaefer and 
Karplus, 1996)    Y  Y  Y 
CHARM_gb+sasa 
Generalized Born + 
Hydrophobic Solvation Energy  CHARMM 19 Forcefield 
(Schaefer and 
Karplus, 1996)    Y  Y  Y 
STC_S_SOL  Hydrophobic Burial  STC package  (Lavigne et al., 
2000)  Y       
                Entropy 
Descriptor Type  Description  Note  Reference  ΔG  ΔΔG  Δkoff  HS 
S_TR 
Change in 
rotational+translational 
entropy upon complex 
formation 
    Y       
S_R 
Change in rotational entropy 
upon complex formation 
rotational      Y       
S_T 
Change in translational 
entropy upon complex 
formation      Y       
S_VIB 
Change in vibrational entropy 
upon binding using normal 
modes via M1 scheme   
(Carrington and 
Mancera, 2004)  Y       
STC_S_SC 
Entropy changes arising from 
restriction of side-chain 
conformation upon binding 
STC Package  (Lavigne et al., 
2000)  Y       
S_GP_ALL2  Disorder to order transitions    (Zhou, 2004)  Y        S_GP_INT2  Disorder to order transitions    (Zhou, 2004)  Y       
S_WLC_ALL2  Disorder to order transitions    (Zhou, 2001)  Y        S_WLC_INT2  Disorder to order transitions    (Zhou, 2001)  Y       
STC_S  Total Entropy Change  STC package 
(Lavigne et al., 
2000) 
 
Y       
Statistical Potentials 
Descriptor Type  Description  Note  Reference  ΔG  ΔΔG  Δkoff  HS 
ROS_FA_PP  Atomistic pair potential  Protein Folding 
(Chaudhury et al., 
2010, Simons et al., 
1999) 
Y       
ROS_CG_PP  Coarse-grained pair potential  Protein Folding 
(Chaudhury et al., 
2010, Simons et al., 
1999) 
Y       
AP_DARS  Atomic distance dependent  Protein Docking 
Inc. AP_URS/AP_MPS 
(Chuang et al., 
2008)    Y  Y  Y 
AP_DOPE  Atomic distance dependent 
Protein Folding 
Inc. AP_DOPE_HR – High 
Res. 
(Shen and Sali, 
2006)    Y  Y  Y 
AP_T  Two-step atomic potential  Protein Docking 
Inc. AP_T1/2.  (Tobi, 2010)    Y  Y  Y 
CP_TSC 
Two-step residue level contact 
potential  Protein Docking  (Tobi, 2010)    Y  Y  Y 
CP_TB  Residue level contact potential  Protein Folding  (Tobi and Bahar, 
2006) 
  Y  Y  Y 
DFIRE  Atom based orientation 
dependent  Protein Folding  (Zhang et al., 2004)  Y  Y  Y  Y Chapter 2: Methods 
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DDFIRE  Atomic distance dependent 
level potential  Protein Folding  (Yang and Zhou, 
2008)  Y  Y  Y  Y 
DCOMPLEX  Atomic distance dependent 
Level potential  Protein Docking  (Liu et al., 2004)  Y  Y  Y  Y 
OPUS_CA  Residue/C-Alpha distance 
dependent  Protein Folding  (Lu et al., 2008)  Y  Y  Y  Y 
OPUS_PSP  Atom contact potential for 
Side-chain packing 
Protein Folding 
Inc. OPUS_PSP1/2/3.  (Lu et al., 2008)  Y  Y  Y  Y 
RF_PP  Residue level potential  Protein Folding 
(Rykunov and 
Fiser, 2010)  Y       
EMPIRE  Atomic level  Protein Docking  (Liang et al., 2007)  Y       
GEOMETRIC 
Packing and distance 
dependent potential function 
Protein Folding / Protein 
Interaction  Unpublished  Y  Y  Y  Y 
CP_RMFCEN1  Side-chain centroid distance 
dependent potential 
Protein Folding  (Rajgaria et al., 
2008) 
  Y  Y  Y 
CP_RMFCEN2  Side-chain centroid distance 
dependent potential  Protein Folding  (Rajgaria et al., 
2008)    Y  Y  Y 
CP_RMFCA  Calpha distance dependent  Protein Folding  (Rajgaria et al., 
2006)    Y  Y  Y 
CP_SKOIP   Residue level interaction 
contact potential  Protein Docking   (Lu et al., 2003)    Y  Y  Y 
FOUR_BODY 
Four-body coarse grain 
potential  Potentials'R'Us  (Feng et al., 2010)  Y  Y  Y  Y 
GEN_4_BODY  Four-body coarse grain 
potential 
Potentials'R'Us  (Feng et al., 2010)  Y  Y  Y  Y 
SHORT_RANGE  Residue level pair potential  Potentials'R'Us  (Feng et al., 2010)  Y  Y  Y  Y 
QA_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as CP_Qa  (Feng et al., 2010)  Y  Y  Y  Y 
QM_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_Qm  (Feng et al., 2010)  Y  Y  Y  Y 
QP_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_Qp  (Feng et al., 2010)  Y  Y  Y  Y 
HLPL_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_HLPL 
(Feng et al., 2010)  Y  Y  Y  Y 
SKOB_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_SKOb 
(Feng et al., 2010)  Y  Y  Y  Y 
SKOA_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_SKOa 
(Feng et al., 2010)  Y  Y  Y  Y 
SKJG_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_SKJG 
(Feng et al., 2010)  Y  Y  Y  Y 
MJPL_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_MJPL 
(Feng et al., 2010)  Y  Y  Y  Y 
MJ3H_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_MJ3h 
(Feng et al., 2010)  Y  Y  Y  Y 
MJ2H_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_MJ2h 
(Feng et al., 2010)  Y  Y  Y  Y 
TS_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_Ts  (Feng et al., 2010)  Y  Y  Y  Y 
BT_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_BT  (Feng et al., 2010)  Y  Y  Y  Y 
BFKV_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_BFKV 
(Feng et al., 2010)  Y  Y  Y  Y 
TD_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as CP_TD  (Feng et al., 2010)  Y  Y  Y  Y 
TEL_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_Tel 
(Feng et al., 2010)  Y  Y  Y  Y 
TES_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_TEs  (Feng et al., 2010)  Y  Y  Y  Y 
RO_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_RO  (Feng et al., 2010)  Y  Y  Y  Y 
MS_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_MS  (Feng et al., 2010)  Y  Y  Y  Y 
MJ1_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_MJ1 
(Feng et al., 2010)  Y  Y  Y  Y 
MJ3_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_MJ3 
(Feng et al., 2010)  Y  Y  Y  Y 
GKS_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_GKS 
(Feng et al., 2010)  Y  Y  Y  Y 
VD_PP  Residue level pair potential  Potentials'R'Us 
Also referred to as CP_VD  (Feng et al., 2010)  Y  Y  Y  Y 
MSBM_PP  Residue level pair potential 
Potentials'R'Us 
Also referred to as 
CP_MSBM 
(Feng et al., 2010)  Y  Y  Y  Y 
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Miscellaneous 
Descriptor Type  Description  Note  Reference  ΔG  ΔΔG  Δkoff  HS 
DASA  Change in surface area upon 
binding  Naccess    Y       
RES_P  % interface residues: polar  Naccess    Y       
RES_NP  % interface residues: non-
polar  Naccess    Y       
RES_C  % interface residues: charged  Naccess    Y        ATOM_P  # interface atoms: polar  Naccess    Y       
ATOM_NP  # interface atoms: non-polar  Naccess    Y        ATOM_N  # interface atoms: charged  Naccess    Y        PLANARITY  Interface planarity  SURFNET  (Laskowski, 1995)  Y       
ECCENTRIC  Numerical eccentricity  SURFNET  (Laskowski, 1995)  Y       
INT_ALPHA 
Proportion of interface 
residues which are in alpha 
helices 
DSSP 
 
Y 
     
INT_BETA 
Proportion of interface 
residues which are in beta 
sheets 
DSSP    Y       
GAP_VOL 
Volume of empty space at the 
interface  SURFNET  (Laskowski, 1995)  Y       
GAP_INDEX 
Volume of empty space at the 
interface divided by interface 
Area 
SURFNET  (Laskowski, 1995)  Y       
NIP  Interface packing score   
(Mitra and Pal, 
2010)  Y  Y  Y  Y 
NSC  Surface complimentarity score 
 
(Mitra and Pal, 
2010) 
Y  Y  Y  Y 
STC_CP  Change in specific heat upon 
binding  STC package  (Lavigne et al., 
2000)  Y       
BIOSIMZ_KON  Predicted log(kon) calculated 
using BioSimz    Li,2011  Y       
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2.3  Machine Learning Algorithms 
 
2.3.1  Random Forest (RF) 
 
The  Random  Forest  (RF)  (Breiman,  2001a)  is  the  most  commonly  employed 
learning algorithm in this thesis. The RF is used both for problems of regression 
and classification and a Matlab implementation of the RF algorithm, as described 
by Breiman (2001a), is used. RF is an ensemble of decisions trees, where the final 
prediction is a majority vote (for classification) or an average (for regression) of 
all the trained decision trees. The ‘Random’ aspect of the RF algorithm is related 
to the way it builds each decision tree. For a training set of N samples, sampling 
with  replacement  is  performed  and  two  thirds  of  this  sample  is  used  as  the 
training set for a given decision tree in the forest. The other one third (termed as 
the oob (out-of-bag) data, is used to get an unbiased estimate of the test error 
and for variable importance measures. The second randomization involved in 
the RF’s decision trees, is that at each node, not all features are available for 
making a split. Rather a random sample of mtry features are chosen at each node 
and the best split is chosen amongst them. An important aspect of the RF is that 
the test error is reduced with more accurate and less correlated decision trees. 
Part of the randomization procedures employed in the tree building are in fact 
aimed at introducing variability in hope of achieving low correlation between 
decision trees. The mtry parameter is therefore central the RF. Given a powerful 
descriptor in the set of features, for high mtry values, it is more likely that this 
descriptor would be chosen in the random sample and subsequently used at the 
node split. Therefore this descriptor would dominate most of the trees, resulting 
in highly accurate trees but with low correlation. If the mtry parameter is set too 
low, then the powerful descriptor might be missed out from most of the trees. 
The  RF  would  then  consist  of  low  correlation  trees  but  with  low  accuracy. 
Though this parameter is the one for which the RF is most sensitive to, it has a 
broad range of optimal values (Breiman, 2001a). This was also found to be true 
in this work, and for most scenarios the mtry parameter was set to be withitn the 
range    where  M is  the number of features  available  in the 
training set.  Chapter 2: Methods 
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RF Variable Importance Measure: After the random forest has been built and the 
oob error estimate for each tree recorded, the importance of each feature to the 
prediction  is  measured  as  follows.  For  each  feature  m,  all  of  its  values  are 
randomly  permuted  and  the  oob  examples  are  fed  through  the  trees  with  m 
randomly permuted. The importance score of feature m is the different between 
the  original  oob  error  estimates,  and  the  new  ones  with  m  permuted.  The 
importance  score  is  then  normalized  by  the  standard  deviation  of  these 
differences across all trees. Large values imply more important features. Another 
feature importance measure available to the RF, and invoked in this work, is the 
case-wise feature importance measure. Here, during permutation, the error of 
each  oob  example  is  recorded.  In  this  way  feature  importance  can  also  be 
quantified in relation to specific examples. 
2.3.2  M5’ Regression Tree (M5’) 
 
The M5 model tree is similar to standard regression trees with the additional 
possibility of having a linear regression model at the leaves (Quinlan, 1992). In 
this work, the M5′ algorithm, a modified version of the original M5 regression 
tree  described  by Wang  and  Witten  (1996)  was  used.  This  version  is  able  to 
achieve more interpretable trees through smaller trees which still have similar 
predictive performance. Two phases are used to build an M5’ tree; the growing 
phase  and  the  pruning  phase.  In  the  growing  phase,  a  greedy  algorithm  is 
employed where  at each node  a  split  is  made  which minimizes  the standard 
deviation  of the  examples  falling on  each side  of the  split. By the end of the 
growing phase, the  tree  is  typically large  and the  samples partitioned by the 
latter splits are small in number. Therefore the error estimates for the latter 
splits become unreliable, and it is likely the tree overfits the data. To address 
this, a pruning stage is performed where a function which considers the tree size 
and  the  estimated  test  error  is  minimised.  The  M5’  implementation  in  the 
M5PrimeLab  toolbox  in  Matlab  was  used  to  construct  one  of  the  empirical 
binding free energy functions described in Chapter 3.  
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2.3.3  Multivariate-Adaptive-Regression-Splines (MARS) 
 
MARS is a non-parametric regression method which uses a set of hinge functions 
to  model  non-linear relationships between  the  input variables and the target 
output (Friedman, 1991). The model is formed from a sum of weighted basis 
functions Bi(x),  
 
 
2.2 
where each basis function contains a hinge function or a product of two or more 
hinge functions, if we seek to model higher order interactions between variables. 
The hinge function takes two forms; max(0, m-constknot) or max(0, constknot -m), 
and is defined by some feature m and a knot constknot. Therefore in the training 
phase, MARS automatically assigns the weights for each basis function wi, the 
variables  for  a  given  hinge  function,  and  the  values  for  the  knot  positions 
constknot. Similar to the M5’ regression tree, the MARS model also has two phases 
termed as the forward pass and the backward pass. In the forward pass, the basis 
functions are added in pairs until a stopping criterion is reached. This is usually 
set by the user, and can be some minimum error threshold or the maximum 
number of basis functions. Given that the forward phase my produce models that 
overfit the training data, in the backward phase, basis function are removed and 
model subsets are compared using a generalized cross-validation (GCV) routine. 
The GCV is a function of the residual sum-of-squares of the training data, the 
number of observations, the number of parameters and the number of knots. 
Therefore more flexible models, with the addition of more knots, are penalized in 
the backward phase. One notable aspect concerning hinge functions is that for 
the range in which the function is zero, the feature associated with it does not 
contribute  to  the  prediction.  Effectively  this  can  be  used  as  a  mechanism  to 
disregard noisy parts of descriptors and a higher weighting to more informative 
regions. The MARS implementation in the ARESLab toolbox in Matlab was used 
to  construct  one  of  the  empirical  binding  free  energy  functions  described  in 
Chapter 3. 
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2.3.4  Radial-Basis-Function Interpolation (RBF) 
 
RBFs are common in both artificial neural networks (ANNs) and support-vector-
machine (SVM) learning algorithms.  They are functions whose value depends on 
some distance from the origin or some point in space. The sum of a set of radial 
basis functions can in turn be used to approximate functions in the form of: 
 
 
2.3 
Several distance functions may be used such as the multiquadric basis function: 
 
 
2.4 
 
Where d=||x-xi||. The fact that weights wi are learnt for examples rather than 
features,  means  that  during  training,  uninformative  examples  are  down-
weighted and representative ones are up-weighted. The RBF implementation in 
Matlab was used to construct one of the empirical binding free energy functions 
described in Chapter 3. 
2.3.5  Genetic Algorithm Feature Selection (GA-FS) 
 
The GA-FS Algorithm runs feature selection on subsets of the off-rate mutation 
dataset defined as data regions. Two separate GA-FS runs are performed, one for 
Linear  Regression  models  and  another  for  Support  Vector  Machine  (RBF) 
Regression  Models  (using  LIBSVM  package).  Two  separate  10-Fold  Cross-
Validation  loops  are  used.  One  to  assess  prediction  accuracy  on  the  off-rate 
mutations for the given data region and the second to derive the optimal feature 
set.  A  10-Fold  inner-cross  validation  loop  is  used  within  the  GA-FS  fitness 
function  to  drive  the  feature  selection  process  with  Pearson’s  Correlation 
Coefficient.  After  the  GA  has  converged,  the  LR/SVM  model  is  tested  for  its 
accuracy on the outer-loop fold. This process is repeated 10 times such that all 
10 outer loop folds are used as a test set validation for the final model. Therefore 
the accuracy of the final model is tested on data that is not used to derive the 
feature  set.  As  an  initial  feature  set  available  for  selection,  110  molecular Chapter 2: Methods 
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descriptors  (as  shown  in  the  Δkoff  column  in  Table  2.1)  and  16  hotspot 
descriptors (as shown in Table 6.3) from the best performing off-rate prediction 
model RFSpot_KFC2 are available. A fixed feature set size of 5 is chosen so as to 
avoid overfitting on smaller sized data regions. Therefore the genome size for the 
GS-FS (LR) is 5 whereas that for GA-FS (SVM) is 7 to also optimise the cost and 
gamma parameters of the RBF. Available Cost parameters values are quantized 
into 111 bins ranging from 2-5 to 26. Gamma parameter values are quantized into 
1300 bins ranging from 2-8 to 25. The GA’s initial population size was set at 1000 
individuals, and generated such that the initial population included at least one 
instance of each of the 126 features. Tournament selection is employed with a 
size of 8 individuals. Uniform random crossover is used with a crossover fraction 
set to 50% and a mutation rate exponentially decreasing with the number of 
generations applied. Note that for each data region 50 separate GA-FS runs are 
performed. 
2.3.6  Hotspot Descriptor Calculation and Dataset 
 
As  depicted  in  Figure  6.1,  for  any  given  complex,  a  computational  alanine 
scanning is first performed on the wild-type interface using a hotspot prediction 
algorithm. This enables calculation of the set of hotspot descriptors summarized 
in Table 6.3 . The respective single-point or multi-point mutation is then applied 
using FoldX (Schymkowitz et al., 2005), and another computational alanine scan 
is performed on the mutated interface, again using the same hotspot prediction 
algorithm  invoked  for  the  wild-type  scan,  from  which  a  new  set  of  hotspot 
descriptors  are  calculated.  The  energetic  value  contributed  by  each  hotspot 
descriptor is then the difference in its energetic value pre- and post-mutations: 
 
_ _ _
MUT WT
HS Desc HS Desc HS Desc E E E      2.5 
 
The hotspot descriptors are calculated for a set of 713 mutations from SKEMPI 
database (Moal and Fernandez-Recio, 2012) described in section 2.1.2. Therefore 
in  total,  for  each  hotspot  prediction  algorithm,  50  wild-type  and  713  mutant 
computational alanine scans are made. To ensure that off-rate predictions are Chapter 2: Methods 
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not  made  via  hotspots  models  trained  on  the  same  examples,  all  713 
computational  alanine-scans  made  by  RFSpot, RFspot_KFC2, RFHotspoint1 and 
RFHotspoint2  are  strictly  20-fold-test  predictions  for  mutations  common 
between  the  off-rate  and  hotspot  datasets,  and  test  predictions  for  the  rest. 
Therefore all hotspot predictions on which the hotspot descriptors are calculated 
are unbiased and not susceptible to over-fitting.  
2.3.7  Hotspot Descriptor Functional Forms and Design 
 
The aim of the hotspot descriptors designed in this work is to capture both the 
energetics and distributional properties of hotspots. These in turn may affect 
complex destabilization to differing degrees. The relevance of each descriptor to 
off-rate variation is then assessed with different feature importance measures 
and the key determinants of the dissociation process reported.  
2.3.7.1  Interface Hotspot Descriptors 
 
Int_Energy_1 is the difference in the sum of the single-point alanine ΔΔGs of all 
interface residues N, pre- and post-mutation. 
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Int_HS_Energy is the difference in the sum of the single-point alanine ΔΔGs of all 
hotspot residues NHS, pre- and post-mutation. 
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No_HS is the change in number of hotspots predicted at the interface pre- and 
post-mutation.  This  can  be  considered  to  be  a  coarse-grained  version  of 
Int_HS_Energy. 
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2.3.7.2  Solvent Accessible Region Hotspot Descriptors 
 
To account for the different solvent accessible regions where hotspots may occur 
at the interface, the following hotspot ΔΔGs are summed separately for the core, 
rim  and  support  regions    and  termed  as  CoreHSEnergy,  RimHSEnergy  and 
SuppHSEnergy respectively. Therefore these hotspot descriptors are similar to 
Int_HS_Energy  but  limited  to  counting  ΔΔG  for  hotspots  that  fall  in  the  given 
region. In addition, CoreHS, RimHS and SuppHS descriptors, count the hotspot 
changes within each region. Again these can be considered as coarse-grained 
versions of their respective counterparts. The core, rim and support regions of 
the complex interface are defined according to Levy (2010). Core residues are 
generally exposed in the unbound configuration but buried in the bound state. 
Rim  regions  are  generally  exposed  in  both  the  bound  and  unbound  states 
whereas support residues are generally buried in both states. The thresholds 
chosen in defining these regions are such that each region has a similar number 
of residues (Levy, 2010). 
2.3.7.3  Hotregion Cooperativity Descriptors 
 
The  cooperativity  of  a  pair  of  residues  m1  and  m2,  can  be  calculated  by 
comparing the gain of adding each residue separately from a neutral reference 
state of both wild-type residues mutated to alanine (ΔΔGA1,A2->A1,m2 + ΔΔG A1,A2-> 
m1,A2) to that of adding both residues concurrently, given the same reference state 
(ΔΔG A1,A2->m1,m2) (Albeck et al., 2000). Namely, let A1 and A2 represent the alanine 
mutation of m1 and m2 respectively, then 
  ΔΔΔG= (ΔΔGA1,A2->A1,m2 + ΔΔG A1,A2-> m1,A2 ) - ΔΔG A1,A2->m1,m2  2.8 
 
If ΔΔΔG is positive, this indicates positive cooperativity as the contribution of 
both residues together is more stabilizing than the sum of their parts. Conversely 
if the ΔΔΔG is negative, this indicates negative cooperativity, whereas if the ΔΔΔG 
is close to zero, then such pairs can be considered to be effectively independent 
of each other hence their contributions to be additive in relation to each other. Chapter 2: Methods 
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Expanding  ΔΔGA1,A2->A1,m2 and ΔΔG A1,A2-> m1,A2 we get 
  ΔΔΔG= ([ΔΔG m1,m2 -> A1,m2 - ΔΔG m1,m2 -> A1,A2] 
 + [ΔΔG m1,m2 -> m1,A2 - ΔΔG m1,m2-> A1,A2])  - ΔΔG A1,A2->m1,m2 
2.9 
  ΔΔΔG= (ΔΔG m1,m2 -> A1,m2 + ΔΔG m1,m2 -> m1,A2) – ΔΔGm1,m2 -> A1,A2  2.10 
 
In this work, we only make single point-mutations during the alanine scan and 
calculate the energetics associated with such complex states as in equation 2.10: 
ΔΔG m1,m2 -> A1,m2 and ΔΔG m1,m2 -> m1,A2. The summation of these energies is then 
used as an estimate of the off-rate. If hotspots within a cluster are additive, then 
the  summation  of  ΔΔG  m1,m2  ->  A1,m2 +  ΔΔG  m1,m2  ->  m1,A2 would  be  a  sufficient 
estimate of the cluster’s contribution to the off-rate. However if m1 and m2 are 
positively  cooperative,  then  their  contribution  towards  the  off-rate  using  the 
summation ΔΔG m1,m2 -> A1,m2 + ΔΔG m1,m2 -> m1,A2 would be an overestimate of the 
true contribution ΔΔGm1,m2 -> A1,A2, hence the positive value for ΔΔΔG. Therefore in 
this case, to account for positive cooperativity we down-weight the summation 
of ΔΔG m1,m2 -> A1,m2 + ΔΔG m1,m2 -> m1,A2. Conversely if m1 and m2 were negatively 
cooperative, then a positive weighting would be more suitable to account for the 
underestimation. Further, higher order cooperativity effects involving three or 
more residues are known (Albeck et al., 2000) and it is likely that many binding 
modules  exhibit  such  complexity,  where  it  is  not  possible  to  decouple  the 
contributions  from  each  individual  residues.  However,  if  we  assume  that 
cooperativity effects are taking place, the weighting applied should also reflect 
the  number  of  residues  suspected  to  be  cooperative.  With  this  in  mind,  the 
cooperativity  hotspot  descriptors  are  designed  as  follows;  given  a  set  of 
predicted hotspots at the interface, each hotspot is categorized according to the 
hotregion  cluster  size  it  is  found  in.  As  Int_HS_Energy  assumes  hotspot 
contribution is additive, the sum of the hotspot energies is independent of the 
hotspot  locations  (equation  2.7).  On  the  other  hand,  HSEner_PosCoop  and 
HSEner_NegCoop  are  the  sum  of  the  hotspot  energies  downweighted  / 
upweighted using simple linearly decreasing / increasing functions related to the 
size of the hotregion the given respective hotspot is in: Chapter 2: Methods 
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where wHRDec = (0.125, 0.25, 0.375, 0.5, 0.625, 0.75, 0.875, 1) and wHRInc = (1, 
0.875, 0.75, 0.625, 0.5, 0.375, 0.25, 0.125) for hotspot nHS in a hotregion of sizes 
(HR=1,  2,  3,  4,  5,  6,  7,  8+)  respectively.  Though  more  complex  non-linear 
weightings could be investigated, such as ones fitted to the off-rate data itself, 
this would require sacrificing parts of the data for fitting. With this in mind, all 
hotspot descriptors designed in this work were independent of any off-rate data. 
Coarse-grained  versions  HS_PosCoop  and  HS_NegCoop,  which  weight  hotspot 
counts instead of energies, are also implemented in the model. One should note 
that  since  the  energetic  contribution  of  a  hotregion  taken  as  a  whole  is 
considered to be additive and independent of other hotregions  (Keskin et al., 
2005, Reichmann et al., 2005) we only aim to investigate and account for intra-
hotregion cooperativity using these descriptors as opposed to inter-hotregion 
cooperativity. 
2.3.7.4  Hotspot Coverage Related Descriptors 
 
Other hotspot descriptors relate to the spread of hotspots across the interface. 
The intuition here is that a heterogeneous distribution of hotspots across the 
interface might be more beneficial to complex stability than if hotspots where 
concentrated onto a specific region of the interface only. AVG_HS_PathLength is 
the average path length between all possible pairs of hotspots at the interface, 
normalized to the average path length of all possible pairs of a random set of 
residues at the interface. The path length between two residues is calculated as 
the least number of contacting residues linking them together. Two residues are 
considered to be in contact if any of their atoms are at a distance smaller than the 
sum of their van der Waals radii + 0.5 Angstroms. No_Clusters counts the number 
of  unique  hot  regions,  where  it  is  likely  that  more  hotregions  may  span  the Chapter 2: Methods 
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interface given that separate hotregions are not in contact. MaxClusterSize counts 
the change in the number of hotspots in the largest hotregion. 
2.3.7.5  Definition of a Hotregion 
 
Some  of  the  hotspot  descriptors  use  hotregion  information  within  them 
(No_Clusters,  MaxClusterSize,  HSEner_PosCoop/HS_PosCoop  and 
HSEner_NegCoop/HS_NegCoop). A hotregion is created whenever two or more 
hotspot residues are in contact. Two hotspot residues are considered to be in 
contact if any of their atoms are at a distance smaller than the sum of their van 
der Waals radii + 0.5Å. A hotspot residue is added to an existing hotregion, if any 
of  its  atoms  makes  contact  with  any  of  the  hotspot  residues  already  in  the 
hotregion. 
2.4  Performance Measures and Significance Tests 
 
A number of performance measures are employed in this work to assess the fine-
grained and coarse-grained ability of both descriptors and model predictions.  
For  fine-grained  assessment  of  how  well  a  descriptor  or  model  predictions 
describe  experimental  data,  the  Pearson’s  product-moment  correlation 
coefficient (PCC) is used. This is calculated as the covariance of the two variables 
divided by the product of their standard deviation. This parametric measure of 
correlation assesses the strength of linear dependence between two variables 
and  is  a  widely  accepted  metric.  A  second  method  employed  is  the  Mann-
Whitney U-test. This checks whether a set of two independent observations have 
smaller or larger values than the other. The test is used to assess the coarse-
grain  predictive  power  of  our  descriptors  or  predictors  in  discriminating 
between  say  stabilizing  mutants  from  destabilizing  mutations.  Several  other 
classification related measures are used for this same purpose also, namely: 
True-Positive-Rate (TPR) / Recall:    
TP
TP FN 
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False-Positive-Rate (FPR):   
FP
FP TN 
 
Specificity:   
TN
TN FP 
 
Precision:   
TP
TP FP 
 
Accuracy:   
TP+TN
TP+FP+FN +TN
 
Matthew’s Correlation Coefficient (MCC): 
( ) ( ) ( ) ( )
TP TN FP FN
TP FP TP FN TN FP TN FN
  
      
 
F1-Score:   
2 precision recall
precision recall


 
where  TP=True-Positive,    FP=False-Positive,  TN=True-Negative,  FN=False-
Negative.  
For  comparison  of  two  PCCs,  say  for  the  comparison  of  two  prediction 
algorithms,  a  significance  of  the  difference  between  the  two  correlations  is 
calculated  using  the  Fisher  r-to-z  transformation.  p-values  less  than  0.05  are 
considered to be significant. 
 
 
  
73 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
3 A Model for Protein-Protein 
Binding Affinity Prediction 
 
 
3.1  Introduction  
 
In this chapter, the characterization and prediction of protein-protein affinities is 
studied. The computational prediction of binding affinities requires not only an 
understanding of the driving forces behind complex formation and stability, but 
also an accurate computational representation of such forces. Subsequently, a 
model  is  then  employed  to  optimally  combine  the  influence  of  each  of  these 
driving forces into one coherent prediction of affinity. Throughout this process, a 
benchmark  set  of  protein-protein  X-ray  structures  and  their  experimentally 
determined  binding  affinities,  is  used  to  validate  the  accuracy  of  the  model 
predictions. 
As detailed in section 1.5.7, up until this work, several attempts at the prediction 
of binding affinities were made. The limitations of these models are highlighted Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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in sections 1.5.7.1, 1.5.7.2 and 1.5.7.3 form the motivations behind the binding 
affinity  prediction  model  devised  in  this  work.  First,  the  dataset  of  protein-
protein  structures  and  their  experimental  affinities  used  to  benchmark  the 
affinity model is described in section 3.3.1. A large set of molecular descriptors 
calculated  on  these  structures  is  detailed  section  3.3.2.  This  descriptor  set 
significantly expands on what was used in previously published affinity models. 
Namely,  besides  a  number  of  physical  descriptors,  it  adds  a  broad  range  of 
statistical  potentials,  new  solvation  models  and  better  entropic  terms.  The 
molecular descriptors are then fed into a number of machine learning models 
(described  in  3.3.3)  that  are  combined  to  make  the  final  prediction.  This  is 
termed as the consensus model. The setup used is that of four base learning 
models: random forest (RF) regression, M5’ regression, multivariate-adaptive-
regression-splines  (MARS)  and  radial-basis-function  (RBF)  interpolation,  with 
the mean of their prediction constituting the final affinity prediction model. The 
motivations  behind  these  learners  are  mostly  based  on  the  limitations 
surrounding  linear  regression  in  modelling,  such  as  accounting  for  non-
linearities and dealing with a large set of noisy descriptors. 
The consensus model approach is successful in increasing upon the accuracy of 
its best base learners and more importantly, outperforms all other published 
methods tested. Two aspects that stood out from this work include firstly, the 
limitations in our ability to predict the affinities for complexes which undergo 
significant  conformational  changes  and  secondly,  the  reduction  in  accuracy 
observed when the errors in experimental binding affinities are not controlled 
for with a validated set of complexes. Finally, in section 3.5, the binding affinity 
methods developed post-publication of this work are discussed and suggestions 
for future work outlined. 
This work was done in collaboration with my colleague Iain Moal. The selection 
and calculation of the molecular descriptor set was performed by Iain Moal. The 
machine learning algorithm selection and design was performed by myself. The 
analysis of the results was performed jointly.   Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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3.2  Approach and Motivations 
 
The limitations mentioned in section 1.5.7.1– bias towards  complexes for which 
their  component  parts  undergo  little  to  no  conformational  change,  section 
1.5.7.2–  static-structures  and  section  1.5.7.3–  models  not  able  to  account  for 
diversity, form the motivations behind the BAP model developed in this work. 
The following methods section 3.3 detailing the dataset, descriptors and learning 
models, shows how the limitations mentioned above are addressed. In section 
3.3.1 the dataset of protein-protein complexes is described. This consists of a 
diverse set of protein-protein interactions with varying conformational changes. 
In section 3.3.2 the affinity descriptors used in this work are presented. These 
include energetic descriptors calculated on conformational ensembles of each 
complex and their unbound components. Finally, in section 3.3.3, the machine 
learning models used for training and prediction are detailed. 
3.3  Methods 
 
In  section  3.3.1  the  dataset  of  protein-protein  complexes  is  described.  This 
consists  of  a  diverse  set  of  protein-protein  interactions  with  varying 
conformational  changes.  In  section  3.3.2  the  affinity  descriptors  used  in  this 
work  are  presented.  These  include  energetic  descriptors  calculated  on 
conformational  ensembles  of  each  complex  and  their  unbound  components. 
Finally,  in  section  3.3.3,  the  machine  learning  models  used  for  training  and 
prediction are detailed.  
3.3.1  Binding Affinity Benchmark Dataset 
 
The  structures  and  experimental  affinities  for  the  recently  published  binding 
affinity  benchmark  (Kastritis  et  al.,  2011)were  used  as  the  main  source  for 
training  and  testing  the  BAP  model  designed  in  this  work.  The  dataset  is 
described more thoroughly in section 2.1.1. In summary, the dataset consists of a 
total of 144 complex structures for which the crystal structures of each complex, 
along with each of its unbound components at high resolution (< 3.25Å), are Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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available. A key aspect of this dataset, which improves upon previous datasets 
used in BAP (see section 1.5.7), is its diversity: 
  Several  receptor/ligand  protein-binding  partners  undergo  significant 
conformational change upon complex formation, of which some exhibit 
disorder to order transitions.  
  Complexes,  within  different  protein  families,  cover  a  wide  range  of 
functions. 
  Wide range of affinities.  
From the total set of 144 complexes, 137 were used. The complexes with protein 
database  codes,  1UUG,  1IQD  and  1NSN,  were  removed,  as  affinities  available 
were only denoted by upper limits; codes, 1DE4, 1M10, 1NCA and 1NB5 were 
removed, as certain features were difficult to calculate for them 
A  high-quality  validated  subset  of  the  original  affinity  dataset  is  analysed 
separately.  This  validated  set  is  used  to  assess  to  which  extent  experimental 
error  in  affinities  affects  the  model  predictions.  One  should  note  that  in  this 
validated set, the diversity in affinity and complex families is still present. More 
details on this validated set are presented in methods section 2.1.1.1. 
3.3.2  You are what you eat.. Affinity Descriptors 
 
In collaboration with Iain Moal, a large set of 200 molecular descriptors were 
calculated on the binding affinity benchmark and fed into the machine learning 
models described in section 3.3.3. A detailed list of the descriptors is provided in 
Table 2.1 of the methods section 2.2. The descriptor set covers a wide-range of 
known  determinants  of  complex  formation  and  affinity.  The  set  contains 
different contributors to the free energy function described in section 1.5, and 
includes  descriptors  related  to  the  potential  energy,  solvation  energy  and 
entropic contributions to binding. In addition to the biophysical descriptors, a 
number of statistical potentials are added, which vary from pair to multi-body 
potentials and contain both coarse-grain and atomistic potentials. Though some 
specific packages are used for a number of descriptors, most  were calculated Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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using the ProtorP server (Reynolds et al., 2009), CHARMM forcefield (Brooks et 
al., 2009), PyRosetta (Chaudhury et al., 2010) and the Potentials ‘R’ Us server 
(Feng et al., 2010). For the assumption that binding is rigid-body, and structures 
are static, descriptors were calculated as:  
 
, , L,b () RL b R b E E E E      3.1 
The motivations behind the descriptors calculated here are several fold. Firstly, 
most of the descriptors are directly related to known physical contributors of 
affinity, including terms for Hydrogen Bonding, Van der Waals and Electrostatics. 
Emphasis  was  given  to  entropy  related  terms,  as  this  effect  is  harder  to 
characterise. Therefore entropic terms include rotational, translation and side-
chain  entropy terms, vibrational and disorder loop entropy terms along with 
terms for the hydrophobic effect. Solvation is another important aspect modelled 
at different levels of sophistication. Here, both simple terms related to buried 
surface  area  and  more  sophisticated  continuum  electrostatics  models  are 
included. Different to other BAP models, in this work we do not limit ourselves to 
physic-based  descriptors  only.  A  number  of  statistical  potentials  and 
miscellaneous descriptors are also added to the descriptor set. The advantage of 
statistical potentials is that they implicitly capture a number of effects that are 
otherwise only modelled individually using physics-based terms. As pH can have 
a  significant  effect  on  binding  affinity,  even  over  a  narrow  range,  some 
descriptors  were  chosen  for  their  ability  to  account  for  variable  protonation 
states. PROPKA was used to determine the pH of the titratable amino acids (Bas 
et  al.,  2008).  The  most  probable  assignment  of  protonation  states,  at  the 
experimental pH, was determined using PDB2PQR (Dolinsky et al., 2004). These 
assignments were used in all of the descriptors calculated using the CHARM22 
forcefield, which are prefixed with ACE22.  
The two major introductions in the BAP model of this work relate to structural 
ensembles  and  unbound  structures.  These  are  described  in  the  following 
sections of 3.3.2.1 and 3.3.2.2 respectively. 
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3.3.2.1  Unbound-Bound Descriptors 
 
To  account  for  potential  conformational  changes,  descriptors  were  also 
calculated on the unbound receptor and ligand. Descriptor calculations ignored 
residues which were not in both the bound and unbound structures. In this way, 
any  energetic  differences  in  the  two  conformational  states,  is  irrespective  of 
additional  residues  in  the  bound.  All  descriptors  calculated  on  the  unbound 
structures have a suffix of ‘_UB’ and are calculated as: 
 
, ,u L, L,u ( ) ( ) UB R b R b E E E E E       3.2 
 
3.3.2.2  Descriptor Ensembles 
 
Proteins both in their unbound and bound forms do not exist as static structures. 
Rather they exist in a number of conformations of varying energetic accessibility 
(See section 1.5.2). As seen in equation in 1.17,  RL U and  RL W  are Boltzmann-
average potentials for the  potential energy and solvation  energy respectively. 
Also, equation 1.13 shows that only the low energy conformations contribute 
significantly  to  the  potential  energy.  Therefore  sampling only  the low  energy 
conformations  provides  a  sufficient  approximation.  To  generate  such 
conformational ensembles, the use of an approximate method CONCOORD (de 
Groot et al., 1997) was preferred to complex molecular dynamics simulations, 
mostly  due  to  computational  efficiency.  Unlike  MD  trajectories,  the 
conformations  generated  by  CONCOORD  have  no  dependencies  on  previous 
conformations;  consequently,  the  conformational  space  is  sampled  more 
broadly.  Comparisons  of  CONCOORD  simulations  against  MD  simulations  on 
common structures show great overlap in both the accessible motions and their 
magnitude (de Groot et al., 1997). 
For  each  example  in  the  benchmark,  an  ensemble  of  100  structures  was 
generated  using  CONCOORD  with  dynamic  tolerance  setting.  This,  for  each 
ligand,  receptor  and  complex.  Descriptors  are  then  calculated  on  these Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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ensembles and given that CONCOORD generates structures of equal plausibility, 
a mean value is taken over all ensembles for each descriptor. To distinguish them 
from  descriptors  calculated  on  a  single  static  structure,  the  ensemble 
calculations have a ‘_ENS’ suffix and are calculated as: 
 
, , L,b () ENS RL b R b E E E E      3.3 
For those descriptor calculations where the ensembles were calculated on the 
unbound ligand and receptor, a suffix of ‘_EBU’ was used, and calculated as: 
 
, ,u L, L,u ( ) ( ) EBU R b R b E E E E E       3.4 
 
3.3.3  Machine Learning Methods 
 
As highlighted in section 1.5.7.3 models for BAP have previously been limited to 
a sum of terms with the weights of each optimised using linear regression. Here, 
a selection of four machine learning methods was combined to form a consensus 
prediction, with the consensus prediction being the mean prediction of the four 
base models. It should be noted that more complex forms of ensemble learning 
are indeed possible (Wolpert, 1992). For example one may have a meta-learner 
learn  weights  for  each  base-learner  according  to  the  input  example  at  hand; 
however attractive, such methods would require a further validation set which is 
not available in this case. The four base models are the Random Forest (RF), the 
M5’ Regression Tree, the Multivariate-Adaptive-Regression-Splines (MARS) and 
the Radial Basis Function Interpolation (RBF) each of which are describe in the 
methods section 0. The aim was not to use the learning models in a black-box 
fashion  but  rather  the  selection  of  models  was  guided  by  the  following 
considerations: 
  Addressing limitations of linear regression. LR has been routinely applied 
to  protein-protein  affinity  prediction  methods.  The  ML  algorithms 
selected here aim to address some of the limitations LR would reach in 
our dataset and feature set. These include; inability to account for non-Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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linear relationships; inability to partition the input space and apply sub-
models; degradation in performance in high-dimensions. 
  Differing conceptual attributes.  The  prediction  of  each  of  the  four  ML 
models is combined to form a final prediction which is the mean of the 
four models. This is similar to a stacked learning methodology in its most 
basic form. Ideally for effective stacking, the base learning models should 
be  accurate  but  show  weak  correlation  between  their  predictions 
(Wolpert,  1992).  The  combination  of  all  four  base  models  would  then 
work synergistically rather than redundantly. To try and achieve this, the 
learners  were  chosen  on  the  basis  of  having  different  conceptual 
attributes in how they form their model. For instance, the RF is derived 
from the consensus of tree models trained on variable subsets of data and 
features. The M5’ method on the other hand is built using one complex 
tree model with the added flexibility of applying further regression sub-
models within the tree itself. Using its hinge functions, the MARS model 
works by allowing certain descriptors to contribute within certain ranges 
and  not  others.  Therefore,  it  can  exploit  the  ‘predictive’  parts  of  a 
descriptor and avoid the ‘noisy’ parts. Moreover, all of the methods above 
base their final prediction on a selection of features, rather than the whole 
available set. Therefore, depending on the final features selected by the 
model,  this  is  likely  to  add  some  variability  in  their  predictions.  The 
variability  in  the  features  making  it  to  each  of  the  final  models  is 
confirmed in the results section 3.4.5. Finally, the RBF method works in a 
completely  opposite  fashion  to  the  other  three  models.  Here,  the 
emphasis is placed on particular data-points that are furthest from the 
current  data-point.  Therefore,  the  RBF  uses  all  descriptors  but  not  all 
examples in its final model.  
  Overfitting avoidance. Given the large set of descriptors available to the 
models and the limited size of the training set, overfitting can be an issue. 
To  avoid  this,  the  methods  chosen  either  implicitly  or  explicitly  avoid 
overfitting.  RFs do not overfit as more trees are added. Rather, the test 
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achieve low bias predictions through trees built from different subsets of 
the data and descriptors, and low variance through averaging the output 
of all trees. The M5’ and MARS learners have inbuilt backward elimination 
routines to reduce model complexity, by the removal of tree branches and 
basis  functions  respectively.  Consequently,  both  of  these  operations 
reduce the number of features in the final model. In the RBF learner, the 
feature  weights  are  not  optimised.  With  this  in  mind,  an  outer-cross 
validation  loop  is  still  performed  for  benchmarking  the  predictions  of 
each model. 
  Parameter optimization. To avoid having to sacrifice data for parameter 
optimization, all  methods  chosen  are  known  to  work  well  under  their 
default  parameters  settings.  No  tweaking  of  learning  parameters  was 
therefore performed. 
  Interpretability and visibility. Understanding how the features are used in 
the final model was a key consideration for selecting the learners. Besides 
forming an accurate predictor of binding affinity, it is also important to 
ascertain the physical plausibility of the final models, by knowing which 
features are essential to the prediction and how they are employed by the 
model itself.  With the RF model, both global feature importance and case-
wise feature importance measures are available. The case-wise feature 
importance  measure  is  particularly  desirable.  For  example,  one  hopes 
that  having  descriptors  which  calculate  energetics  on  the  unbound 
structures of the complex would help the affinity prediction of complexes 
which  undergo  significant  conformational  changes.  Invoking  the  case-
wise  feature  importance  measure  one  could  verify  this  specifically  by 
checking whether the features on unbound structures are shown as being 
important  for  those  cases  which  undergo  significant  conformational 
change. The M5’ regression trees used, lack an inbuilt feature importance 
measure;  however,  the  trees  can  be  easily  visualized  and  feature 
importance  was  still  evaluated.  The  nature  of  the  MARS  model  basis 
functions, not only indicates which features form part of the final model, 
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function shows us the parts where the given feature has little influence, 
and where it positively contributes to the prediction. 
3.3.3.1  Random Forest (RF) 
 
A Matlab implementation of the RF algorithm, as described by (Breiman, 2001a), 
was used. The workings of the RF algorithm are detailed in section 2.3.1. In this 
implementation, the number of decision trees was set to 750 and, when building 
the  decision  trees,  the  mtry  parameter  was  limited  to  20  at  each  node;  no 
maximum was set on the three depths and the final prediction is returned as the 
mean of all trees.  
3.3.3.2  M5’ Regression Tree (M5’) 
 
The M5’ model tree is similar to standard regression trees with the additional 
possibility of having a linear regression model at the leaves (Quinlan, 1992). The 
workings of the M5’ algorithm are detailed in section 2.3.2. Rather than applying 
one M5′ to the full feature set, an ensemble of M5′ regression trees was used. In 
total 16 M5’ regression trees were divided into four tree sets of four. For each 
tree  set,  all  features  are  divided  randomly  into  four  feature  subsets.  Each 
different random feature subset is then used to train each of the four trees within 
this tree set. Therefore, for a given tree set, all features are available for use, but 
for each tree within the tree-set, a random subset of features is available. For 
prediction, the mean output of all of the 16 trees is used.  
3.3.3.3  Multivariate-Adaptive-Regression-Splines (MARS) 
 
MARS is a non-parametric regression method which uses a set of hinge functions 
to  model  non-linear relationships between  the  input variables and the target 
output (Friedman, 1991). Default values were used without tuning, as follows: 
the maximum limit on the number of basis functions grown in the forward phase 
is 21, there was no limit on the number of basis functions used in the final model 
after pruning. Model complexity is also limited by setting the knot-cost to the 
recommended value of two. Piece-wise cubic modelling was used to model hinge 
regions for smoother transitions. To keep the model as interpretable as possible, Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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no  self-interactions  between  input  variables  and  no  interactions  between 
variables  in  the  basis  functions  were  allowed.  The  ARESLab  toolbox 
implementation was used. 
 
3.3.3.4  Radial-Basis-Function Interpolation (RBF) 
 
A  Matlab  implementation  of  the  RBF  method,  as  section  2.3.4  was  used.  All 
descriptors values were normalized in the range [0, 1] before training. The key 
parameter in the RBF is the choice of the basis function. For this, the default 
multiquadric basis function was used. A unique characteristic for the RBF is that 
the model finds weights for examples as opposed to features. Therefore in this 
way, uninformative examples as opposed to uninformative features are weighted 
out of the model. 
3.3.4  Model Evaluation 
 
To assess our ability to model and predict binding affinities, leave-one-out cross-
validation (LOO-CV) was employed and the predicted affinities were compared 
to  the  experimental  affinities  using  Pearson’s  product-moment  correlation 
coefficient.  To  establish  significant  differences  in  correlations  achieved  by 
different models, a Fisher r to z transformation of the correlation coefficients 
was used.  
 
3.4  Results 
 
3.4.1  Model Performance on the Binding Affinity Benchmark – Validated Set 
 
Initially the four base learners (MARS, M5’, RF and RBF) were trained and tested 
using leave-one-out cross-validation on the validated set. The performance of 
which  is  shown  in  Figure  3.1  alongside  that  of  the  Consensus  model  (Cons.), 
which combines the prediction of the four base learners by taking the mean of 
their predictions.  Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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Figure 3.1: Model performance for the 57 complexes in the validated set.  
Correlation between the experimental and predicted binding affinities for the 
learners  and  their  consensus,  using  leave-one-out  cross-validation.  The 
potentials of Liu et al. (2004) (DFIRE) and Su et al. (2009) (PMF) are also shown 
for comparison. 
 
As a benchmark comparison, the performance of DFIRE (Su et al., 2009) and PMF 
(Liu et al., 2004) are also shown. To assess the effect of conformational changes 
on the prediction accuracy, performance is separately tested for cases which are 
rigid (Rig. with Calpha RMSD < 1.5 Å) and flexible (Flex. with Calpha RMSD > 1.5 Å). 
The  consensus  model  achieves  a  correlation  of  RVAL=0.77  with  experimental 
affinity, which is significantly higher than that achieved by the potentials PMF 
(RVAL=0.51 p=0.012) and DFIRE (RVAL=0.44 p=0.003).  
 
3.4.2  Model Performance on Binding Affinity Benchmark – Entire Dataset 
 
The  learners  presented  in  Figure  3.1  were  also  evaluated  on  the  remaining 
complexes that are not part of the validated set. To observe the performance 
over the complete dataset, the learners were trained on all 137 complexes, and 
the  leave-one-out  cross  validated  predictions  of  the  non-validated  complexes 
amalgamated with those of the validated set in Section 3.4.1. The correlations of 
the learners and experimental affinities, in a similar fashion to Figure 3.1, are 
presented in Figure 3.2. Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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Figure 3.2: Model performance for the 137 complexes in the whole 
benchmark. 
Correlation  between  the  experimental  and predicted binding affinities 
for the learners and their consensus. The potentials of Liu et al. (2004) 
(DFIRE) and Su et al. (2009) (PMF) are also shown for comparison. 
 
Though,  in  comparison  to  the  results  on  the  validated  set,  the  relative 
performance  of  the  four  base  leaners  changed,  the  consensus  model  still 
performs better than the most accurate base learner. In addition, the consensus 
model  achieves  significantly  higher  correlations  (RALL=0.7)  to  that  of  DFIRE 
(RALL=0.52, p=0.02) and PMF (RALL=0.62,p=0.03). 
Comparison  of  Figure  3.1  and  Figure  3.2  indicates  a  clear  drop  in  predictive 
power across all methods as experimental affinities that are not validated are 
used. One should note that, this drop is despite the fact that the validated set still 
has a proportion of non-rigid cases and interaction types similar to that of the 
entire  set  (see  section  2.1.1).  These  results  provide  strong  evidence  to  the 
importance  of  having  affinity  data  that  is  corroborated  using  different 
experimental techniques. To remove any possibility that this drop in accuracy is 
model  dependant,  a  number  of  methods  are  tested  on  the  37  complexes  for 
which predictions are available for all methods, and presented in Figure 3.3.  Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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Figure 3.3: Performance of the consensus model on the 37 complexes in the 
intersection between the dataset of (Kastritis and Bonvin, 2010) and the 
benchmark  (All),  and  the  14  in  the  intersection  with  the  validated  set 
(Validated).  
Leave-one-out cross-validation is used for the interactions which intersect the 
validated set. Correlations for a number of other energy functions are also shown 
(see Section 3.4). 
 
Comparing the performance of each method on all 37 complexes, and the 14 of 
which  are  validated,  a  consistent  trend  is  observed  were  methods  tend  to 
perform  better  on  the  validated  set.  Once  again,  here  it  is  shown  how  the 
consensus model is still the best performer, even on these specific test subsets. Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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Figure 3.4: Scatter plot for predicted and experimental affinities.  
Flexible (green circles) and rigid (red squares) proteins are shown. Leave-one-
out cross-validated values for the validated set are highlighted in solid. 
 
Figure 3.4 shows the scatter plot of predicted and experimental affinities were 
the validated complexes are marked in solid. There are two notable features, the 
first being the lower spread of points for the validated set. The second, that the 
dense  upper  left  corner  indicates  that  for  those  cases,  the  affinity  is 
overestimated. Given that most of these data-points are flexible complexes, the 
entropy loss due to conformational change is not characterised well enough to 
balance out the enthalpic contribution towards binding affinity. 
3.4.3  Consensus Model vs. a Single Learning Algorithm. 
 
The consensus model in all three data types (All validated RVAL=0.77, rigid RVAL-
RIG=0.9 and flexible RVAL-FLEX=0.59) achieves a correlation, which is higher or as 
good as the best base learner in the set. For example, M5’ achieves the highest 
correlation  of  RVAL-RIG=0.59  on  the  flexible  cases,  but  one  of  the  poorest  in 
predicting  the  rigid  cases.  In  the  latter  case,  the  RBF  achieves  the  highest 
correlation (RVAL-RIG=0.87) of all base learners. The consensus model is able to 
take the best of both worlds by achieving the highest correlations  in both of 
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synergistically  together  and  taking  the  mean  of  their  predictions  is  a  valid 
approach.  The  correlations  between  the  predictions  of  each  of  the  four  base 
learners, is also evaluated. As expected, the tree-based learners (RF and M5’) are 
highly correlated with R=0.95. The RBF method shows a correlation of R=0.87 
and R=0.86 with the RF and M5’ learners. The MARS model showed the least 
correlation  with  the  other  methods  (R=0.65,  R=0.69,  R=0.68,  respectively). 
Though this may suggest that the MARS is picking out features that the other 
learners  are  not,  one  must  also  keep  in  mind  that  the  MARS  model  was  the 
weakest learner of all.  
3.4.4  Descriptors Derived from Unbound Structures, Improves Performance for 
Flexible Cases. 
 
A key element of the BAP method developed in this work, as described in section 
3.3.2, is the introduction of ensembles and unbound structures. To determine the 
gain in having energetics calculated on the unbound and non-static structures as 
part of the model, the consensus model is trained on specific feature subsets. 
These  are:  the  UnBound  (UB)  subset;  features  calculated  on  the  unbound 
structures, the ENSemble subset (ENS); features calculated using the CONCOORD 
ensembles  of  the  bound  components,  the  Ensemble  Bound/Unbound  EBU: 
features calculated using the ensembles of bound and unbound structures and 
BASIC in which neither ensembles nor unbound structures are considered. The 
LOO-CV correlation achieved by training the consensus model on just the BASIC 
descriptors is used as a reference point to assess  gain or loss in predictive power 
by adding the UB, ENS, EBU features to this BASIC subset. 
 
 
 
 
 
 
 
 
 
 
 Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
89 
 
Table 3.1: Performance of the consensus model trained on different feature 
subsets.  
The  UB  subset:  features  calculated  on  the  unbound  structures,  ENS:  features 
calculated  using  the  CONCOORD  ensembles  of  the  bound  components,  EBU: 
features calculated using the ensembles of the bound and unbound structures 
and BASIC in which neither ensembles nor unbound structures are considered. 
The  correlation  achieved  by  training  the  consensus  model  on  just  the  BASIC 
descriptors is used as a reference point to assess what is gained by adding the 
UB, ENS, EBU features to this BASIC subset. All correlations shown are those 
between the LOO-CV predictions with the experimental affinities. 
Feature Subset  All  Rigid  Flexible 
BASIC  0.67  0.91  0.44 
BASIC+ENS  0.69  0.85  0.45 
BASIC+UB  0.74  0.91  0.47 
BASIC+EBU  0.73  0.90  0.54 
ALL  0.77  0.90  0.59 
 
The results are summarized in Table 3.1. First, it is noted that the addition of the 
unbound descriptors, both on the unbound static structures (UB) an d on the 
unbound ensemble structures (EBU), increases the correlations over the BASIC 
model. BASIC RVAL=0.67,  whereas  BASIC+UB  and  BASIC+EBU  models  achieve 
correlations of RVAL=0.74 and RVAL=0.73 respectively. This increase in the overall 
correlation results from the additional accuracy in predicting the flexible cases 
(from  RVAL-FLEX=0.44  to  RVAL-FLEX=0.47  and  RVAL-FLEX=0.54  for  BASIC,  BASIC+UB, 
BASIC+EBU respectively). In fact, the prediction of rigid cases remained constant 
at around RVAL-RIG=0.9. One should note however that the increase in correlation 
with the addition of the unbound descriptors is mostly evident when ensembles 
were calculated on the unbound structures. Conversely, the addition of bound 
ensembles (with no consideration of the unbound structures) to the BASIC set 
has,  as  expected,  no  effect  on  the  prediction  of  flexible  cases.  An  interesting 
result is that addition of ensembles actually degrades the signal for rigid cases 
(BASIC RVAL-RIG=0.91 and BASIC+ENS RVAL-RIG=0.85). This may be explained by 
some  conformational  ensembles  generated,  not  being  representative  of  those 
accessible by the rigid complex in question. It may be the case that, for these 
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generated by CONCOORD. This translates itself as noise added to the true signal 
to be captured. 
From these results, it can be concluded that the inclusion of descriptors derived 
from  the  unbound  structures  improves  the  performance  for  the  flexible 
complexes,  without  compromising  the  accuracy  for  the  rigid  cases.  This 
improvement is enhanced when used in combination with structural ensembles, 
despite  the  ensembles not  enhancing the  consensus model  when  information 
derived from the unbound structures is omitted. These results should still be 
treated  with  caution,  as  the  increases/decreases  in  correlation  are  not 
statistically significant with p<0.05 as the number of data-points is restricted to 
the 57 complexes in the validated set. Therefore, when the data allows, the same 
analysis  must  be  performed  again  on  a  larger  dataset  to  confirm  the  claims 
above.  With  this  in  mind,  one  complex,  which  for  example  shows  clear 
improvement  in  the  prediction  of  its  affinity  upon  the  inclusion  of  unbound 
descriptors, is the interaction between MK2 and p36 MAPK (PDB code, 2OZA). 
MK2  undergoes  a  significant  disorder-order  transition  upon  binding,  and  the 
strongest within the dataset. In this case, when training the consensus model on 
the  BASIC  set  of  features  (i.e.  not  including  unbound-bound  transitions),  the 
predicted  affinity  (17.4kcal  mol-1)  overestimates  the  experimental  affinity  of 
(11.7kcal mol-1). Once descriptors on the unbound were calculated, the learners 
are able to make use of available descriptors that calculate the entropy changes 
due  to  disorder-order  transitions,  and  the  predicted  affinity  (10.9kcal  mol-1) 
achieved was a closer approximation to the experimental affinity.  
3.4.5  Learning from the Learners – Assessment of the Physical Plausibility of the 
Learning Models and the Key Determinants of Affinity. 
 
One  of  the  driving  forces  behind  the  selection  of  the  base  learners  for  the 
consensus model is the interpretability of the models. In this section, the learnt 
models from each of the base learners, is probed further for validation of their 
selected features. 
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RF base learner: Both the global features importance and the case-wise feature 
importance measures are invoked for the RF learner which was trained on the 
full set of descriptors and validated set of affinities.  
 
Table 3.2: Top 10 most important descriptors using for the RF base learner 
trained on the validated set.  
Feature importance in this case is the mean decrease in normalised mean square 
error generated from the RF learner.  
Rank  Descriptor  Descriptor Importance 
1  ACE19_HYDR  0.100 
2  ROS_FA_ATR  0.094 
3  ACE22_VDW  0.094 
4  ROS_HBOND_ENS  0.078 
5  DDFIRE_ENS  0.076 
6  S_VIB  0.063 
7  MJ2H_PP  0.049 
8  ROS_FA_ATR_ENS  0.047 
9  MJ1_PP  0.046 
10  H_BOND_ENS  0.044 
 
The  top  10  most  important  features  making  up  the  RF  model  include  a 
combination of thermodynamic terms, statistical potentials and miscellaneous 
descriptors.  The  most  prominent  being  hydrophobic  burial  (ACE12_HYDR), 
London  dispersion  forces  (ROS_FA_ATR),  Van  der  Waals  (ACE22_VDW)  and 
hydrogen bonding (ROS_HBOND_ENS). Also ranked highly are the  change in 
vibrational entropy (S_VIB) and a number of statistical potentials (DDFIRE_ENS, 
MJ2H_PP and MJ1_PP). This confirms the physical plausibility of the model as it 
includes terms related to the  potential  and  solvation  energy  and  also those 
related to entropic contributions (See section 1.5). 
 From the top 10 descriptors, four terms are calculated on structural ensembles, 
but no descriptors using the unbound structures are listed. In section 3.4.4 it was 
shown that the introduction of UB and EBU descriptors improves the prediction 
of the flexible cases, the case -wise feature importance measure of the RF was 
invoked in order to understand whether the UB/ EBU descriptors were at least 
being invoked for the flexible cases. Here, a feature calculated using the unbound 
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complexes (55%). This compares to only 3 of the 28 rigid complexes (11%); this 
indicates, that to some extent, the learnt model is making correct use of the UB 
and EBU descriptors for the complexes that should gain from it. 
 
M5’ Base Learner: The full descriptor set was assigned randomly to the four sub-
trees within a tree set. A descriptor can therefore be in the final model of only 
one of the four sub-trees in a tree-set. This means that at most, a given descriptor 
can show up four times in the whole set of 16 M5’ trees. Each of the M5’ sub-tree 
models  was  analysed,  its  features  extracted and  their  occurrence  summed  in 
Table 3.3. 
 
Table  3.3:  Top  10  most  important  descriptors  using  for  the  M5’  base 
learner trained on the validated set.  
Descriptor importance refers to the number of times a descriptor is part of a sub-
tree. The maximum of which is four. 
Rank  Descriptor  Descriptor  Importance 
1  NSC  4 
2  OPUS PSP ENS  4 
3  ROS CG BETA  4 
4  ROS FA ATR  4 
5  BIOSIMZ KON  3 
6  DDFIRE ENS  3 
7  GEOMETRIC EBU  3 
8  H BOND  3 
9  INTERNAL UB  3 
10  NUM HB  3 
11  PLANARITY  3 
12  ROS FA REP ENS  3 
13  S R  3 
14  SKJG PP  3 
15  STC G ENS  3 
 
It  is  interesting  to  note  that  even  though  both  RF  and  M5’  are  tree  based 
algorithms,  only  a  few  descriptors  such  as  DDFIRE_ENS,  ROS_FA_ATR  and 
H_BOND  are  common  between  them  in  the  set  of  most  important  features. 
Similar to the RF, the most important descriptors in the case of the M5’ trees are 
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number  of  entropic  terms  are  available  to  the  learning  models,  besides  the 
change in vibrational entropy (S_VIB) and change in rotational entropy (S_R), 
entropic terms are not as common in the top features of the RF and M5’ models.  
 
MARS base learner: The MARS model trained on the validated set terminates with 
14 basis functions using a total of 10 descriptors. The descriptors are ranked 
according to their global importance to the model and presented in Table 3.4. 
 
Table  3.4:  Top  10  most  important  descriptors  using  for  the  MARS  base 
learner trained on the validated set.  
Descriptor importance is ranked according to the standard deviation (STD). As 
stated  by  Friedman  (1991),  the  STD  gives  an  indication  to  the  relative 
importance  of  the  descriptors  to  the  overall  model,  and  is  similar  to  a 
standardized  regression  coefficient  in  a  linear  model.  Shown  also  are  the 
generalized-cross-validation (GCV) scores. This represents the decrease in GCV 
upon  removal  of  the  descriptor.  Lastly,  #basis  indicates  the  number  of  basis 
function the descriptor is part of. 
 
 
 
 
 
 
 
 
Similar to the M5’ and RF models, the London dispersion term ROS_FA_ATR is 
the most prominent descriptor followed by the vibrational entropy term S_VIB. 
Other  descriptors  include  solvation  terms,  hydrogen  bonding  and  statistical 
potentials. Most significant here is that the MARS model makes use of a number 
of  descriptors  on  the  unbound  structures  (ROS_HBOND_UB,  OPUS_CA_UB, 
ROS_FA_PP_EBU, IRMSD). A key aspect of the MARS model is that it is able to 
assign a variable weight for each descriptor across its range. Effectively, it can 
choose to ignore the ‘noisy’ parts of a region of a descriptor by assigning a zero 
weight  within  that  region.  It  then  provides  a  weighting  to  more  informative 
Rank  Descriptor  STD / GCV/  #basis 
1  ROS FA ATR  0.618 / 0.690 / 2 
2  S_VIB  0.456 / 0.230 / 1 
3  ROS HBOND UB  0.365 / 0.071 / 2 
4  OPUS CA UB  0.364 / 0.065 / 2 
5  IRMSD  0.259 / 0.097 / 1 
6  OPUS PSP  0.191 / 0.048 / 1 
7  ROS HBOND  0.176 / 0.069 / 1 
8  SKOA PP  0.174 / 0.052 / 2 
9  ACE19 SOLV  0.172 / 0.062 / 1 
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regions of the descriptor. Such weights are presented and explained in Figure 
3.5.  
 
Figure 3.5: Descriptor contribution profiles for the descriptors selected by 
MARS.  
Normalised descriptor values are on the (x-axis) and normalised affiniies are on 
the (y-axis). The normalisation is such that 0 is the lowest affinity (ΔG = -5.66kcal 
mol-1) in the dataset and postively higher values indicate an increase in affinity 
(e.g at 0.53 the ΔG=-12.28kcal mol-1 and at 1 the ΔG=-18.04 kcal mol-1) The ‘+’ 
plots  show  the  experimental  normalised  affinities.  The  line  graphs  show  the 
contribution towards affinity from the basis functions of the given descriptor.  
 
For most of the data, ROS_FA_ATR’s contribution to the binding affinity linearly 
increases  with  more  favourable  dispersion  forces  (the  normalisation  in 
ROS_FA_ATR  is  such  that  0  is  highly  negative  in  energy).  However,  a  hinge 
function  models the outlier 2OZA to have a lower affinity then one would expect 
with its highly favourable dispersion forces  (owing to its large interface). The 
role of the hinge function is to compensate for the entropy reduction resulting 
from the disorder to order transitions occurring in a loop and at the C-terminal 
region of 2OZA. The second most significant descriptor is the vibrational entropy 
term S_VIB. At low values, its contribution is approximately zero, but becomes 
linear for higher values. This is consistent with the interpretation that, because 
this descriptor is approximate (Carrington and Mancera, 2004), the learner is 
presumably choosing to use it when its contribution to the binding energy is 
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performed  with  linear  regression  and  such  a  descriptor  might  be  completely 
down weighted and not form any significant contribution to the final model.  
 
RBF base learner: The RBF model does not learn weights on descriptors, rather it 
down weights and up weights examples according to how much they help the 
prediction of other examples. The prediction function of the RBF model takes the 
form of  
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Where u is the mean of the training affinities. The affinity prediction of a complex 
x, is lower than the mean affinity if ai is negative, and higher if ai is positive. The 
magnitude of this deviation from the mean depends on how many complexes are 
furthest from it in feature space. Conversely, the closer it is to complexes in the 
training set, the closer is its predicted affinity to the mean. The weights ai learnt 
by the RBF function trained on the validated set are presented in Figure 3.6. High 
affinity complexes tend to have a negative weight ai. This means that if a complex 
affinity is to be predicted, the further in feature space it is from high affinity 
complexes,  the  lower  from  the  mean  its  affinity  would  be.  Effectively  this 
translates to a low affinity prediction. In this way, the model is a plausible and 
the coefficients learnt are in line with what one would expect to see. One may 
also appreciate that certain complexes have an ai very close to zero and have no 
significant contribution in the final RBF model. 
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Figure 3.6:  The distribution of regression coefficients  learnt by the RBF 
model versus binding affinity.  
Negative  coefficients  weaken  the  predicted  affinity  of  complexes  far  away  in 
feature space. Positive coefficients strengthen the predicted affinity of complexes 
far away in feature space. 
 
3.5  Discussion 
 
This work on binding affinity prediction is a first in many ways. Previous to the 
described consensus model, the datasets used to train and benchmark models 
did not include a diverse enough set of complex families with a wide range of 
conformational changes. There were no such limitations to this study. Namely; 
both the unbound and bound structures were considered; energetics were also 
calculated  on  a  set  of  sampled  conformational  states;  and  complexes  from  a 
variety of complex families, undergoing a broad range of conformational changes 
included. The use of non-linear machine learning methods for the prediction of 
affinities  was  also  put  forward  as  an  alternative  to  linear  regression.  The 
consensus  model,  which  is  the  mean  prediction  of  four  machine  learning 
algorithms, achieves a correlation with experimental binding affinities of R=0.77 
on a validated set of experimental affinities. The consensus model outperforms 
other previously published methods both on this dataset and when tested on 
different subsets of the dataset. 
Two major influences on the prediction of affinities. The results from this work 
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ability  to  accurately  predict  affinities  for  flexible  cases  (those  undergoing 
significant conformational change) as opposed to rigid cases. To address this, 
several descriptors related to entropy were included, along with calculations of 
descriptors on the unbound complexes. Such additions specifically increased the 
accuracy of flexible complexes, yet correlations are still in the region 0.6 with 
experimental  affinities.  On  the  other  hand,  for  rigid  cases  (RVAL-RIG=0.9),  the 
RMSE of 1.67 kcal mol-1 is within the variation expected due to experimental 
errors and unaccounted environment factors, around 1.4 kcal mol-1 (Kastritis et 
al., 2011). A second finding, and that which had a striking effect on the prediction 
of  affinities,  is  the  training  and  benchmarking  of  models  on  affinities 
corroborated  by  different  experimental  methods  or  studies;  one  should  be 
critical of generalizations concerning the importance of descriptors when used in 
models  trained  on  non-validated  affinities  as  the  descriptors  in  such  models 
might be only acting as noise-compensators rather than their intended purpose. 
Linear regression models are even more susceptible to using descriptors in this 
unintended way.  
Consistent  determinants  of  affinity.  In  this  work,  four  machine-learning 
algorithms,  with  different  conceptual  attributes,  were  used.  Their  prediction 
outputs  were  then  combined  in  a  consensus  model.  Analysis  of  the  most 
important  descriptors  for  each  model  showed  that  certain  descriptors  were 
common  to  all models. This  inspite  of the ML algorithms having significantly 
different  methods  in  the  way  they  build  their  models.  Such  consistent 
descriptors include; London dispersion forces (ROS_FA_ATR), several hydrogen 
bonding  terms,  and the  change  in  vibrational  entropy  (S_VIB).  The  two  most 
common statistical potentials were the DDFIRE and OPUS PSP. For the most part 
however,  descriptors  which  were  important  to  each  model  for  its  prediction 
were not shared across models. Again, this should be taken into consideration 
when making outright claims on the importance of a descriptor from the feature 
importance list of only one learning model.  
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Binding affinity prediction methods published after this work. Subsequent to the 
work  described  in  this  chapter,  three  notable  BAP  methods  were  published 
(Vreven et al., 2012, Yan et al., 2013, Ma et al., 2014), all of which use the same 
benchmark set of complexes used in this work (Kastritis et al., 2011). In the work 
of Vreven et al. (2012), a linear combination of nine terms (ZAPP) achieves a 
correlation coefficient of RALL=0.63 with the whole benchmark of experimental 
affinities. This is in comparison to RALL=0.55 that was achieved in this work, on 
the same full benchmark. Given the reduction in accuracy reported in this thesis 
work when complexes with non-validated experimental affinities are used, the 
subset  of  predictions  from  ZAPP  which  form  part  of  the  validated  set  were 
extracted. The correlation for the whole validated set, rigid and flexible subsets 
respectively, were (RVAL=0.72, RVAL-RIG=0.78, RVAL-FLEX=0.65). This in comparison 
to  the  consensus  model  of  this  thesis  with  (RVAL=0.77,  RVAL-RIG=0.9,  RVAL-
FLEX=0.59). The higher accuracy (RALL=0.55) achieved on the whole benchmark by 
ZAPP, is most likely due to the fact that most of the terms in their final model are 
residue-based,  which  as  they  claim,  introduce  less-noise  than  atomic-based 
terms. With this in mind, once the validated set is considered, ZAPP performs 
worse than the consensus model reported in this work, most notably for the rigid 
cases. One should also note that in ZAPP, no unbound structures are used for the 
calculation  of  descriptors.  Yet  still,  the  correlation  on  the  flexible  cases  is 
consistent and better than the consensus model. Interestingly, the only feature 
which may account for the flexible cases in ZAPP is ‘MisRes’. This feature counts 
the number of residues in the interface that are present in the bound, but not in 
the unbound form (Vreven et al., 2012). One point that is not clear in the ZAPP 
method is how the final set of nine features are chosen in the final model. The 
authors’ state that they were chosen from a larger set of features, yet details on 
any separate dataset for this feature selection is not given. Therefore, one could 
not rule out biased results. A second work which attempts BAP on the same 
benchmark set of structures, is the scoring function SPA-PP (Yan et al., 2013). 
Here, a statistical potential which incorporates both the specificity and affinity of 
an interaction into the optimisation is developed. Comparison is only provided 
on the whole benchmark where SPA-PP achieves (RALL=0.39, RALL-RIG=0.63, RALL-
FLEX=0.24),  compared  to  (RALL=0.55,  RALL-RIG=0.70,  RALL-FLEX=0.36)  for  the Chapter 3. A Model for Protein-Protein Binding Affinity Prediction 
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consensus model developed in this chapter. The third BAP method developed 
after the publication of the consensus model was that of Ma et al. (2014). A RF 
learner is trained on a set of 154 features and the method benchmarked on a test 
set  of  31  samples,  which  is  a  subset  of  the  affinity  benchmark.  The  authors’ 
correlation on this 31 sample test set is RSAMPLE=0.91, compared to RSAMPLE=0.89 
for the consensus model and RSAMPLE=0.88 for the ZAPP method (Vreven et al., 
2012). On this test set, there are no significant differences between the three 
methods. An interesting aspect of the work of Ma et al. (2014), is the attempt to 
introduce categorical variables which indicate what type of complex family the 
interaction is part of. In theory, this could lead the algorithm to apply different 
models according to the complex family. However, the authors failed to note that 
RF would only make a split and apply separate models if the immediate split 
decreases the MSE. To achieve the intended goal of the authors, one would need 
look-ahead-regression models, or explicitly separate models for each complex 
family type. 
Future  directions.  The  prediction  of  protein-protein  binding  affinities  would 
benefit from the derivation of features, which are able to accurately characterise 
the affinity of complexes that undergo significant conformational changes and 
account for entropic contributions. As starting points, it has been shown in this 
work how the vibrational entropy term and the inclusion of unbound structures 
into  the  modelling  process,  improve  the  prediction  of  these  flexible  cases. 
Similarly the ‘MisRes’ feature developed in ZAPP (Vreven et al., 2012) has an 
equally contributing effect. It might be the case that the descriptors for rigid 
complexes and flexible complexes are incompatible within the same model. To 
rule out this effect, models specifically trained on flexible cases only should be 
investigated.  This  principle  could  also  be  applied  to  complexes  derived  from 
different functional families. As stated by Wallqvist et al. (1995), though the free 
energy  change  of  binding  has  many  known  contributions,  it  is  not  always 
possible to invoke any general statements about the relative importance of each 
of these terms, as diverse arrangements occur that can contradict any attempted 
generalizations. For example, though on average the protein interface is more 
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hydrophobic  residues  at  an  interface  reveals  a  larger  variability  than  in  the 
interior of proteins (Tsai et al., 1997). In addition, there are many examples of 
complexes whose interfaces are largely hydrophilic  in nature (Xu et al., 1997). 
This provides two possible routes for future BAP methods; The first one, having 
family-specific  models  for  complexes  of  different  biological  function  that  are 
further partitioned according to the extent of predicted conformational change 
upon complex formation. The second and alternative route is that of having one 
learning model and with carefully designed descriptors which together are able 
to account for such diversity. Therefore further investigations on ML models and 
categorical descriptors of this sort I feel is a fruitful pursuit in this regard. 
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Chapter 4 
4 Models for Predicting Changes in 
Binding Affinity upon Mutation 
4.1  Introduction 
 
Having an accurate binding affinity predictor is straightforwardly generalizable 
to  the  prediction  of  changes  in  binding  affinity  upon  mutation.  Rather  than 
predicting the affinity of a number of unrelated complexes, the problem shifts to 
that of predicting the affinity of a single complex and a number of mutations 
applied to it. Effectively, models for the prediction of wild-type binding affinities, 
as  presented  in  Chapter  3,  are  a  precursor  to  affinity  optimisation  in 
computational drug design methods (Fleishman et al., 2011).  
This chapter specifically deals with the design of a scoring function which is able 
to rank order tentative mutations on a computationally designed interface. Such 
a scoring function must be able to detect those few rare mutations that are able 
to enhance the affinity of the designed interaction, even further. For practical 
purposes, the detection of these beneficiary mutations must also be accompanied 
by a low number of false-positives. Both the design and benchmarking of the 
scoring function developed in this work, is benchmarked in a special round of 
CAPRI (Round 26), on two targets T55 and T56, described below in section 4.2. Chapter 4. Models for Predicting Changes in Binding Affinity upon Mutation 
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Traditionally,  CAPRI  is  a  blind-trial  community-wide  benchmark  for  docking 
algorithms. In this round however, the structures of the target complexes were 
given, and the task for the community was to predict the effect on binding for 
each  mutation  in  a  large  set  of  around  1800  single-point  mutations  on  two 
hemagglutinin influenza protein binding constructs. CAPRI round 26 was divided 
into two phases, and the prediction models designed for each are detailed in 
sections 4.3.1 and 4.4.1 respectively. In sections 4.3.2 and 4.4.2, the results for 
our laboratory’s model predictions and all the participant groups are presented 
for round 1 and round 2 respectively. Throughout both rounds, most particularly 
in the detection of the rare beneficiary mutations, the model derived in this work 
was one of the top performing predictors (Moretti et al., 2013). The novelties, 
merits and shortcomings of this approach are discussed in sections 4.3.2, 4.4.2 
and 4.4.3. 
 
4.2  CAPRI Round 26 Targets T55 and T56: Blind Trial Prediction of 
Mutations on de novo Protein Drugs to Bind the Flu Virus 
Hemagglutinin. 
 
In  (Fleishman  et  al.,  2011),  two  computationally  designed  hemagglutinin 
influenza protein construct binders HB36.4 and HB80.3 (See Figure 4.1) were 
used as a starting point for a large set of single-point mutants to further enhance 
the affinity of their interaction. For each of the 53 and 45 positions of HB36.4 
(T55) and HB80.3 (T56), single-point mutations were created to all 20 amino 
acids. An experimental enrichment value, used as a proxy for ΔΔG, was measured 
for each of the mutations as described in (Moretti et al., 2013, Whitehead et al., 
2012).  
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Figure 4.1: The structures of (A) HB36 (B) HB80 in complex with the flu 
virus hemagglutinin.  
Residues for which experimental enrichment values were available and given to 
the community are in orange; the remainder are in grey. Interface residues are 
shown  as  sticks.  As  observed,  mutations  on  these  residues  may  also  affect 
binding by affecting monomer stability. Figure taken from (Moretti et al., 2013). 
 
The participants were asked to rank the mutations according to how beneficiary 
they are to the stability of the complex on an arbitrary scale of 0-1. In addition, it 
was  also necessary to  assign  a  class to  each  mutation  (beneficial / neutral  / 
deleterious). As starting structures, HB36.3 (PDB code, 3R2X) and HB80.4 (PDB 
code, 4EEF) were provided to the community. The difference between HB36.3 
and HB36.4, and their respective  wild-type structures, on which experimental 
mutations were made and measured, is a K64N mutation for HB80.4, and the 
mutations G12K, L17I, L21I, A35K and S42K for HB80.3. Two phases were set for 
the community. In the first, participants had to make predictions on 1007 and 
856 mutations for T55 and T56 respectively. In the second, the enrichment ratios 
of  half  of  the  mutations  for  each  residue  site  mutated  were  given  to  the 
community to train on. In this way it could be evaluated to which extent the 
prediction is enhanced upon having some mutational data on the complexes in 
question. 
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4.3  CAPRI Round 26 Targets T55 and T56: Round 1 
 
4.3.1  Dataset / Molecular Descriptors / Learning Model and Training Results 
 
The  problem  of  predicting  the  enrichment  ratio  for  the  single-point  mutants 
defined in section 4.2 was treated as a ΔΔG prediction problem i.e. predicting the 
change  in  binding  affinity  upon  mutation.  The  methodology  employed  was 
similar to the one used in Chapter 3. The major difference is that whereas for the 
wild-type ΔG prediction in Chapter 3, calculations on molecular descriptors took 
the form of 
  ΔG = Complex – (Receptor + Ligand)  4.1 
Here, for the change in binding affinity, the following equation was used 
  ΔΔG = [Complex – (Receptor + Ligand)]MUT –  
[Complex – (Receptor + Ligand)]WT 
4.2 
Training  dataset:  A  training  set  of  mutations  was  first  compiled  from  the 
literature. This amounted to a dataset of 645 single-point/multi-point mutations 
(with  experimentally  measured  ΔΔGs)  on  40  protein-protein  complexes 
determined by X-ray crystallography. 
Molecular feature set. Taking note of the successful features (a combination of 
physics-based,  statistical  potentials  and  miscellaneous  descriptors)  for  the 
consensus wild-type binding affinity models described in Chapter 3, a series of 
features were similarly calculated. These include a number of energy terms from 
FoldX (Carra et al., 2012, Schymkowitz et al., 2005), CHARMM (Brooks et al., 
2009), PyRosetta (Chaudhury et al., 2010) and STC (Lavigne et al., 2000). These 
include  all  of  the  standard  thermodynamic  equations,  including  solvation, 
electrostatics and entropy terms. In addition a number of statistical potentials 
were also calculated DFIRE/DCOMPLEX (Zhang et al., 2004), OPUS-PSP (Lu et al., 
2008), GOAP (Zhou and Skolnick, 2011) , GEOMTRIC and DECK (Liu and Vakser, 
2011).  Finally,  miscellaneous  descriptors  such  as  the  change  in  solvent 
accessibility  and  change  in  normalised  solvent  accessibility,  residue 
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were also calculated (Mitra and Pal, 2010). Since monomer stability may also 
effect binding indirectly, some of the statistical potentials included are originally 
folding potentials. In addition I-Mutant 2.0 (Capriotti et al., 2005), a predictor of 
changes in protein stability upon mutation, was also added to the feature set. 
Unbound  structures  of  the  complex  were  not  considered  in  the  calculations; 
however, 100 structural ensembles were generated using CONCOORD (de Groot 
et al., 1997), and feature calculations averaged over these structures. 
Model training results: The RF regression algorithm was employed for learning 
and  prediction.  The  number  of  forest  trees  was  set  to  1000  and  the  mtry 
parameter to 15. To assess the generalization ability of the RF model, in advance 
of  predictions  for  round  1,  a  10-fold  cross-validation  was  performed.  A 
correlation coefficient of R=0.86 between experimental and predicted ΔΔGs was 
achieved, the scatter plot of which is shown in the left hand panel of Figure 4.2.  
 
Figure  4.2:  Cross-validated  test  predictions  for  the  RF  model  on  645 
experimental  single-point  and  multi-point  ΔΔGs  for  40  protein-protein 
complexes.  
Experimental ΔΔG values are shown on the x-axis and predicted ΔΔG values on 
the  y-axis.  10-fold  cross-validation  is  shown  in  left  panel.  To  gain  a  more 
representative generalization ability of the blind prediction on T55 and T56, a 
leave-complex-out cross-validation was also performed (right panel). Here all 
mutations of a particular complex are left out as a test set in each fold.  This has 
the  effect  of  underestimating  the  magnitude  of  affinity  increasing/decreasing 
mutations. 
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Leave-complex  out  cross  validation,  where  a  whole  complex  along  with  its 
respective  mutations  is  taken  out  for  each  fold,  was  also  performed.  The 
correlation  coefficient  in  this  scenario  dropped  to  R=0.73  (Figure  4.2  right 
panel), but gives a better indication of the model’s generalization ability when 
making predictions on unseen complexes such as those for T55 and T56. 
4.3.2  Affinity Prediction Results on T55 and T56 
 
The  Capri  organisation  committee  required  participants  to  submit  both 
numerical  and  categorical  predictions  for  the  1007  and  856  single-point 
mutations on T55 and T56 respectively. For the numerical predictions, the RF 
predictions were scaled to [0, 1] with the ΔΔG=0 neutral point at 0.8246. Using 
the unscaled prediction from the RF, the thresholds for destabilizing, neutral and 
stabilizing mutations were set at ΔΔG > 1 kcal mol-1, 0 kcal mol-1 < ΔΔG < 1 kcal 
mol-1 and ΔΔG < 0 kcal mol-1 respectively. After submission of all participant 
predictions,  results  for  the  continuous  predictions  were  evaluated  using  the 
Kendall tau-b correlation to the log2 (enrichment ratio) values. In this metric, all 
possible pairs of predictions are evaluated as concordant (e.g. enrichment 1 > 
enrichment 2 and prediction 1 > prediction 2) or discordant (e.g. enrichment 1 > 
enrichment 2 and prediction 1 < prediction 2). Then 
Tau-b = (concordant pairs – discordant pairs) / NxNp, 
Where Nx and Np are the number of total pairs not tied on experimental and 
predicted values, respectively. For categorical prediction, the F1-score was used 
(see methods section 2.4. 
Figure 4.3 and Figure 4.4 show the results for the 22 participant groups. The 
reference BLOSUM62 prediction is highlighted in blue, and our group (G05s) is 
highlighted in green. For numerical predictions, our model performs worse than 
BLOSUM 62. Numerical predictive performance is largely affected by how well 
the  destabilizing mutations  are ranked against  each other. For computational 
design purposes however, the interest lies more in the ability to detect those few 
mutations  that  are  beneficial  (Moretti  et  al.,  2013),  irrespective  of  how  well 
destabilizing  mutations  are  ranked  against  each  other.  For  HB36  (T55), Chapter 4. Models for Predicting Changes in Binding Affinity upon Mutation 
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beneficial mutations amount to only 3.4% of the substitutions, and only 2.4% for 
HB80 (T56) (Moretti et al., 2013). In contrast to the performance on numerical 
predictions,  our  RF  model  excels  at  the  categorical  detection  of  beneficial 
mutations. For T55, our group ranked 1st from the 22 groups (F1-Score=0.34), 
and 6th on T56 (F1-Score=0.14). From 22 groups, only our model and two other 
were able to achieve precisions better than 10% for both proteins (Moretti et al., 
2013). 
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Figure 4.3:  CAPRI 26, target T55 round 1, prediction performance of all 
participant groups. 
 A number of residue sites on T55 are mutated to each of the 20 amino-acid 
residues and an experimental enrichment ratio (proxy to the ΔΔG) is measured 
for each. This amounts to 1007 mutations on T55, for which the participants 
were  asked  to  submit  their  blind  predictions.  Predictions  were  submitted  in 
numerical  form,  scaled  in  the  range  of  [0,1]  according  to  how  beneficial  the 
mutation  is  thought  to  be.  The  groups’  numerical  predictions  are  ranked 
according to the Kendall’s tau (top panel). Predictions were also submitted in 
categories (Deleterious/Neutral/Beneficial) and the F1-Score used for ranking 
the performance of the beneficial mutation detection (bottom panel). In blue are 
the reference BLOSUM62 predictions and in green (group G05s) the prediction of 
our group. 
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Figure 4.4:  CAPRI 26, target T56 round 1, prediction performance of all 
participant groups.  
A number of residue sites  on  T56 are mutated to  each of the  20 amino-acid 
residues and an experimental enrichment ratio (proxy to the ΔΔG) is measured 
for each. This amounts to 856 mutations on T56, for which the participants were 
asked to submit their blind predictions. Predictions were submitted in numerical 
form, scaled in the range of [0,1] according to how beneficial the mutation is 
thought to be. The groups’ numerical predictions are ranked according to the 
Kendall’s  tau  (top  panel).  Predictions  were  also  submitted  in  categories 
(Deleterious/Neutral/Beneficial)  and  the  F1-Score  used  for  ranking  the 
performance of the beneficial mutation detection (bottom panel). In blue are the 
reference BLOSUM62 predictions and in green (group G05s) the prediction of 
our group. 
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After careful analysis of the results, two things in our methodology might have 
negatively affected our predictions. Firstly, our descriptor calculations were not 
performed on the exact structures used to derive the experimental enrichment 
ratios from the mutations. T55 differed by one mutation to the structure our 
calculations were made on, however T56 differed by 5 mutations. Given that 
each residue site was mutated to every other possible residue, then 1.9% (19 of 
1007 mutations) and 11% (95 of 855 mutations) of mutation predictions, were 
affected  for  T55  and  T56  respectively.  In  addition  to  this,  the  results  for 
neighbouring  residues  which  were  also  mutated  are  also  affected. Given  that 
>95% of all residues of T55 and T56 were mutated, it is reasonable to assume 
that for each mutated residue site, there are at least 3 other residues sites in 
contact with it which are also mutated (and hence required predictions for). This 
potentially increases the amount of mutations affected for T55 and T56 to ~6% 
and  ~30%  respectively.  Hence,  whereas  for  T55  the  predictions  are  largely 
unaffected, the results for T56 must be treated with caution. This also should 
explain why the performance on T56 was markedly lower than that of T55. A 
second  aspect  of  our  methodology  which  could  have  negatively  affected  the 
results,  was  the  use  of  the  coarse-grain  conformational  ensembles  generated 
using the program CONCOORD.  The subtle effect of the single-point mutations 
for which predictions were to be made, was more than likely subdued by the 
conformations  generated  by  CONCOORD.  In  fact  redoing  the  methodology 
without the CONCOORD structures revealed that this was a significant source of 
error. With this  in mind the  use of such ensembles  was  avoided in  round  2, 
however  structures  used  remained  the  same  and  thus  predictions  for  T56 
remained severely constrained even in round 2.   
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Figure 4.5: Depiction of the Capri 26, round 2, strategy. 
 (A) For each mutated site, the participants were given the enrichment values for 
9  randomly  selected  mutations  to  train  upon.  Our  approach  was  to  try  and 
uncover correlations between similar residues at a given site. A Position-Specific 
Model (PSM) was built for this purpose at each mutated site. This PSM model 
learns why at a given mutation-site, certain mutations have similar Enrichment 
Ratios (ER). For example, the residue groups (A,R,S) in blue and (F,Y) in yellow 
depicted above. (B) Shows a toy-example of a tree model that might be learnt at a 
given mutation-site using the amino-acid properties from  
 
Hydrophobicity <0.4 
Bulkiness < 0.5 
ER = 1.8 
ER = -3 
Charge > 
0.75 
ER = 0.05 
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Table 4.1 as features. 
4.4  CAPRI Round 26 Targets T55 and T56: Round 2 
 
To test whether having some mutational data on T55 and T56 available to the 
participants,  would  help  prediction,  an  extended  round  of  predictions  was 
performed. For each residue position, the experimental enrichment values for 
half  of  the  mutations  were  given  to  the  participants.  The  9  mutations  were 
selected randomly at each position. The task for the community was to make 
predictions on the remaining half of mutations at each position as depicted in 
Figure 4.5. 
 
4.4.1  Design of a Position Specific Model for ΔΔG Prediction 
 
The most straightforward use of the additional mutation data provided in round 
2, is to use it to extend the ΔΔG training dataset built in round 1, and retrain the 
RF model. However, this method does not exploit the wealth of information we 
have at each position and a novel position-specific model (PSM) was developed 
for this extended round. This position specific model is based on the hypothesis 
that 
 ‘At a given position, ‘similar’ residue substitutions should act ‘similarly’’ 
The emphasis here is that similar residues should act similarly only at a given 
residue site i.e. where the context surrounding is controlled for, and constant. By 
‘act  similarly’  the  hope  is  that  similar  residues  would  have  comparable 
enrichment  ratios.  The  central  issue  to  this  method  is  that  defining  residue 
similarity  is  non-trivial,  and  depends  on  what  amino-acid  property  one 
considers. For example at one residue site, the enrichment ratios for leucine are 
similar to other hydrophobic residue mutations, whereas at another residue site, 
they  are  more  similar  to  mutations  to  large  residues.  Therefore,  rather  than 
limiting  ourselves  to  one  specific  amino-acid  property  for  calculating  residue 
similarity,  the  similarity  was  instead  learnt  using  a  learning  model.  More 
precisely,  a  site-specific  model  learns  which  properties  are  indicative  of Chapter 4. Models for Predicting Changes in Binding Affinity upon Mutation 
113 
 
correlations  between  enrichment  values  for  a  set  of  amino  acids  at  a  given 
position. For each residue site (53 positions on T55 and 46 positions on T56), the 
9 training mutations, for which the enrichment ratios were available, were used 
as training data for a RF regression model. The feature set of which, consisted of 
a set of amino-acid properties shown in  
Table 4.1. The prediction of enrichment ratios for each residue site therefore 
has, their own unique RF model, training data, and features as depicted in Figure 
4.5. 
 
Table 4.1: A selection of amino-acid properties that form the feature set 
available to each PSM model.  
Feature Type   Amino-Acid features 
Numerical  Hydrophobicity 
Numerical  Isoelectric point  
Numerical  Molecular weight 
Categorical  Acyclic 
Categorical  Aliphatic 
Categorical  Hydrophobic 
Categorical  Negative 
Categorical  Positive 
Numerical  Hydropathy 
Numerical  Solvation Potential 
Numerical  Linker Propensity 
Numerical  Surface Exposure 
Numerical  Polarity 
Numerical  Hydrophobicity 
Numerical  Flexibility 
Numerical  Coil Propensity 
Numerical  Bulkiness 
 
To estimate the generalization ability of the PSM model in advance of the round 2 
predictions, 9-fold CV was performed at each position. The PSM-Score achieved 
an Area Under the Curve (AUC) value of 0.88 for T55 and 0.83 for T56 assuming 
enrichment ratio of >0 as stabilizing. For the predictions on the blind test set of 
1040 mutations as required for round 2 of Capri 26, the thresholds for beneficial 
mutations were taken at > 0.5 and > -1 for T55 and T56 respectively. Chapter 4. Models for Predicting Changes in Binding Affinity upon Mutation 
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4.4.2  Results for T55 and T56 using PSMs 
 
Similar metrics to the ones described in section 4.3.2 in round 1 were used to 
assess  the  predictions  of  all  participants.  Numerical  prediction  performance 
ranked  according  to  the  tau-b  metric  and  detection  of  beneficial  mutations 
ranked according to F1-Score. The results for all participant groups are shown in 
Figure 4.6 for T55 and Figure 4.7 for T56. The BLOSUM62 is highlighted in blue 
as a reference and our laboratory’s group (G05s) predictions in green. Our model 
for  T55  ranked  1st  in  both  the  numerical  estimation  (Kendal-tau=0.51)  and 
categorical prediction of beneficial mutations (F1-Score=0.49). For T56 results 
were also consistent for the numerical estimation of enrichment ratios, ranking 
2nd with Kendal-tau of 0.41. The detection of beneficial mutations however was 
not satisfactory and ranked very low with and F1-Score of 0.12. The discrepancy 
in performance for T56 on the detection of beneficial mutations is more than 
likely due to using a structure which differed by 5 mutations to that on which the 
experimental mutations were made on. The improvement in results from round 
1  to  round  2,  which  is  shared  across  most  of  the  groups,  clearly  shows  that 
indeed  having  some  mutational  information  on  the  complex  in  question 
increases prediction performance. With this in mind, the only other group to 
show similar success to our group (G-21 Fernandez Recio) was the only other 
group to exploited positional information in their model. In their case, rather 
than having regression models unique to each position, amino-acid properties 
were added to the feature-set. Though not a purely position specific model, the 
learner in this  case  is potentially able  to  exploit  correlations  across different 
mutations using their amino-acid properties. Monomer stability may still affect 
binding indirectly and accounting for monomer stability was also found to be a 
key component in the top performing groups, including our own (Moretti et al., 
2013).  
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Figure 4.6: CAPRI 26 T55, round 2 prediction performance of all participant 
groups.  
A number of residue sites  on  T55 are mutated to  each of the  20 amino-acid 
residues and an experimental enrichment ratio (proxy to the ΔΔG) is measured 
for each. Round 2 differs from round 1 in that at each residue site mutated, the 
enrichment  ratios  of  10  randomly  selected  mutations  are  given  to  the 
participants to train upon. The participants are asked to make predictions on the 
remaining mutations. Predictions were submitted in numerical form, scaled in 
the range of [0,1] according to how beneficial the mutation is thought to be. The 
groups’  numerical  predictions  are  ranked  according  to  the  Kendall’s  tau  (top 
panel).  Predictions  were  also  submitted  in  categories 
(Deleterious/Neutral/Beneficial)  and  the  F1-Score  used  for  ranking  the 
performance of the beneficial mutation detection (bottom panel). In blue are the 
reference BLOSUM62 predictions and in green (G05s) are the prediction result 
assessment scores from our group. 
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Figure 4.7: CAPRI 26 T56, round 2 prediction performance of all participant 
groups. Figure legend details as for Figure 4.8. 
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4.4.3  Contribution of the PSM Model to Prediction Accuracy 
 
Though the groups exploiting positional information were identified as the top 
performing groups in Capri 26 round 2, to assess whether the PSM-Score was in 
fact  the  driving  force  behind  the  success  of  our  results,  further  analysis  was 
performed. Three sets of test predictions on T55 were generated. Training was 
performed on half of the T55 mutations given in round 1 and testing performed 
on the second half. T56 was excluded from this analysis as part of the structure 
was incorrect (see section 4.3.2). The first set ‘All Molecular’, refer to predictions 
from  a  RF  model  trained  on  the  feature  set  compromising  of  all  molecular 
features described in 4.3.1 (i.e. without the PSM-Score as a feature). A second set 
‘PSM-Score’, are predictions from the PSM model and a third set, predictions 
from  a  RF  model  trained  on  all  features  including  the  PSM-Score  combined. 
Several classification measures (described in methods section 2.4) were used to 
assess the performance of each model and presented in Table 4.2. The PSM-Score 
on its own (F1-Score=0.571) performs markedly better than the ‘All Molecular’ 
model (F1-Score=0.273). The addition of the PSM-Score with the ‘All Molecular’ 
feature set improves the performance over that of the ‘All Molecular’ set (F1-
Score=0.444).  To  further  confirm  the  prominence  of  the  PSM-Score,  the  RF 
feature  importance  measures  were invoked  for the  model  trained  on  the  ‘All 
molecular’ features and that when the PSM-Score was added to the feature set. 
The  top  10  features  are  presented  in  Table  4.3.  These  include,  statistical 
potentials, OPUS_PSP  (Lu et al., 2008), and  GOAP  (Zhou and Skolnick, 2011), 
together  with  physics-based  terms  such  as  the  Lenard-Jones  repulsive  terms 
(fa_rep) from PyRosetta (Chaudhury et al., 2010) and FoldX (Schymkowitz et al., 
2005);  and  the  position  of  the  applied  mutation  as  captured  by  its  solvent 
accessibility using Naccess. Upon including the PSM-Score to this feature set, the 
RF model ranks it as the most important feature, superseding the importance (5-
Fold increase  over 2nd ranked descriptor) of any other molecular  descriptor 
available. From these results, we can conclude that the success of our group’s 
predictions for T55 in Round 2 was mostly attributed to the PSM-Score. 
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Table  4.2:  Classification  Performance  for  3  RF  Classifiers  on  T55  Test 
Mutations.  
All RF Models are trained on half of the T55 mutations (enrichment ratios) given 
to the participants of Capri 26 round 1. Performance shown in table that of the 
test predictions for the remaining half of the T55 mutations (enrichment ratios). 
‘All Molecular’, refer to predictions from a RF model trained on the feature set 
compromising of all molecular features described in 4.3.1 (i.e. without the PSM-
Score  as  a  feature).  A  second  set  ‘PSM-Score’,  are  predictions  from  the  PSM 
model  and  a  third  set,  predictions  from  a  RF  model  trained  on  all  features 
including the PSM-Score combined. 
  Feature Set  TPR  FPR  MCC  F1  Acc  Spec  Prec  Rec 
All Molecular  0.158  0.000  0.391  0.273  0.969  1.000  1.000  0.158 
PSM-Score  0.421  0.002  0.603  0.571  0.977  0.998  0.889  0.421 
All Molecular + PSM-Score  0.316  0.004  0.475  0.444  0.971  0.996  0.750  0.316 
 
 
Table 4.3: Comparison of Top 10 Features for ‘All Molecular’ Model and ‘All 
Molecular + PSM-Score’ Model. 
 Importance is extracted from the in-built RF feature importance measure. 
                       All Molecular                                All Molecular + PSM-Score 
Feature Name  RF 
Importance    Feature Name  RF 
Importance 
fxGOAP2  209.6    PSM-Score  853.7 
SolvAccessNorm  181.7    fxGOAP2  151.8 
fxOPUS1  171.4    SolvAccessNorm  117.4 
pyfa_rep  164.9    fxOPUS1  99.6 
fxGOAP1  127.4    pyfa_rep  96.7 
fxfa_rep  126.1    fxGOAP1  94.0 
SolvAccess  101.6    fxfa_rep  78.4 
dFOLDX  96.6    SolvAccess  74.6 
fxvdwaals  92.5    fxOPUS3  72.1 
fxelec  81.6    Fxvdwaals  66.6 
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4.5  Discussion and Conclusions 
 
The blind test trial in the first round, were no mutational information was given 
for the targets in question, does highlight the current inability to characterise 
mutations  on  unseen  complexes  for  most  models.  The  mean  and  maximum 
values from all participating groups show an increase in predictive performance 
upon  the  availability  of  mutational  information  on  the  target  complexes  (See 
Table 4.4). 
Table 4.4: Performance comparison of group predictions for T55 and T56 
from round 1 to round 2. 
 Shown are the mean Kendall-tau and F1-Score values for all groups; the Kendall-
tau and F1-Score values for the best performing group; the Kendall-tau and F1-
Score values for our Laboratory’s group (G05s). 
Performance 
Measure  Round 1  Round 2 
(available mutational information) 
  T55  T56  T55  T56 
Kendall-tau 
(mean / max / 
G05s) 
0.14 / 0.30 /  
0.09 
0.09/ 0.23 /  
0.09 
0.21 / 0.51 / 
0.51 
0.21 / 0.42 / 
0.41 
F1-Score 
(mean / max / 
G05s) 
0.11 / 0.34 /  
0.34 
0.12 / 0.26 / 
0.14 
0.19 / 0.49 / 
0.49 
0.16 / 0.5 /  
0.11 
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Figure 4.8: Plot of the AUC for the detection of beneficial mutations vs. that 
of deleterious mutations. 
 Left  panel  HB36  (T55)  and  right  panel  HB80  (T56).  Black  circles  show  the 
prediction  for  the  first  round  and  blue  squares  show  the  predictions  for  the 
second round. The AUC values for the BLOSUM prediction are indicated by an 
orange  diamond  and  grey  dotted  line.  Figure  taken  from  supplementary 
information of (Moretti et al., 2013). 
A  similar  observation  is  made  on  assessment  of  the  AUCs  when  having  no 
mutational information (Figure 4.8 black dots) to having mutational information 
(Figure  4.8  blue  dots).  Though  clearly  present,  targeting  the  source  of  this 
reduction  in  ability  to  predict  changes  in  binding  affinity  upon  mutations  on 
complexes not in the training set is not trivial. This may be due to insufficiently 
diverse datasets of protein-protein structures on which training is performed or 
an underrepresentation of certain residue types. For example most ΔΔG training 
sets are dominated by alanine-scanning data. The training set derived from the 
literature for the training of our round 1 model contained > 50% single-point 
alanine mutations. In contrast, only 5% of the mutations on T55 and T56 were 
alanine  mutations.  This  also  stresses  the  importance  of  performing  leave-
complex-out  and  more  stringent  forms  of  cross  validation  which  account  for 
related complexes when evaluating models for ΔΔG prediction (Moal et al., 2011, 
Lise et al., 2011).  
Whereas  the  participant’  results  from  round  2  show  that  the  availability  of 
mutational  information  for  the  complex  on  which  other  mutations  must  be 
predicted, helps this endeavour, the PSM model takes this one step further. This, Chapter 4. Models for Predicting Changes in Binding Affinity upon Mutation 
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by showing that the availability of mutational information at the given site on 
which  other  mutations  must  be  predicted,  helps  further  the  prediction. 
Interestingly  enough,  an  approach  similar  to  the  one  taken  here,  with  the 
difference that it is applied for the ΔΔG of protein stability and not binding, also 
confirmed  that  using    known  ΔΔG  values  of  mutations  at  the  query  position 
improves the accuracy of ΔΔG predictions for other mutations in that position 
(Wainreb  et  al.,  2011).  Unfortunately,  the  necessity  of  this  site  specific 
mutational informational for training, limits the PSMs application, as rarely is 
such experimental data on binding available. 
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Chapter 5 
5 Prediction of Hotspot Residues on 
Protein-Protein Interfaces 
 
5.1  Introduction 
In Chapters 6-8, a number of descriptors derived from hotspot counts, energies 
and distribution are designed. These are termed as hotspot descriptors, and are 
used  for  characterizing  the  change  in  off-rate  of  protein  interactions  upon 
mutation. To generate the hotspot descriptors six hotspot prediction algorithms 
are used. Two are designed in this work; RFSpot and RFSpot_KFC2. In addition, 
hotspot  descriptors  were  also  generated  using  publicly  available  hotspot 
predictors  KFC2  (KFC2a,  KFC2b)  (Zhu  and  Mitchell,  2011)  and  Hotpoint 
(RFHotpoint1, RFHotpoint2) (Tuncbag et al., 2010).   
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5.2  Methods 
 
5.2.1  RFSpot and RFSpot_KFC2 
 
For training and benchmarking the hotspot predictors RFSpot and RFSpot_KFC2, 
the SKEMPI alanine dataset described in 2.1.4 is used. For each training example 
in  the  dataset  and  hence  wild-type  complex  PDB  structure,  a  number  of 
molecular  descriptors,  describing  various  aspects  of  the  interaction,  were 
calculated.  These  descriptors  have  already  proven  successful  in  our  previous 
work related to the prediction of wild-type binding free energies (Moal et al., 
2011) and wild-type kinetic rate constants (Moal and Bates, 2012). A full list and 
explanation of the molecular descriptors can be found in the Table 2.1 under the 
column  HS.  After  calculation  of  the  molecular  descriptors  on  the  wild-type 
complex  PDB  structure,  each  respective  structural  mutation  was  made  using 
FoldX  (Schymkowitz  et  al.,  2005)  and  the  same  set  of  molecular  descriptors 
recalculated. Each descriptor, fed into the learning model, is determined as the 
difference between the mutant and wild-type descriptor value: 
  MUT WT
Desc Desc Desc E E E      5.1 
 
As a learning algorithm the Random Forest (RF) classifier model is employed 
(Breiman,  2001b),  using  1000  trees  and  an  mtry  (i.e.  number  of  random 
variables sampled as candidates for a split) of 15. The RF learner is well suited 
for high dimension datasets, such as the one described here with 110 features. 
Throughout  the  thesis,  this  RF  hotspot  classifier  algorithm  is  referred  to  as 
RFSpot. RFSpot_KFC2 is a similar classifier model to RFSpot with the difference 
that  it  adds  to  the  110  molecular  features  set,  13  features  from  the  original 
KFC2a and KFC2b models. These include: res_hp, pos_per, delta_tot, core_rim, rot5, 
plast4, plast5, fp10 from KFC2a and res_size, ratio5, rot4, hp5, fp9 from KFC2b. 
Details on the calculation of each specific descriptors are described in (Zhu and 
Mitchell, 2011), most notably they include features which position the mutation 
using  solvent  accessibility.  This  enables  the  model  to  exploit  the  fact  that Chapter 5: Prediction of Hotspot Residues on Protein-Protein Interfaces 
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hotspots tend to occur in regions of low solvent accessibility (Bogan and Thorn, 
1998) and is the key difference between RFSpot and RFSpot_KFC2. 
5.2.2  RFHotpoint1, RFHotpoint2, KFC2a and KFC2b 
 
Similar to RFSpot and RFSpot_KFC2, RFHotpoint1 and RFHotpoint2, are Random 
Forest hotspot classifiers trained on the SKEMPI alanine dataset which use only 
features  from  the  original  Hotpoint  server  as  features.    These  include: 
relativeComplexASA,  relativeMonomerASA,  pairPotential,  complexASA  as 
described in (Tuncbag et al., 2010). RFHotpoint2 differs from RFHotpoint1 in that 
for the former, the threshold is lowered to allow for more hotspot detections at 
the cost of a higher FPR. The reason behind developing the RFHotpoint models is 
due to the fact that the original Hotpoint server does not associate an energetic 
or confidence value to its hotspot prediction, hence hotspot descriptors which 
make use of hotspot energies cannot be calculated. RFHotpoint models therefore 
enable us to use Hotpoint features, trained on a larger dataset of SKEMPI instead 
of  ASEdB  (as  in  the  original  Hotpoint  algorithm)  and  most  importantly, 
associated confidence values to our hotspot predictions using the Random Forest 
model. To validate RFHotpoint1 and RFHotpoint2 as a representative alternative 
to Hotpoint, predictions from Hotpoint server were generated for the SKEMPI 
alanine  dataset.  Any  prediction  for  mutations  also  in  ASEdB  where  removed 
since Hotpoint uses ASEdB as training data. The predictions are compared to the 
20-fold test predictions of RFHotpoint1 and RFHotpoint2 for the same mutations 
and classification results are shown below in Table 5.1. Both RFHotpoint1 and 
RFHotpoint2  achieve  higher  MCCs  than  Hotpoint  and  are  therefore  fare 
representations of this hotspot predictor. 
Table 5.1: Performance comparison of RFHotpoint1 and RFHotpoint2 with 
server prediction of Hotpoint on SKEMPI. 
Hotpot Predictor  TPR  FPR  MCC  F1  Acc  Spec  Prec 
Hotpoint  0.500  0.379  0.113  0.424  0.584  0.621  0.368 
RFHotpoint1  0.360  0.128  0.268  0.437  0.715  0.872  0.554 
RFHotpoint2  0.570  0.303  0.253  0.505  0.658  0.697  0.454 
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For KFC2a and KFC2b, no models needed to be re-trained again, as the original 
predictions from KFC2 server have associated with them an energetic value that 
can be directly used for the calculation of the hotspot descriptors. 
5.2.3  Generation of Hotspot Energies 
 
In the Random Forest classifier model used in RFSpot, RFSpot_KFC, RFHotpoint1 
and RFHotpoint2, each tree in the 1000-tree forest makes is own class prediction 
(Hotspot  /  Non-Hotspot)  of  the  mutation  in  question.  The  class  which 
accumulates the majority of tree-votes, is the predicted class, and the difference 
in the number of votes for the hotspot class relative to the non-hotspot class 
(VotesHotspot- VotesNon-Hotspot ) indicates the model’s confidence in the predicted 
class. In this work, these confidence values are used as an estimation of hotspot 
ΔΔGs. The rationale is that the higher the confidence value, the more trees have 
predicted this to be a hotspot, implying that larger numbers of different feature 
subsets consider this to be a hotspot also. Given that several different aspects of 
the protein interaction have vouched for the example to be a hotspot, then it is 
expected  that  the  hotspot  ΔΔG  is  larger  in  magnitude.  To  confirm  this,  RF 
regression models are trained on the same training data as RFSpot, RFSpot_KFC2, 
RFHotpoint1  &  RFHotpoint2  RF  classifiers,  in  order  to  generate  true  ΔΔG 
predictions and compared to the confidence values generated by each of them. 
Note that RFHotpoint1 and RFHotpoint2 use same confidence values and only 
differ by their threshold on those confidence values; hence one correlation for 
the  confidence  values  is  presented  for  both.  The  confidence  values  of  the 
classifier  models,  show  correlations  of  R=0.88,  R=0.86,  R=0.86  with  the 
regression models’ ΔΔG predictions for RFSpot, RFSpot_KFC2 and RFHotpoint1 & 
2 respectively. Therefore, apart from the differences in their absolute values, the 
confidence  values  do  provide  relative  values,  which  have  a  direct  linear 
relationship to ΔΔG. On assessment of the MCCs of the regression RF models at a 
threshold of >=2 kcal/mol, the regression models achieve lower MCCs to that of 
the classifier models, all of which are the result of higher FPR. Given that 75% of 
the ΔΔG data is of the negative non-hotspot class, minimal increases in the FPR 
add  a  significant  number  of  false-positives,  which  would  subdue  the  gain  of 
additional  hotspots,  correctly  detected.  Therefore  the  use  of  a  classifier  in Chapter 5: Prediction of Hotspot Residues on Protein-Protein Interfaces 
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RFSpot,  RFSpot_KFC2,  RFHotpoint1  and  RFHotpoint2,  enables  us  to  achieve  a 
lower false positive rate, to that of a regression model, but still be able to have 
confidence values that relate directly to ΔΔG.  For the sake of simplicity, we refer 
to the ΔΔG confidence values extracted by the method described here as ΔΔGs. 
 
5.3  Results 
5.3.1  Performance of Hotspot Predictors on the SKEMPI Alanine Dataset 
 
The  predictive  accuracy  of  the  hotspot  predictors  from  which  the  hotspot 
descriptors  are  generated  from  (i.e.  RFSpot,  RFSpot_KFC2,  RFHotpoint1, 
RFHotpoint2, KFC2a and KFC2b), is assessed on the SKEMPI alanine dataset using 
a  number  of  classification  performance  measures.  All  hotspot  prediction 
algorithms and performance measures in this section are related to how well the 
hotspot  predictors  are  able  to  detect  ΔΔGs  of  single-point  alanine  mutations 
which  satisfy  ΔΔG  >  2kcal/mol  i.e.  the  prediction  of  hotspots.  For  RFSpot, 
RFSpot_KF2, RFHotspoint1 & RFHotpoint2, the prediction results from a 20–Fold 
cross-validation are used, whereas for KFC2a and KFC2b the predictions from 
KFC2 (Zhu and Mitchell, 2011) server are used. Note that for KFC2a and KFC2b, 
the predictions for the data, which is in SKEMPI and not in ASEdB is presented, 
as KFC2 server algorithm uses ASEdB mutations for model design and training. 
The  predictions  are  compared  to  a  number  of  hotspot  prediction  algorithms 
(KFC2  (Zhu  and  Mitchell,  2011)  HotPoint  (Tuncbag  et  al.,  2010),  Robetta 
(Kortemme and Baker, 2002), RFMirror (Wang et al., 2012), and TSVM (Lise et 
al.,  2009)).  Details  on  each  hotspot  predictors  and  the  sources  of  their 
predictions are presented in Table 5.2. 
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Table 5.2. Summary of hotspot predictors benchmarked in this work and the 
datasets used. 
Hotpot Predictor  Description and Source of Predictions 
RFSpot 
RFSpot*:  Random  Forest  Model  trained  on  SKEMPI 
alanine data, with molecular features. 
RFSpot_KFC2*:  Random  Forest  Model  trained  on 
SKEMPI  alanine  data,  with  molecular    features  and 
features from KFC2a and KFC2b for which KFC2a and 
KFC2b  Features  from  KFC2  server  where  available. 
Random  Forest  threshold  adjusted  to  achieve  same 
FPR of RFSpot for comparison. 
KFC2 (Zhu and Mitchell, 2011) 
KFC2a_Orig: uses predictions on ASEdB. 
KFC2b_Orig: uses predictions on ASEdB 
KFC2a *: uses server predictions on SKEMPI alanine 
data which is not in ASEdB from KFC2 Server 
KFC2b*: uses server predictions on SKEMPI alanine 
data which is not in ASEdB from KFC2 Server 
Robetta (Kortemme and Baker, 2002)  Robetta: uses predictions on ASEdB. 
Hotpoint (Tuncbag et al., 2009) 
Hotpoint_Orig: uses predictions on ASEdB. 
Hotpoint  uses  server  prediction  on  SKEMPI  alanine 
data which is not in ASEdB  from Hotpoint Prediction 
Server 
RFHotpoint1*:  Random  Forest  Model  trained  on 
SKEMPI alanine data, with original Hotpoint Features  
for  which  Hotpoint  Features  from  Hotpoint  server 
where available 
RFHotpoint2*:  Random  Forest  Model  trained  on 
SKEMPI  alanine  data,  with  Hotpoint  Features  for 
which Hotpoint Features from server where available. 
Random Forest Threshold lowered to allow for more 
TPs 
RFMirror (Wang et al., 2012)  RFMirror: uses predictions on ASEdB. 
SVM score (Lise et al., 2009)  SVM score: uses predictions on ASEdB. 
TSVM score  (Lise et al., 2009)  TSVM score: uses predictions on ASEdB. 
 
* Indicate Hotspot Predictors used for the generation of hotspot descriptors  
The performance of each hotspot predictor is shown in the Table 5.3. The test 
sets on which the performance measures are calculated, are different for each 
predictor.  Namely,  each  test  set  is  the  intersection  between  SKEMPI  and  the 
original test set used in each respective work. The highest MCC is achieved by 
TSVM score (Lise et al., 2011). Note however that, though ranked according to 
MCC,  Table  5.3  shows  their  performance  on  different  mutations,  therefore 
cannot be relatively compared. A relative comparison between two predictors 
can  only  be  performed  on  the  intersections  of  mutations  for  which  both 
algorithms have unbiased predictions for. Since the all-vs-all comparison of the 
hotspot predictor algorithms is beyond the scope of this work, the comparison is 
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and  RFSpot_KFC2.  Given  that  RFSpot  and  RFSpot_KFC2  both  use  SKEMPI,  the 
dataset intersection with other predictors’ datasets is the same. First, for each 
predictor, the test set intersection with SKEMPI is extracted, and each predictor’s 
performance  on  this  intersection  is  shown  in  Table  5.4.  For  comparison,  the 
performance of RFSpot  and RFSpot_KFC2 on these same dataset intersections is 
presented in Table 5.5 and Table 5.6 respectively. Therefore the performance 
values  in  corresponding  cells  of  in  Table  5.4,  Table  5.5  and  Table  5.6  are 
comparable. For better visual inspection, in blue are highlighted the instances in 
which  RFSpot  or  RFSpot_KFC2  perform  better  than  the  respective  hotspot 
predictor. RFSpot_KFC2 outperforms all hotspot predictors with the exception of 
TSVM (Lise et al., 2011).  TSVM achieves a higher MCC as a result of a higher TPR, 
though RFSpot_KFC2 achieves higher accuracy specificity and precision than that 
of TSVM. With this, it can be concluded that RFSpot_KFC2 is as good as the best 
hotspot prediction algorithm available. This gives confidence that the hotspot 
predictions  from  RFSpot_KFC2  that  will  be  used  in  further  chapters  for  the 
generation  of  hotspot  descriptors  and  off-rate  prediction  are  high  quality 
predictions. 
Table 5.3. Performance of Hotspot Descriptors - part 1. 
Performance of Hotspot Predictors on intersection of original data used in 
original hotspot predictors and SKEMPI. Predictors are ranked according to MCC. 
Predictor 
Intersection 
with SKEMPI 
TPR  FPR  MCC  F1  Acc  Spec  Prec 
TSVM score  TSVM score  0.673  0.136  0.508  0.619  0.823  0.864  0.574 
RFSpot_KFC2*  RFSpot_KFC2*  0.490  0.083  0.452  0.560  0.814  0.917  0.652 
SVM score  SVM score  0.615  0.152  0.438  0.566  0.798  0.848  0.525 
RFMirror  RFMirror  0.500  0.094  0.434  0.545  0.816  0.906  0.600 
KFC2a*  KFC2a*  0.734  0.279  0.402  0.568  0.724  0.721  0.463 
KFC2b  KFC2b  0.452  0.103  0.383  0.509  0.789  0.897  0.583 
Hotpoint_Orig  Hotpoint_Orig  0.552  0.196  0.368  0.593  0.707  0.804  0.640 
KFC2b*  KFC2b*  0.436  0.129  0.328  0.477  0.764  0.871  0.526 
Robetta  Robetta  0.458  0.155  0.295  0.440  0.769  0.845  0.423 
RFSpot*  RFSpot*  0.268  0.083  0.237  0.350  0.761  0.917  0.506 
RFHotpoint1*  RFHotpoint1*  0.319  0.125  0.229  0.395  0.711  0.875  0.517 
RFHotpoint2*  RFHotpoint2*  0.504  0.277  0.218  0.466  0.658  0.723  0.433 
KFC2a_Orig  KFC2a_Orig  0.258  0.124  0.159  0.314  0.727  0.876  0.400 
Hotpoint  Hotpoint  0.500  0.379  0.113  0.424  0.584  0.621  0.368 
* Indicate Hotspot Predictors used for the generation of hotspot descriptors. 
 
 
 Chapter 5: Prediction of Hotspot Residues on Protein-Protein Interfaces 
129 
 
Table 5.4: Performance of Hotspot Predictors on SKEMPI part 2. 
Performance  of  Hotspot  Predictors  on  intersection  of  original  data  used  in 
original hotspot predictors and SKEMPI. Positioned for comparison with Table 
5.5 and Table 5.6. 
Predictor 
Intersection 
with SKEMPI 
TPR  FPR  MCC  F1  Acc  Spec  Prec 
RFSpot_KFC2*  RFSpot_KFC2*  0.490  0.083  0.452  0.560  0.814  0.917  0.652 
RFSpot*  RFSpot*  0.268  0.083  0.237  0.350  0.761  0.917  0.506 
KFC2a*  KFC2a*  0.734  0.279  0.402  0.568  0.724  0.721  0.463 
KFC2b*  KFC2b*  0.436  0.129  0.328  0.477  0.764  0.871  0.526 
Hotpoint  Hotpoint  0.500  0.379  0.113  0.424  0.584  0.621  0.368 
RFHotpoint1*  RFHotpoint1*  0.319  0.125  0.229  0.395  0.711  0.875  0.517 
RFHotpoint2*  RFHotpoint2*  0.504  0.277  0.218  0.466  0.658  0.723  0.433 
KFC2a_Orig  KFC2a_Orig  0.258  0.124  0.159  0.314  0.727  0.876  0.400 
KFC2b_Orig  KFC2b_Orig  0.452  0.103  0.383  0.509  0.789  0.897  0.583 
Robetta  Robetta  0.458  0.155  0.295  0.440  0.769  0.845  0.423 
Hotpoint_Orig  Hotpoint_Orig  0.552  0.196  0.368  0.593  0.707  0.804  0.640 
RFMirror  RFMirror  0.500  0.094  0.434  0.545  0.816  0.906  0.600 
SVM score  SVM score  0.615  0.152  0.438  0.566  0.798  0.848  0.525 
TSVM score  TSVM score  0.673  0.136  0.508  0.619  0.823  0.864  0.574 
* Indicate Hotspot Predictors used for the generation of hotspot descriptors 
 
Table 5.5: Performance of RFSpot and Hotspot Predictors .  
Performance of RFSpot on intersection of original data used in original hotspot 
predictors  and  SKEMPI.  Highlighted  in  Blue  are  instances  where  RFSpot 
performs better than respective hotspot predictor, as compared with values in 
the corresponding cells of  Table 5.4. 
Predictor 
Intersection 
with SKEMPI 
TPR  FPR  MCC  F1  Acc  Spec  Prec 
RFSpot  RFSpot_KFC2*  0.268  0.083  0.237  0.350  0.761  0.917  0.506 
RFSpot  RFSpot*  0.268  0.083  0.237  0.350  0.761  0.917  0.506 
RFSpot  KFC2a*  0.255  0.080  0.230  0.340  0.756  0.920  0.511 
RFSpot  KFC2b*  0.255  0.080  0.230  0.340  0.756  0.920  0.511 
RFSpot  Hotpoint  0.279  0.118  0.199  0.361  0.698  0.882  0.511 
RFSpot  RFHotpoint1*  0.291  0.110  0.223  0.374  0.713  0.890  0.526 
RFSpot  RFHotpoint2*  0.291  0.110  0.223  0.374  0.713  0.890  0.526 
RFSpot  KFC2a_Orig  0.323  0.072  0.316  0.417  0.781  0.928  0.588 
RFSpot  KFC2b_Orig  0.323  0.072  0.316  0.417  0.781  0.928  0.588 
RFSpot  Robetta  0.417  0.062  0.418  0.500  0.835  0.938  0.625 
RFSpot  Hotpoint_Orig  0.310  0.087  0.287  0.429  0.680  0.913  0.692 
RFSpot  RFMirror  0.296  0.079  0.272  0.376  0.784  0.921  0.516 
RFSpot  SVM score  0.269  0.073  0.252  0.350  0.786  0.927  0.500 
RFSpot  TSVM score  0.269  0.073  0.252  0.350  0.786  0.927  0.500 
* Indicate Hotspot Predictors used for the generation of hotspot descriptors.  
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Table 5.6: RFSpot_KFC2 and Hotspot Predictors. 
Performance of  RFSpot_KFC2 on intersection of original data used in original 
hotspot  predictors  and  SKEMPI.  Highlighted  in  Blue  are  instances  where 
RFSpot_KFC2  performs  better  than  respective  hotspot  predictor  as  compared 
with values in the corresponding cells of  Table 5.4. 
Predictor 
Intersection 
with SKEMPI 
TPR  FPR  MCC  F1  Acc  Spec  Prec 
RFSpot_KFC2  RFSpot_KFC2*  0.490  0.083  0.452  0.560  0.814  0.917  0.652 
RFSpot_KFC2  RFSpot*  0.490  0.083  0.452  0.560  0.814  0.917  0.652 
RFSpot_KFC2  KFC2a*  0.500  0.098  0.436  0.556  0.803  0.902  0.627 
RFSpot_KFC2  KFC2b*  0.500  0.098  0.436  0.556  0.803  0.902  0.627 
RFSpot_KFC2  Hotpoint  0.535  0.133  0.424  0.582  0.765  0.867  0.639 
RFSpot_KFC2  RFHotpoint1*  0.511  0.113  0.431  0.574  0.776  0.887  0.655 
RFSpot_KFC2  RFHotpoint2*  0.511  0.113  0.431  0.574  0.776  0.887  0.655 
RFSpot_KFC2  KFC2a_Orig  0.452  0.082  0.419  0.528  0.805  0.918  0.636 
RFSpot_KFC2  KFC2b_Orig  0.452  0.082  0.419  0.528  0.805  0.918  0.636 
RFSpot_KFC2  Robetta  0.583  0.052  0.583  0.651  0.876  0.948  0.737 
RFSpot_KFC2  Hotpoint_Orig  0.483  0.087  0.451  0.596  0.747  0.913  0.778 
RFSpot_KFC2  RFMirror  0.500  0.063  0.495  0.581  0.841  0.937  0.692 
RFSpot_KFC2  SVM score  0.519  0.068  0.499  0.587  0.844  0.932  0.675 
RFSpot_KFC2  TSVM score  0.519  0.068  0.499  0.587  0.844  0.932  0.675 
* Indicate Hotspot Predictors used for the generation of hotspot descriptors. 
 
5.4  Discussion 
 
In  this  chapter,  the  computational  prediction  of  hotspot  residues  was 
investigated. Using a large set of mutations from SKEMPI, two hotspot predictors 
were  built  and  benchmarked  against  a  number  of  hotspot  predictors.  Both 
RFSpot  and  RFSpot_KFC2  use  a  set  of  statistical  and  physical  descriptors  to 
characterize the ΔΔG of the mutated residue in question. In addition to these 
features, RFSpot_KFC2 also uses features which estimate the local flexibility of 
the  neighbouring  residues,  and  the  solvent  accessibility  of  the  residue  in 
question. To maintain an unbiased prediction scheme, based purely on molecular 
and  physical  descriptors,  the  inclusion  of  such  descriptors  in  RFSpot  is 
intentionally  avoided,  and  this  is  the  probable  reason  for  its  low  TPR.  It  is 
understood that the addition of descriptors which relate to solvent accessibility 
may  increase  the  TPR  of  RFSpot  as  this  would  enable  the  RF  learner  to 
distinguish between mutations performed at the core as opposed to those at the 
rim, where less hotspots occur (Bogan and Thorn, 1998). Indeed, it has been 
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sensitivity of 0.87 (i.e. TP/(TP+FN)) for the BID test set (Zhu and Mitchell, 2011). 
This is also confirmed using RFSpot_KFC2 which introduces features related to 
solvent accessibility and upon setting the threshold to achieve the same FPR to 
that  of  RFSpot,  the  TPR  is  increased  from  0.27  (in  RFSpot)  to  0.49  (in 
RFSpot_KFC2).  With  this  in  mind,  low  solvent  accessibility  is  not  a  sufficient 
indicator of hotspots as most residues at the core are still non-hotspots (Bogan 
and  Thorn,  1998,  Zhu  and  Mitchell,  2011).  Such  models  are  biased  towards 
predicting hotspots at the core regions and may lay the risk of not being able to 
detect mutations in other regions, as accurately. The risk is higher if the training 
set is small and other regions outside the core are underrepresented. Though 
RFSpot_KFC2 uses such solvent accessibility descriptors, the model uses other 
molecular features and is trained on a more diverse alanine dataset of SKEMPI as 
opposed to the ASEdB. The use of a data-partitioning model such as the random 
forest is particularly useful in this scenario; as it is able to characterize mutations 
in regions of low solvent accessibility with different features to those in regions 
of high solvent accessibility. 
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Chapter 6 
6 Characterizing Change in Off-Rate 
upon Mutation using Hotspot 
Energy and Architecture 
 
‘Non agunt nisi fixat’ - A substance will not work unless it is bound [Paul Ehrlich] 
 
6.1  Introduction 
 
In this chapter, the stability of protein-protein complexes is further probed using 
features and models specifically designed for the prediction of off-rates. Several 
mutational studies show that the off-rate can be independently modulated with 
no change to on-rate of an interaction (Moal and Fernandez-Recio, 2012), which 
suggests that at least in particular situations, some energetic factors are specific 
to the off-rate. As described in section 2.1.2, in contrast to on-rates, the off-rates 
are generally insensitive to ionic strength (Moore et al., 1999, Alexander-Brett 
and Fremont, 2007) indicating short-range forces should be more prominent. In 
the  work  of  Moal  and  Bates  (2012),  a  large  set  of  molecular  descriptors  are  
133 
 
assessed for their correlation with kon and koff. In contrast to kon, no significant 
correlations  where  found  for  koff.  This  suggests  that  currently 
available  descriptors  are  not  able  to  represent  the  correlative  effects  of  the 
dissociation rate, or more possibly there is no single dominant contributor to the 
stability to koff. Counter intuitive to what one would expect, the most prominent 
descriptors were found to be coarse-grained statistical potentials, rather than 
fine-grained atomic potentials (Moal and Bates, 2012). Nevertheless, correlations 
for  koff were  still  lower  than  0.35  and  insignificant  with  (p>0.01).  Here,  it  is 
proposed that the change in off-rate brought about by an interface mutation, can 
be explained by changes in the hotspot energy landscape as a result of the same 
mutation.  For  a  mutation  in  question,  computational  alanine  scans  are 
preformed pre- and post-mutation to determine the hotspot energy landscape in 
each case. Hotspot descriptors are then designed to capture the changes in the 
pre- and post-mutation landscape. Using these hotspot descriptors, several off-
rate prediction models are then developed and their performance compared to 
models using standard molecular descriptors. 
 
Work on hotspots can be divided into three categories; the design of hotspot 
predictor algorithms (Tong et al., 2004, Wang et al., 2012, Xia et al., 2010, Darnell 
et al., 2007, Morrow and Zhang, 2012, Tuncbag et al., 2010, Zhu and Mitchell, 
2011, Lise et al., 2009, Lise et al., 2011, Kortemme and Baker, 2002); the study of 
distribution related properties of hotspots (Bogan and Thorn, 1998, Keskin et al., 
2005); and investigations into the use of hotspot regions as drug target sites 
(Grosdidier and Fernandez-Recio, 2012, Ma and Nussinov, 2007, Thangudu et al., 
2012). However, no work has used hotspot architecture to infer the dynamics of 
complex dissociation. In this chapter, it is shown how using hotspot descriptors 
and  hence,  the  energies  of  single-point  mutations  to  alanine,  can  be  used  to 
describe off-rate changes by mutations other than alanine, and also, multi-point 
mutations.  
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6.1.1  Anchor Points of Interaction – Hypothesis for Linking Hotspots Energy and 
Distribution to the Off-Rate 
 
The hotspot descriptors designed in this work aim to capture both the energetics 
and distribution (referred to as the ‘hotspot landscape’  for sake of clarity) of 
hotspot residues across the interface – more precisely, they capture the changes 
to the hotspot landscape brought about by the mutation in question. To link this 
to change in off-rate, the following hypothesis is proposed: 
 
‘Thinking of hotspot residues as the ‘anchor points’ of an interaction, if a mutation 
increases the number of ‘anchor points’ (or more precisely, the hotspot landscape 
has more favourable energy and distribution), this will result in higher complex 
stability, which manifests itself as a decrease in the off-rate’ 
 
 
6.1.2  Why Hotspots? 
 
There are two main properties of hotspots that could qualify them to be the ideal 
candidates to use as features over conventional molecular features: 
1.  Synergy: What makes a hotspot? Essentially, the occurrence of a hotspot 
is  not  limited  to  any  particular  physical  phenomena.  Instead,  hotspots 
result  from  the  synergistic  effect  of  a  number  of  factors.  These  may 
include  physicochemical  and  structural  properties  (Ofran  and  Rost, 
2007).  Therefore,  in  terms  of  computation,  hotspots  prediction 
algorithms may encompass the combined contribution from a number of 
features; for example in this work, the hotspot  prediction algorithm is 
built  using  a  broad  range  of  molecular  features  listed  in  Table  2.1  of 
Methods section 2.2 
 
2.  Distribution: Hotspots share defined patterns of distributions that are not 
always observable in more traditional protein-protein interface features. 
It is known that hotspots tend to cluster into hotregions, within which, 
hotspots  are  suggested  to  be  energetically  cooperative  (Keskin  et  al., Chapter 6: Characterizing Changes in Off-Rate upon Mutation using Hotspot Descriptors 
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2005, Reichmann et al., 2005). It has also been shown that hotspots tend 
to occur more at the core regions as opposed to the rims; however, low 
solvent  accessibility  is  not  a  sufficient  property  for  a  residue  to  be  a 
hotspot  (Bogan  and  Thorn,  1998).  Even  though  these  distributional 
patterns  have  been  found  at  protein-protein  interfaces,  their  effect  on 
protein  complex  stability  has  not  yet  been  investigated,  nor  exploited. 
Trying to uncover the advantage, if any, of these properties in complex 
stability is the aim of using some of the hotspot descriptors designed in 
this work. 
 
3.  Simplicity: The description of an interface though hotspots is conceptually 
and  visually  straightforward.  From  a  computational  stand-point,  the 
advantage  is  that  one  is  able  to  represent  an  interface  with  a  much 
smaller set of features without compromising accuracy, as the effects of 
several phenomena is still encompassed within the hotspots themselves. 
This  reduction  in  feature  set  size  is  also  particularly  attractive  in  the 
context of machine learning algorithms. 
 
6.2  Methods 
6.2.1  Hotspot Descriptor Generation  
 
The  use  of  hotspot  predictions  and  subsequently  hotspot  descriptors  for 
characterizing off-rates is depicted in Figure 6.1. First a pre-mutation alanine scan 
is performed; essentially this translates to using a hotspot predictor of choice on 
each residue at the interface. This generates a collection of single-point alanine 
ΔΔGs that are then employed differently depending on the hotspot descriptor in 
question (See Table 6.3 for a list of hotspot descriptors). For example if one uses 
Int_HS_Energy, then this hotspot descriptor will sum all the energies of only the 
hotspot residues. After all the hotspot descriptors for the wild-type complex are 
calculated, the mutation in question is applied using FoldX (Schymkowitz et al., 
2005),  such  as  the  Arg  to  Leu  mutation  in  Figure  6.1.  Then,  using  a  hotspot 
predictor  as  in  the  wild-type  scan,  another  computational  alanine  scan  is Chapter 6: Characterizing Changes in Off-Rate upon Mutation using Hotspot Descriptors 
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performed on the mutated interface. Again, all single-point alanine ΔΔGs are then 
fed into the hotspot descriptors. Continuing with the example of Int_HS_Energy 
as  a  hotspot  descriptor,  here  the  ΔΔGs  of  only  the  hotspot  residues  on  the 
mutated interface are summed, and the final descriptor value will be the change 
in the sum of the single-point ΔΔGs to alanine of all hotspot residues pre- and 
post-mutation. This value is then correlated to Δkoff Leu->Arg.  
 
Figure 6.1:  Off-rate estimation using hotspot energies and organization.  
In this work a set of hotspot descriptors for characterizing off-rate changes upon 
mutation  is  generated.  The  hotspot  descriptors  use  single-point  alanine ΔΔGs 
from computational alanine-scans performed by hotspot prediction algorithms. 
The single-point alanine ΔΔGs are encapsulated in hotspot descriptors, which are 
then applied to the prediction of changes in off-rate upon single-point and multi-
point  mutations  to  all  residue  types.  To  do  so,  for  a  given wild-type complex 
structure,  the  interface  is  scanned  for  hotspots  using  a  hotspot  prediction 
algorithm. The single-point alanine ΔΔGs from the scan are extracted and stored. Chapter 6: Characterizing Changes in Off-Rate upon Mutation using Hotspot Descriptors 
137 
 
Next, the structural mutation in question is applied and the mutated interface re-
scanned for hotspots. This generates a new set of single-point alanine ΔΔGs for 
the mutated interface. Note that the mutation in question may also affect the 
hotspot energies of other neighbouring residues that are not mutated. The two 
sets of ΔΔGs are then used to generate a set of hotspot descriptors, where the 
final hotspot descriptor value is the change in the descriptor's value from mutant 
to  wild-type.  For  example  in  the  case  of Int_HS_Energy,  the  final  value  is  the 
change in the sum of the ΔΔGs, of all hotspot residues, pre- and post-mutation.  
6.3  Results 
6.3.1  Hypothesis Validation Part 1 - Explaining Off-Rate Changes Using ΔΔG 
Energies from Single-Point Alanine Mutations  
 
The hotspot descriptors map the effects of single-point and multipoint mutations 
to  all  residue  types  into  energies  of  only  single-point  alanine  mutations. 
Therefore,  this  enables  off-the-shelf  hotspot  predictors  to  be  used  for  a  new 
application,  the  prediction  of  off-rate  change  upon  mutation.  To  assess  the 
proposition,  a  representative  hotspot  descriptor  Int_HS_Energy  is  used  as  an 
example: 
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6.1 
where the difference of hotspot energies pre- and post-mutation is used as an 
estimate for the koff term,  Δlog10(koff).  Int_HS_Energy shows a PCC of R = -0.51 
with  the  713  experimental  Δlog10(koff)  mutation  values  found  in  the  SKEMPI 
database.  This  correlation  (R=-0.51)  is  the  average  of  six  PCC  values,  as 
generated  per  each  Int_HS_Energy  descriptor  of  the  six-hotspot  predictors 
assessed in this work.  One should note that even through the hotspot predictors 
in this  work employ different features  and learning algorithms to  build their 
hotspot  models  (See  5.2),  all  hotspot  predictors  except  one  (the  worst 
performing  hotspot  predictor)  show  a  consistent  correlation  of  |R|>0.5  with 
Int_HS_Energy  (See  Table  6.1).  The  strength  of  observed  correlations  of 
Int_HS_Energy with Δlog10(koff) is in line with the hypothesis proposed and shows 
that  when  considering  changes  in  off-rate,  single-point  and  multi-point 
mutations to all residue types can be explained by energies of only single-point 
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an increase in ‘anchor points’ – more precisely an increase in hotspot energies 
(from wild-type to mutant), results in a more stable interface and hence a lower 
off-rate. 
Table 6.1:  Pearson's  Correlation Coefficient (PCC) of hotspot descriptors 
with experimental Δlog10(koff). 
Correlations are shown for the 713 off-rate mutations in the SKEMPI database 
and for hotspot descriptors generated by each hotspot predictor.  
Hotspot Descriptor  RFHotpoint1  RFHotpoint2  KFC2a  KFC2b  RFSpot  RFSpot_KFC2 
Mean 
PCC 
Variance 
in PCC 
Int_Energy_1  -0.312  -0.312  -0.472  -0.432  -0.182  -0.289  -0.333  0.105 
No_HS  -0.433  -0.266  -0.429  -0.496  -0.493  -0.496  -0.436  0.089 
Int_HS_Energy  -0.568  -0.312  -0.546  -0.527  -0.532  -0.559  -0.508  0.097 
No_Clusters  0.101  -0.069  -0.075  -0.272  -0.284  -0.285  -0.147  0.159 
MaxClusterSize  -0.225  0.022  0.094  0.052  -0.163  -0.292  -0.085  0.162 
AVG_HS_PathLength  -0.152  -0.139  -0.031  -0.197  -0.110  -0.016  -0.108  0.071 
CoreHSEnergy  -0.608  -0.365  -0.369  -0.427  -0.541  -0.560  -0.479  0.105 
RimHSEnergy  -0.415  0.020  -0.100  0.000  -0.367  -0.329  -0.198  0.194 
SuppHSEnergy  -0.153  -0.162  -0.617  -0.489  -0.385  -0.465  -0.379  0.187 
CoreHS  -0.413  -0.281  -0.232  -0.476  -0.342  -0.440  -0.364  0.095 
RimHS  -0.319  -0.071  -0.181  0.000  -0.128  -0.176  -0.146  0.109 
SuppHS  -0.156  -0.153  -0.430  -0.344  -0.480  -0.441  -0.334  0.146 
HSEner_NegCoop  -0.487  -0.282  -0.475  -0.260  -0.414  -0.514  -0.405  0.109 
HS_NegCoop  -0.330  0.013  -0.049  -0.356  -0.415  -0.460  -0.266  0.198 
HSEner_PosCoop  -0.278  -0.192  -0.218  -0.437  -0.573  -0.444  -0.357  0.150 
HS_PosCoop  -0.013  -0.256  -0.138  -0.154  -0.494  -0.457  -0.252  0.190 
 
6.3.2  Hypothesis  Validation  Part  2  -  Explaining  Off-Rate  Changes  Using 
ΔΔG Energies from Single-Point Alanine Mutations  
 
In 4.3.1 it was shown how the change in the sum of ΔΔG energies of single-point 
mutations to alanine pre- and post-mutation shows a significant correlation to 
the change in off-rate. Though using experimental off-rates, this was found to be 
true; there are two confounding factors that need to be addressed. Firstly, ΔΔGs 
are used to estimate off-rates. Secondly, single-point ΔΔGs of alanine mutations 
are used to estimate the off-rate of mutations to non-alanine mutations, which 
also include multi-point mutations (along with single-point alanine mutations). Chapter 6: Characterizing Changes in Off-Rate upon Mutation using Hotspot Descriptors 
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Starting first by addressing the second point; Let us assume we have a single-
point mutation at a specific residue position, from Leu to Arg, then the Δkoff  may 
be calculated as 
 
  ΔkoffLEU->ARG = koffLEU - koffARG  6.2 
 
If we assume that most of the change in binding free energy of the mutation ΔΔG, 
is a result of a change in koff  with minimal change in kon, then 
  
  ΔkoffLEU->ARG α ΔΔGLEU->ARG 
 
6.3 
Now,  
  ΔΔGLEU->ARG= ΔGARG – ΔGLEU 
 
6.4 
  = [GARGComplex- (GARGReceptor + GARGLigand)] 
 - [GLEUComplex- (GLEUReceptor + GLEULigand)] 
 
6.5 
  = GARGComplex- GARGReceptor -  GARGLigand 
 - GLEUComplex + GLEUReceptor + GLEULigand 
 
6.6 
Approaching this using only ALA mutations we have, 
  ΔΔGARG->ALA – ΔΔGLEU->ALA =  
[GALAComplex- GALAReceptor –  GALALigand – GARGComplex + GARGReceptor + 
GARGLigand]  
- [GALAComplex- GALAReceptor -  GALALigand - GLEUComplex + GLEUReceptor + 
GLEULigand] 
 
6.7 
  =  – GARGComplex + GARGReceptor + GARGLigand  +  GLEUComplex - GLEUReceptor - 
GLEULigand 
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  = - ΔΔGLEU->ARG 
 
6.9 
Therefore, 
  – ( ΔΔGARG->ALA – ΔΔGLEU->ALA ) = ΔΔGLEU->ARG α ΔkoffLEU->ARG 
 
6.10 
Hence for the mutation Leu->Arg,  
where ΔΔGARG->ALA > ΔΔGLEU->ALA , the change in off-rate is negative (i.e. the off-rate 
of mutant is lower than the off-rate of the wild-type), and hence the mutation is 
stabilising. Conversely, if ΔΔGARG->ALA < ΔΔGLEU->ALA then this results in a positive 
Δkoff and hence the mutation is destabilizing. 
The key assumption here is that the change in binding free energy is mostly 
reflected through a change in the off-rate rather than the on-rate (See 6.3). To 
validate this, for the 713 off-rate mutations used in this work, the corresponding 
experimental  values  for  ΔΔG  are  correlated  to  the  Δlog10(kon)  and  Δlog10(koff)  
values for the same mutations. The respective PCCs between them are shown in 
Table 3A.  
Table 6.2: Relationship between experimental ΔΔG, Δlog10(koff), Δlog10(kon) 
and change in interface hotspot energy (Int_HS_Energy) for 713 mutations 
in the SKEMPI database.  
(A)  PCC  between  experimental  ΔΔG  with  the  respective  Δlog10(koff)  and 
Δlog10(kon) for single-point alanine, single-point non-alanine, multi-point and all 
713  mutations.  (B)  PCC  between  Int_HS_Energy  with  the  respective,  ΔΔG 
withΔlog10(koff)  and  Δlog10(kon)  for  single-point,  single-point  non-alanine, 
multipoint and all 713  mutations. Experimental values for the 713 mutations 
used here are extracted from SKEMPI and detailed in Methods section 2.1.2. 
A  ΔΔG  Single-point alanine  Single-point alanine  Multi-point alanine  All Types 
 
Δlog10(koff)  0.57  0.92  0.96  0.83 
 
Δlog10(kon)  -0.56  -0.65  -0.65  -0.60 
B  Int_HS_Energy  Single-point alanine  Single-point alanine  Multi-point alanine  All Types 
 
Δlog10(koff)  -0.33  -0.34  -0.62  -0.51 
 
Δlog10(kon)  0.12  0.08  0.22  0.17 
 
ΔΔG  -0.48  -0.29  -0.57 
-0.53 
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The correlations are calculated for single-point alanine mutations, single-point 
non-alanine, multi-point, and on all mutations. Namely, ΔΔG, shows a correlation 
of R=0.83 with Δlog10(koff) and R=-0.6 with Δlog10(kon). More notable is that the 
ΔΔG of multi-point and a non-alanine mutation is strongly reflected through a 
change in Δlog10(koff) (R=0.96, R=0.92 respectively). Other lines of evidence also 
show  that  the  change  in  binding  free  energy  is  largely  explained  through  a 
change  in  off-rate;  For  example,  mutagenesis  studies  (Castro  and  Anderson, 
1996,  Jin  and  Wells,  1994)  have  shown  that  increases  in  dissociation  rate 
constants are the dominant cause for a decrease in binding affinity, and work on 
the related phenomenon of protein-DNA binding shows that 78% of the variance 
of  log2(koff)  is  explained  by  the  variance  of  information  of  the  binding  site 
sequence as opposed to 49% of the variance of log2(kon) (Shultzaberger et al., 
2007). Similarly, work on the enhancement of protein-protein association rate 
shows that mutations that affect binding free energy, as a result of affecting the 
on-rate with no change in the off-rate, are found at surface-exposed sites and 
located  at  the  vicinity  of,  but  outside,  the  binding  site  -  as  those  within  the 
binding site are generally off-rate modulating (Kiel et al., 2004).  Thus, for the 
713 off-rate mutation dataset, only 25% of the mutants are located at the edges 
(Rim) or outside the binding site (Surface), hence it may also be expect that the 
larger portion  of mutants in the  data  used in  this  analysis, to  predominantly 
affect the off-rate, as is also confirmed by the correlations in Table 3A. 
 
6.3.3  The Hotspot Descriptors and Hotspot Predictors 
 
Using Int_HS_Energy derived from our hypothesis which links hotspot energies to 
off-rates, an additional 15 hotspot descriptors were designed. The motivations 
and  calculation  for  each  of  the  16-hotspot  descriptors  is  detailed  in  2.3.7.  In 
summary (See Table 6.3); Int_HS_Energy, is the difference in the sum of hotspot 
residue energies pre- and post-mutation. HSEner_PosCoop and HSEner_NegCoop 
are identical to Int_HS_Energy except that, in order to account for positive and 
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energies  are  down-weighted  and  up-weighted  accordingly  to  the  size  of 
hotregion they are in. CoreHSEnergy, RimHSEnergy and SuppHSEnergy, are 
 
Table 6.3: Summary of Hotspot Descriptors. 
The functional form of each hotspot descriptor and the motivations behind its 
design, are detailed in the methods sections of 2.3.7. 
Hotspot Descriptor  Description 
Int_Energy_1  Change in Total Interface ΔΔGALA Energy  
Int_HS_Energy  Change in Total Interface ΔΔGALA Energy of Hotspots  
No_HS  Change in Number of Hotspots  
No_Clusters  Change in Number of Unique Hotregions  
MaxClusterSize  Change in Number of Hotspots in Largest Hotregion  
AVG_HS_PathLength  Change in Hotspot Coverage  
CoreHSEnergy   Change in Total ΔΔGALA Energy of Hotspots in Core Region   
CoreHS  Change in Number of Hotspots in Core Region  
RimHSEnergy  Change in Total ΔΔGALA Energy of Hotspots in Rim Region  
RimHS  Change in Number of Hotspots in Rim Region 
SuppHSEnergy  Change in Total ΔΔGALA Energy of Hotspots in Support Region 
SuppHS  Change in Number of Hotspots in Support Region 
HSEner_PosCoop  Change in Total Hotspot ΔΔGALA Energy Accounting for Positive Cooperativity in 
Hotregions 
HS_PosCoop  Change in Hotspot Counts Accounting for Positive Cooperativity in Hotregions 
HSEner_NegCoop  Change in Total Hotspot ΔΔGALA Energy Accounting for Negative Cooperativity in 
Hotregions 
HS_NegCoop  Change in Hotspot Counts Accounting for Negative Cooperativity in Hotregions 
 
similar to Int_HS_Energy, except that changes in hotspot energies are limited to 
the  given  region  on  the  interface. Each of the  six descriptors also  have  their 
coarse-grain counterparts (No_HS, HS_PosCoop, HSNegCoop, CoreHS, RimHS and 
SuppHS),  where  only  hotspot  counts  instead  of  energies  are  used  in  the 
calculations.  Other  hotspot  descriptors  include  the  change  in  the  size  of  the 
largest hotregion (MaxClusterSize), the number of hotregions (No_Clusters), the 
spread of the hotspots at the interface (AVG_HS_PathLength) and Int_Energy_1 
that sums the changes of all single-point alanine mutations at the interface. 
A number of hotspot predictors are investigated for the generation of hotspot 
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include hotspot descriptors generated from available hotspot prediction servers, 
KFC2a, KFC2b (Zhu and Mitchell, 2011), RFHotpoint1 and RFHotpoint2 (Tuncbag 
et  al.,  2010),  along  with  the  hotspot  descriptors  generated  from  hotspot 
prediction  algorithms  developed  in  this  work  (RFSpot,  RFSpot_KFC2). 
Performance comparisons of the hotspot prediction algorithms can be found in 
5.2. The use of multiple hotspot predictors enables us to probe consistencies and 
anomalies in the predictive abilities of the hotspot descriptors. 
6.3.4  Comparison of Hotspot Descriptors with Molecular Descriptors 
 
The PCCs achieved by Int_HS_Energy and the rest of the hotspot descriptors with 
Δlog10(koff), is compared to those achieved by the benchmark set of molecular 
descriptors (See Table 2.1 in Methods section  2.2  for the full list). The molecular 
descriptor set consists of a complex and comprehensive set of 110 structure-
related descriptors characterizing various aspects of protein-protein interactions 
and  their  energetics.  For  the  hotspot  descriptors,  16  hotspot  descriptors  as 
generated  by  each  of  the  six-hotspot  predictors  are  assessed.  With  713 
mutations in the dataset, all absolute correlations of |R|>0.1 are significant with 
p<0.001.  Figure  6.2(A)  shows  all  descriptors  (Hotspot  descriptors  in  green 
superimposed on the molecular descriptors in black) ranked according to their 
absolute  PCCs.  Consistently  higher  PCC  values  are  observed  for  the  hotspot 
descriptors. It should be noted that here one is comparing the raw predictive 
power of each descriptor in estimating Δlog10(koff); this is independent of any 
learning models trained on Δlog10(koff) data. 
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Figure 6.2: Hotspot and molecular descriptors for estimating change in off-
rate using PCC. 
 The hotspot descriptors designed in this work are benchmarked against a set of 
110 molecular descriptors; both in their ability to estimate Δlog10(koff) and in 
their ability to detect stabilizing mutations of Δlog10(koff)  < −1. The performance 
measures  shown  here  enable  us  to  assess  the  raw  predictive  power  of  the 
descriptors independent of any learning models. Green and black bars highlight 
descriptors  from  the  hotspot  and  molecular  descriptor  sets  respectively.  (A) 
Comparison  of  the  distribution  of  the  absolute  PCC  values  for  the  hotspot 
descriptors designed in this work against that for the molecular descriptors. (B) 
The  top  ten  hotspot  descriptors  (green)  followed  by  the  top  ten  molecular 
descriptors (black), ranked according to the PCC. The highest ranked descriptors 
all relate to energetic changes in hotspots suggesting that changes in hotspot 
counts is not sufficient to characterise changes in off-rate. The most common of 
which are the Int_HS_Energy and CoreHSEnergy, where the latter only considers 
changes  in  hotspot  energies  in  the  core  region  of  protein-protein  interfaces. 
Apart from the DARS atomic potential, AP_MPS (Chuang et al., 2008), designed 
for protein-protein docking with |R|=0.46, the top 10 molecular descriptors are 
dominated by coarse-grain statistical potentials. The bias toward coarse-grain 
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models for wild-type off-rates were built. The correlation power of the molecular 
descriptors  decreases  markedly  down  to  |R|=0.3  at  just  the  10th  ranked 
molecular descriptor, in contrast to the hotspot descriptors where |R|=0.5.  
 
Figure  6.3:  Scatter  plots  of  best  performing  hotspot  and  molecular 
descriptors according to PCC.  
The relationship between experimental values for Δlog10(koff) and (A) hotspot 
descriptors showing highest correlation with Δlog10(koff) (SuppHSEnergyKFC2a - 
changes in hotspot energies in the support region as predicted by KFC2a (Zhu 
and Mitchell, 2011)) and (B) molecular descriptor showing highest correlation 
with Δlog10(koff) (AP_MPS - the DARS atomic potential (Chuang et al., 2008)).  
 
Scatter  plots  of  the  top  performing  (according  to  PCC)  hotspot  descriptor 
SuppHSEnergyKFC2a  (R=-0.62)  and  the  top  performing  molecular  descriptor 
AP_MPS (R=0.46.) are shown in Figure 6.3. These descriptors are the best from 
their  set  at  globally  estimating  the  changes  in  off-rate,  which  as  observed  in 
Figure  6.3.  Their  accuracy  mostly  stems  from  their  ability  to  model  the 
destabilizing (off-rate increasing) portion of the dataset.  The underestimation of 
stabilising (off-rate decreasing) mutations and descriptors, which are better able 
to detect such mutations, is investigated in subsequent sections. 
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6.3.5  Detection of Complex Stabilizing Mutations 
 
To assess the discriminatory power of the hotspot and molecular descriptors, the 
dataset is partitioned into (Δlog10(koff)  < -1), representing the stabilizing portion 
of the dataset, and (Δlog10(koff)  > 0), representing the neutral to destabilizing 
portion of the dataset (referred to as CDS1 – Classification Dataset 1). Another 
dataset, which removes the neutral mutations as detailed in 2.1.3, is also used 
(referred to as CDS2). For an unbiased assessment of descriptor discrimination 
ability,  two  discrimination  performance  measures  are  calculated;  the  Mann 
Whitney U-Test (Figure 6.4 C,E), the MCC (Figure 6.4 D,F) – both of which are 
described in methods section 2.4. Similar to the correlations with Δlog10(koff) (i.e 
Figure 6.2 A,B), the changes in hotspot descriptors show better discrimination 
abilities than changes in molecular descriptors (Figure 6.4 C-F). This confirms 
that the hotspot descriptors, as well as possessing fine-grain predictive ability, 
also  possess  coarse-grain  predictive  ability.  For  example,  the  most 
discriminatory hotspot descriptor under the U-Test, achieves a 4-fold (CDS1) and 
5-fold (CDS2) increase in  discriminatory power over the most discriminatory 
molecular descriptor. Once again, those hotspot descriptors that use the energies 
of hotspots, as opposed to counts, dominate. 
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Figure 6.4: Hotspot and molecular descriptors for estimating change in off-
rate using the MCC/U-Test.  
The hotspot descriptors designed in this work are benchmarked against a set of 
110 molecular descriptors; both in their ability to estimate Δlog10(koff) and in 
their ability to detect stabilizing mutations of Δlog10(koff)  < −1. The performance 
measures  shown  here  enable  assessment  of  the  raw  predictive  power  of  the 
descriptors independent of any learning models. Green and black bars highlight 
descriptors  from  the  hotspot  and  molecular  descriptor  sets  respectively.  (C) 
Mann  Whitney  U-Test  rankings  for  all  descriptors  where  values  are  ranked 
according  to  −log10  (pval)  and  represent  the  discrimination  ability  of  the 
descriptors  for  the  detection  of  stabilizing  mutants  (Δlog10(koff) <  −1)  from 
neutral  to  destabilizing  mutants  (Δlog10(koff) >0)  (Referred  to  as  CDS1).  This 
dataset contains 31 stabilizing mutants and 503 neutral to destabilizing mutants. 
(D) Matthew's Correlation Coefficient (MCC) rankings for all descriptors on same 
dataset. (E) and (F) are identical to (C) and (D) except that results are for off-
rates that satisfy |Δlog10(koff)|  > 1. This dataset contains 31 stabilizing mutants 
and 213 destabilizing mutants (referred to as CDS2). 
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Figure  6.5:  Scatter  plots  of  best  performing  hotspot  and  molecular 
descriptors according to MCC.  
The  relationship  between  experimental  values  for  Δlog10(koff)  and  (A)  top 
performing  hotspot  descriptor  for  the  detection  of  stabilizing  mutants 
(HSEner_PosCoopRFSpot – changes in hotspot energies on accounting for positive 
cooperativity in hotregions) and (B) top performing molecular descriptor for the 
detection of stabilizing mutants (CP_TB – coarse grained protein-protein docking 
potential). 
 
Scatter plots of a  representative hotspot  (HSEnerPosCoopRFspot) and molecular 
descriptor (CP_TB) (Tobi, 2010), are shown in Figure 6.5 C,D. These descriptors 
do  well  on  both  CDS1  and  CDS2,  though  they  still  show  a  tendency  to 
underestimate  stabilizing  mutations.  For  both  CDS1  and  CDS2,  the  positive 
cooperativity  descriptors  HSEner_PosCoop/HS_PosCoop  dominate  the  ranked 
lists  (Figure  6.4  C-F)  and  RimHSEnergy/RimHS  for  CDS1  (Figure  6.4  D).  For 
example, HSEner_PosCoopRFSpot achieves a TPR/FPR/MCC of 0.58/0.05/0.62 for 
the detection of stabilizing mutants on CDS2. Given that  HSEner_PosCoopRFSpot 
supersedes  Int_HS_Energy  (additivity  within  hotregions  assumption)  and 
HSEner_NegCoop  (negative  cooperativity  within  hotregions  assumption), 
applying  the  general  assumption  of  positive  cooperativity  between  hotspots 
within  a  hotregion,  and  accounting  for  it,  provides  higher  detection  rates  of 
stabilizing mutations (i.e. Δlog10(koff)  < -1). It should be noted however, that out 
of the three-hotspot predictors, which generate the most discriminatory hotspot 
descriptors  (i.e.  RFSpot,  RFSpot_KFC2  and  KFC2a),  the  positive  cooperativity 
descriptors  which  show  high  discrimination  abilities,  are  limited  to  those 
generated  by  RFSpot  and  RFSpot_KFC2.  The  relationship  of  Δlog10(koff)  and 
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cooperative  effects  within  hotregions  is  discussed  further  in  the  subsequent 
section 8.3 of Chapter 8. An interesting observation is that whereas for a good 
global  correlation,  the  coarse-grain  statistical  potential  are  preferred  to  their 
atom-based  counterparts,  this  is  not  the  case  for  the  detection  of  stabilizing 
mutations. Here, the physics-based energetic terms play a more important role. 
 
6.4  Discussion 
 
In this chapter, it is proposed that the energetics and architecture of hotspots on 
protein-protein  interfaces  can  be  used  to  estimate  changes  in  off-rate.  More 
specifically, the change in the sum of hotspot energies at an interface pre- and 
post-mutation correlates to a change in off-rate brought about by that mutation. 
Using a dataset of 713 mutations with experimental off-rates, correlations as a 
high as R=0.62 are observed for hotspot descriptors based on this proposition. 
More importantly, such hotspot descriptors perform consistently better than the 
more traditional molecular descriptors. 
This begs the question, why do hotspot  descriptors dominate over molecular 
descriptors?  To  gain  insight  into  why  this  is  so,  the  key  differences  between 
hotspot  descriptors  and  molecular  descriptors  are  discussed.  Essentially,  a 
hotspot is the realisation of an optimal ‘state’ of several energetic factors. A state 
here represents the residue in question and its context i.e. surrounding residues, 
solvent accessibility etc. For an optimal state, a number of energetic contributors 
favourably combine. Naturally, one would expect that changes to these states (as 
represented  by  changes  caused  to  hotspot  residues)  would  have  a  more 
correlative effect to the off-rate than molecular descriptors, which consider a 
very specific energetic contribution. With this in mind, several of the molecular 
descriptors are statistical potentials, which themselves implicitly encompass a 
number  of  energetic  contributions.  Hence  synergy  alone  is  not  sufficient  to 
explain  the  better  performance  of  hotspot  descriptors  over  molecular 
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Another aspect of hotspot descriptors, which distinguished them from molecular 
descriptors, is the way they are calculated. Take for example the electrostatic 
interaction between all pairs of contacts;  
 
Figure  6.6:  Distribution  of  energy  across  a  protein-protein  interface. 
Favourable  interactions  across  a  complex  interface  are  not  distributed 
homogenously.  
Molecular descriptors traditionally perform a summation over all favourable and 
unfavourable  contributions  that  in  turn  result  in  an  averaging  out  effect. 
Effectively, any positional of favourable interactions is lost. Hotspot descriptors, 
on the other hand, consider the contribution of only a subset of residues or those 
in  specific  regions  of  the  interface.  Hence  the  averaging  out  effect  is  less 
prominent.  If  distribution  and  not  only  the  sum  of  favourable  interactions 
contribute  to  complex  stability,  then  hotspot  descriptors  may  indeed  capture 
effects critical for the stability of a complex that traditional molecular descriptors 
will miss. 
 
Once the summation is performed over all pairs, the resulting effect is essentially 
an  averaging  out  effect  of  favourable  and  unfavourable  interactions  at  the 
interface. Therefore, any positional information is lost. The cost of this loss of 
information, if any, is  explained using a toy scenario, Figure 6.6. Let’s assume 
EnergyX is an enthalpic contributor, important for the stability of the complex. In 
this example, EnergyX’s total energetic contribution after summation is neutral at 
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0 kcal/mol. Before summation, one could appreciate a central core of favourable 
energy  (-9  kcal/mol)  surrounded  by  less  favourable  interactions  distributed 
sparsely in the outer shell. Does this central core of favourable energy override 
the global neutrality of the total energetic sum? Whether or not this is so, the 
summation of energetic contribution across all contacts of an interface does not 
allow for this effect to be accounted for. In contrast, the hotspot descriptors are 
not a sum over all residues of the interface. Int_HS_Energy (mean PCC of R=-0.51 
with  Δlog10(koff))  for  example,  only  sums  the  energies  of  hotspots  –  hence 
ignoring the energetic contribution of the majority of the residues. Interestingly, 
when one considers the energetic contribution of all interface residues, and not 
only hotspots, the signal degrades, where Int_Energy has a mean PCC of R=-0.33. 
Therefore,  any  signal  observed  if  one  only  considers  the  energies  of  hotspot 
residues,  is  lost  after  including  the  energies  of  the  remaining  non-hotspot 
interface residues. Hotspot descriptors, such as Core_HS_Energy, are even more 
selective concerning which residues they score. In this case, only the core region 
hotspots are considered yet a mean PCC of R=-0.48 and a maximum of R=-0.61 is 
achieved.  Even  though,  on  average  some  signal  is  lost  when  not  considering 
hotspots outside the core region, one must keep in mind that its maximum R=-
0.61,  is  still  significantly  higher  to  that  achieved  by  the  best  preforming 
molecular descriptor AP_MPS (R=0.46) with p<<0.001.  
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Chapter 7 
7  Prediction of Off-Rate Changes 
upon Mutation Using Machine 
Learning Models and Hotspot 
Descriptors 
 
In  Chapter  6  it  was  described  how  changes  in  the  hotspot  energy 
landscape  can  be  transformed  into  hotspot  descriptors,  which  are  able  to 
estimate  changes  in  the  off-rate.  Most  importantly,  the  individual  power  of 
hotspots  surpasses  that  of  standard  physics-based  energetic  terms  statistical 
potentials. In this chapter, the aforementioned descriptors are combined using 
machine learning models to achieve even higher predictive performance in the 
prediction of off-rate change upon mutation.  In section 7.1 several regression 
models using both hotspot and molecular descriptors are built and the detection 
of rare residence-time increasing (off-rate decreasing) mutations is investigated 
using a number of classification models in 7.2. In section 7.3, the 713 mutations Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
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in the off-rate dataset are categorized into what may be termed, data regions. 
Such data regions represent mutations that have a common physical property, or 
come from a similar type of complex or region at the interface. The effects of 
mutations  within  a  particular  data  region  might  be  more  or  less  difficult  to 
predict than mutations within another. Therefore, data region analysis enables 
us to  identify current  strengths in  the  prediction of off-rates  and  conversely, 
mutations,  which  are  consistently  harder  to  characterise.  The  effects  of 
conformational  changes  and  cross-validation  routines  are  presented  in  the 
remaining sections. 
 
7.1  Off-Rate Prediction Using Machine Learning Models with 
Hotspot and Molecular Descriptors 
 
Confirming that energy estimates of single point-alanine mutations can be used 
to describe the effects of off-rate changes of single- and multi-point mutations 
not limited to alanine, it is next assessed whether the whole set of 16 hotspot 
descriptors,  from  each  hotspot  prediction  algorithm,  can  be  combined 
synergistically  in  a  model  for  off-rate  prediction  to  achieve  even  higher 
correlations. A separate Random Forest (RF) regression model is trained on the 
713  off-rate  mutant  dataset  using  the  hotspot  descriptors  generated  by  each 
hotspot  predictor  (RFSpotOff-Rate,  RFSpot_KFC2Off-Rate,  RFHotpoint1Off-Rate, 
RFHotpoint2Off-Rate, KFC2aOff-Rate and KFC2bOff-Rate). In addition, models that add the 
set of 110 molecular descriptors to the hotspot descriptors (RFSpot+MolOff-Rate, 
RFSpot_KFC2+MolOff-Rate,  RFHotpoint1+MolOff-Rate,  RFHotpoint2+MolOff-Rate, 
KFC2a+MolOff-Rate and KFC2b+MolOff-Rate) are also built for comparison. Note that 
the  Off-Rate subscript  is  used to  distinguish  the  off-rate  predictor trained on 
hotspots, from the actual hotspot predictor generating the hotspot descriptors in 
question. The 20-fold cross-validation (CV) results are concatenated to form of a 
set  of  713  test  predictions  and  their  PCC  with  Δlog10(koff)  calculated  and 
presented in Table 7.1. 
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Table 7.1 PCC values of off-rate regression models.  
PCC values are generated using the experimental values for Δlog10(koff) from 
713  off-rate  mutations  in  the  SKEMPI  database  and  the  predicted  values  for 
Δlog10(koff) from the regression models using 20-Fold CV. CP – Coarse-Grain 
Potentials, AP – Atomic-Based Potentials, CP-AP, All statistical Potentials, PB – 
Physics based Energy Terms.  
 
Figure 7.1: Scatter plots of best performing off-rate regression models.  
The  relationship  between  experimental  values  for  Δlog10(koff)  and  predicted 
values for  Δlog10(koff) with (A) RFSpot_KFC2Off-Rate+Mol, the best performing off-
rate  prediction  model  combining  hotspot  and  molecular  descriptors.  Hotspot 
descriptors  for  this  model  are  generated  using  the  RFSpot_KFC2  hotspot 
prediction algorithm. (B) RFSpot_KFC2Off-Rate+Mol, the best performing off-rate 
Hotspot Descriptor + Molecular Descriptor Models 
Model  PCC 
RFSpotOff-Rate, + MOL  0.78 
RFSpot_KFC2Off-Rate + MOL  0.79 
RFHotpoint1Off-Rate + MOL  0.77 
RFHotpoint2Off-Rate + MOL  0.75 
KFC2aOff-Rate + MOL  0.74 
KFC2bOff-Rate + MOL  0.75 
Hotspot Descriptor Models 
Model  PCC 
RFSpotOff-Rate,  0.74 
RFSpot_KFC2Off-Rate  0.77 
RFHotpoint1Off-Rate  0.73 
RFHotpoint2Off-Rate  0.7 
KFC2aOff-Rate  0.7 
KFC2bOff-Rate  0.71 
Molecular Descriptor Models 
Model  PCC 
CPOff-Rate  0.68 
APOff-Rate  0.61 
CP_APOff-Rate  0.69 
PBOff-Rate  0.72 
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prediction  model  using  only  hotspot  descriptors.  Hotspot  descriptors  for  this 
model are again generated using the RFSpot_KFC2 hotspot prediction algorithm. 
(C) MolecularOff-Rate, off-rate prediction model using molecular descriptors. The 
addition of hotspot descriptors as observed in (A) compared to the molecular 
descriptor  model  only  as  shown  in  (B)  notably  improves  the  prediction  of 
stabilizing  mutants,  which  are  all  found  in  the  lower  left  quadrant  for 
RFSpotKFC2Off-Rate+Mol. 
Figure 7.1, shows the best performing off-rate models from each class. The class 
here  refers  to  the  type  of  features  used  for  off-rate  prediction  –  molecular 
descriptors  only  (Figure  7.1c  R=0.73),  hotspot  descriptors  only  (Figure  7.1b 
R=0.77 and p<0.05 to R=0.73), hotspot and molecular descriptors (Figure 7.1a 
R=0.79 and p<0.005 to R=0.73). Besides exhibiting higher correlations, off-rate 
models  using  hotspot  descriptors  (Figure  7.1a  and  Figure  7.1b),  show  fewer 
mutations in the lower right quadrant, and hence better at identifying off-rate 
decreasing mutations than a model using molecular descriptors (Figure 7.1c). 
This  is  investigated  more  specifically  in  7.2  using  classification  models  and 
performance  measures.  The  performance  of  models  created  from  different 
categories of molecular descriptors is also investigated (See Table 7.1 ). These 
include Atomic Potentials (AP), Coarse-grain Potentials (CP) and Physics-Based 
energy  terms  (PB).  The  physics-based  descriptors  model  (PBOff-Rate,  R=0.72) 
which include CHARMM (Brooks et al., 2009), FoldX (Schymkowitz et al., 2005) 
and PyRosetta (Chaudhury et al., 2010) energy terms performs better than the 
coarse-grain  (CPOff-Rate,  R=0.68)  and  atomic  (APOff-Rate,  R=0.61)  statistical 
potentials alone or combined (CP_APOff-Rate, R=0.69). RFSpot_KFC2Off-Rate (R=0.77) 
built  on  hotspot  descriptors only, achieves  higher PCC than a model with all 
molecular descriptors combined (CP_AP_PBOff-Rate, R=0.72), whereas the highest 
correlation  is  still  achieved  when  combining  both  molecular  and  hotspot 
descriptors (RFSpot_KFC2+MolOff-Rate, R=0.79), as previously highlighted.  
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7.2  Prediction of Stabilizing Mutations 
 
Similar  to  the  regression  Random  Forest  models,  several  Random  Forest 
classification models are also built for the detection of stabilizing (i.e. Δlog10(koff)  
< -1) mutants and models trained and tested on both Classifier Dataset 1 (CDS1) 
and  Classifier  Dataset  2    (CDS2)  using  20-Fold  CV.  Comparison  of  the  MCCs 
achieved on CDS1 and CDS2 shows that the ability to detect stabilizing mutants is 
diminished when neutral mutations are present. The highest MCC achieved for 
CDS1 is achieved by RFSpot_KFC2Off-RateC (MCC=0.60, TPR=0.45, FPR=0.01) and 
RFSpot+MolOff-RateC for CDS2 (MCC=0.82, TPR=0.84, FPR=0.02). 
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Table 7.2: MCC values of off-rate classification models.  
MCC values for off-rate classifier model predictions for classification data sets 
CDS1 and CDS2. CDS1 includes neutral mutations whereas CDS2 excludes neutral 
mutations; hence the detection of stabilizing mutants is enhanced in the latter, 
though  results  for  CDS1 are more  relevant  for interface design scenarios.  All 
results are based on 20-fold CV. CP – Coarse-Grain Potentials, AP – Atomic-Based 
Potentials, CP-AP, All statistical Potentials, PB – Physics based Energy Terms. 
Hotspot + Molecular Descriptor Models 
Model  MCC CDS1  MCC CDS2 
RFSpotOff-RateC, + MOL  0.56  0.82 
RFSpot_KFC2Off-RateC + MOL  0.58  0.72 
RFHotpoint1Off-RateC + MOL  0.53  0.55 
RFHotpoint2Off-RateC + MOL  0.56  0.63 
KFC2aOff-RateC + MOL  0.44  0.6 
KFC2bOff-RateC + MOL  0.5  0.63 
Hotspot Descriptor Models 
Model  MCC CDS1  MCC CDS2 
RFSpotOff-RateC  0.53  0.73 
RFSpot_KFC2Off-RateC  0.6  0.79 
RFHotpoint1Off-RateC  0.3  0.5 
RFHotpoint2Off-RateC  0.53  0.62 
KFC2aOff-RateC  0.4  0.66 
KFC2bOff-RateC  0.43  0.55 
Molecular Descriptor Models 
Model  MCC CDS1  MCC CDS2 
CPOff-RateC  0.43  0.54 
APOff-RateC  0.35  0.43 
CP_APOff-RateC  0.5  0.51 
PBOff-RateC  0.4  0.53 
MolecularOff-RateC  0.53  0.68 
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Figure 7.2: Detection of rare complex stabilizing mutations using off-rate 
classification models.  
(A) Ranked list of 31 stabilizing mutations (Δlog10(koff) <-1) in the SKEMPI off-
rate dataset. The list is ranked according to the number of off-rate prediction 
classification  models  that  detect  the  mutation  in  question  as  stabilizing. 
Detections per model (B) are highlighted with white cross in a blue box, and non-
detections highlighted with a white box.  The lower portion of (A) is dominated 
by single-point mutations to alanine residues, which suggests that the stabilizing 
effects  of  these  mutations,  as  opposed  to  their  more  common 
neutralizing/destabilizing effects, are much harder to characterise. 
Figure  7.2  shows  the  list  of  31  stabilizing  mutants  (Δlog10(koff)    <  -1)  sorted 
according  to  the  number  of  classifiers  that  detect  the  given  mutation  as 
stabilizing.    Of  particular  interest  are  those  stabilizing  mutations  that  go 
undetected,  and  therefore  only  data  from  CDS2  is  used  as  all  mutations 
undetected in CDS2 were also undetected in CDS1 (though not the contrary). 
Two stabilizing mutants go undetected by of the all the predictors, namely the 
double alanine mutant VA216A-YB50A for protein complex 1JTG (RSCB protein 
data bank code) and the 4-point mutant CB161L-CB299F-KB287C-KB294C for 
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the  classifiers,  generally  involve  a  mutation  to  an  alanine  residue.  Alanine 
mutations are generally neutral in their ability to destabilize a complex. For the 
rare  situation  in  which  an  alanine  mutation  actually  stabilizes  a  complex 
interface  the  likely  interpretation  is  that  several  side-chains  may  sometimes 
hinder  binding  (Clackson  et  al.,  1998,  Cunningham  and  Wells,  1989).  For 
example several alanine-shaving experiments show an increase in the binding 
affinity and an octa-alanine mutant of hGH, binding hGHbp 50-fold times tighter 
than the wild-type (Clackson et al., 1998, Cunningham and Wells, 1989).  
7.3  Prediction Patterns and Data Region Analysis 
 
So far it is observed that an off-rate prediction model with hotspot descriptors 
does better than one with molecular descriptors and the highest performance is 
achieved when combining both sets of descriptors. As a consequence, several 
questions come to mind; for which mutation types are the hotspot descriptor off-
rate  models  achieving  an  enhanced  performance  compared  with  molecular 
descriptor off rate models? What information is gained by adding the molecular 
descriptors to the hotspot descriptor off-rate models? Is there any orthogonal 
information that the hotspot and molecular descriptors are capturing?  
To address these questions, the performance of the off-rate models is assessed at 
subsets of the dataset, termed ‘Data Regions’. The data regions include mutations 
at  the  core/rim/support  (CORE/RIM/SUPP)  regions;  mutations  on  complexes 
with large/small interface areas (LIA/SIA); mutations to alanine (ALA) and non-
alanine (N_ALA); mutations to polar/hydrophobic/charged (POL/HYD/CHARG) 
residues  and  finally  single-point  (SP)  mutations  as  well  as  multi-point  (MP) 
mutations. 
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7.3.1  Orthogonal Information Content in Hotspot and Molecular Descriptor 
Models 
 
 
Figure  7.3:  Orthogonal  information  content  in  hotspot  and  molecular 
descriptor models.  
The 713 off-rate data set is divided into data regions where the performance of 
the off-rate regression models can be assessed on the subset of mutations that 
are  in  the  given  region.  The  data  regions  include  mutations  at  the 
core/rim/support  (CORE/RIM/SUPP)  regions;  mutations  on  complexes  with 
large/small  interface  areas  (LIA/SIA);  mutations  to  alanine  (ALA)  and  non-
alanine (N_ALA); mutations to polar/hydrophobic/charged (POL/HYD/CHARG) 
residues  and  finally  single-point  (SP)  mutations  as  well  as  multi-point  (MP) 
mutations. Black bars indicate the change in PCC for the given data region when 
adding hotspot descriptors to a molecular descriptor off-rate model. Conversely, 
blue bars represent the change in PCC for the given data region when adding 
molecular descriptors to a hotspot descriptor an off-rate model. 
Keeping in mind that MolecularOff-Rate is a model trained only using molecular 
descriptors,  and  RFSpot_KFC2Off-Rate  is  one  trained  using  only  hotspot 
descriptors, the model which combines both hotspot descriptors and molecular 
descriptors  (RFSpot_KFC2Off-Rate+Mol)  can  be  assessed  in  two  ways  –  the 
improvement  in  correlation  achieved  by  adding  hotspot  descriptors  to 
MolecularOff-Rate  (Figure  7.3  black  bars)  or  vice-verse,  the  improvement  in 
correlation  achieved  by  adding  molecular  descriptors  to  RFSpot_KFC2Off-Rate 
(Figure  7.3  blue  bars).  The  magnitude  of  each  positive  change  indicates  the 
extent  that  the  addition  of  the  descriptor  adds  new  (or  rather  orthogonal) 
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information to the model, which is then exploited by the learning model. This is 
what is observed for ten of the twelve data regions when hotspot descriptors are 
added to MolecularOff-Rate (as shown by the positive black bars in Figure 7.3). On 
the other hand, no and minimal change (characteristic of the blue bars), suggest 
that  the  addition  of  the  molecular  descriptors  does  not  provide  any  new 
information that was not available in the existing hotspot descriptor model, or in 
some situations, even compromise the accuracy of the hotspot descriptor model 
by  contributing  to  noise  in  model  output  as  a  consequence  of  being  a  weak 
descriptor.  
7.3.2  Accurate and Weak Regions of Accuracy in the Prediction of Off-Rates 
Using Data Regions  
 
The performance of regression models trained on the whole 713 off-rate dataset 
is assessed by calculating the PCC on the mutations of each data-region. Figure 
7.4 shows, for each data region, a heatmap with these PCCs. From this it can be 
observed:  
1.  Rim  regions  are  poorly  characterised:  All  off-rate  predictors  obtain  good 
correlation  for  core  mutations,  less  so  for  support  region  mutations,  and  the 
weakest  correlations  are  found  for  rim  region  mutations.  The  addition  of 
molecular  descriptors  to  the  models,  as  presented  in  the  lower  half  of  the 
heatmap, increases the accuracy of the predictors both at the core and support 
regions, though rim regions are still inadequately characterised. One should note 
that there are 355 mutations, which affect the core region in the dataset to only 
148 and 182 affecting the rim and support regions. This imbalance in the dataset 
may attribute to a weaker performance in the rim region mutations. The lowest 
correlations  are  for  the  rim  regions,  and  found  for  the  models  derived  from 
statistical  potentials  (CPOff-Rate,  APOff-Rate,  CP_APOff-Rate).  The  lack  of  predictive 
power here may lie in their inability to model solvation effects, which are more 
prominent at the rim. Off-rate models using the physics-based descriptors show 
a  higher  correlation  of  R=0.4  at  the  rim  regions.  Models  with  only  hotspot 
descriptors,  on  the  other  hand,  generally  achieve  correlations  of  R>0.5  with 
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Figure 7.4: Correlation heatmap of off-rate regression algorithms on data 
regions. 
(A) Off-Rate regression models that use hotspot descriptors, or a combination of 
hotspot and molecular descriptors. The different methods indicate the hotspot 
prediction method by which the hotspot descriptors where generated from. The 
respective data regions are shown on the x-axis and values in matrix show the 
PCC achieved by the given model for the given data region. (B) is similar to (A) 
except that off-rate prediction models using subsets of molecular descriptors are 
investigated. CP – Coarse-Grain Potentials; AP – Atomic-Based Potentials; CP-AP 
– All Statistical Potentials; PB – Physics Based Energy Terms. As a benchmark 
comparison,  results  for  RFSpot_KFC2Off-Rate  (best  performing  off-rate  predictor 
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using hotspot  descriptors) and  RF_Spot_KFC2Off-Rate+MOL  (best performing off-
rate predictor using hotspot and molecular descriptors) are also included. 
2. Predictions  on  Large-Interface-Area Complexes, for Non-Alanine  Mutations, 
improved  with  molecular  descriptors:  The  hotspot  descriptor  predictors  are 
better at capturing effects of mutants on Small-Interface-Area (SIA) than Large-
Interface-Area (LIA) complexes. This discrepancy is alleviated with the addition 
of molecular descriptors to the  models. Single-point mutations to alanine  are 
generally better characterised than single-point mutations to non-alanine. This 
discrepancy is most accentuated for the less accurate hotspot predictor models 
and less so for the molecular descriptor models.  
3. The hotspot descriptor model outperforms the molecular descriptor model for 
mutations  to  polar,  hydrophobic  and  charged  residues:  The  all-molecular 
descriptor  off-rate  model  achieves  PCCs  of  R=0.6,  R=0.53,  R=0.42  on  polar, 
hydrophobic and charged residues respectively. Even though certain molecular 
descriptors are designed specifically for addressing electrostatics, degradation in 
performance is observed for charged residues. Interestingly, an accurate hotspot 
descriptor  off-rate  model,  such  as  RFSpotOff-Rate,  achieves  PCCs  of  R=0.67 
(p=0.12), R=0.61 (p=0.28) and R=0.62 (p<0.001) for the same data regions, and 
shows significant increases in correlation to its molecular model counterpart on 
the prediction of charged residues; here p-values show the significance of the 
difference in PCC when compared to the molecular descriptor models. 
4.  Multi-point  mutations  are  notably  better  characterised  than  single-point 
mutations: Correlations for multi-point (MP) mutations have an average PCC of 
RMEAN=0.85 and are as high as RMAX=0.9 for certain models. This is in contrast to 
the PCCs achieved for single-point (SP) mutations (RMEAN=0.55) and indicates 
that the subtleties of SP mutations are harder to characterise than the collective 
effect of multi-point mutations. Note that, though theoretically, MP mutations 
have the potential to cause off-rate changes of larger magnitudes, this is not so in 
the present dataset, where the mean and standard deviation of |Δlog10(koff)| for 
MP  mutations  is  0.96  and  1.4  compared  to  1.17  and  1.48  for  SP  mutations. 
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point mutations is related to being able to predict extreme changes in Δlog10(koff) 
better than subtle changes in Δlog10(koff).  
 
7.3.3  Specialized Feature Selection Models for Off-Rate Prediction 
 
The above analysis was performed using models trained on all the 713 off-rate 
mutations in the dataset, of which the predictions were then subset into data 
regions for separate analysis. Here, off-rate models, which are only trained on 
subsets of mutations, as defined by the data regions, are investigated. Separate 
models are built  for the different data regions of the dataset using a Genetic 
Algorithm for Feature Selection (GA-FS). All 110 molecular descriptors and 16 
hotspot  descriptors  generated  from  the  RFSpot_KFC2  hotspot  predictor  were 
made available for feature selection. The feature set size was set to five features 
to avoid over-fitting and both non-linear (using Support Vector Machines, SVM) 
and linear (using Linear Regression, LR) models were investigated. For every 
data region, 50 separate GA-FS runs were performed; an inner-cross validation 
loop was used for FS (and SVM parameter optimization), whereas an outer-cross 
validation loop was used for testing the final model. The results of specialized 
models for the data regions are shown in Figure 7.5 (GS-FS LR in Red and GA-FS 
SVM in blue). The performance of the specialized models on the data regions is 
compared to that of the best performing global off-rate prediction model (i.e. 
RFSpot_KFC2+MolOff-Rate). For most of the data regions, there is no advantage in 
having such specialized models, as having a  global one-fits-all model suffices. 
However, for mutations in the rim region, and mutations to charged residues, 
having a specialized model significantly increases the correlation of off-rates in 
these data regions (p=0.04 and p<<0.001 respectively).  
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Figure 7.5: Performance comparison of specialized models against one-fits 
all model.  
GA-FS Feature Selection Models using Genetic Algorithm are run for different 
data  regions  of  the  off-rate  dataset  for  which  both  linear  (using  Linear 
Regression  - GA-FS (LR) ) and non-linear (using SVM Regression GA-FS (SVM)) 
models are investigated. The figure shows the mean PCC of the optimal models 
found by the GA-FS runs for each data region. For comparison, PCC results on the 
data regions results are also shown for RFSpot_KFC2Off-Rate+Mol. Note that the 
latter model  is  trained on  all 713 off-rate  mutations, and the  predictions  are 
separated  post  prediction  into  data  regions  and  analysed  for  their  PCC.  This 
effectively compares the predictions of specialized models vs. one-fits-all model. 
Though there is no overall evidence that specialized models perform better than 
a  one-fits-all  model,  certain  subsets  of  mutations,  such  as  those  at  the  rim 
regions, show notable improvements when a specialized model is employed. 
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7.3.3.1  Broadly Predictive and Highly Specific Descriptors for Off-Rate Data 
Regions 
 
Figure 7.6: Dataset heterogeneity in the 713 off-rate dataset.  
(A) and (B) shows the importance of the most selected features for each data 
region. The features shown are those that are part of the final model, for any data 
region for more than 50% of the GA-FS runs; colour bar displays this percentage. 
The  features  on  the  y-axis  are  ranked  starting  from  (Coarse-grain  Potentials, 
Atomic-based Potentials, Physics-Based Energy Terms and Hotspot Descriptors). 
The heat maps show how different descriptors are needed to accurately predict 
the mutations on different data regions. 
 
Here, the relationship between the descriptors and data regions is investigated 
using the final features selected in the GA-FS runs. Initially available for the GA-
FS algorithms are a set of 16 hotspot descriptors (generated from the hotspot 
predictor  RFSpot_KFC2)  and  110  molecular  descriptors.  For  each  region,  the 
descriptors which are part of the final model, in at least half of the total number 
of runs, are singled out for analysis and presented in heat maps which indicate 
their importance to the given data region (Figure 7.6a: GS-FS (LR) and Figure 7.6b 
GS-FS (SVM)). On the y-axis, the singled out descriptors are listed and sorted 
according to descriptor type (CP, AP, PB, and hotspot descriptors from top to 
bottom), with each data region shown on the x-axis. Globally, it is observed that 
whereas for LR models, top features are distributed throughout the four main 
feature  categories,  for  the  non-linear  SVM  models,  61%  of  the  features  are 
hotspot  descriptors, suggesting that non-linear relationships between  hotspot Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
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descriptors can be better exploited for the predictions of off-rates. Note that, if 
hotspot descriptors were equally important to molecular descriptors, only 12% 
of the final features would be expected to be hotspot descriptors. 
 
Figure 7.7: Descriptor – data region networks. 
 (C) and (D) are descriptor-data region networks for Figure 7.6a and Figure 7.6b 
respectively. Circled nodes represent data regions and square nodes represent 
features; therefore, only edges between circle and square nodes are present. An 
edge is present if the feature is in the final model for the given data region in 
more than 50% of the GA-FS runs (dotted edge), between 70-90% of the GA-FS 
runs (normal edge), more than 90% of the GA-FS runs (bold edge). Coarse-grain 
Potentials (blue), Atomic-based Potentials (yellow), Physics-Based Energy Terms 
(green), Hotspot descriptors (pink) and data regions (gray). From the descriptor-
data region networks, descriptors highly specific to certain classes of off-rate 
mutations can be observed. Conversely, as in the case of the GA-FS (SVM) data 
region network, a cluster of broadly predictive hotspot descriptors is also shown. 
 
To  visualize  the  interconnections  between  descriptors  and  data  regions, 
descriptor-data region networks are generated for both the LR (Figure 7.7 C) and 
SVM (Figure 7.7 D) GA-FS runs. An edge between a descriptor and a data region is 
shown if the given descriptor is part of the final GA-FS model in at least 50% of 
the  GA-FS  runs  for  the  given  data  region  (with  increasing  edge  weight  for  > 
50%). Several descriptors are highly specific to certain data regions. For instance 
in the LR model (Figure 7.7 D), two statistical potentials, (AP_T1 (Tobi, 2010)  and 
CP_MJ2 (Miyazawa and Jernigan, 1996)), are specific to rim region mutations. 
Whereas  others,  such as  HS_PosCoop, as highlighted by their high degree, are Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
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broader in their predictive value and can explain off-rate changes in a number of 
data regions collectively. Interestingly, for the support regions, MaxClusterSize is 
invoked which suggests that larger hotregions in the support regions may be 
important for complex stabilization. Certain descriptor-data region relationships 
hold  for  both  LR  and  SVM  models,  such  as  the  electrostatic  contributions 
(CHARMM_elec (Brooks  et  al.,  2009))  from  mutations  on  complexes  of  large-
interface-area  (LIA).  The  ability  to  model  nonlinearities  between  features, 
invokes some different descriptors. Most notably, a key observation specific to 
the  SVM  descriptor-data  region  network  is  a  central  cluster  of  highly 
interconnected hotspot descriptors and data regions, which involve HS_PosCoop, 
HSEner_PosCoop, Int_HS_Energy and RimHSEnergy. 
 
7.4  Off-rate Prediction and Conformational Changes 
 
Predictions  of  all  off-rate  regression  models  are  analysed  separately  for 
mutations on complexes that show significant backbone conformational changes 
for,  either  or  both,  binding  partners  upon  complex  formation.  The  subset  of 
complexes for which the unbound crystal structures of the wild-type complex are 
available,  were  singled-out  and  their  I_RMSD  values  for  backbone 
conformational rearrangements were extracted from the work of Kastritis et al. 
(2011).  This  subset  of  complexes  for  which  unbound  crystal  structures  are 
available, amounts to 17 complexes and 332 mutations. A total of 67 mutations 
on four complexes show significant conformational changes with (I_RMSD  >1.5 
Å),  and  if  the  threshold  is  lowered  to  (I_RMSD    >1  Å),  this  results  in  119 
mutations on six complexes. Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
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Figure 7.8: Effects of conformational changes on off-rate prediction.  
From the predictions of the original 13 regression models developed for off-rate 
prediction. The predictions are assessed separately (PCC with Δlog10(koff)) for 
mutations  on  complexes  which  undergo  significant  backbone  conformational 
changes  of  I_RMSD  >  1.5  Å  (dark  green),  notable  conformational  changes  of  
I_RMSD > 1 Å (light green) and little to no conformational changes I_RMSD < 1 Å 
(dark  blue).  Predicted  accuracy  is  directly  related  to  the  magnitude  of 
conformational  change  and  becomes  highly  dependent  on  the  model  at  high 
conformational changes. I_RMSD values extracted from (Kastritis et al., 2011). 
 The PCCs for the off-rate model predictions with Δlog10(koff) are shown under 
three  conformational  change  categories  (Figure  7.8).  The  PCC,  for  complexes 
which show little to no conformational change (I_RMSD < 1.5 Å), averaged over 
all prediction models, shows a correlation of R=0.86, which decreases to R=0.58 
at (I_RMSD >1 Å) and R= 0.28 at (I_RMSD > 1.5 Å). Though for the latter category, 
RFSpotOff-Rate achieves a correlation of R=0.43. Changes in the different models 
are  more  apparent  for  complexes  with  higher  conformational  changes,  most 
notably is the discrepancy in PCC between Molecular and RFSpotOFF-Rate Off-Rate 
prediction  models.  This  discrepancy  is  minimal  at  complexes  with  little 
conformational changes, ΔR= 0.01I_RMSD <1.5 Å and increases to ΔRI_RMSD >1 Å =0.11 
and ΔRI_RMSD >1.5 Å= 0.24 for complexes with significant conformational changes.  Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
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7.5  Effects of Cross-Validation Routine on Off-Rate Prediction 
Performance 
 
 
Figure  7.9:  PCCs  for  off-rate  prediction  models  using  the  713  off-rate 
mutant dataset from SKEMPI.  
Leave-Complex-Out CV(LCO-CV), Leave-Homology-Out CV (LHO-CV) and LCO-CV 
for complex which undergo minimal to no conformational changes with I_RMSD 
< 1.5 Å as defined in (Kastritis et al., 2011). The models differ by their features 
sets. First six use hotspot descriptor sets, followed by a molecular descriptor set 
model  (Molecular),  and  models  that  combine  both  (+Mol).  Degradation  in 
performance is observed when using both LHO (blue bars) and LCO-CV (beige 
bars)  routines.  This  degradation  is  less  evident  once  controlled  for 
conformational changes (green bars). 
 
The results presented in previous sections which use 20-fold cross validation for 
the generation of test predictions, are an estimate of predictive power given one 
already has some mutant information on the complex in question to train upon. 
This type of cross validation is not a valid estimate of a model’s general ability to 
predict  on  an  unseen  complex.  Therefore,  two  additional  cross-validation 
mechanisms  were  also  applied;  Leave-Complex-Out  CV  (LCO-CV),  where  all 
mutations of a complex are left out as a test set and Leave-Homology-Out CV  
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(LHO-CV);  a  more  stringent  form  of  cross-validation  which  accounts  for 
homology  and  interface  similarity  as  devised  in  the  work  of  (Moal  and 
Fernandez-Recio, 2012). The proteins held out in each LHO-CV fold are listed in 
the appendices Table 10.1. The PCCs of the test predictions with Δlog10(koff), of 
the two CV routines, are shown Figure 7.9. Given that for 20-Fold CV, R > 0.7, for 
LCO-CV  and  LHO-CV,  the  models  severely  over-fit.  In  essence,  the  predictive 
ability  of  the  hotspot  descriptors  such  as  HSEner_PosCoopRFSpot  (|R|=0.57), 
Int_HS_EnergyHotpoint1  (|R|=0.57)  and  SuppHSEnergyKFC2a  (|R|=0.62)  is  being 
impeded by the learning model and noise from other features.  It is important to 
note that the LHO-CV might not be well suited for certain practical purposes. For 
example, if one wishes to be able to predict mutations on an enzyme inhibitor 
complex, it would be natural to have such complexes in the training set, unlike 
what  is  actually  done  here  for  LHO-CV.  The  largest  amount  of  over-fitting  is 
observed  for  the  molecular  descriptor  model,  which  is  alleviated  with  the 
hotspot descriptor models and in both CV mechanisms, the correlations achieved 
by the hotspot descriptor models, is higher than that achieved by the molecular 
descriptor set model. LCO-CV was also performed on the subset of 14 complexes 
and 265 mutations, which show little to no conformational change. It is observed 
that  the  reduction  in  ability  to  model  the  effects  of  mutations  on 
unseen/unrelated is largely affected by conformational changes. For example, for 
RFSpot_KFC2Off-Rate, the correlation  achieved is  as  high as 0.8  when  limited to 
rigid complexes, even when LCO-CV is being performed.  
 
7.6  Discrepancy in Prominent Features Across LHO Folds 
 
The  low  prediction  accuracy  across  LHO  folds  suggests  that  descriptors 
responsible  for  one  fold  are  not  generalizable  to  others.  To  investigate  this, 
models  are  built  for  mutations  only  within  a  fold  and  the  most  important 
features  are  highlighted  and  compared  to  the  features  from  models  built  on 
other LHO folds. Genetic Algorithm Feature Selection (GA-FS) is used to build 
such  specialized  off-rate  prediction  models  and  both  linear  and  non-linear 
models are investigated. Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
and Hotspot Descriptors 
172 
 
 
Figure 7.10: Heterogeneity across different protein families.  
Left: GA-FS (LR), Right: GA-FS (SVM). The colour bar indicates the percentage 
number of times the given feature made it to the feature set of the final model 
after a GA-FS run. Features shown are those which make it to the final model 
more than 50% of the time for at least one set on the x-axis. As observed in both 
heat  maps,  different  protein-families  need  to  employ  different  descriptors  in 
order to be accurately predicted.  
 
The Features that make it to the final models (Figure 7.10 left for LR and Figure 
7.10 right for SVM) indicate heterogeneity in the features selected across folds, 
and no one-feature-fits-all may be identified. This again may contribute to the 
reduction  in  PCCs  when  using  LHO-CV  mechanisms,  as  mutations  on  unseen 
complexes may be better predicted using features that were not prominent in 
the  training  set  mutations.  Biases  related  to  different  experimental  methods 
from which the Δlog10(koff) of the mutations where calculated are also known to 
have significant effects on the prediction of binding free energies (Kastritis and 
Bonvin, 2010, Moal et al., 2011) and may also play a role in the reduction of 
accuracy when using LHO- and LCO-CV mechanisms. Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
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7.7  Dicussion 
 
To  assess  the  predictive  abilities  of  hotspot  descriptors  when  combined  in 
learning  models,  several  machine  learning  models  trained  on  Δlog10(koff)  are 
investigated in this chapter. Hotspot descriptor models provide more accurate 
predictions  for    Δlog10(koff)   than  molecular  descriptor  models  and  the  best 
regression  model,  which  combines  both  molecular  and  hotspot  descriptors, 
RFSpot_KFC2Off-Rate+Mol, achieves a PCC of R=0.79 with experimental off-rates.  
 
7.7.1  Dataset Heterogeneity, Descriptors and Learning Models 
 
The  assessment  of  predictor  performance  on  different  subsets  of  the  dataset 
termed  as  ‘data  regions’  and  the  subsequent  generation  of  ‘descriptor-data 
region networks’, proved to be an insightful exercise. Firstly, it puts to light the 
interconnected  relationship  between,  dataset  heterogeneity,  descriptors  and 
learning models and secondly it highlights regions that still require attention.  
An example, which is representative of both these points, is the prediction of 
mutations in rim regions. When using a global off-rate model, there is a striking 
discrepancy in our ability to model off-rate changes for mutations in rim regions 
as opposed to the core regions. What is special about rim mutations that render 
them  to  act  differently  than  other  mutations?  What  makes  them  harder  to 
predict? There are several mechanisms at play that must be considered. Firstly, 
what has been uncovered is that the features, which are able to characterise 
changes in off-rate for the majority of mutations, fail to do so for the subset of 
mutations at the rim regions. This does not necessarily mean that there are not 
descriptors that are able to characterise the rim region mutations well. Rather, it 
may  very  well  be  that  there  are  very  specific  descriptors  which  are  able  to 
characterise mutations at the rim regions, but the learning model has no way to 
distinguish between rim mutations and core mutations. Therefore, the learning 
model cannot apply different descriptors to such regions separately.  To assess if 
the latter is true, models specific to (trained and tested on) rim region mutations 
only, were built using the (GA-FS SVM/LR) models. Here the GA-FS SVM model Chapter 7. Prediction of Off-Rate Changes upon Mutation using Machine Learning Models 
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achieves R=0.58. This  in comparison to R=0.38 (p=0.04) achieved on the rim 
region mutations using a global off-rate model. This shows that indeed, there are 
descriptors within the feature set, which are able to characterise rim regions 
better, and such descriptors are highly specific to mutations occurring at the rim. 
However, it is important to note that the increase in correlation to R=0.58 for rim 
region mutations is only achieved using the non-linear model (SVM). This is not 
the case with the linear LR model, even though the LR model is also specific to 
(i.e. trained and tested on) rim region mutations. One can therefore appreciate 
that  in  datasets  which  are  heterogeneous,  any  generalizations  about  the 
importance of descriptors, are highly dependent on not only the data-region in 
question but also on the learning model used.  
 
Figure 7.11: Ways in which different learning algorithms link descriptors 
to a dataset. 
 Datasets of protein-protein interactions and mutations at protein interfaces are 
intrinsically heterogeneous. This renders the ‘one-fits-all’ assumption of Linear 
Regression  (A)  very  limiting,  even  if  not  considering  the  limitations  brought 
about  by  the  linear  assumption.  (B)  Learners  which  are  able  to  distinguish 
between different ‘data regions’ within a dataset may apply descriptors which 
are specific to that region only. These include Look-Ahead Regression Trees and 
Hierarchical Mixture Models. (C) Certain descriptors might not be only accurate 
within certain ranges, hence models such as Multi-Adaptive-Regression-Splines 
(MARS), which are selective on which regions of the descriptor are used in the 
final model, maybe be used. 
Understanding  this  3-way  relationship  between  descriptors,  data-regions  and 
the learning models used, is an important consideration for the prediction of off-
rates on similar datasets to that used in this work. Effectively, the learning model 
is nothing but a linker of descriptors to data. The various scenarios differing by 
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the way learning models link descriptors to data are summarized in Figure 7.11. 
If the dataset is heterogeneous, and data-regions for which certain descriptors 
are  specific  to  do  exist,  then  the  data-regions  should  be  made  visible  to  the 
model.  Introducing  categorical  features  as  an  indicator  to  a  data  region,  for 
example, may do this. In  addition, the  learning  model chosen should be  able 
exploit these categorical features and selectively apply descriptors specifically to 
the data regions indicated by them. Examples of which are; non-greedy decision 
trees  and  hierarchical-mixtures-models,  as  these  models  do  not  necessarily 
assume  features  to  be  ordinal.  Effectively,  the  use  of  such  models  has  the 
advantage of still having just one learning model for the whole dataset, but also 
the added flexibility of having specialized models for different data-regions.  
7.7.2  Future Endeavors – Conformational Changes 
 
Predicting  the  effects  of  mutations  of  complexes,  which  undergo  significant 
backbone conformational change, remains a challenge. This is shown to be true 
both when predicting wild-type binding free energies described in Chapter 2, and 
here  in  the  prediction  of  off-rate  changes  upon  mutations.  Reasons  for  the 
reduction in performance can be several-fold, but more than likely stem from the 
fact that all calculations use only the bound conformations of the receptor-ligand 
complex. This effectively translates itself into a one-step binding process, 
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7.1 
For complexes which undergo minimal conformational changes, this is indeed a 
sufficient approximation, as confirmed by the mean correlation of RAVG=0.86 for 
complexes with <1.5A backbone rearrangement. Once conformational changes 
come  into  play,  then  binding  is  better  approximated  using  a  2-step  binding 
process. 
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Here, the koff can be decreased even if mutations destabilize the bound-state RL*. 
Rather, the decrease in off-rate is brought about by an increased stability of the 
transition state RL (Lu and Tonge, 2010). Therefore, the accurate characterization 
of the transition state RL, which is not trivial, becomes as important as that of the 
final  bound  state  RL*.    With  conformational  changes,  different  binding 
mechanisms also come in to play. For example Weikl and von Deuster (2009) 
show that depending on the binding mechanism (conformational  selection or 
induced-fit), mutations that do not affect the stability of the interface, but affect 
the conformational equilibrium of the receptor R, also affect the off-rate. Last but 
not  least,  complexes  are  not  static  structures,  and  ideally,  a  similar 
conformational  sampling  mechanism  to  the  one  used  in  Chapter  2  is  also 
employed  to  the  off-rate  scenario.  This  might  be  particularly  important  for 
complexes, which are natively unstructured/disordered in local regions, as these 
regions may still remain disordered even in the bound state (Xia et al., 2004, Zeth 
et al., 2002). Binding site variability has also been observed in certain complexes 
where  the  variability  is  not  explained  by  experimental  or  procedural 
inaccuracies (Hamp and Rost, 2012).  
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Chapter 8 
8 Distribution of Stability in Protein-
Protein Interfaces 
 
Chapters 6 and 7 show how counting the energies of hotspot energies, pre- and 
post-mutation provides an accurate description of changes in Δlog10(koff). Here, 
the focus shifts on understanding to which extent, the off-rate of a complex is 
affected  by  the  distribution  of  hotspots.  Given  that  protein-protein interfaces 
contain a number of hotspots, which may occur in disjointed regions, the central 
question  addressed  here  is  the  following;  Are  certain  hotspot  regions  of  the 
interface  more  susceptible  to  destabilizing/stabilizing  the  interaction  upon 
mutation?  For  example,  are  hotspots  at  the  core  sufficient  for  high  complex 
stability? Can rim hotspot  residues share  a role as  important as  that of core 
hotspot residues? Given an interface with a number of hotpots, do hotregions 
provide an added level of stability which hotspots on their own do not? Knowing  
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which hotspot regions are more important to the stability of the interaction is 
critical  for  inhibiting  protein-protein  interactions  (see  section 
1.4.1) and designing better protein drugs (see section 1.4.2) and to date, there is 
no study investigating this. As a basis on which the computational experiments 
are designed, results from previous work related to the distributional patterns of 
hotspots are used as initial hypotheses. 
In the first part of this work (section 8.1), the role of the core and rim hotspot 
residues is revisited in the context of the dissociation rate. To do so, the initial 
assumption  taken  is  that  the  critical  region  of  stability  of  a  protein-protein 
interaction emanates from the core hotspots, as evidenced in the work of Bogan 
and Thorn (1998). With a number of additional computational experiments, our 
observations suggest that, for off-rates, the above only holds for large complexes. 
As for small complexes, all regions of the interface are critical for the stability of 
the  interaction  i.e.  rim  hotspot  residues  are  as  equally  responsible  for  low 
dissociation rates. A second property of hotspots related to their distribution, is 
that hotspots tend to cluster into tightly packed regions known has hotregions 
(Keskin et al., 2005). The authors report that the conservation of this type of 
organization suggests that they are important for protein-protein association. 
However, the aforementioned analysis is not performed in relation to binding 
free energies or off-rates for protein-protein interactions and the suggestion is 
somewhat speculative in nature. In section 8.2, the extent to which the presence, 
number and size of hotregions is advantageous to complex stability, is therefore 
investigated.  In  the  same  work  of  (Keskin  et  al.,  2005),  it  is  suggested  that 
hotregions are cooperative in nature and future scoring functions should account 
for  this  effect  so  as  not  to  overestimate/underestimate  the  contribution  of 
hotregions. In the latter sections of this work, when hotregions are tested for 
potential cooperative effects (section 8.3), no prevalent form of cooperativity is 
observed. In addition the contribution of hotregions of different sizes towards 
stability is determined under different cooperativity assumptions (section 8.4).  
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8.1  Critical Regions of Stability in Protein-Protein Complexes 
 
In the previous chapters 6 and 7, it was shown how the change in the off-rate of a 
complex  is  directly  related  to  a  change  in  the  sum  of  its  hotspot  energies. 
Therefore  no  distinction  is  made  on  which  hotspot  energies  the  mutation  is 
modulating. Using the hotspot energies at the core, rim and support regions, it is 
assessed whether complex stability can be effectively disrupted homogenously 
across  the  interface  (equally  across  the  three  regions)  or  preferentially  in  a 
particular region. CoreHSEnergy, RimHSEnergy and SuppHSEnergy represent the 
change  in  total  hotspot  energies  limited  to  each  region  upon  mutation. 
Effectively, the PCC of these descriptors with the off-rate expresses how well 
changes  in  the  given  region  show  themselves  as  changes  in  log10(koff)  - 
irrespective of changes in hotspot energies in any other region. Therefore, by 
assessing the relative PCCs of the three regions we can gauge whether a given 
region acts independently and dominates in its contribution to complex stability 
compared  to  other  regions.  Given  that  there  are  6  instances  of  each  hotspot 
descriptor, as generated per each hotspot predictor,  the correlations for each 
descriptor shown are the mean of each descriptor’s correlation under the six-
hotspot predictors. Hence results can be considered to be independent of the 
hotspot predictor generating the hotspot descriptors.  
From the PCCs of the three-hotspot region specific descriptors (CoreHSEnergy 
|R| = 0.48, RimHSEnergy |R|= 0.20 and SuppHSEnergy |R| = 0.38), it is observed 
that  changes  in  the  hotspot  energies  at  the  core  affect  the  off-rate  more 
significantly than the rim (p<<0.01) and support region (p<0.01). Given that 355 
mutations affect hotspot energies in the core region compared to 148 and 182 
for rim and support regions respectively, results may however be biased. For 
example, if fewer events are observed at the rim region, there is less chance of 
the rim region playing a significant role in off-rate changes, when looking at it 
globally over a population of complexes as is done presently. To remove this 
potential  bias,  the  subset  of  mutations,  which  affect  all  three  regions 
simultaneously,  is  extracted  and  PCC  recalculated.  The  PCCs  still  suggest Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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dominance  from  the  core  region  (|R|=  0.53),  more  significantly  than  the  rim 
region (|R| = 0.22 p<<0.01).  
8.1.1  Stability Regions in Small and Large Interfaces 
 
To investigate whether the relative importance of these three regions of stability 
changes when considering complexes of different interface areas, the dataset is 
divided into small interface area (SIA) complexes (< 1600 Å2 buried surface area) 
and large interface area (LIA) complexes (> 1600 Å2 buried surface area). The 
threshold of 1600 Å2 is such that both subsets are of similar number of examples. 
The mean PCC for the CoreHSEnergy, SuppHSEnergy and RimHSEnergy for LIA 
and  SIA  complexes  is  calculated  and  shown  in  Figure  8.1a  and  Figure  8.1b 
respectively. 
 
 
Figure 8.1: Critical Regions of Stability as a function of Complex Interface 
Area.  
(A) The absolute PCC of the sum of changes in hotspot energies at the Core, Rim 
and Support Interface Regions with experimental log10(koff) - for complexes with 
large interface areas. (B) Similar to (A) but for complexes with small interface 
areas. The threshold for large / small interface area of 1600 Å2 is chosen in such 
a way that divides the dataset into samples of similar size. 
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For the LIA complexes, a dominant contribution from the changes in core hotspot 
energies (CoreHSEnergy |R|=0.48) and minimal contribution from SuppHSEnergy 
(|R|=0.37) and RimHSEnergy (|R|=0.20) is observed (Figure 9A). Therefore, even 
though a given set of mutations might be affecting support or rim regions, it is 
the  changes  in  hotspot  energies  at  the  core  region  which  show  up  as  the 
dominant  changes  in  the  off-rate  |R|=0.48).  For  SIA  complexes  (Figure  9B), 
changes in hotspot energies at the rim regions, show a highly significant 2-fold 
increase in correlation (p<<0.01). This renders all three regions with somewhat 
similar  contributions  to  complex  stability  (CoreHSEnergy  |R|=0.56, 
SuppHSEnergy |R|=0.46, RimHSEnergy |R|=0.40). For LIA complexes, mutations 
applied in positions that affect the core to those that affect the rim is 2:1. On 
considering SIA complexes the ratios increase to 3:1. Therefore the increase in 
importance of the rim hotspot energies occurs in spite of a decreasing ratio. As 
an additional test, which accounts for biases in the number of examples affecting 
each region, the correlations are calculated for only the mutations, which make 
changes  in  the  respective  region,  again  taking  an  average  over  all  6  hotspot 
predictors’ descriptors. Here no significant changes in correlation are observed 
in LIA and SIA complexes for the core and support region. For LIA complexes, 
changes  in  rim  hotspot  energies  have  minimal  effect  on  the  off-rate  with 
|R|=0.29, whereas for SIA complexes, a 1.75-fold increase (p<0.01) in correlation 
is observed (|R|=0.51). This confirms that hotspots at the rim of the interface can 
have a role as dominant to that of core region hotspots. 
8.1.2  Stability Regions in Small and Large Complexes 
 
The dataset is divided into the mutations, which are found on Large-Complex-
Size (LCS) (with 231 mutations), and Small-Complex-Size (SCS) complexes (with 
482  mutations).  The  PCC  for  CoreHSEnergy,  RimHSEnergy,  SuppHSEnergy 
averaged over the descriptors from all hotspot predictors is calculated for both 
LCS and SCS Figure 8.2a and Figure 8.2b respectively.  Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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Figure 8.2: Critical Regions of Stability as a function of Complex Size.  
(A) The absolute PCC of the sum of changes in hotspot energies at the Core, Rim 
and  Support  Interface  Regions  with  experimental  log10(koff)  –  for  large 
complexes. (B) Similar to (A) but for small complexes. The threshold for large / 
small  complex  size  of  500  residues  is  chosen  in  such  a  way  that divides  the 
dataset into samples of similar size. 
 
Core  hotspots  are  critical  to  the  stability  of  LCS  complexes  whereas  for  SCS 
complexes, all three regions are important. This effect is synonymous with what 
is  observed in LIA and SIA complexes, though the  increase  in correlation  for 
RimHSEnergy (R=0.07 to R=-0.36 p<<0.001) is more pronounced for complex 
size  rather  than  interface  area.  Even  though  fewer  mutations  are  on  LCS 
complexes  (231),  the  percentage  of  mutants  affecting  each  region  in  LCS, 
compared to that for SCS, is similar across the three regions (61%, 52% and 46% 
for  core,  rim  and  support  regions  respectively)  and  therefore  shows  no 
relationship to the changes seen in the PCC of the three regions from LCS to SCS.  
8.1.3  The Role of Rim Regions in Small Complex Sizes 
 
On the 50 complexes considered in the 713 off-rate mutant dataset, complex size 
and interface size show a correlation of R=0.55 (Figure 8.3i). The correlation is 
higher  (R=0.74)  for  complexes  sizes  of  less  than  500  residues,  and  becomes 
insignificant  (R=0.18)  beyond  complex  sizes  of  500  residues  and  above.  The 
dataset is therefore further divided into four regions (Figure 8.3i), which include: 
SIA-SCS (191 mutations), SIA-LCS (67 mutations), LIA-SCS (191 mutations), LIA-
LCS  (164  mutations)  and  again  the  PCC  for  CoreHSEnergy,  RimHSEnergy, 
A  B Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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SuppHSEnergy  averaged  over  the  descriptors  of  all  hotspot  predicators  is 
calculated and shown in Figure 8.3g: SIA-SCS, Figure 8.3h: SIA-LCS, Figure 8.3e: 
LIA-SCS and Figure 8.3f: LIA-LCS.  
 
Figure 8.3: Stability regions, interface-area and complex-size.  
The changes in hotspot energies upon mutation are assessed at three interface 
regions. This enables exploration of changes in the distribution of stability for 
complexes of different size and interface-area. CORE, RIM and SUPP represent 
the  PCCs  of  CoreHSEnergy/RimHSEnergy/SuppHSEnergy  averaged  for  the  6 
hotspot  prediction  algorithms  with  Δlog10(koff).(A)  PCCs  for  mutants  on 
Complexes  with  interface-area  >1600  Å2 (LIA).  (B)  PCCs  for  mutants  on 
complexes  with  interface-area  <1600  Å2 (SIA).  (C)  PCCs  for  mutants  on 
complexes with size <500 residues (SCS). (D) PCCs for mutants on complexes 
with size >500 residues (LCS). (E) LIA-SCS, (F) LIA-LCS, (G) SIA-SCS, (H) SIA-LCS. 
(I) Scatter plot of complex size vs. interface area for all complexes in off-rate 
mutant dataset. Here it is observed that complex stability is distributed across all 
three regions for small-size complexes (C, E and G), whereas the core becomes a 
localized region of stability for large-complex sizes (D, F, H). On analysis of the 
interface-area  vs.  complex-size  subsets  (E–H),  the  distribution  of  stability 
regions is affected primarily through complex-size irrespective of interface-area. Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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Here it is observed that given a fixed complex size (SCS or LCS), moving from 
small  interface  areas  to  larger  interface  areas,  the  landscape  for  the 
contributions of the Core, Rim and Support regions is unchanging. Therefore, 
independent of the interface area size, for low complex sizes off-rate has the 
propensity to be affected equally from all regions of the interface, whereas for 
high-complex sizes, stability is primarily emanating from core hotspots. More so, 
when  moving  from  LCS  to  SCS,  rim  regions  transition  from  having  to  an 
insignificant  role to  a more  primary one  –  equal to  that of core  and support 
regions. 
Further analysis of SCS and LCS complexes shows a greater sensitivity in off-rate 
changes upon mutations for SCS complexes; the mean |Δlog10(koff)| is 1.4 and 
0.69 for SCS and LCS complexes respectively. Though the latter result is intuitive, 
in that changes on large complexes are less likely to have effects as significant as 
those on small complexes, the key finding here is that on dissection of the three 
interface regions, the reduction in the ability to make significant changes in LCS 
is not equally shared equally on the three regions. Rather, mutations at the core 
can still have notable effects on the stability of large complexes as in the case of 
smaller  complexes.  Conversely,  the  higher  sensitivity  of  SCS  complexes  to 
mutations is due to the increase in importance of role of the rim regions and also 
possibly the support regions. 
 
8.2  Effect of Hotregion Size, Count and Complex Dissociation Rate. 
 
Analysis  of  the  mean  PCCs  for No_Clusters (the  change  in  the  number  of 
hotregions upon mutation, R = −0.15) and MaxClusterSize (the change in size of 
the largest hotregion R = −0.09), show no notable contribution to changes in the 
off-rate (See Table 6.1). Both the change in interface hotspot energy, and change 
in the number of hotspots show higher correlations (R = −0.51 and R = −0.44 
respectively).  For the  hotspot  predictor  RFSpotKFC2,  both No_Clusters  and 
MaxClusterSize show higher correlations than the average (R = −0.29, for both), Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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and  the  combination  of  the  two  descriptors  into  one  using  multiplication 
increases the PCC with Δlog10(koff) to R = −0.48. Though this may suggest that, 
larger and more hotregions in a complex result in a higher dissociation rate, its 
correlation  of  R  =  0.6  with  the  change  in  hotspot  energies  (Int_HS_Energy), 
suggests that the  underlying mechanism might still be  the  change  in hotspot 
energies, irrespective of hotregion size and count. From this analysis, though it 
cannot be concluded that larger hotregions do not provide added stability to the 
complex, it is shown that the disruption of the largest hotregions, is not critical to 
complex stability.  
 
8.3  Hotregion Cooperativity and Complex stability. 
 
Probing the importance of the tendency for hotspots to cluster into hotregions, 
and for that matter, the importance of both size and number of hotregions for 
complex  stability,  has  also  to  be  done  in  the  light  of  hotspot  cooperativity. 
Cooperativity within hotregions has been suggested to be a natural consequence 
of the tight packing ratios found for hotspot residues in hotregions (Keskin et al., 
2005). This adds another layer of complexity in validating the role of hotregions, 
as under cooperativity, larger hotregions do not necessarily contribute more to 
complex stability. In turn, this knowledge is critical in order not to overestimate 
or underestimate the contribution of hotspot energies within hotregions. There 
are two caveats to this, firstly it is not obvious what type of cooperativity exists 
within the hotregions and complexes in the dataset, and secondly, if present, this 
cooperativity has to be accounted for with a function. To our knowledge, this is 
the  first  work  to  include  energetic  descriptors  which  account  for  potential 
cooperative effects in an empirical scoring function. 
The approach taken here is that no assumption is made before hand for any type 
of cooperativity prevalent in the complexes and hotregions within our dataset. 
Rather  the  two  hypotheses  of  positive  cooperativity  (HSEner_PosCoop)  and 
negative cooperativity (HSEner_NegCoop) are investigated and compared to the 
baseline hypothesis of additive hotspot energies (Int_HS_Energy). For ease of Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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reference,  these  three  descriptors  are  referred  to  as  the  cooperativity 
descriptors and the motivation behind their functional forms are detailed in the 
methods section 2.3.7.3. Effectively, the higher the PCC of these descriptors with 
the off-rate, the more likely it is that hotregions on the complexes of the 713 off-
rate mutant dataset, show the given type of cooperative/additive effect. 
 
Figure 8.4: PCCs of Hotspot Cooperativity Descriptors with  experimental 
Δlog10(koff).  
Int_HS_Energy  assumes  no  cooperativity  within  hotregions  and  therefore  all 
hotspot  energies  are  additive  within  a  hotregion.  HSEner_PosCoop  assumes 
positive cooperativity within hotregions, where its total energy is greater than 
the  sum  of  its  parts.  HSEner_PosCoop  assumes  negative  cooperativity  within 
hotregions and therefore the total energy of a hotregion is less than the sum of 
its  parts.  The  design  and  functional  forms  of  each  descriptor  are  detailed  in 
methods section 2.3.7.3. From the correlations of the descriptors generated by 
the predictions of different hotspot predictor algorithms, there is no prevalent 
form of cooperativity observed within hotregions. Rather, the data suggests that 
the additivity assumption is the safest one to take. 
 
 In Figure  8.4,  the  PCCs  of  cooperativity  descriptors  with  Δlog10(koff)  are 
highlighted  for  every  hotspot  predictor  investigated.  From  these  results,  no 
evidence  is  found  for  a  prevalent  form  of  cooperativity  in  hotregions,  as  the 
additivity  assumption  works  generally  better  than  positive  or  negative 
cooperativity  assumption.  Several  alanine  scanning  experiments  on  protein-
protein  interactions  indicate  that  mutations  are,  to  a  large  extent,  naturally 
additive  (Pal  et  al.,  2005,  Horovitz,  1996,  Gregoret  and  Sauer,  1993).  Eleven 
residues  in  the  helix-turn-helix  motif  of  the  N-terminal  domain  of  Gamma Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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repressor,  found  in  a  region  important  for  DNA  binding,  were  substituted  to 
alanine  using  binomial  mutagenesis (Gregoret  and  Sauer,  1993).  The  authors 
confirmed their nature to be additive and a model assuming additive interactions 
was able to predict the activity class of mutants with 90% accuracy (Gregoret 
and Sauer, 1993). In similar fashion, nineteen residues within the hGH site 1 for 
binding to the hGHR were randomized using a combinatorial, shotgun alanine-
scanning  library (Pal  et  al.,  2005).  On  comparison  of  the  counts  of  double 
alanine-mutations in hGH site 1 variants selected for binding to the hGHR , from 
the 144 pairwise combinations, only 15 pairs (10%) behave in a cooperative 
manner. Still, the experiments mentioned above are not specific to only hotspot 
residues, and therefore their results are not directly comparable to ours which 
are  specific  to  hotregions;  for  example  combinatorial  mutant  analysis  of  the 
TEM1-BLIP complex which is performed on residues in tight packed modules, 
and hence more akin to hotregions, shows that residues within a cluster tend to 
show strong positive cooperativity (Reichmann et al., 2005). The inclusivity of 
these results are discussed further in section 8.5. 
 
8.4  Effects of Cooperativity on the Effective Energetic Contribution 
of Hotregions. 
 
As  highlighted  in  the  previous  section,  understanding  hotspot  cooperativity 
within hotregions is necessary so as not to overestimate or underestimate the 
importance of the given hotregion. In order to understand better the effects of 
the  cooperativity  descriptors,  the  average  hotspot  and  hotregion  energies  of 
different  hotregions  sizes  is  plotted  for  each  of  the  three  cooperativity 
assumptions.  
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Figure 8.5: The summation of single-point alanine ΔΔGs of a hotregion may 
underestimate/overestimate  its  contribution  if  negative/positive 
cooperative effects are at play respectively.  
Here, the effects of accounting for cooperative/additive effects on the predicted 
hotspot and hotregions energies on all mutated complexes used in this work, is 
shown.  (A)  The  mean  hotspot  energies  for  hotregion  sizes  of  1  to  8  hotspot 
residues. Each column shows the predictions of different hotspot predictors. (A) 
First  row  (blue),  shows  the  raw  mean  hotspot  energies,  which  essentially 
assumes  all  hotspots  are  additive  within  a  hotregion.  (A)  Second  row  (red), 
assumes  negative  cooperativity  within  hotregions.  To  account  for  negative 
cooperativity,  a  linearly  increasing  weight  is  applied  to  the  hotspot  energies 
according to the size of the hotregion they are in (see methods section 2.3.7.3). 
(A) Third row (green), assumes positive cooperativity within hotregions and a 
linearly decreasing weight is applied to the hotspot energies according to the 
size of hotregion (see methods section 2.3.7.3). (B) is similar to (A) but values 
are now the mean of the total hotregion energy of the given size. Effectively, the 
additive  hotspot  energy  assumption  results  in  hotregions  contributing  in  a 
linearly  increasing  manner  according  to  their  size,  the  negative  cooperativity 
assumption results in hotregions contributing in an increasing exponential-like 
manner  as  the  hotregions  increase  in  size,  and  the  positive  cooperativity 
assumption results in hotregions reaching a maximum contribution at around a 
hotregion size of 5, with their contribution decreasing beyond. Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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Analysis of the mean hotspot energies predicted by each hotspot predictor (first 
row in Figure 8.5a) shows a constant mean energy profile of hotspot energies 
within  different  hotregions.  For  the  additive  energy  assumption  (first  row 
in Figure 8.5b) and the negative cooperativity assumption (second row in Figure 
8.5b), a linear and exponential-like increase of energetic contribution from larger 
hotregions  is  shown  respectively.  For  the  positive  cooperativity  assumption, 
application of a linearly decreasing function on increasing hotregion sizes which 
have  constant  hotspot  energies  to  start  off  with,  results  in  a  bell-shape 
contribution from hotregions. This suggests that maximum stability is provided 
by hotregion sizes of around 5; therefore, a saturation of hotregion contribution 
is achieved, beyond which larger hotregions do not necessarily increase complex 
stability. 
 
8.5  Discussion 
 
After confirming in the previous chapters of 6 and 7 that the change in the sum of 
the hotspot energies across an interface correlates to a change in off-rate, in this 
chapter, several aspects of hotspot distribution were studied in relation to the 
off-rate of a complex. Two previously reported properties of hotspots motivated 
this work; their tendency to occur at core interface regions (Bogan and Thorn, 
1998), and their tendency to cluster into hotregions (Keskin et al., 2005). The 
advantage,  if  any,  of  these  distributional  properties  to  complex  stability  is 
therefore examined.  
The off-rate of small complexes is more sensitive to mutations than that in large 
complexes. In section 8.1.3 it is shown that the higher sensitivity observed in 
small complexes, is a result of the increased importance of hotspots at the rim 
regions. Namely, mutations affecting these regions can have effects on the off-
rate as significant as those in the core region. From the data available, in section 
8.2, no evidence is found that complexes with more or larger hotregions have 
lower dissociation rates. In order to understand better the role of hotregions, the 
effects  of  cooperativity  between  hotspots  in  a  hotregion  are  considered  in Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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section 8.3. No prevalent form of cooperativity, positive or negative, is observed. 
Rather,  interactions  in  hotregions  are  best  described  by  the  additivity  rule. 
Finally in section 8.4, the contribution towards stability of hotregions of different 
sizes,  is  presented.  Under  a  negative  cooperativity  assumption,  hotregion 
contribution increases exponentially with its size. Under a positive cooperativity 
assumption, a bell-like contribution towards stability is observed. In this case, 
maximal stability is reached with hotregions of size five and reduces with sizes 
larger or smaller than this optimal size. 
Our  results  in  section  8.1  are  best  discussed  in  the  light  of  the  ‘O-Ring’ 
hypothesis. Hotspots are preferentially found in regions at the interface of low 
solvent accessibility (Bogan and Thorn, 1998). With this in mind, low solvent 
accessibility is necessary but not sufficient for high energy hotspots, as a number 
of  residues  with  low  to  zero  solvent  accessibility  may  still  not  contribute 
significantly to binding. The O-Ring hypothesis, describes the protein interface as 
one where the stability critical residues are found at the core and are surrounded 
by  a  ring  of  energetically  unimportant  rim  residues.  The  role  of  the  ring  is 
suggested to be secondary one; namely its purpose is to occlude the bulk solvent 
from  the  interactions  at  the  core.  This  provides  a  lower  effective  dielectric 
constant  for  stronger  electrostatic  and  hydrogen  bonding  interactions  at  the 
core. In our analysis presented in section 8.1, in line with this hypothesis, it is 
observed that mutations effecting hotspot at the core region have a significant 
correlative effect on the off-rate. This is in contrast to the other regions of the 
interface i.e. the rim and support regions. Under the O-ring hypothesis, it might 
be natural to think that if the distance between solvent and the core hotspots 
becomes smaller, then hotspot residues at the rim might have an increased role. 
Therefore, additional investigations were performed on small vs. large interfaces 
and on small vs. large interfaces. As shown in Figure 8.3, irrespective of interface 
area, mutations affecting hotspot regions at the rim are able to modulate the off-
rate equally as those affecting core hotspot regions. This is in contrast to what is 
observed in large complexes, where mutations affecting rim hotspot energies are 
inconsequential to the off-rate. Therefore as it seems, rim residues do have a 
significant role for small complexes.  Rim region residues are generally exposed Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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both in the unbound and bound states, but form inter-protein contacts in the 
complex  state.  Therefore  it  is  unclear,  through  which  underlying  mechanism; 
mutations affecting rim hotspot energies are affecting the off-rate significantly. 
One mechanism might simply be the disruption of a strong inter-protein contact 
as a result of the mutation, irrespective of any effect on solvent shielding. The 
other might be that the inter-protein disruption increases the susceptibility to 
solvent entry. For additional validation, analysis of the rim regions using MD 
simulations simulating complex unbinding, for large and small complexes both 
with small-interface-areas may give further insights. 
In section 8.2, no evidence is found that the disruption of large hotregions is 
critical  to  complex  stability.  Nor  is  it  observed  that  having  more  hotregions 
increase complex stability.  In the context of protein drug design such as the one 
presented in Chapter 4, finding mutations which are able to increase further the 
stability of the interaction is a daunting task. The hotspot representation may 
facilitate  this  process  if  hotspot  distribution  is  completely  understood.  For 
example given a hotregion at an interface is it best to make mutations such that 
the existing hotregion grows larger in size, or is it more advantageous to create a 
new  hotregion.  Understanding  if  there  is  any  advantage,  when  attempting  to 
increase  complex  stability,  in  having  larger  hotregions,  or  more  hotregions, 
would ultimately require analysis which controls for the number of hotspots, 
varies the number of hotregions or their size and assesses changes in the off-
rate. However, current experimental data is limited in size and diversity for this 
to be performed comprehensively. 
Counting  of  the  ΔΔGs  of  all  hotspots  in  hotregion  may  overestimate  or 
underestimate the hotregions contribution if cooperativity between the hotspots 
exists. By designing functions which account for potential positive or negative 
cooperative effect, in section 8.3 no prevalent form of cooperativity is observed. 
No conclusion could be made as the results are highly dependent on the hotspot 
predictor generating the hotspots. With this in mind, the additivity assumption 
showed  consistently  higher  correlations  across  different  hotspot  predictors, 
suggesting that hotregions are most additive in nature. This result, contrasts to 
that of Keskin et al. (2005), where it is proposed that hotregions are cooperative Chapter 8. Distribution of Stability in Protein-Protein Interfaces 
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in  nature.  One  should  note  that  this  proposition  is  only  based  on  the  high-
packing ratios of residues in a hotregion to those that are not. With this in mind, 
the results in of Figure 8.4 in section 8.3 are dependent on both the definition of 
a contact and that of a hotregion. There is no rule of thumb on how to define a 
contact or hotregion; in the work of Keskin et al. (2005), the distance between 
radii balls, with origins set on each C-α atom of the residues in question, is used 
to define a contact between two hotspot residues. A hotspot residue is added to a 
hotregion cluster if it is in contact with at least two existing hotspot residues. In 
this work, the definition uses a more fine-grain approach as a contact between 
two hotspot residues is created if any of their atoms are at a distance less than 
their  van  der  Waals  radii  +0.5  Å  (see  methods  section  2.3.7.5).  Though  for 
hotspot residues to be added in an existing hotregion, it only needs to be in 
contact with any other of the hotspot residues, and therefore might be a more 
lenient way of adding hotspot residues to a hotregion cluster, which in turn may 
render  less  packed  hotregions.  Other  contact  methods  also  include  weighted 
contacts  according  to  whether  side-chain  or  backbone  atoms  are  in 
contact (Reichmann et al., 2005). Most importantly, these different definitions 
generate  different  clusters  of  different  packing  ratios  depending  on  their 
leniency  and  stringency,  and  therefore  may  affect  the  levels  of  cooperativity 
observed. Another factor which may account for the inconclusiveness regarding 
the  more  prevalent  form  of  cooperativity  is  the  modelling  of  cooperativity 
functions itself. Finding the right weights to apply to hotregions to account for 
cooperativity  is  not  trivial,  as  experimental  data  (such  as that  found  in 
Reichmann et al. (2005)) is not common enough to be able to learn cooperativity 
functions from experimental data. Last but not least, the diversity of interactions 
within  the  dataset  may  be  better  characterised  with  different  cooperativity 
functions. Interestingly, this diversity of cooperative effects is also observed in 
the  GA-FS  runs  performed  on  subsets  of  related  complexes  in  Figure  7.6  of 
Chapter  7.  Namely  we  observe  that  HSEner_PosCoop,  HSEner_NegCoop  and 
Int_HS_Energy tend to be important for different sets of related complexes in a 
mutually exclusive manner. This re-stresses the importance of detecting when a 
given type of cooperativity is present as much as it is important to model or 
account for it accurately.  
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Chapter 9 
9 Epilogue 
 
In this thesis, the stability of protein-protein interactions is studied at different 
levels. Predictive models for the binding free energy and dissociation rate are 
built and the effect of mutations on both, characterised.  
A  number  of  themes  reverberate  throughout  this  thesis;  firstly,  that  of 
conformational changes upon complex formation. Modelling the stability of such 
complexes remains a major challenge, as is that of characterizing mutations on 
such complexes. Hopefully the research presented in this thesis, sets a precedent 
for future models to come. For example, energetics calculated on a single ‘snap-
shot’ of a bound complex can neither account for the conformational changes 
upon  complex  formation,  nor  for  the  delicate  balance  between  enthalpic  and 
entropic contributions involved. Unappreciated still in modelling stability, and 
somewhat  related  to  conformational  changes,  is  the  binding  and  unbinding 
mechanisms at play. Transition states or encounter complexes play a critical role Chapter 8: Epilogue 
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in  the  stability  of  a  complex.  For  example,  mutations  which  stabilize  an 
interaction might be doing so through increasing the stability of the transition 
state rather than the final bound state. Therefore characterization of binding and 
unbinding funnels, and the dynamics involved, will undoubtedly play a critical 
role in predicting the effects of mutations on protein-protein stability. 
The machine learning framework is one which is consistently used throughout 
this work. The ease with which certain machine learning models can be used in 
‘black-box’  fashion  has  unfortunately  sometimes  resulted  in  very  dubious 
procedures and results throughout the years – some of which are mentioned in 
section 3.5. With powerful tools, comes greater responsibility and the hope is 
that this work highlights clearly these potential pitfalls, and responsibly avoids 
them. Be it with adapting cross-validation routines with domain knowledge, for 
example by using leave-complex-out validation routines; or by making sure the 
data on which predictor performance is stated, is not at any moment seen during 
any parameter optimization or feature selection routines. One aspect of machine 
learning  modelling  which  is  still  unappreciated  is  their  potential  for 
understanding the mechanisms at play. This is not limited to just global feature 
importance  measures.  For  example,  the  random  forest  algorithm  may  output 
descriptors which work hand-in-hand in the prediction. The use of such routines 
can help us understand the interplay between different determinants of stability. 
As attractive as linear models remain to the community, the inaccuracies and 
approximations  in  stability  descriptors,  the  non-additivity  of  the  physical 
determinants of affinity, and the diversity of protein-protein interactions, cannot 
be accounted for using linear modelling. Therefore, I believe that future efforts 
should shift towards exploiting the advantages of machine learning modelling, 
where learner choice is made with respect to the descriptors and data at hand 
and where visibility and interpretability share equal priority to that of predictive 
power. 
I do hope that the work presented in this thesis, at the least improves upon the 
inaccuracies of previous methods, and at the most makes clear where the current 
limitations are, and which challenges must be addressed for further advances to 
be made. I always like to think of this work in the context of developments being Chapter 8: Epilogue 
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made  in  other  important  topics  related  to  structural  computational  biology; 
including, protein structure prediction, docking and binding partner prediction. 
All of these share many similarities both in the underlying physical processes, 
and sometimes, in where we fail. Nevertheless, what is certain is that as these 
methods become more precise and efficient, their potential is nothing short of 
becoming an enabling technology for interpreting disease mutations, designing 
better  drugs  and  uncovering  further  the  nodes  and  links  of  the  molecular 
networks governing our life processes. 
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10 Appendices 
 
Table 10.1. Hold out Proteins in Leave-Homology-OUT (LHO) Cross Validtion.  
For  more  stringent  cross-validation  mechanism,  proteins  which  are  from  the  same  complex  category  (enzyme-inhibitor/antibody-
antigen) or which share a common binding site, are put in the same test fold. Categories taken according to Moal and Fernandez-Recio 
(2012). 
LHO Cross 
Validation 
Folds 
1  2  3  4  5  6  7  8  9  10  11 
Fold 
Category   
Share binding 
site on 
same/homolo
gous protein 
Share binding 
site on 
same/homol
ogous protein 
Enzyme-
Inhibitor   
Share binding 
site on 
same/homolo
gous protein 
Share binding 
site on 
same/homolo
gous protein 
 
Antibody-
Antigen   
Share binding 
site on 
same/homologo
us protein 
                       
Mutation 
Count  58  62  79  39  74  87  63  36  84  100  31 
PDB_IDs  1A22_A_B  1A4Y_A_B  1B2S_A_D  1CBW_F
GH_I 
1DAN_HL
_UT  1EMV_A_B  1FC2_C_D  1IAR_A_B  1JRH_LH_I  1JTG_A_B  1KTZ_A_B 
    1Z7X_W_X  1B2U_A_D  1GL0_E_I    1FR2_A_B  1LFD_A_B    1NMB_N_LH    1REW_AB_C 
      1B3S_A_D  1GL1_A_I    2GYK_A_B  1MAH_A_F    2I26_N_L    2QJ9_AB_C 
      1BRS_A_D  1TM1_E_I    2VLN_A_B  1MQ8_A_B    2VIR_AB_C    2QJA_AB_C 
      1X1W_A_D  2FTL_E_I    2VLO_A_B  2AJF_A_E    2VIS_AB_C    2QJB_AB_C 
      1X1X_A_D  2SIC_E_I    2VLP_A_B  2B42_A_B   
2VLJ_ABC_D
E     
            2VLQ_A_B  2GOX_A_B   
2VLR_ABC_D
E     
            2WPT_A_B  3D5R_A_C    3HFM_HL_Y     
              3D5S_A_C         
              3BP8_A_C         
              3BK3_A_C         
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Table 10.2. ΔG Dataset 
Complex 
PDB / 
Chains  Type 
Unbound 
PDB 
Protein  
1 
Unbound 
PDB 
Protein 
 2 
Pubmed 
ID  -ΔG  I-RMSD  Method 
                   
1A2K_C:AB  OG  1QG4_A  Ran GTPase-GDP  1OUN_AB  Nuclear transport factor 2  10681579  9.31  1.11  ITC 
1ACB_E:I  EI  4CHA_ABC  Chymotrypsin  1EGL_A  Eglin C  3071573  13.05  1.08 
Spectrophotometric 
inhibition assay 
1AHW_AB:C  A  1FGN_LH  Fab 5g9  1TFH_A  Tissue factor  9480775  11.55  0.69  Competitive Inhibition assay 
1AK4_A:D  OX  2CPL_A  Cyclophilin  1E6J_P  HIV capsid  9223641  6.43  1.33  ITC 
1AKJ_AB:DE  OX  2CLR_DE  MHC class 1 HLA-A2  1CD8_AB  T-cell CD8 coreceptor  10072074  5.32  1.14  SPR 
1ATN_A:D  OX  1IJJ_B  Actin  3DNI_A  Dnase I  6244947  12.07  3.28 
Spectrophotometric 
inhibition assay 
1AVX_A:B  EI  1QQU_A  Porcine trypsin  1BA7_B  Soybean trypsin inhibitor 
 
12.5  0.47  Potentiometric 
1AVZ_B:C  OX  1AVV_A  HIV-1-NEF protein  1FYN_A  Fyn kinase SH3 domain  9778343  6.55  0.73  ITC 
1AY7_A:B  EI  1RGH_B  Rnase SA  1A19_B  Barstar 
 
13.23  0.54 
Fluorescence inhibition 
assay 
1B6C_A:B  OX  1D6O_A  FKBP binding protein  1IAS_A  TGFbeta receptor  11583628  8.94  1.96  SPR 
1BJ1_HL:VW  AB  1BJ1_HL  Fab - vEGF  2VPF_GH  vEGF  9753694  11.55  0.5  SPR 
1BRS_A:D  EI  1A2P_A  Barnase  1A19_B  Barstar  8507637  17.32  0.42 
Fluorescence inhibition 
assay 
1BUH_A:B  EI  1HCL_A  CDK2 kinase  1DKS_A  Ckshs1  8601310  9.7  0.75  SPR 
1BVK_DE:F  A  1BVL_BA  Fv Hulys11  3LZT_A  HEW lysozyme  1560463  10.53  1.24  Stopped-flow inhibition 
1BVN_P:T  EI  1PIG_A  Alpha-amylase  1HOE_A  Tendamistat  14715318  15.06  0.87  SPR 
1CBW_ABC:D  EI  4CHA_ABC  Chymotrypsin  9PTI_A  BPTI  8784199  10.75  0.74 
Spectrophotometric 
inhibition assay 
1DE4_AB:CF  OX  1A6Z_AB 
Hemochromatosis protein 
HFE  1CX8_AB 
Transferrin receptor 
ectodom.  11800564  9.78  2.59  SPR 
1DFJ_E:I  EI  9RSA_B  Ribonuclease A  2BNH_A  Rnase inhibitor  2271559  18.05  1.02 
Inhibition assay (indirect-
Upa Hydrolysis) 
1DQJ_AB:C  A  1DQQ_CD  Fab Hyhel63  3LZT_A  HEW lysozyme  10828942  11.67  0.75  SPR 
1E4K_AB:C  OR  2DTQ_AB  FC fragment of human IgG 1  1FNL_A  Human FCGR III  11544262  7.87  2.59  SPR 
1E6E_A:B  ES  1E1N_A  Adrenoxin reductase  1CJE_D  Adrenoxin  15181009  8.28  1.33  SPR Appendices: ΔG Dataset 
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Complex 
PDB / 
Chains  Type 
Unbound 
PDB 
Protein  
1 
Unbound 
PDB 
Protein 
 2 
Pubmed 
ID  -ΔG  I-RMSD  Method 
1E6J_HL:P  A  1E6O_HL  Fab 13B5  1A43_A  HIV-1 capsid protein p24  11080628  10.28  1.05  SPR 
1E96_A:B  OG  1MH1_A  Rac GTPase  1HH8_A  p67 Phox  11090627  7.42  0.71  ITC 
1EFN_B:A  OX  1AVV_A  HIV-1-NEF protein  1FYN_A  Fyn kinase SH3 domain  7588629  10.12  0.9  SPR 
1EMV_A:B  EI  1FSJ_B  Colicin E9 nuclease  1IMQ_A  Im9 immunity protein  7577967  18.58  1.28  Stopped-flow fluormetry 
1EWY_A:C  ES  1GJR_A  Ferredoxin reductase  1CZP_A  Ferredoxin  1910307  7.43  0.8  Spectroscopic assay 
1EZU_C:AB  EI  1TRM_A  D102N Trypsin  1ECZ_AB  Y69F D70P Ecotin  9642073  13.77  1.21 
Spectroscopic inhibition 
assay 
1F34_A:B  EI  4PEP_A  Porcine pepsin  1F32_A  Ascaris inhibitor 3  4594130  14.19  0.93 
Spectroscopic inhibition 
assay 
1F6M_A:C  ES  1CL0_A  Thioredoxin reductase  2TIR_A  Thioredoxin 1  19933368  7.6  4.9 
 
1FC2_C:D  OX  1BDD_A  Staphylococcus Protein A  1FC1_AB  Human Fc fragment  7646442  10.43  1.69  Stopped-flow fluorescence 
1FFW_A:B  OX  3CHY_A  Chemotaxis protein CheY  1FWP_A  Chemotaxis protein CheA  8377825  8.09  1.43  ITC 
1FLE_E:I  EI  9EST_A  Elastase 
2REL_A(4
)  Elafin  2394696  12.28  1.02  Inhibition assay 
1FQJ_A:B  OG  1TND_C  Gt-alpha  1FQI_A  RGS9  10085118  9.79  0.91  Fluorescence spectroscopy 
1FSK_BC:A  AB  1FSK_BC 
Fab - Birch pollen antigen 
Bet V1  1BV1_A 
Birch pollen antigen Bet 
V1 
 
13.12  0.45  SPR 
1GCQ_B:C  OX  1GRI_B  GRB2 C-ter SH3 domain  1GCP_B  Vav N-ter SH3 domain  11406576  6.51  0.92  SPR 
1GL1_A:I  EI  4CHA_ABC  Chymotrypsin 
1PMC_A(
6)  PMP-C (LCMI II)  7592720  13.23  1.2  Inhibition assay 
1GLA_G:F  ER  1BU6_0  Glycerol Kinase  1F3Z_A  Glucose specific IIIGlc  9538005  6.76  0.98  Spectroscopy 
1GPW_A:B  OX  1THF_D  HISF protein  1K9V_F  Amidotransferase HISH 
 
11.32  0.65  Fluorescence Titration 
1GRN_A:B  OG  1A4R_A  CDC42 GTPase  1RGP_A  CDC42 GAP  9468490  9.03  1.22  Fluorescence Spectroscopy 
1GXD_A:C  EI  1CK7_A 
ProMMP2 type IV 
collagenase  1BR9_A 
Metalloproteinase 
inhibitor 2  9368077  11.3  1.39  SPR 
1H1V_A:G  OX  1IJJ_B  Actin  1P8X_A  Gelsolin precursor C-term  2836434  10.2  1.05  Fluorescence spectroscopy 
1H9D_A:B  OX  1EAN_A 
Runx1 domain of 
CBFalpha1  1ILF_A(1) 
Dimerisation domain of 
CBF-beta  10984496  9.18  1.32 
Electrophoretic mobility shift 
assays 
1HCF_AB:X  OR  1B98_AM  Neurotrophin-4  1WWB_X 
TrkB-d5 growth factor 
receptor  11855816  13.08  0.88  SPR 
1HE8_B:A  OG  821P_A  Ras GTPase  1E8Z_A  PIP3 kinase  11136978  7.37  0.92  Stopped-flow fluometry Appendices: ΔG Dataset 
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Complex 
PDB / 
Chains  Type 
Unbound 
PDB 
Protein  
1 
Unbound 
PDB 
Protein 
 2 
Pubmed 
ID  -ΔG  I-RMSD  Method 
1HIA_AB:I  EI  2PKA_XY  Kallikrein  1BX8_A  Hirustatin  8112345  10.76  1.4  Inhibition assay 
1I2M_A:B  OG  1QG4_A  Ran GTPase-GDP  1A12_A  RCC1  7548002  15.83  2.12  Stopped-flow fluometry 
1I4D_D:AB  OG  1MH1_A  Rac GTPase  1I49_AB  Arfaptin  11346801  7.46  1.41  ITC 
1IB1_AB:E  OX  1QJB_AB  14-3-3 protein  1KUY_A  Serotonin N-acteylase  11336675  9.76  2.09  Sedimentation equilibrium 
1IQD_AB:C  AB  1IQD_AB  Fab - Factor VIII domain C2  1D7P_M  Factor VIII domain C2  9657749  15  0.48  SPR 
1J2J_A:B  OG  1O3Y_A  Arf1 GTPase.GNP-RanBD1  1OXZ_A  GAT domain of GGA1  12679809  8.13  0.63  SPR 
1JIW_P:I  EI  1AKL_A  Alkaline metallo-proteinase 
2RN4_A(
1)  Proteinase inhibitor  10770939  15.55  2.07  Inhibition assay 
1JMO_A:HL  ER  1JMJ_A  Heparin cofactor  2CN0_HL  Thrombin  9162031  9.47  3.21  Inhibition assay 
1JPS_HL:T  A  1JPT_HL  Fab D3H44  1TFH_B  Tissue factor  11307801  13.64  0.51  SPR 
1JTG_B:A  EI  3GMU_B 
beta-lactamase inhibitor 
protein  1ZG4_A  beta-lactamase TEM-1  9890878  12.82  0.49  SPR 
1JWH_CD:A  ER  3EED_AB  Casein kinase II beta chain  3C13_A 
Casein kinase II alpha 
chain  18824508  11.14  1.27  ITC 
1K5D_AB:C  OG  1RRP_AB  Ran GTPase  1YRG_B  Ran GAP  14585972  12.77  1.19  Stopped-flow fluorescence 
1KAC_A:B  OR  1NOB_F 
Adenovirus fiber knob 
protein  1F5W_B  Adenovirus receptor  10684297  10.68  0.95  SPR 
1KKL_ABC:H  ES  1JB1_ABC  HPr kinase C-ter domain  2HPR_A  HPr  12009882  10.02  2.2  SPR 
1KLU_AB:D  OX  1H15_AB  MHC class 2 HLA-DR1  1STE_A 
Staphylococcus 
enterotoxin C3  10229190  7.28  0.43  SPR 
1KTZ_A:B  OR  1TGK_A  TGF-beta  1M9Z_A  TGF-beta receptor  16300789  8.92  0.39  SPR 
1KXP_A:D  OX  1IJJ_B  Actin  1KW2_B  Vitamin D binding protein  2910852  12.34  1.12  Inhibition assay 
1KXQ_H:A  AB  1KXQ_H 
Camel VHH - Pancreatic 
alpha-amylase  1PPI_A  Pancreatic alpha-amylase  9649422  11.54  0.72  SPR 
1LFD_B:A  OG  5P21_A  Ras.GNP  1LXD_A 
RalGDS Ras-interacting 
domain  15197281  7.79  1.79  Stopped-flow fluorescence 
1M10_A:B  ER  1AUQ_A 
Von Willebrand Factor dom. 
A1  1M0Z_B  Glycoprotein IB-alpha  12183630  11.24  2.1  SPR 
1MAH_A:F  EI  1J06_B  Acetylcholinesterase  1FSC_A  Fasciculin  8509385  14.51  0.61  Inhibition assay 
1MLC_AB:E  A  1MLB_AB  Fab44.1  3LZT_A  HEW lysozyme  10229844  9.61  0.6  SPR 
1MQ8_A:B  OX  1IAM_A  ICAM-1 domain 1-2  1MQ9_A  Integrin alpha-L I domain  12526797  7.53  1.76  SPR Appendices: ΔG Dataset 
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Complex 
PDB / 
Chains  Type 
Unbound 
PDB 
Protein  
1 
Unbound 
PDB 
Protein 
 2 
Pubmed 
ID  -ΔG  I-RMSD  Method 
1NB5_AP:I  EI  8PCH_A  Cathepsin H  1DVC_A  Stefin A  8898076  13.86  1.58  Inhibition assay 
1NCA_HL:N  AB  1NCA_HL 
Fab - Flu virus 
neuraminidase N9  7NN9_A 
Flu virus neuraminidase 
N9  9692956  11.02  0.24 
Fluorescence inhibition 
assay 
1NSN_HL:S  AB  1NSN_HL 
Fab N10 - Staphylococcal 
nuclease  1KDC_A  Staphylococcal nuclease  1704035  14  0.35  ELISA inhibiton assay 
1NVU_Q:S  OG  1LF0_A  Ras GTPase.GTP  2II0_B  Son of sevenless  15507210  7.43  1.98  Fluorescence anisotropy 
1NVU_R:S  OG  1LF0_A  Ras GTPase.GTP  2II0_B  Son of sevenless  15507210  7.8  3.09 
 
1OPH_A:B  EI  1QLP_A  Alpha-1-antitrypsin  2PTN_A  Trypsin  9012804  11.32  1.2 
Fluorescence inhibition 
assay 
1P2C_AB:C  A  2Q76_AB  FabF10.6.6  3LZT_A  HEW lysozyme  14988501  13.63  0.46  SPR 
1PPE_E:I  EI  2PTN_A  Trypsin  1LU0_A  CMTI-1 squash inhibitor  8543044  15.56  0.34 
Spectrophotometric 
inhibition assay 
1PVH_A:B  OR  1BQU_A 
IL6 receptor beta chain D2-
D3 domains  1EMR_A  Leukemia inhibitory factor  14527405  9.52  0.34  ITC 
1PXV_A:C  EI  1X9Y_A 
Staphylococcus aureus 
cystein protease  1NYC_A  Cystein protease inhibitor  17261086  12.97  2.63  Inhibition assay 
1QA9_A:B  OX  1HNF_A  CD2  1CCZ_A  CD58  7520278  7.16  0.73  SPR 
1R0R_E:I  EI  1SCN_E  Subtilisin carlsberg  2GKR_I  OMTKY  7046785  14.17  0.45  Spectrophotometry 
1R6Q_A:C  ER  1R6C_X  Clp protease subunit ClpA  2W9R_A 
Clp protease adaptor 
protein ClpS  12426582  8.84  1.67  SPR 
1RLB_ABCD:E  OX  2PAB_ABCD  Transthyretin  1HBP_A  Retinol binding protein  8639713  8.18  0.66  Fluorescence anisotropy 
1RV6_VW:X  OR  1FZV_AB 
PIGF receptor binding 
domain  1QSZ_A  Flt1 protein domain 2  8822205  13.86  1.09  Inhibition assay 
1S1Q_A:B  OX  2F0R_A  UEV domain  1YJ1_A  Ubiquitin  12006492  4.29  0.98  SPR 
1T6B_X:Y  OR  1ACC_A  Anthrax protective antigen  1SHU_X  Anthrax toxin receptor  15044490  13.1  0.62  Stopped-flow fluorescence 
1US7_A:B  ER  2FXS_A 
Heat shock protein 82 N-ter 
domain  2W0G_A 
HSP90 co-chaperone 
CDC37 C-ter domain  14718169  8.09  1.06  ITC 
1UUG_A:B  EI  3EUG_A  Uracyl-DNA glycosylase  2UGI_B  Glycosylase inhibitor  8262921  18  0.77  Stopped-flow fluorescence 
1VFB_AB:C  A  1VFA_AB  Fv D1.3  8LYZ_A  HEW lysozyme  8302837  11.46  1.02  ITC 
1WDW_BD:A  ER  1V8Z_AB 
Tryptophan synthase beta 
chain 1  1GEQ_A 
Tryptophan synthase 
alpha chain  12643278  12.72  1.29  ITC 
1WEJ_HL:F  A  1QBL_HL  Fab E8  1HRC_A  Cytochrome C  2993413  12.48  0.31 
Spectroscopic inhibition 
assay Appendices: ΔG Dataset 
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Complex 
PDB / 
Chains  Type 
Unbound 
PDB 
Protein  
1 
Unbound 
PDB 
Protein 
 2 
Pubmed 
ID  -ΔG  I-RMSD  Method 
1WQ1_R:G  OG  6Q21_D  Ras GTPase.GDP  1WER_A  Ras GAP  8262937  6.62  1.16  Fluorescence 
1XD3_A:B  OX  1UCH_A  UCH-L3  1YJ1_A  Ubiquitin  9485312  8.9  1.24 
Fluorescence 
spectrophotometry 
1XQS_A:C  OX  1XQR_A  HspBP1  1S3X_A  Hsp70 ATPase domain  15694338  7.08  1.77  SPR 
1XU1_ABD:T  OR  1U5Y_ABD  TNF domain of APRIL 
1XUT_A(
11) 
TNF receptor superfamily 
member 13B TACI CRD2 
domain  10956646  11.18  1.3  SPR 
1YVB_A:I  EI  2GHU_A  Falcipain 2  1CEW_I  Cystatin  17502099  11.17  0.51  Inhibition assay 
1Z0K_A:B  OG  2BME_A  Rab4A GTPase.GNP  1YZM_A 
RAB4 binding domain of 
Rabenosyn  16034420  6.98  0.53  SPR 
1ZM4_A:B  ES  1N0V_C  Elongation factor 2  1XK9_A 
Diphtheria toxin A 
catalytic domain  12270928  8.03  2.94  Flourescence 
2A9K_A:B  ES  1U8Z_A  Ral-A.GDP  2C8B_X 
Mono-ADP-
ribosyltransferase C3  16177825  10.25  0.85  ITC 
2ABZ_B:E  EI  3I1U_A  Carboxypeptidase A1  1ZFI_A(1) 
Leech carboxypeptidase 
inhibitor  16126224  11.67  0.9  Spectroscopic inbition assay 
2AJF_A:E  OR  1R42_A 
Angiotensin-converting 
enzyme 2  2GHV_E 
SARS spike protein 
receptor binding domain  15791205  10.63  0.65  SPR 
2AQ3_A:B  OX  1BEC_A  TCR Vbeta8.2  1CK1_A  SEC3  20836565  6.71  1.82  ITC 
2B42_A:B  EI  2DCY_A  Xylanase  1T6E_X  Xylanase inhibitor  16279951  12.11  0.72  SPR 
2B4J_AB:C  OX  1BIZ_AB  Integrase (HIV-1) 
1Z9E_A(1
) 
PC4 and SFRS1 interacting 
protein  19801648  10.86  0.99 
Fluorescence inhibition 
assay 
2BTF_A:P  OX  1IJJ_B  Actin  1PNE_A  Profilin  9788869  7.69  0.75  Inhibition assay 
2C0L_A:B  OX  1FCH_A  TRP region of PEX5  1C44_A  Sterol carrier protein 2  17157249  9.82  2.62  ITC 
2FJU_B:A  OG  2ZKM_X  Phospholipase beta 2  1MH1_A  Rac GTPase  12657629  7.2  1.04  SPR 
2GOX_A:B  OX  1C3D_A  Complement C3d fragment  2GOM_A 
Staphylococcus aureus 
Efb-C  18687868  12.08  0.6  SPR 
2HLE_A:B  OR  2BBA_A  Ephrin B4 receptor  1IKO_P  Ephrin B2 ectodomain  16472751  10.09  1.4  ITC 
2HQS_A:H  OX  1CRZ_A  TolB  1OAP_A  Pal  17375930  10.15  1.14  ITC 
2HRK_A:B  OX  2HRA_A  Glutamyl-t-RNA synthetase  2HQT_A 
GU-4 nucleic binding 
protein  17976650  10.98  2.03  SPR 
2I25_N:L  A  2I24_N 
Shark single domain 
antigen receptor  3LZT_A  HEW lysozyme  16446445  12.28  1.21  SPR 
2I9B_E:A  OR  1YWH_A 
Urokinase plasminogen 
activator surface receptor  2I9A_A 
Urokinase-type 
plasminogen activator  15003263  12.93  3.79  SPR Appendices: ΔG Dataset 
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Complex 
PDB / 
Chains  Type 
Unbound 
PDB 
Protein  
1 
Unbound 
PDB 
Protein 
 2 
Pubmed 
ID  -ΔG  I-RMSD  Method 
2J0T_A:D  EI  966C_A 
MMP1 Intersitial 
collagenase 
1D2B_A(
20) 
Metalloproteinase 
inhibitor 1  12515831  13.34  1.23 
Fluorescence inhibition 
assay 
2JEL_HL:P  AB  2JEL_HL  Fab Jel42 - HPr  1POH_A  HPr  9671548  11.59  0.17 
Fluorescence inhibition 
assay 
2MTA_HL:A  ES  2BBK_JM 
Methylamine 
dehydrogenase  2RAC_A  Amicyanin  8347660  7.42  0.41 
Spectroscopic inhibition 
assay 
2NYZ_AB:D  OR  1MKF_AB 
Viral chemokine binding p. 
M3  1J9O_A  Chemokine XCL1  18070938  12.69  2.09  SPR 
2O3B_A:B  EI  1ZM8_A  NucA nuclease  1J57_A  NuiA nuclease inhibitor  17138564  15.68  3.13  Inhibition assay 
2OOB_A:B  ES  2OOA_A 
E3 ubiquitin-protein ligase 
CBL-B UBA domain  1YJ1_A  Ubiquitin  17897937  5.66  0.85  ITC 
2OOR_AB:C  ER  1L7E_AB 
NAD(P) transhydrogenase 
subunit alpha part 1  1E3T_A 
NAD(P) transhydrogenase 
subunit beta  8898902  10.65  1.42  Fluorescence 
2PCB_A:B  ES  1CCP_A  Cyt C peroxidase  1HRC_A  Cytochrome C  9092837  6.82  0.45  ITC 
2PCC_A:B  ES  1CCP_A  Cyt C peroxidase  1YCC_A  Cytochrome C, yeast  11148036  7.91  0.39  ITC 
2PTC_E:I  EI  2PTN_A  Trypsin  9PTI_A  BPTI  5041905  18.04  0.28  Inhibition assay 
2SIC_E:I  EI  1SUP_A  Subtilisin  3SSI_A 
Streptomyces subtilisin 
inhibitor  32173  13.84  0.36  Fluorescence titration 
2SNI_E:I  EI  1UBN_A  Subtilisin  2CI2_I  Chymotrypsin inhibitor 2  10065709  15.96  0.35  Inhibition assay 
2TGP_Z:I  EI  1TGB_A  Trypsinogen  9PTI_A  BPTI  311834  7.54  0.57 
Spectroscopic inhibition 
assay 
2UUY_A:B  EI  2PTN_A  Trypsin  2UUX_A 
Tryptase inhibitor from 
tick  17391695  11.26  0.44  Inhibition assay 
2VDB_A:B  OX  3CX9_A  Serum albumin  2J5Y_A 
Peptostreptococcalalbumi
n-binding protein  8900134  13.4  0.47  Radioligand inhibition assay 
2VIR_AB:C  A  1GIG_LH  Fab  2HMG_AB  Flu virus hemagglutinin  9461077  12.28  0.8  SPR 
2VIS_AB:C  A  1GIG_LH  Fab  2VIU_ACE  Flu virus hemagglutinin  9461077  7.36  0.8  SPR 
2WPT_A:B  EI  1FSJ_B  Colicin E9 nuclease  2NO8_A  Im2 immunity protein  9718299  10.67  1.61  Stopped-flow fluormetry 
3BP8_AB:C  OX  1Z6R_AB  Mlc transcription regulator  3BP3_A 
PTS glucose-specific 
enzyme EIICB  18319344  11.44  0.45  SPR 
3BZD_A:B  OX  1BEC_A  TCR Vbeta8.2  3BVZ_A  SEC3-1A4  20836565  9.57  1.08  ITC 
3CPH_G:A  OG  1G16_A  Ras-related protein Sec4  3CPI_G 
Rab GDP-dissociation 
inhibitor  18426803  8.84  2.12  ITC 
3SGB_E:I  EI  2QA9_E  Streptogrisin B  2OVO_A 
Ovomucoid inhibitor third 
domain  3555488  14.51  0.36 
Spectrophotometric 
inhibition assay Appendices: ΔG Dataset 
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Complex 
PDB / 
Chains  Type 
Unbound 
PDB 
Protein  
1 
Unbound 
PDB 
Protein 
 2 
Pubmed 
ID  -ΔG  I-RMSD  Method 
4CPA_A:I  EI  8CPA_A  Carboxypeptidase A 
1H20_A(
9) 
Potato carboxypeptidase 
inhibitor  4415398  11.32  1.52 
Spectrophotometric 
inhibition assay 
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Table 10.3. Δkoff Dataset 
Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1TM1_E_I  YI61A  2.56E-04  1.06E-05  1.38  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  YI61G  1.88E-02  1.06E-05  3.25  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI65A  3.47E-04  6.10E-06  1.75  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI67A  3.15E-04  6.10E-06  1.71  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI67C  3.03E-04  6.10E-06  1.7  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI67A,RI65A  7.92E-03  1.06E-05  2.87  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  TI58D  3.40E-05  3.90E-06  0.94  7947796  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  TI58A  2.06E-04  3.90E-06  1.72  7947796  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  TI58D,EI60A  1.07E-05  3.90E-06  0.44  7947796  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  VI70A  3.40E-06  3.90E-06  -0.06  7947796  Subtilisin BPN  Chymotrypsin inhibitor 2 
2SIC_E_I  MI73E  1.10E-04  9.00E-05  0.09  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
2SIC_E_I  MI73D  2.60E-04  9.00E-05  0.46  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
2SIC_E_I  MI73H  4.10E-04  9.00E-05  0.66  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
2SIC_E_I  MI73G  1.30E-04  9.00E-05  0.16  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
2SIC_E_I  MI73A  1.40E-04  9.00E-05  0.19  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
2SIC_E_I  MI73L  2.10E-04  9.00E-05  0.37  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
2SIC_E_I  MI73V  3.50E-04  9.00E-05  0.59  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
2SIC_E_I  MI73I  1.70E-03  9.00E-05  1.28  8276767  Subtilisin BPN 
Streptomyces subtilisin 
inhibitor 
1IAR_A_B  IA5A  1.40E-02  2.10E-03  0.82  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  IA5R  8.70E-03  2.10E-03  0.62  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  TA6A  1.90E-03  2.10E-03  -0.04  9050834  Interleukin-4  Interleukin-4 receptor Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1IAR_A_B  TA6D  1.50E-02  2.10E-03  0.85  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  QA8A  2.50E-03  2.10E-03  0.08  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  QA8R  1.90E-03  2.10E-03  -0.04  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  EA9Q  2.70E-01  2.10E-03  2.11  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  IA11A  2.00E-03  2.10E-03  -0.02  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  KA12S  1.90E-03  2.10E-03  -0.04  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  KA12E  1.50E-03  2.10E-03  -0.15  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  TA13A  7.10E-03  2.10E-03  0.53  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  TA13D  8.50E-04  2.10E-03  -0.39  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  NA15A  2.30E-03  2.10E-03  0.04  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  NA15D  1.70E-03  2.10E-03  -0.09  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  SA16A  1.90E-03  2.10E-03  -0.04  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  SA16D  1.50E-03  2.10E-03  -0.15  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  EA19A  1.70E-03  2.10E-03  -0.09  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  EA19R  1.60E-03  2.10E-03  -0.12  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA53Q  7.30E-03  2.10E-03  0.54  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  KA77A  2.10E-03  2.10E-03  0  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  KA77E  2.00E-03  2.10E-03  -0.02  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  QA78A  2.20E-03  2.10E-03  0.02  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  QA78E  2.70E-03  2.10E-03  0.11  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA81A  2.80E-03  2.10E-03  0.13  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA81E  6.10E-03  2.10E-03  0.46  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  FA82A  2.10E-03  2.10E-03  0  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  FA82D  7.30E-04  2.10E-03  -0.46  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  KA84A  2.90E-03  2.10E-03  0.14  9050834  Interleukin-4  Interleukin-4 receptor Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1IAR_A_B  KA84D  9.30E-03  2.10E-03  0.65  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA85A  2.70E-03  2.10E-03  0.11  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA85E  4.60E-03  2.10E-03  0.34  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA88Q  1.40E-01  2.10E-03  1.82  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA88A  7.60E-01  2.10E-03  2.56  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  NA89A  2.70E-02  2.10E-03  1.11  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  WA91A  6.10E-03  2.10E-03  0.46  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  WA91D  8.50E-03  2.10E-03  0.61  9050834  Interleukin-4  Interleukin-4 receptor 
1BRS_A_D  RA59A  2.40E-03  3.73E-06  2.81  7739054  Barnase  Barstar 
1BRS_A_D  RA83Q  1.00E-02  3.73E-06  3.43  7739054  Barnase  Barstar 
1BRS_A_D  RA87A  1.70E-02  3.73E-06  3.66  7739054  Barnase  Barstar 
1BRS_A_D  HA102A  1.29E-01  3.73E-06  4.54  7739054  Barnase  Barstar 
1BRS_A_D  YD29F  2.40E-06  3.73E-06  -0.19  7739054  Barnase  Barstar 
1BRS_A_D  YD29A  1.00E-03  3.73E-06  2.43  7739054  Barnase  Barstar 
1BRS_A_D  DD35A  3.80E-03  3.73E-06  3.01  7739054  Barnase  Barstar 
1BRS_A_D  WD38F  7.00E-05  3.73E-06  1.27  7739054  Barnase  Barstar 
1BRS_A_D  DD39A  9.00E-01  3.73E-06  5.38  7739054  Barnase  Barstar 
1BRS_A_D  TD42A  7.20E-05  3.73E-06  1.29  7739054  Barnase  Barstar 
1BRS_A_D  WD44F  3.40E-06  3.73E-06  -0.04  7739054  Barnase  Barstar 
1BRS_A_D  ED76A  2.10E-05  3.73E-06  0.75  7739054  Barnase  Barstar 
1BRS_A_D  ED80A  5.20E-06  3.73E-06  0.14  7739054  Barnase  Barstar 
1BRS_A_D  KA27A,YD29A  9.70E-01  3.73E-06  5.42  7739054  Barnase  Barstar 
1BRS_A_D  KA27A,DD35A  3.60E+00  3.73E-06  5.98  7739054  Barnase  Barstar 
1BRS_A_D  KA27A,WD38F  2.10E-02  3.73E-06  3.75  7739054  Barnase  Barstar 
1BRS_A_D  KA27A,DD39A  6.80E-01  3.73E-06  5.26  7739054  Barnase  Barstar Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1BRS_A_D  KA27A,TD42A  6.80E-03  3.73E-06  3.26  7739054  Barnase  Barstar 
1BRS_A_D  KA27A,ED76A  1.30E-02  3.73E-06  3.54  7739054  Barnase  Barstar 
1BRS_A_D  KA27A,ED80A  3.50E-03  3.73E-06  2.97  7739054  Barnase  Barstar 
1BRS_A_D  RA59A,YD29A  2.50E-01  3.73E-06  4.83  7739054  Barnase  Barstar 
1BRS_A_D  RA59A,DD35A  1.40E-02  3.73E-06  3.57  7739054  Barnase  Barstar 
1BRS_A_D  RA59A,WD38F  1.30E-02  3.73E-06  3.54  7739054  Barnase  Barstar 
1BRS_A_D  RA59A,TD42A  2.30E-02  3.73E-06  3.79  7739054  Barnase  Barstar 
1BRS_A_D  RA59A,ED76A  1.60E-03  3.73E-06  2.63  7739054  Barnase  Barstar 
1BRS_A_D  RA59A,ED80A  2.00E-03  3.73E-06  2.73  7739054  Barnase  Barstar 
1BRS_A_D  RA83Q,YD29A  1.10E+00  3.73E-06  5.47  7739054  Barnase  Barstar 
1BRS_A_D  RA83Q,DD35A  7.10E+00  3.73E-06  6.28  7739054  Barnase  Barstar 
1BRS_A_D  RA83Q,DD39A  5.30E-02  3.73E-06  4.15  7739054  Barnase  Barstar 
1BRS_A_D  RA83Q,TD42A  3.50E-02  3.73E-06  3.97  7739054  Barnase  Barstar 
1BRS_A_D  RA83Q,ED76A  3.40E-02  3.73E-06  3.96  7739054  Barnase  Barstar 
1BRS_A_D  RA83Q,ED80A  1.10E-02  3.73E-06  3.47  7739054  Barnase  Barstar 
1BRS_A_D  RA87A,YD29A  1.30E+00  3.73E-06  5.54  7739054  Barnase  Barstar 
1BRS_A_D  RA87A,WD38F  2.75E-01  3.73E-06  4.87  7739054  Barnase  Barstar 
1BRS_A_D  RA87A,DD39A  3.00E-01  3.73E-06  4.91  7739054  Barnase  Barstar 
1BRS_A_D  RA87A,TD42A  3.10E-01  3.73E-06  4.92  7739054  Barnase  Barstar 
1BRS_A_D  RA87A,ED76A  7.40E-02  3.73E-06  4.3  7739054  Barnase  Barstar 
1BRS_A_D  RA87A,ED80A  2.40E-02  3.73E-06  3.81  7739054  Barnase  Barstar 
1BRS_A_D  HA102A,YD29A  1.50E-01  3.73E-06  4.6  7739054  Barnase  Barstar 
1BRS_A_D  HA102A,YD29F  4.50E-02  3.73E-06  4.08  7739054  Barnase  Barstar 
1BRS_A_D  HA102A,WD38F  1.28E+00  3.73E-06  5.54  7739054  Barnase  Barstar 
1BRS_A_D  HA102A,DD39A  1.70E+01  3.73E-06  6.66  7739054  Barnase  Barstar Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1BRS_A_D  HA102A,TD42A  2.40E+00  3.73E-06  5.81  7739054  Barnase  Barstar 
1BRS_A_D  HA102A,ED76A  5.90E-01  3.73E-06  5.2  7739054  Barnase  Barstar 
1BRS_A_D  HA102A,ED80A  1.80E-01  3.73E-06  4.68  7739054  Barnase  Barstar 
1B2U_A_D  AA27K  3.80E-03  3.60E+00  -2.98  7739054  Barnase  Barstar 
1B2U_A_D  AD36D  4.50E-03  3.60E+00  -2.9  7739054  Barnase  Barstar 
1B2U_A_D  AA27K,AD36D  3.70E-06  3.60E+00  -5.99  7739054  Barnase  Barstar 
1B2S_A_D  AA27K  7.20E-05  6.80E-03  -1.98  7739054  Barnase  Barstar 
1B2S_A_D  AD43T  4.50E-03  6.80E-03  -0.18  7739054  Barnase  Barstar 
1B2S_A_D  AA27K,AD43T  3.70E-06  6.80E-03  -3.26  7739054  Barnase  Barstar 
1B3S_A_D  AA102H  2.40E-06  4.50E-02  -4.27  7739054  Barnase  Barstar 
1B3S_A_D  FD30Y  1.29E-01  4.50E-02  0.46  7739054  Barnase  Barstar 
1B3S_A_D  AA102H,FD30Y  3.70E-06  4.50E-02  -4.09  7739054  Barnase  Barstar 
1BRS_A_D  DD35A  2.73E-02  1.15E-04  2.38 
 
Barnase  Barstar 
1BRS_A_D  DD39A  4.57E-01  1.15E-04  3.6 
 
Barnase  Barstar 
1BRS_A_D  ED80A  2.28E-04  1.15E-04  0.3 
 
Barnase  Barstar 
1X1W_A_D  AD80E  1.15E-04  2.28E-04  -0.3 
 
Barnase  Barstar 
1X1X_A_D  AD76E  1.15E-04  4.75E-04  -0.62 
 
Barnase  Barstar 
1BRS_A_D  KA27A  6.60E-03  8.00E-06  2.92  8494892  Barnase  Barstar 
1BRS_A_D  WA35F  8.00E-05  8.00E-06  1  8494892  Barnase  Barstar 
1BRS_A_D  DA54A  5.30E-06  8.00E-06  -0.18  8494892  Barnase  Barstar 
1BRS_A_D  NA58A  6.40E-04  8.00E-06  1.9  8494892  Barnase  Barstar 
1BRS_A_D  RA59A  3.70E-03  8.00E-06  2.67  8494892  Barnase  Barstar 
1BRS_A_D  EA60A  3.40E-05  8.00E-06  0.63  8494892  Barnase  Barstar 
1BRS_A_D  EA73A  7.40E-04  8.00E-06  1.97  8494892  Barnase  Barstar 
1BRS_A_D  RA87A  6.70E-02  8.00E-06  3.92  8494892  Barnase  Barstar Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1BRS_A_D  HA102A  2.20E-01  8.00E-06  4.44  8494892  Barnase  Barstar 
1BRS_A_D  KA27A  6.10E-03  1.50E-05  2.61  8494892  Barnase  Barstar 
1BRS_A_D  WA35F  9.60E-05  1.50E-05  0.81  8494892  Barnase  Barstar 
1BRS_A_D  DA54A  1.80E-05  1.50E-05  0.08  8494892  Barnase  Barstar 
1BRS_A_D  NA58A  9.10E-04  1.50E-05  1.78  8494892  Barnase  Barstar 
1BRS_A_D  RA59A  6.50E-03  1.50E-05  2.64  8494892  Barnase  Barstar 
1BRS_A_D  EA60A  1.30E-04  1.50E-05  0.94  8494892  Barnase  Barstar 
1BRS_A_D  EA73A  2.60E-03  1.50E-05  2.24  8494892  Barnase  Barstar 
1BRS_A_D  HA102A  3.50E-01  1.50E-05  4.37  8494892  Barnase  Barstar 
2B42_A_B  HA374A  1.59E-03  3.60E-04  0.65  16279951  TAXI-I  B. subtilis endoxylanase 
2B42_A_B  HA374Q  1.18E-03  3.60E-04  0.52  16279951  TAXI-I  B. subtilis endoxylanase 
2B42_A_B  HA374K  3.44E-03  3.60E-04  0.98  16279951  TAXI-I  B. subtilis endoxylanase 
2I26_N_L  AN30V  1.60E-03  2.00E-03  -0.1  16446445  Type II IgNAR  HEW Lysozyme 
2I26_N_L  SN61R  1.20E-03  2.00E-03  -0.22  16446445  Type II IgNAR  HEW Lysozyme 
2GOX_A_B  RB131A  6.87E-02  5.63E-04  2.09  18687868  Complement C3d 
Fibrinogen-binding 
protein Efb-C 
2GOX_A_B  NB138A  2.14E-02  5.63E-04  1.58  18687868  Complement C3d 
Fibrinogen-binding 
protein Efb-C 
3D5S_A_C  AC41R  5.63E-04  6.87E-02  -2.09  18687868  Complement C3d 
Fibrinogen-binding 
protein Efb-C 
3BP8_A_C  FA136A  1.30E-02  3.85E-03  0.53  18319344 
Mlc transcription 
regulator 
PTS glucose-specific 
enzyme EIICB 
3BP8_A_C  AC63F  8.79E-03  3.85E-03  0.36  18319344 
Mlc transcription 
regulator 
PTS glucose-specific 
enzyme EIICB 
3BP8_A_C  FA136A,AC63F  2.25E-03  3.85E-03  -0.23  18319344 
Mlc transcription 
regulator 
PTS glucose-specific 
enzyme EIICB 
2VIS_AB_C  IC131T  1.10E-04  2.16E-03  -1.29  9461077  IgG1 lambda FAB  Flu virus hemagglutinin 
2VIR_AB_C  TC131I  2.16E-03  1.10E-04  1.29  9461077  IgG1 lambda FAB  Flu virus hemagglutinin 
2WPT_A_B  DA33L  3.80E-03  7.30E-01  -2.28  9718299 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
2WPT_A_B  NA34V  1.60E-01  7.30E-01  -0.66  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  RA38T  2.90E-01  7.30E-01  -0.4  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  EA39H  8.80E-01  7.30E-01  0.08  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  RA42E  5.00E-01  7.30E-01  -0.16  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  NA34V,RA38T  1.80E-02  7.30E-01  -1.61  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  DA33L,NA34V,RA38T  3.70E-05  7.30E-01  -4.3  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  NA34V,RA38T,RA42E  1.20E-02  7.30E-01  -1.78  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  NA34V,RA38T,EA39H,RA42E  1.30E-02  7.30E-01  -1.75  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  EA30A  2.80E-07  7.30E-01  -6.42  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  DA33A  1.20E-08  7.30E-01  -7.78  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  NA34A  7.90E-09  7.30E-01  -7.97  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  VA37A  9.30E-06  7.30E-01  -4.89  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  RA38A  2.30E-09  7.30E-01  -8.5  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  EA41A  3.00E-05  7.30E-01  -4.39  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  RA42A  1.00E-08  7.30E-01  -7.86  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  SA50A  9.00E-07  7.30E-01  -5.91  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  PA56A  2.10E-06  7.30E-01  -5.54  9718299 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  NB72A  1.08E+01  9.00E-01  1.08  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  SB74A  2.70E-01  9.00E-01  -0.52  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  NB75A  3.76E+01  9.00E-01  1.62  18471830 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
2WPT_A_B  SB77A  3.30E-01  9.00E-01  -0.44  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  SB78A  6.50E-01  9.00E-01  -0.14  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  SB84A  8.00E-01  9.00E-01  -0.05  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  FB86A  5.49E+01  9.00E-01  1.79  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  TB87A  1.03E+00  9.00E-01  0.06  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  QB92A  4.10E-01  9.00E-01  -0.34  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  KB97A  6.80E-01  9.00E-01  -0.12  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2WPT_A_B  VB98A  1.05E+00  9.00E-01  0.07  18471830 
Colicin E2 immunity 
protein  Colicin E9 DNase 
2VLP_A_B  AB54R  2.36E-06  3.54E-05  -1.18  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
2VLN_A_B  AB75N  2.36E-06  1.68E-04  -1.85  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
2VLQ_A_B  AB86F  2.36E-06  1.80E-03  -2.88  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
2VLO_A_B  AB97K  2.36E-06  3.05E-05  -1.11  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  RB54A  3.54E-05  2.36E-06  1.18  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  NB72A  1.28E-05  2.36E-06  0.73  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SB74A  1.75E-06  2.36E-06  -0.13  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  NB75A  1.68E-04  2.36E-06  1.85  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SB77A  1.58E-06  2.36E-06  -0.17  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SB78A  1.02E-06  2.36E-06  -0.36  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SB84A  1.87E-06  2.36E-06  -0.1  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  FB86A  1.80E-03  2.36E-06  2.88  18471830 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1EMV_A_B  QB92A  1.59E-06  2.36E-06  -0.17  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  KB97A  3.05E-05  2.36E-06  1.11  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  VB98A  1.45E-05  2.36E-06  0.79  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  FB86A,LA33A  1.50E-01  2.36E-06  4.8  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  FB86A,VA34A  4.97E-03  2.36E-06  3.32  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  FB86A,VA37A  1.70E-03  2.36E-06  2.86  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  FB86A,YA54A  3.18E+00  2.36E-06  6.13  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  FB86A,YA55A  3.00E+00  2.36E-06  6.1  18471830 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  CA23A  6.09E-06  1.83E-06  0.52  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  NA24A  1.98E-06  1.83E-06  0.03  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  DA26A  2.95E-06  1.83E-06  0.21  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  TA27A  3.37E-06  1.83E-06  0.27  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SA28A  1.91E-06  1.83E-06  0.02  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SA29A  7.13E-06  1.83E-06  0.59  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  EA30A  1.48E-05  1.83E-06  0.91  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  EA31A  2.19E-06  1.83E-06  0.08  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  EA32A  2.44E-06  1.83E-06  0.13  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  LA33A  4.00E-04  1.83E-06  2.34  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  VA34A  9.54E-05  1.83E-06  1.72  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  KA35A  2.20E-06  1.83E-06  0.08  9425068 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1EMV_A_B  LA36A  4.75E-06  1.83E-06  0.41  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  VA37A  2.09E-05  1.83E-06  1.06  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  TA38A  5.13E-06  1.83E-06  0.45  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  EA42A  3.25E-06  1.83E-06  0.25  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  TA44A  2.70E-06  1.83E-06  0.17  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  EA45A  2.04E-06  1.83E-06  0.05  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  HA46A  3.98E-06  1.83E-06  0.34  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  PA47A  2.26E-06  1.83E-06  0.09  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SA48A  1.77E-06  1.83E-06  -0.01  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  GA49A  1.22E-05  1.83E-06  0.82  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SA50A  5.14E-05  1.83E-06  1.45  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  DA51A  6.11E-03  1.83E-06  3.52  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  LA52A  2.87E-06  1.83E-06  0.2  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  IA53A  6.06E-06  1.83E-06  0.52  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  YA54A  2.55E-03  1.83E-06  3.14  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  YA55A  2.75E-03  1.83E-06  3.18  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  PA56A  1.30E-05  1.83E-06  0.85  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  DA60A  2.69E-06  1.83E-06  0.17  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  SA63A  4.54E-06  1.83E-06  0.4  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1EMV_A_B  VA68A  1.59E-05  1.83E-06  0.94  9425068 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1EMV_A_B  NA69A  2.46E-06  1.83E-06  0.13  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
1FR2_A_B  AA41E  1.83E-06  1.42E-05  -0.89  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
2GYK_A_B  AA51D  1.83E-06  6.11E-03  -3.52  9425068 
Colicin E9 immunity 
protein  Colicin E9 DNase 
2AJF_A_E  KE344R  1.04E-03  1.16E-03  -0.05  15791205 
Human 
Angiotensin-
converting enzyme 
2 
SARS spike protein 
receptor binding domain 
2AJF_A_E  FE360S  8.80E-04  1.16E-03  -0.12  15791205 
Human 
Angiotensin-
converting enzyme 
2 
SARS spike protein 
receptor binding domain 
2AJF_A_E  NE479K  2.77E-02  1.16E-03  1.38  15791205 
Human 
Angiotensin-
converting enzyme 
2 
SARS spike protein 
receptor binding domain 
2AJF_A_E  TE487S  1.32E-02  1.16E-03  1.06  15791205 
Human 
Angiotensin-
converting enzyme 
2 
SARS spike protein 
receptor binding domain 
1MQ8_A_B  CB161L,CB299F  4.60E+00  4.30E-01  1.03  12526797 
Intercellular 
adhesion molecule I  Integrin alpha-L 
1MQ8_A_B 
CB161L,CB299F,KB287C,KB2
94C  1.40E-02  4.30E-01  -1.49  12526797 
Intercellular 
adhesion molecule I  Integrin alpha-L 
1MQ8_A_B 
CB161L,CB299F,EB284C,EB3
01C  4.50E-02  4.30E-01  -0.98  12526797 
Intercellular 
adhesion molecule I  Integrin alpha-L 
1MQ8_A_B 
CB161L,CB299F,KB160C,TB3
00C  1.20E+00  4.30E-01  0.45  12526797 
Intercellular 
adhesion molecule I  Integrin alpha-L 
1MQ8_A_B 
CB161L,CB299F,LB289C,KB2
94C  3.60E+00  4.30E-01  0.92  12526797 
Intercellular 
adhesion molecule I  Integrin alpha-L 
1MQ8_A_B  CB161L,KB160C  7.70E-01  4.30E-01  0.25  12526797 
Intercellular 
adhesion molecule I  Integrin alpha-L 
1MQ8_A_B  CB299F,TB300C  7.60E-01  4.30E-01  0.25  12526797 
Intercellular 
adhesion molecule I  Integrin alpha-L 
1MAH_A_F  FA295L  3.70E-03  4.40E-03  -0.08  8157652 
Acetylcholinesteras
e  Fasciculin 
1MAH_A_F  FA297I  6.00E-03  4.40E-03  0.14  8157652 
Acetylcholinesteras
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1MAH_A_F  FA297Y  3.10E-03  4.40E-03  -0.15  8157652 
Acetylcholinesteras
e  Fasciculin 
1MAH_A_F  YA337A  6.80E-03  4.40E-03  0.19  8157652 
Acetylcholinesteras
e  Fasciculin 
1MAH_A_F  DA74N  4.00E-02  4.40E-03  0.96  8157652 
Acetylcholinesteras
e  Fasciculin 
1MAH_A_F  YA124Q  2.90E-01  4.40E-03  1.82  8157652 
Acetylcholinesteras
e  Fasciculin 
1LFD_A_B  RA20A  3.30E+01  1.49E+01  0.35  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  SA22K  2.54E+01  1.49E+01  0.23  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  LA23K  1.68E+01  1.49E+01  0.05  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  NA27K  4.46E+01  1.49E+01  0.48  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  MA30K  6.70E+00  1.49E+01  -0.35  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  KA32A  4.00E+01  1.49E+01  0.43  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  KA48A  1.68E+01  1.49E+01  0.05  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  DA51K  9.30E+00  1.49E+01  -0.21  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  KA52A  2.83E+01  1.49E+01  0.28  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  NA54K  4.20E+00  1.49E+01  -0.55  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  LA55K  1.11E+01  1.49E+01  -0.13  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  DA56A  2.23E+01  1.49E+01  0.18  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  EA57A  2.09E+01  1.49E+01  0.15  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  EA57K  2.30E+01  1.49E+01  0.19  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  DA58K  6.40E+00  1.49E+01  -0.37  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  NA92K  1.61E+01  1.49E+01  0.03  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  YA93K  4.80E+01  1.49E+01  0.51  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  DA94K  7.90E+00  1.49E+01  -0.28  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  MA30K,DA58K  5.80E+00  1.49E+01  -0.41  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  MA30K,DA94K  1.99E+01  1.49E+01  0.13  15197281  RalGSD-RBD  H-Ras1 Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1LFD_A_B  MA30K,DA51K,DA58K  7.80E+00  1.49E+01  -0.28  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B 
MA30K,DA51K,DA58K,DA94
K  1.00E+01  1.49E+01  -0.17  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  DA51K,DA56K,EA57K  6.00E+00  1.49E+01  -0.4  15197281  RalGSD-RBD  H-Ras1 
1LFD_A_B  DA58K,DA94K  1.99E+01  1.49E+01  0.13  15197281  RalGSD-RBD  H-Ras1 
1KTZ_A_B  VA92I  7.20E-02  5.40E-02  0.13  19161338 
Transforming 
growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  RA25K  2.00E-01  5.40E-02  0.57  19161338 
Transforming 
growth factor beta 3  TGF-beta type II receptor 
1REW_AB_C  DA30A,DB30A  1.20E-03  4.00E-04  0.48  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  WA31A,WB31A  2.28E-03  4.00E-04  0.76  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C 
DA30A,WA31A,DB30A,WB31
A  1.20E-02  4.00E-04  1.48  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  FA49A,FB49A  4.00E-04  4.00E-04  0  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  PA50A,PB50A  3.20E-04  4.00E-04  -0.1  10880444 
Bone 
morphogenetic   BMPR-IA receptor 
1REW_AB_C  HA39D,HB39D  4.40E-04  4.00E-04  0.04  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  SA88A,SB88A  4.40E-04  4.00E-04  0.04  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  LA100A,LB100A  4.80E-04  4.00E-04  0.08  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  HA39D,SA88A,HB39D,SB88A  4.80E-04  4.00E-04  0.08  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C 
HA39D,LA100A,HB39D,LB10
0A  4.40E-04  4.00E-04  0.04  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor Appendices: SKEMPI Δkoff Dataset 
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1REW_AB_C  AA34D,AB34D  2.24E-04  4.00E-04  -0.25  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  DA53A,DB53A  4.40E-04  4.00E-04  0.04  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  EA109R,EB109R  4.80E-04  4.00E-04  0.08  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  DA30A,AA34D,DB30A,AB34D  7.60E-04  4.00E-04  0.28  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C  AA34D,DA53A,AB34D,DB53A  4.40E-04  4.00E-04  0.04  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C 
DA53A,EA109R,DB53A,EB10
9R  5.60E-04  4.00E-04  0.15  10880444 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C 
KC88R,SC90T,KC92I,AC93P,Q
C94H,LC95Q,TC98D  9.70E-04  2.40E-04  0.61  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
2QJ9_AB_C 
RC88K,TC90S,IC92K,PC93A,H
C94Q,QC95L,SC98T  2.40E-04  9.70E-04  -0.61  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C 
KC88R,SC90T,KC92I,AC93P,Q
C94H,LC95Q,TC98D,AC74T,M
C78L,KC79G,YC80L  3.40E-04  2.40E-04  0.15  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
2QJ9_AB_C  AC74T,MC78L,KC79G,YC80L  3.40E-04  9.70E-04  -0.46  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
2QJA_AB_C 
RC88K,TC90S,IC92K,PC93A,H
C94Q,QC95L,SC98T,TC74A,L
C78M,GC79K,LC80Y  2.40E-04  3.40E-04  -0.15  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
1REW_AB_C 
KC88R,SC90T,KC92I,AC93P,Q
C94H,LC95Q,TC98D,AC74T,M
C78L,KC79G,YC80L,GC42H,D
C46E,AC61T,IC62M  1.11E-03  2.40E-04  0.67  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
2QJ9_AB_C 
AC74T,MC78L,KC79G,YC80L,
GC42H,DC46E,AC61T,IC62M  1.11E-03  9.70E-04  0.06  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor Appendices: SKEMPI Δkoff Dataset 
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Pubmed 
ID  Protein 1  Protein 2 
2QJA_AB_C  GC42H,DC46E,AC61T,IC62M  1.11E-03  3.40E-04  0.51  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
2QJB_AB_C  HC42G,EC46D,TC61A,MC62I  3.40E-04  1.11E-03  -0.51  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
2QJB_AB_C 
TC74A,LC78M,GC79K,LC80Y,
HC42G,EC46D,TC61A,MC62I  9.70E-04  1.11E-03  -0.06  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
2QJB_AB_C 
RC88K,TC90S,IC92K,PC93A,H
C94Q,QC95L,SC98T,TC74A,L
C78M,GC79K,LC80Y,HC42G,E
C46D,TC61A,MC62I  2.40E-04  1.11E-03  -0.67  18160401 
Bone 
morphogenetic 
protein-2  BMPR-IA receptor 
3BK3_A_C  LC1A  2.80E-02  2.60E-02  0.03  18477456 
Bone 
morphogenetic 
protein-2  Crossveinless 2 
3BK3_A_C  LC1R  2.80E-02  2.60E-02  0.03  18477456 
Bone 
morphogenetic 
protein-2  Crossveinless 2 
3BK3_A_C  TC3P  4.80E-02  2.60E-02  0.27  18477456 
Bone 
morphogenetic 
protein-2  Crossveinless 2 
3BK3_A_C  TC5P  7.50E-02  2.60E-02  0.46  18477456 
Bone 
morphogenetic 
protein-2  Crossveinless 2 
3BK3_A_C  IC18A  4.40E-02  2.60E-02  0.23  18477456 
Bone 
morphogenetic 
protein-2  Crossveinless 2 
3BK3_A_C  IC18R  8.90E-02  2.60E-02  0.53  18477456 
Bone 
morphogenetic 
protein-2  Crossveinless 2 
1JTG_A_B  DB49A  7.89E-03  2.80E-04  1.45  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SA235A,DB49A  6.22E-03  2.80E-04  1.35  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SA235A,SA130A,DB49A  2.47E-03  2.80E-04  0.95  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A,DB49A  2.05E-03  2.80E-04  0.87  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  KA234A,DB49A  5.27E-03  2.80E-04  1.27  10772866  TEM-1 beta- BLIP Appendices: SKEMPI Δkoff Dataset 
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lactamase 
1JTG_A_B  RA243A,SA235A,DB49A  6.40E-04  2.80E-04  0.36  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A,SA130A,DB49A  2.27E-03  2.80E-04  0.91  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SA235A,KA234A,DB49A  3.19E-03  2.80E-04  1.06  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  KA234A,SA130A,DB49A  1.58E-03  2.80E-04  0.75  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B 
RA243A,SA235A,SA130A,DB
49A  1.05E-03  2.80E-04  0.57  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B 
SA235A,SA130A,KA234A,DB
49A  1.09E-03  2.80E-04  0.59  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A,KA234A,DB49A  5.10E-03  2.80E-04  1.26  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B 
RA243A,SA235A,KA234A,DB
49A  4.86E-03  2.80E-04  1.24  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B 
KA234A,SA130A,RA243A,DB
49A  3.13E-03  2.80E-04  1.05  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B 
KA234A,SA235A,SA130A,RA
243A,DB49A  3.90E-03  2.80E-04  1.14  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SA235A  2.60E-03  2.80E-04  0.97  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SA130A  6.50E-04  2.80E-04  0.37  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SA235A,SA130A  1.10E-03  2.80E-04  0.59  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A  7.20E-04  2.80E-04  0.41  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  KA234A  1.12E-03  2.80E-04  0.6  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A,SA235A  3.10E-04  2.80E-04  0.04  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A,SA130A  1.55E-03  2.80E-04  0.74  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SA235A,KA234A  1.87E-03  2.80E-04  0.83  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  KA234A,SA130A  1.16E-03  2.80E-04  0.62  10772866 
TEM-1 beta-
lactamase  BLIP Appendices: SKEMPI Δkoff Dataset 
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1JTG_A_B  RA243A,SA235A,SA130A  1.06E-03  2.80E-04  0.58  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A,KA234A  2.74E-03  2.80E-04  0.99  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  RA243A,SA235A,KA234A  2.68E-03  2.80E-04  0.98  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  KA234A,SA130A,RA243A  1.89E-03  2.80E-04  0.83  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B 
KA234A,SA235A,SA130A,RA
243A  3.78E-03  2.80E-04  1.13  10772866 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A  3.19E-04  1.50E-04  0.33  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A  1.16E-04  1.50E-04  -0.11  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  VA103A  4.03E-03  1.50E-04  1.43  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA104A  8.67E-03  1.50E-04  1.76  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  PA107A  2.01E-04  1.50E-04  0.13  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  MA129A  3.35E-04  1.50E-04  0.35  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A  1.78E-04  1.50E-04  0.07  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  VA216A  2.96E-05  1.50E-04  -0.71  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  FB36A  1.52E-02  1.50E-04  2.01  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  HB41A  3.70E-02  1.50E-04  2.39  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  DB49A  2.90E-03  1.50E-04  1.29  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  YB50A  3.92E-05  1.50E-04  -0.58  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  YB53A  8.27E-03  1.50E-04  1.74  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SB71A  4.05E-04  1.50E-04  0.43  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  WB112A  3.22E-02  1.50E-04  2.33  17070843 
TEM-1 beta-
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1JTG_A_B  SB113A  1.74E-04  1.50E-04  0.06  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  FB142A  9.80E-03  1.50E-04  1.82  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  HB148A  1.40E-02  1.50E-04  1.97  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  WB150A  9.08E-02  1.50E-04  2.78  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  WB162A  9.40E-03  1.50E-04  1.8  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A,HB148A  8.00E-02  1.50E-04  2.73  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A,WB150A  3.81E-02  1.50E-04  2.4  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A,RB160A  1.14E-02  1.50E-04  1.88  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,HB148A  8.11E-03  1.50E-04  1.73  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,WB150A  1.10E-01  1.50E-04  2.87  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,RB160A  1.77E-03  1.50E-04  1.07  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A,WB162A  5.17E-03  1.50E-04  1.54  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  VA103A,WB162A  9.00E-02  1.50E-04  2.78  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  MA129A,YB53A  2.99E-02  1.50E-04  2.3  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  MA129A,YB50A  2.27E-04  1.50E-04  0.18  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  MA129A,FB36A  1.60E-02  1.50E-04  2.03  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  PA107A,HB41A  1.03E-02  1.50E-04  1.84  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  PA107A,YB50A  8.75E-05  1.50E-04  -0.23  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  PA107A,YB53A  4.34E-03  1.50E-04  1.46  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  VA216A,YB50A  1.16E-05  1.50E-04  -1.11  17070843 
TEM-1 beta-
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1JTG_A_B  EA110A,SB113A,SB71A  1.25E-03  1.50E-04  0.92  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  SB71A,SB113A  6.08E-04  1.50E-04  0.61  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA104A,SB113A  5.29E-03  1.50E-04  1.55  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A,WB112A  5.19E-02  1.50E-04  2.54  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A,WB162A  2.87E-02  1.50E-04  2.28  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A,KB74A  9.33E-02  1.50E-04  2.79  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  QA99A,FB142A  2.81E-02  1.50E-04  2.27  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,WB112A  1.46E-02  1.50E-04  1.99  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,WB162A  3.59E-03  1.50E-04  1.38  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,RB160A  1.77E-03  1.50E-04  1.07  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,KB74A  4.12E-02  1.50E-04  2.44  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,FB142A  7.31E-03  1.50E-04  1.69  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NA100A,DB49A  1.57E-03  1.50E-04  1.02  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A,WB112A  1.65E-02  1.50E-04  2.04  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A,WB150A  7.70E-02  1.50E-04  2.71  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A,RB160A  2.00E-03  1.50E-04  1.12  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A,KB74A  6.83E-02  1.50E-04  2.66  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A,FB142A  1.10E-02  1.50E-04  1.87  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA168A,DB49A  2.29E-03  1.50E-04  1.18  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  MA129A,SB113A,SB71A  1.58E-03  1.50E-04  1.02  17070843 
TEM-1 beta-
lactamase  BLIP Appendices: SKEMPI Δkoff Dataset 
223 
 
Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1JTG_A_B  VA216A,FB142A  2.17E-03  1.50E-04  1.16  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  EA104A,SB113A,SB71A  2.58E-02  1.50E-04  2.24  17070843 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  TB32K  6.00E-04  2.80E-04  0.33  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  VB93K  3.00E-04  2.80E-04  0.03  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  TB140K  6.60E-04  2.80E-04  0.37  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  NB89K  3.60E-04  2.80E-04  0.11  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  DB163A  2.40E-04  2.80E-04  -0.07  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  DB163K  2.20E-04  2.80E-04  -0.11  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  TB140K,QB157K  6.70E-04  2.80E-04  0.38  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B  VB165K,DB163K,NB89K  2.70E-04  2.80E-04  -0.02  10876236 
TEM-1 beta-
lactamase  BLIP 
1JTG_A_B 
VB165K,DB163K,DB135K,NB
89K  2.30E-04  2.80E-04  -0.09  10876236 
TEM-1 beta-
lactamase  BLIP 
1GL1_A_I  KI31M,AI32G  7.40E-05  1.62E-04  -0.34  7592720 
Bovine alpha-
chymotrypsin  PMP-C insect inhibitor 
1GL0_E_I  MI30K  1.10E-04  2.10E-04  -0.28  7592720 
Bovine alpha-
chymotrypsin  PMP-D2v insect inhibitor 
1FC2_C_D  LC136D  3.60E-03  3.20E-03  0.05  8588944  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  NC147A  8.40E-03  3.20E-03  0.42  8588944  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  FC149A  4.30E-03  3.20E-03  0.13  8588944  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  IC150A  6.20E-03  3.20E-03  0.29  8588944  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  KC154A  3.10E-02  3.20E-03  0.99  8588944  Protein A/Z  IgG1 MO61 Fc 
2FTL_E_I  GI12A  1.90E-05  5.00E-08  2.58  8784199  Bovine trypsin  BPTI 
2FTL_E_I  KI15A  4.20E-05  5.00E-08  2.92  8784199  Bovine trypsin  BPTI 
2FTL_E_I  II18A  9.20E-05  5.00E-08  3.26  8784199  Bovine trypsin  BPTI 
2FTL_E_I  GI36A  1.10E-04  5.00E-08  3.34  8784199  Bovine trypsin  BPTI Appendices: SKEMPI Δkoff Dataset 
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1CBW_FGH_I  TI11A  2.30E-03  1.80E-03  0.11  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  GI12A  2.00E-03  1.80E-03  0.05  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  PI13A  2.30E-03  1.80E-03  0.11  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  KI15A  2.00E-02  1.80E-03  1.05  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  RI17A  4.90E-03  1.80E-03  0.44  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  II18A  1.70E-02  1.80E-03  0.98  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  II19A  2.50E-03  1.80E-03  0.14  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  RI20A  3.90E-03  1.80E-03  0.34  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  FI33A  2.40E-03  1.80E-03  0.13  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  VI34A  2.80E-03  1.80E-03  0.19  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  YI35A  8.90E-03  1.80E-03  0.69  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  GI36A  5.60E-03  1.80E-03  0.49  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  GI37A  5.00E-03  1.80E-03  0.44  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1CBW_FGH_I  KI46A  1.20E-03  1.80E-03  -0.18  8784199 
Bovine alpha-
chymotrypsin  BPTI 
1A4Y_A_B  HB8A  4.50E-07  1.40E-07  0.51  9050852 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  QB12A  2.00E-07  1.40E-07  0.16  9050852 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  NB68A  2.30E-07  1.40E-07  0.22  9050852 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  EB108A  1.60E-07  1.40E-07  0.06  9050852 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  YA434A  7.30E-06  1.10E-07  1.82  9050852 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  DA435A  1.40E-05  1.10E-07  2.1  9050852 
Ribonuclease 
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1A4Y_A_B  YA437A  3.10E-07  1.10E-07  0.45  9050852 
Ribonuclease 
inhibitor  Angiogenin 
1Z7X_W_X  YW437A  7.40E-04  1.20E-05  1.79  9050852 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  QW430A,VW432A  4.00E-05  1.20E-05  0.52  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  WW438A,SW439A,EW440A  2.50E-04  1.20E-05  1.32  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  RW457A  3.20E-05  1.20E-05  0.43  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  IW459A  1.20E-05  1.20E-05  0  10970748 
Ribonuclease 
inhibitor  RNase A 
1A4Y_A_B  QA430A,VA432A  8.40E-08  1.10E-07  -0.12  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  WA438A,SA439A,EA440A  1.70E-06  1.10E-07  1.19  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RA457A  5.80E-08  1.10E-07  -0.28  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  IA459A  2.00E-07  1.10E-07  0.26  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1Z7X_W_X  EW206A  7.60E-05  1.20E-05  0.8  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  WW261A  8.00E-05  1.20E-05  0.82  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  WW263A  4.60E-04  1.20E-05  1.58  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  EW287A  5.20E-05  1.20E-05  0.64  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  SW289A  3.40E-05  1.20E-05  0.45  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  KW320A  5.60E-05  1.20E-05  0.67  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  EW344A  1.10E-04  1.20E-05  0.96  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  WW375A  9.90E-05  1.20E-05  0.92  10970748 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  EW401A  4.30E-05  1.20E-05  0.55  10970748 
Ribonuclease 
inhibitor  RNase A 
1A4Y_A_B  HB84A  1.40E-07  1.10E-07  0.11  10970748 
Ribonuclease 
inhibitor  Angiogenin Appendices: SKEMPI Δkoff Dataset 
226 
 
Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1A4Y_A_B  WB89A  1.60E-07  1.10E-07  0.16  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  WA261A  1.00E-07  1.10E-07  -0.04  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  WA263A  6.90E-07  1.10E-07  0.8  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  EA287A  8.80E-08  1.10E-07  -0.1  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  SA289A  6.30E-08  1.10E-07  -0.24  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  WA318A  1.30E-06  1.10E-07  1.07  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KA320A  9.40E-08  1.10E-07  -0.07  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  EA344A  9.80E-08  1.10E-07  -0.05  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  WA375A  3.10E-07  1.10E-07  0.45  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  EA401A  3.20E-07  1.10E-07  0.46  10970748 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB5A  3.90E-06  1.30E-07  1.48  1281426 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB32A  7.80E-07  1.30E-07  0.78  1281426 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB66A  1.80E-07  1.30E-07  0.14  1281426 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB70A  1.10E-07  1.30E-07  -0.07  1281426 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB31A  1.60E-07  1.50E-07  0.03  1281426 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB33A  2.20E-07  1.50E-07  0.17  1281426 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KB40Q  5.70E-05  1.30E-07  2.64  2742853 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  HB13A  8.10E-08  1.50E-07  -0.27  2479414 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  YA434F  1.60E-07  1.10E-07  0.16  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  YA437F  9.00E-08  1.10E-07  -0.09  10413501 
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inhibitor  Angiogenin Appendices: SKEMPI Δkoff Dataset 
227 
 
Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1A4Y_A_B  YA434A,DA435A  2.70E-03  1.10E-07  4.39  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  YA434A,YA437A  1.70E-03  1.10E-07  4.19  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB5A,YA434A  2.80E-03  1.10E-07  4.41  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB5A,DA435A  2.70E-03  1.10E-07  4.39  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB5A,YA434A,DA435A  6.20E-01  1.10E-07  6.75  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  RB5A,YA434A,YA437A  2.80E-02  1.10E-07  5.41  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KB40G  1.20E-05  1.10E-07  2.04  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KB40G,YA434F  9.30E-04  1.10E-07  3.93  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KB40G,DA435A  1.90E-05  1.10E-07  2.24  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KB40G,YA437A  5.60E-04  1.10E-07  3.71  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KB40G,YA434A,DA435A  1.90E-03  1.10E-07  4.24  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1A4Y_A_B  KB40G,YA434A,YA437A  1.90E-02  1.10E-07  5.24  10413501 
Ribonuclease 
inhibitor  Angiogenin 
1Z7X_W_X  YW434F  1.00E-05  1.20E-05  -0.08  10413501 
Ribonuclease 
inhibitor  RNase A 
1Z7X_W_X  YW437F  2.90E-04  1.20E-05  1.38  10413501 
Ribonuclease 
inhibitor  RNase A 
1A22_A_B  MA14A  3.24E-04  2.70E-04  0.08  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  HA18A  1.11E-04  2.70E-04  -0.39  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  HA21A  3.51E-04  2.70E-04  0.11  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  QA22A  1.67E-04  2.70E-04  -0.21  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  FA25A  1.27E-04  2.70E-04  -0.33  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  DA26A  2.13E-04  2.70E-04  -0.1  7504735 
Human growth 
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1A22_A_B  QA29A  1.03E-04  2.70E-04  -0.42  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  LA45A  1.16E-03  2.70E-04  0.63  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  QA46A  2.43E-04  2.70E-04  -0.05  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  PA48A  3.24E-04  2.70E-04  0.08  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  SA51A  3.24E-04  2.70E-04  0.08  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  EA56A  5.67E-04  2.70E-04  0.32  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  PA61A  1.94E-03  2.70E-04  0.86  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  SA62A  4.32E-04  2.70E-04  0.2  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  NA63A  3.24E-04  2.70E-04  0.08  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  RA64A  2.13E-03  2.70E-04  0.9  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  EA65A  1.86E-04  2.70E-04  -0.16  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  QA68A  8.91E-04  2.70E-04  0.52  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  YA164A  5.67E-04  2.70E-04  0.32  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  RA167A  1.32E-04  2.70E-04  -0.31  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  KA168A  1.73E-04  2.70E-04  -0.19  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  DA171A  1.24E-03  2.70E-04  0.66  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  KA172A  5.40E-03  2.70E-04  1.3  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  EA174A  8.91E-05  2.70E-04  -0.48  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  TA175A  6.75E-03  2.70E-04  1.4  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  FA176A  5.94E-03  2.70E-04  1.34  7504735 
Human growth 
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1A22_A_B  RA178A  6.48E-03  2.70E-04  1.38  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  IA179A  7.83E-04  2.70E-04  0.46  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  RA183A  3.78E-04  2.70E-04  0.15  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  EA186A  2.62E-04  2.70E-04  -0.01  7504735 
Human growth 
hormone  hGH binding protein 
1A22_A_B  EB244A  1.42E-03  5.10E-05  1.44  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  RB270A  1.72E-04  5.10E-05  0.53  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  WB276A  7.65E-05  5.10E-05  0.18  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  SB298A  3.39E-05  5.10E-05  -0.18  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  SB302A  2.81E-05  5.10E-05  -0.26  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  IB303A  1.15E-03  5.10E-05  1.35  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  IB305A  1.08E-03  5.10E-05  1.33  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  PB306A  5.14E-04  5.10E-05  1  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  EB320A  4.42E-05  5.10E-05  -0.06  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  KB321A  4.39E-05  5.10E-05  -0.07  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  DB326A  4.91E-04  5.10E-05  0.98  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  EB327A  2.86E-04  5.10E-05  0.75  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  DB364A  6.08E-04  5.10E-05  1.08  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  IB365A  1.66E-03  5.10E-05  1.51  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  QB366A  3.89E-05  5.10E-05  -0.12  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  VB371A  1.53E-05  5.10E-05  -0.52  9571026 
Human growth 
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1A22_A_B  QB416A  1.86E-04  5.10E-05  0.56  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  RB417A  7.05E-05  5.10E-05  0.14  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  NB418A  8.65E-05  5.10E-05  0.23  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  SB419A  4.05E-05  5.10E-05  -0.1  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  NB272A  6.97E-05  5.10E-05  0.14  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  TB277A  6.41E-05  5.10E-05  0.1  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  KB415A  2.02E-04  5.10E-05  0.6  9571026 
Human growth 
hormone  hGH binding protein 
1A22_A_B  FA25A  2.80E-04  4.90E-04  -0.24  8756685 
Human growth 
hormone  hGH binding protein 
1A22_A_B  YA42A,QA46A  8.50E-04  4.90E-04  0.24  8756685 
Human growth 
hormone  hGH binding protein 
1JRH_LH_I  NI48A  4.81E-03  8.75E-03  -0.26  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  NI48Q  9.62E-03  8.75E-03  0.04  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  YI49F  3.88E-02  8.75E-03  0.65  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  VI51A  2.06E-01  8.75E-03  1.37  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  KI52A  3.32E-03  8.75E-03  -0.42  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  NI53A  7.61E-03  8.75E-03  -0.06  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  SI54A  1.29E-02  8.75E-03  0.17  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  EI55A  4.29E-03  8.75E-03  -0.31  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  WI56F  3.50E-03  8.75E-03  -0.4  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  WI56Y  7.52E-03  8.75E-03  -0.07  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  NI79A  4.64E-03  8.75E-03  -0.28  9878445  mAbs A6 
Interferon gamma 
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koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1JRH_LH_I  WI82F  6.37E-02  8.75E-03  0.86  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  WI82Y  5.01E-02  8.75E-03  0.76  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  RI84A  5.34E-03  8.75E-03  -0.21  9878445  mAbs A6 
Interferon gamma 
receptor 
1JRH_LH_I  KI98A  1.08E-02  8.75E-03  0.09  9878445  mAbs A6 
Interferon gamma 
receptor 
1DAN_HL_UT  RH134A  1.80E-03  5.70E-04  0.5  8962059  Factor VIIa  Tissue factor 
1DAN_HL_UT  MH164A  1.50E-03  5.70E-04  0.42  8962059  Factor VIIa  Tissue factor 
1DAN_HL_UT  KH192A  3.90E-04  5.70E-04  -0.17  8962059  Factor VIIa  Tissue factor 
1DAN_HL_UT  LH144A  5.70E-04  5.70E-04  0  8962059  Factor VIIa  Tissue factor 
1NMB_N_LH  DH56N  2.90E-03  5.20E-03  -0.25  9579662 
Subtype N9 
neuraminidase  Antibody NC10 
1NMB_N_LH  YH99A  5.88E-02  5.20E-03  1.05  9579662 
Subtype N9 
neuraminidase  Antibody NC10 
1NMB_N_LH  YH100aF  5.60E-03  5.20E-03  0.03  9579662  Subtype N9   Antibody NC10 
1NMB_N_LH  TL93F  4.30E-03  5.20E-03  -0.08  9579662 
Subtype N9 
neuraminidase  Antibody NC10 
1NMB_N_LH  TL93W  6.30E-03  5.20E-03  0.08  9579662 
Subtype N9 
neuraminidase  Antibody NC10 
1NMB_N_LH  LL94V  1.11E-02  5.20E-03  0.33  9579662 
Subtype N9 
neuraminidase  Antibody NC10 
3HFM_HL_Y  NL31D  3.68E-04  5.40E-05  0.83  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YL50F  2.06E-03  5.40E-05  1.58  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DH32A  1.19E-03  5.40E-05  1.34  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DH32N  3.30E-05  5.40E-05  -0.21  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DH32A,KY97M  5.80E-04  5.40E-05  1.03  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DH32N,KY97M  1.12E-04  5.40E-05  0.32  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  KY97M  2.80E-04  5.40E-05  0.72  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21A  2.71E-04  5.40E-05  0.7  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  SH31A  4.80E-05  5.40E-05  -0.05  10338006  HyHEL-10  HEW Lysozyme Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
3HFM_HL_Y  QL53A  2.00E-04  5.40E-05  0.57  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YL96A  2.30E-03  5.40E-05  1.63  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YL96F  4.50E-04  5.40E-05  0.92  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21G  5.80E-03  1.12E-04  1.71  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21A  4.40E-04  1.12E-04  0.59  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21N  4.50E-03  1.12E-04  1.6  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21E  1.80E-03  1.12E-04  1.21  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21Q  5.80E-03  1.12E-04  1.71  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21H  4.40E-03  1.12E-04  1.59  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21M  1.43E-03  1.12E-04  1.11  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21K  1.50E-03  1.12E-04  1.13  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21W  2.00E-03  1.12E-04  1.25  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  KY97E  1.50E-02  1.12E-04  2.13  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  KY97M  1.70E-04  1.12E-04  0.18  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  KY97R  8.20E-03  1.12E-04  1.86  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101G  1.10E-04  1.12E-04  -0.01  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101S  1.00E-03  1.12E-04  0.95  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101N  6.00E-04  1.12E-04  0.73  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101E  3.60E-03  1.12E-04  1.51  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101Q  1.80E-03  1.12E-04  1.21  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101K  1.10E-03  1.12E-04  0.99  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101F  9.00E-04  1.12E-04  0.91  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101R  1.30E-03  1.12E-04  1.06  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YY20F  6.10E-05  1.12E-04  -0.26  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  GY102V  1.00E-04  1.12E-04  -0.05  9761467  HyHEL-10  HEW Lysozyme Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
3HFM_HL_Y  HY15A  6.30E-05  1.00E-04  -0.2  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21A  4.40E-04  1.00E-04  0.64  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  WY63A  1.77E-04  1.00E-04  0.25  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY73A  6.20E-05  1.00E-04  -0.21  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  LY75A  1.64E-04  1.00E-04  0.22  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  TY89A  1.13E-04  1.00E-04  0.05  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  NY93A  1.50E-04  1.00E-04  0.18  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  IY98A  9.10E-05  1.00E-04  -0.04  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  SY100A  1.60E-04  1.00E-04  0.2  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101A  2.90E-04  1.00E-04  0.46  9761468  HyHEL-10  HEW Lysozyme 
1DAN_HL_UT  EU208A  1.82E-03  2.10E-03  -0.06  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  VU207A  1.76E-03  2.10E-03  -0.08  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU203A  1.98E-03  2.10E-03  -0.03  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KU201A,DU204A  2.18E-03  2.10E-03  0.02  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  NU199A,RU200A  2.86E-03  2.10E-03  0.13  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU197A,VU198A  2.07E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  SU195A  2.11E-03  2.10E-03  0  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  SU195A,RU196A  3.37E-03  2.10E-03  0.21  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  YU185A  1.78E-03  2.10E-03  -0.07  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KU181A  2.42E-03  2.10E-03  0.06  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  LU176A  2.01E-03  2.10E-03  -0.02  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  NU173A,EU174A  2.40E-03  2.10E-03  0.06  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU172A  1.90E-03  2.10E-03  -0.04  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KU169A  2.00E-03  2.10E-03  -0.02  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU167A  2.71E-03  2.10E-03  0.11  7654692  Factor VIIa  Tissue factor Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1DAN_HL_UT  KU165A,KU166A  1.69E-03  2.10E-03  -0.09  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  GU164R  2.07E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  SU163A  1.93E-03  2.10E-03  -0.04  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  WU158F  1.70E-03  2.10E-03  -0.09  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  YU156L  1.95E-03  2.10E-03  -0.03  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  IU152A  2.58E-03  2.10E-03  0.09  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KU149A,DU150A  1.63E-03  2.10E-03  -0.11  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DU145A  1.37E-03  2.10E-03  -0.19  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  RU144A  2.14E-03  2.10E-03  0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  FU140A  1.86E-02  2.10E-03  0.95  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU139A  2.09E-03  2.10E-03  0  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  RU136A,NU137A,NU138A  1.73E-03  2.10E-03  -0.08  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  RU135A  3.11E-03  2.10E-03  0.17  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  LU133A  1.68E-03  2.10E-03  -0.1  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  EU130A,RU131F  2.08E-03  2.10E-03  0  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DU129A  2.18E-03  2.10E-03  0.02  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  EU128A  2.15E-03  2.10E-03  0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KU122A  2.07E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  QU114A,EU117A  1.74E-03  2.10E-03  -0.08  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  NU107A,QU110A  4.55E-03  2.10E-03  0.34  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  LU104A,EU105A  1.88E-03  2.10E-03  -0.05  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  EU99A  2.07E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT68A  2.42E-03  2.10E-03  0.06  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT68A,QT69A  1.88E-03  2.10E-03  -0.05  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT65A,DT66A  6.85E-04  2.10E-03  -0.49  7654692  Factor VIIa  Tissue factor Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1DAN_HL_UT  DT61A,ET62A  2.05E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT58E  3.08E-02  2.10E-03  1.17  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT58A  4.97E-02  2.10E-03  1.37  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT54A,ET56A  3.95E-03  2.10E-03  0.27  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TT52A  2.07E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  FT50A  3.99E-03  2.10E-03  0.28  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT48A  2.70E-03  2.10E-03  0.11  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  ST47A  2.07E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT46A  2.16E-03  2.10E-03  0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT46A,KT48A  1.51E-02  2.10E-03  0.86  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  WT45F  5.45E-02  2.10E-03  1.41  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT44A  5.77E-03  2.10E-03  0.44  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  ST42A  1.95E-03  2.10E-03  -0.03  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT41A  3.01E-03  2.10E-03  0.16  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT41A,DT44A  5.25E-02  2.10E-03  1.4  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  QT37A  4.56E-03  2.10E-03  0.34  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT28A  2.08E-03  2.10E-03  0  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  ET26A  2.09E-03  2.10E-03  0  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  WT25F  8.93E-04  2.10E-03  -0.37  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  ET24A  5.51E-03  2.10E-03  0.42  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  IT22A  6.53E-03  2.10E-03  0.49  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TT21A  2.06E-03  2.10E-03  -0.01  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT20R  4.23E-02  2.10E-03  1.3  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT20A  1.30E-02  2.10E-03  0.79  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  NT18A  1.76E-03  2.10E-03  -0.08  7654692  Factor VIIa 
Tissue factor Appendices: SKEMPI Δkoff Dataset 
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Complex 
PDB / 
Chains  Mutation(s) 
koff_mut 
(s^(-1)) 
koff_wt 
(s^(-1))  Δlog10(koff) 
Pubmed 
ID  Protein 1  Protein 2 
1DAN_HL_UT  KT15A  1.25E-03  2.10E-03  -0.23  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  WT14F  1.24E-03  2.10E-03  -0.23  7654692  Factor VIIa  Tissue factor 
2VLR_ABC_DE  AE99S  1.60E-01  2.90E-01  -0.26  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  IE53V  1.30E-01  1.60E-01  -0.09  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  IE53L  4.00E-01  1.60E-01  0.4  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  NE55A  6.30E-01  1.60E-01  0.6  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  NE55D  3.80E-01  1.60E-01  0.38  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  DE56A  2.50E-01  1.60E-01  0.19  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  QE58A  3.40E-01  1.60E-01  0.33  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  QE58E  2.60E-01  1.60E-01  0.21  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  SE99A  2.90E-01  1.60E-01  0.26  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  YE101F  2.10E-01  1.60E-01  0.12  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  SD31A  2.00E-01  1.60E-01  0.1  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  SD32A  4.60E-01  1.60E-01  0.46  18275829  HL-A2-flu  JM22 
2VLJ_ABC_DE  QD34A  1.03E+00  1.60E-01  0.81  18275829  HL-A2-flu  JM22 
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Table 10.4. SKEMPI Hotspot (ΔΔG) Dataset 
Protein  Mutation(s)_PDB  Location(s)  ΔΔG  Reference  Protein 1  Protein 2 
 
1A22_A_B  HA18A  COR  -0.48639  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  HA21A  SUP  0.155438  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  QA22A  RIM  -0.21984  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  FA25A  COR  -0.44731  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  DA26A  RIM  -0.21131  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  YA42A  COR  0.199344  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  LA45A  COR  1.224517  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  QA46A  RIM  0.108017  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  PA48A  COR  0.410656  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  SA51A  SUP  0.348235  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  EA56A  RIM  0.410656  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  PA61A  SUP  1.209325  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  SA62A  COR  0.155438  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  NA63A  COR  0.314372  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  RA64A  COR  1.642626  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  EA65A  RIM  -0.47308  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  QA68A  RIM  0.588454  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  YA164A  SUP  0.348235  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  RA167A  SUP  0.278455  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  KA168A  COR  -0.15485  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  DA171A  COR  0.790924  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  KA172A  SUP  2.015046  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  EA174A  COR  -0.92461  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  TA175A  COR  1.907029  7504735  Human growth hormone  hGH binding protein Appendices: SKEMPI Hotspot ΔΔG Dataset 
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Protein  Mutation(s)_PDB  Location(s)  ΔΔG  Reference  Protein 1  Protein 2 
 
1A22_A_B  FA176A  SUP  0.410656  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  RA178A  COR  2.425703  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  IA179A  SUP  0.806313  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  RA183A  RIM  0.542858  7504735  Human growth hormone  hGH binding protein 
1A22_A_B  RB243A  SUP  2.116247  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  EB244A  RIM  1.692722  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  RB270A  SUP  0.690199  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  RB271A  COR  0.535847  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  TB273A  RIM  0.110914  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  QB274A  RIM  0  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  EB275A  RIM  -0.09424  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  WB276A  COR  0.514301  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  WB280A  RIM  -0.01769  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  SB298A  RIM  -0.05473  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  SB302A  SUP  -0.18217  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  IB303A  SUP  1.607865  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  IB305A  SUP  1.941551  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  PB306A  SUP  3.305722  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  EB320A  RIM  -0.18217  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  KB321A  COR  0.081285  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  SB324A  SUP  0.274082  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  DB326A  SUP  0.993925  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  EB327A  RIM  0.970688  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  DB364A  SUP  1.486534  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  IB365A  COR  2.130757  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  QB366A  RIM  0.017174  9571026  Human growth hormone  hGH binding protein Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1A22_A_B  KB367A  RIM  -0.01769  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  VB371A  COR  -0.61701  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  TB395A  RIM  -0.09424  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  QB416A  SUP  0.891094  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  RB417A  COR  0.274082  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  NB418A  COR  0.295628  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  SB419A  COR  0.033864  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  TB301A  SUP  1.761612  9571026  Human growth hormone  hGH binding protein 
1A22_A_B  RB243A  SUP  0.278455  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  EB244A  RIM  0.650875  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  RB270A  SUP  0.418016  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  RB271A  COR  0.599325  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  EB275A  RIM  -0.07911  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  DB326A  SUP  0.982421  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  EB327A  RIM  0.410656  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  RB417A  COR  0.331545  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  WB276A  COR  0.56037  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  WB280A  RIM  0.166723  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  TB273A  RIM  -0.44105  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  QB274A  RIM  -0.58109  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  SB298A  RIM  -0.32785  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  SB299A  RIM  -0.50694  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  TB301A  SUP  1.085717  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  SB302A  SUP  0.467123  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  IB303A  SUP  0.432467  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  IB305A  SUP  0.132202  2034689  Human growth hormone  hGH binding protein Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1A22_A_B  PB306A  SUP  2.626807  2034689  Human growth hormone  hGH binding protein 
1A22_A_B  FA25A  COR  -0.43145  8756685  Human growth hormone  hGH binding protein 
1A22_A_B  RB243A  SUP  2.200368  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  EB244A  RIM  1.800119  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  TB273A  RIM  0.099964  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  QB274A  RIM  0  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  EB275A  RIM  -0.10032  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  WB276A  COR  0.599716  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  WB280A  RIM  0  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  SB298A  RIM  -0.10032  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  SB302A  SUP  -0.20008  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  IB303A  SUP  1.800119  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  IB305A  SUP  2.000724  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  CB308A  SUP  0  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  EB320A  RIM  -0.20008  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  KB321A  COR  0.099964  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  CB322A  COR  0  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  SB324A  SUP  0.200134  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  DB326A  SUP  1.000226  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  EB327A  RIM  1.000226  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  DB364A  SUP  1.598413  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  IB365A  COR  2.200368  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  QB366A  RIM  0  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  KB367A  RIM  0  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  VB371A  COR  -0.70092  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  TB395A  RIM  -0.10032  7529940  Human growth hormone  hGH binding protein Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1A22_A_B  QB416A  SUP  0.900116  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  RB417A  COR  0.200134  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  NB418A  COR  0.300791  7529940  Human growth hormone  hGH binding protein 
1A22_A_B  CA182A  COR  1.010373  2471267  Human growth hormone  hGH binding protein 
1A22_A_B  FA191A  RIM  0.191291  2471267  Human growth hormone  hGH binding protein 
1A4Y_A_B  HB8A  RIM  0.904115  9050852  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  QB12A  SUP  0.300265  9050852  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  NB68A  RIM  0.11781  9050852  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  EB108A  COR  -0.32272  9050852  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  YA434A  COR  3.262015  9050852  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  DA435A  COR  3.485544  9050852  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  YA437A  COR  0.836312  9050852  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  RA457A  RIM  -0.22399  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  IA459A  SUP  0.679432  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  HB84A  COR  0.170438  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  WB89A  RIM  0.240219  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  WA261A  COR  0.100657  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  WA263A  COR  1.171374  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  SA289A  SUP  0.042336  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  WA318A  SUP  1.500745  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  KA320A  COR  -0.31  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  EA344A  COR  0.17861  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  WA375A  SUP  1.035362  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  EA401A  COR  0.883734  10970748  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  RB5A  COR  2.309282  1281426  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  RB32A  RIM  0.910251  1281426  Ribonuclease inhibitor  Angiogenin Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1A4Y_A_B  RB31A  COR  0.250522  1281426  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  HB13A  SUP  -0.29669  2479414  Ribonuclease inhibitor  Angiogenin 
1A4Y_A_B  HB114A  COR  0.656829  2479414  Ribonuclease inhibitor  Angiogenin 
1AHW_AB_C  YC157A  SUP  -1.88986  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AHW_AB_C  TC167A  COR  -0.07415  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AHW_AB_C  TC170A  SUP  1.106266  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AHW_AB_C  LC176A  RIM  0.987378  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AHW_AB_C  DC178A  RIM  -0.48481  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AHW_AB_C  TC197A  RIM  1.346485  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AHW_AB_C  VC198A  RIM  -0.31437  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AHW_AB_C  NC199A  RIM  1.078705  9480775  Immunoglobulin FAB 5G9  Tissue factor 
1AK4_A_D  PD485A  RIM  2.449888  9223641  Cyclophilin A  HIV-1 capsid protein 
1AK4_A_D  VD486A  COR  2.355922  9223641  Cyclophilin A  HIV-1 capsid protein 
1AK4_A_D  HD487A  RIM  2.374152  9223641  Cyclophilin A  HIV-1 capsid protein 
1AK4_A_D  GD489A  COR  3.441638  9223641  Cyclophilin A  HIV-1 capsid protein 
1AK4_A_D  PD490A  COR  3.537182  9223641  Cyclophilin A  HIV-1 capsid protein 
1AK4_A_D  ID491A  RIM  1.60439  9223641  Cyclophilin A  HIV-1 capsid protein 
1AK4_A_D  PD493A  RIM  2.047078  9223641  Cyclophilin A  HIV-1 capsid protein 
1BRS_A_D  KA27A  COR  5.380949  7739054  Barnase  Barstar 
 
1BRS_A_D  RA59A  COR  5.245372  7739054  Barnase  Barstar 
 
1BRS_A_D  RA87A  SUP  5.564701  7739054  Barnase  Barstar 
 
1BRS_A_D  HA102A  COR  6.145795  7739054  Barnase  Barstar 
 
1BRS_A_D  YD29A  RIM  3.470544  7739054  Barnase  Barstar 
 
1BRS_A_D  DD35A  COR  4.50317  7739054  Barnase  Barstar 
 
1BRS_A_D  DD39A  COR  7.650989  7739054  Barnase  Barstar 
 
1BRS_A_D  TD42A  COR  1.85763  7739054  Barnase  Barstar 
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1BRS_A_D  ED76A  RIM  1.364171  7739054  Barnase  Barstar 
 
1BRS_A_D  EA73A  SUP  2.347719  9126847  Barnase  Barstar 
 
1BRS_A_D  RA59A  COR  4.635372  8507637  Barnase  Barstar 
 
1BRS_A_D  HA102A  COR  6.912182  8507637  Barnase  Barstar 
 
1BRS_A_D  DD35A  COR  4.069636  -3, 2004  Barnase  Barstar 
 
1BRS_A_D  DD39A  COR  5.935123 
 
Barnase  Barstar 
 
1BRS_A_D  ED76A  RIM  0.823553 
 
Barnase  Barstar 
 
1BRS_A_D  KA27A  COR  5.409263  8494892  Barnase  Barstar 
 
1BRS_A_D  NA58A  SUP  3.066363  8494892  Barnase  Barstar 
 
1BRS_A_D  RA59A  COR  5.183674  8494892  Barnase  Barstar 
 
1BRS_A_D  EA60A  RIM  -0.32588  8494892  Barnase  Barstar 
 
1BRS_A_D  EA73A  SUP  1.897844  8494892  Barnase  Barstar 
 
1BRS_A_D  RA87A  SUP  5.952121  8494892  Barnase  Barstar 
 
1BRS_A_D  HA102A  COR  6.254761  8494892  Barnase  Barstar 
 
1BRS_A_D  KA27A  COR  4.58795  8494892  Barnase  Barstar 
 
1BRS_A_D  NA58A  SUP  3.115762  8494892  Barnase  Barstar 
 
1BRS_A_D  RA59A  COR  4.89059  8494892  Barnase  Barstar 
 
1BRS_A_D  EA60A  RIM  0.514863  8494892  Barnase  Barstar 
 
1BRS_A_D  EA73A  SUP  2.813123  8494892  Barnase  Barstar 
 
1BRS_A_D  HA102A  COR  6.076371  8494892  Barnase  Barstar 
 
1CBW_FGH_I  TI11A  COR  0.221988  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  GI12A  SUP  0.685735  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  PI13A  COR  -0.05647  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  KI15A  COR  2.015046  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  RI17A  COR  0.553533  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  II18A  COR  1.415721  8784199  Bovine alpha-chymotrypsin  BPTI 
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1CBW_FGH_I  II19A  RIM  0.142877  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  VI34A  RIM  0.05155  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  GI36A  SUP  0.96419  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  GI37A  COR  0.821313  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  RI39A  RIM  0.221988  8784199  Bovine alpha-chymotrypsin  BPTI 
 
1CBW_FGH_I  KI15A  COR  2.210915  10339415  Bovine alpha-chymotrypsin  BPTI 
 
1CHO_EFG_I  LI18A  COR  4.76622  9047374  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  TI17A  COR  4.158528  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  EI19A  COR  2.333248  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  YI20A  COR  2.543463  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  RI21A  RIM  3.191768  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  PI14A  RIM  0.380623  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  KI13A  RIM  0.181043  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  GI32A  SUP  -1.0918  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  NI36A  COR  -1.36417  11171964  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  GI32A  SUP  -0.77164 
Stephen 
Ming-teh Lu, 
PhD Thesis, 
Purdue 
University, 
2000  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  TI17A  COR  4.317521 
Stephen 
Ming-teh Lu, 
PhD Thesis, 
Purdue 
University, 
2000  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain 
1CHO_EFG_I  LI18A  COR  4.932125 
Stephen 
Ming-teh Lu, 
PhD Thesis, 
Purdue 
University, 
2000  Bovine alpha-chymotrypsin  Turkey ovomucoid third domain Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1DAN_HL_UT  WT45A  COR  1.500008  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  ST47A  COR  -0.12653  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  YT51A  RIM  -0.12653  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  FT76A  COR  1.105437  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  YT78A  RIM  0.627639  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  PU92A  RIM  -0.18583  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  YU94A  COR  0.311685  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  QT37A  SUP  0.729036  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  GT43A  COR  0.064695  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT48A  SUP  0.920722  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  TT60A  SUP  2.224076  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT44A  RIM  1.379911  7756258  Factor VIIa  Tissue factor 
1DAN_HL_UT  RH134A  COR  0.749025  8962059  Factor VIIa  Tissue factor 
1DAN_HL_UT  MH164A  COR  0.744485  8962059  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT20A  COR  2.438602  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT44A  RIM  2.387218  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  WT45A  COR  2.371096  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT46A  COR  0.894808  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  QU110A  COR  1.305465  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  RU135A  RIM  0.986135  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  FU140A  COR  2.215453  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  VU207A  COR  1.569868  7947809  Factor VIIa  Tissue factor 
1DAN_HL_UT  ST16A  COR  -0.12981  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT61A  COR  0.242044  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  ET62A  SUP  0  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  IT63A  SUP  0  8312277  Factor VIIa  Tissue factor Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1DAN_HL_UT  VT64A  COR  0  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  QT69A  RIM  0  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  LT72A  COR  -0.05984  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  EU105A  RIM  -0.05984  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU106A  COR  -0.05984  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  NU107A  RIM  0  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  RU131A  RIM  0  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU132A  SUP  0  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  NU138A  RIM  0  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  VU146A  COR  0.19954  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  FU147A  SUP  -0.05984  8312277  Factor VIIa  Tissue factor 
1DAN_HL_UT  EU208A  RIM  -0.00483  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  VU207A  COR  -0.18867  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TU203A  RIM  0.135272  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  SU163A  RIM  0.022644  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  FU140A  COR  1.281753  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  RU135A  RIM  0.519314  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  LU133A  COR  -0.02756  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  EU128A  RIM  0.085805  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  EU99A  RIM  -0.17559  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  YU94A  COR  1.02415  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT68A  RIM  -0.07038  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT58A  COR  1.989497  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  FT50A  COR  0.437911  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT48A  SUP  0.414491  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  ST47A  COR  0.043562  7654692  Factor VIIa  Tissue factor Appendices: SKEMPI Hotspot ΔΔG Dataset 
247 
 
Protein  Mutation(s)_PDB  Location(s)  ΔΔG  Reference  Protein 1  Protein 2 
 
1DAN_HL_UT  KT46A  COR  0.231824  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  DT44A  RIM  0.735014  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  ST42A  RIM  -0.0693  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT41A  RIM  0.321569  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  QT37A  SUP  0.546693  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  ET24A  RIM  0.657886  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  IT22A  SUP  0.645076  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TT21A  SUP  -0.15901  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT20A  COR  2.587908  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  NT18A  COR  0.180215  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  TT17A  COR  0.120547  7654692  Factor VIIa  Tissue factor 
1DAN_HL_UT  KT15A  RIM  -0.39734  7654692  Factor VIIa  Tissue factor 
1DQJ_AB_C  YC20A  COR  3.28718  10828942  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  RC21A  COR  1.169074  10828942  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  WC63A  SUP  1.346872  10828942  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  KC97A  COR  3.521282  10828942  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  DC101A  COR  1.453057  10828942  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  YC20A  COR  3.28718  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  RC21A  COR  1.259554  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  WC62A  RIM  0.758418  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  WC63A  SUP  1.346872  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  LC75A  COR  1.453057  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  TC89A  COR  0.84122  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  NC93A  COR  0.650164  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  KC96A  SUP  6.158576  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  KC97A  COR  3.521282  12515535  HyHEL-63 Fab  HEW Lysozyme Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1DQJ_AB_C  SC100A  COR  0.77593  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  DC101A  COR  1.301276  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  NA31A  COR  2.014335  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  NA32A  SUP  4.092513  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  YA50A  COR  2.679498  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  SA91A  SUP  1.432529  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  YA96A  COR  1.135559  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  DB32A  COR  2.014335  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  YB33A  COR  5.526939  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  YB50A  SUP  6.89111  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  YB53A  COR  1.180807  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DQJ_AB_C  WB98A  COR  4.933734  12515535  HyHEL-63 Fab  HEW Lysozyme 
1DVF_AB_CD  HA30A  RIM  1.650121  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YA32A  COR  2.031279  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YA49A  COR  1.629452  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YA50A  RIM  0.688082  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  WA92A  COR  0.340876  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  SA93A  COR  1.162959  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  TB30A  RIM  0.907919  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YB32A  COR  1.832291  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  WB52A  COR  4.134849  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  DB54A  RIM  4.283173  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  NB56A  COR  1.162959  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  DB58A  COR  1.600721  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  EB98A  SUP  4.188524  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  RB99A  COR  1.875485  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
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1DVF_AB_CD  DB100A  RIM  2.790763  8703938  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  EB98A  SUP  4.188524  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  DB54A  RIM  4.283173  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  DB58A  COR  1.600721  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YA49A  COR  1.729232  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YA32A  COR  2.031279  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  NB56A  COR  1.162959  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  WB52A  COR  4.134849  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  DB100A  RIM  2.790763  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YD98A  COR  4.741557  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  YC49A  COR  1.861434  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  QD100A  COR  1.629452  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  ND54A  RIM  1.861434  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  RD100bA  COR  4.092513  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  KD30A  RIM  1.003967  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  HD33A  COR  1.861434  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  DD52A  SUP  1.683043  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1DVF_AB_CD  ID97A  COR  2.682746  8993317  IgG1-kappa D1.3 Fv  E5.2 Fv 
 
1EAW_A_B  QA38A  COR  -0.51891  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  IA41A  SUP  -0.82251  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  IA60A  RIM  -0.19436  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  DA60bA  RIM  1.502775  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  RA60cA  RIM  0.587615  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  FA60eA  SUP  -0.42881  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  YA60gA  SUP  -0.07894  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  FA94A  SUP  0.728594  17475279  Membrane-type serine protease 1  BPTI 
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1EAW_A_B  DA96A  RIM  0.65444  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  FA97A  RIM  0.89202  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  HA143A  COR  -0.01448  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  YA146A  RIM  0.502154  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  TA150A  RIM  0.089451  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  QA175A  RIM  -0.1331  17475279  Membrane-type serine protease 1  BPTI 
 
1EAW_A_B  DA217A  RIM  2.229134  17475279  Membrane-type serine protease 1  BPTI 
 
1EFN_A_B  IA96A  COR  1.451027  7588629  Fyn SH3 domain R96I mutant  HIV-1 Nef 
1EMV_A_B  RB54A  COR  1.666447  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  NB72A  COR  1.165191  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SB74A  COR  -0.24113  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  NB75A  SUP  2.335586  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SB77A  COR  -0.23299  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SB78A  SUP  -0.54014  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SB84A  SUP  -0.10947  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  FB86A  COR  3.880681  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  TB87A  SUP  0.158506  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  QB92A  SUP  -0.27773  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  KB97A  COR  1.960515  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  VB98A  SUP  1.08934  18471830  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  CA23A  COR  0.92197  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  NA24A  RIM  0.139471  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  TA27A  COR  0.72846  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SA28A  RIM  0.173174  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SA29A  RIM  0.956433  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  EA30A  RIM  1.416635  9425068  Colicin E9 immunity protein  Colicin E9 DNase Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1EMV_A_B  LA33A  SUP  3.419279  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  VA34A  COR  2.57945  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  VA37A  SUP  1.664612  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  TA38A  RIM  0.899966  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  EA41A  COR  2.084014  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  HA46A  SUP  0.832184  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  PA47A  RIM  0.437469  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SA48A  COR  0.007269  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  GA49A  SUP  1.486044  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  SA50A  COR  2.18822  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  DA51A  COR  5.918129  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  IA53A  SUP  0.848125  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  YA54A  COR  4.836801  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  YA55A  RIM  4.636833  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1EMV_A_B  PA56A  RIM  1.24284  9425068  Colicin E9 immunity protein  Colicin E9 DNase 
1F47_A_B  DA4A  RIM  0.691506  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  YA5A  RIM  0.869367  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  LA6A  COR  0.925431  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  DA7A  RIM  1.733659  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  IA8A  COR  2.516245  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  PA9A  RIM  -0.05756  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  FA11A  COR  2.445483  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  LA12A  COR  2.295326  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  KA14A  RIM  -0.04264  10880432  FtsZ fragment  ZipA 
 
1F47_A_B  QA15A  RIM  -0.0456  10880432  FtsZ fragment  ZipA 
 
1FC2_C_D  NC147A  RIM  0.605702  8588944  Protein A/Z  IgG1 MO61 Fc Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1FC2_C_D  IC150A  SUP  5.276767  8588944  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  KC154A  RIM  1.526621  8588944  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  NC147A  RIM  0.582278  8332602  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  IC150A  SUP  2.185484  8332602  Protein A/Z  IgG1 MO61 Fc 
1FC2_C_D  KC154A  RIM  1.231969  8332602  Protein A/Z  IgG1 MO61 Fc 
1FCC_A_C  TC25A  COR  0.240219  10452608  IgG1 MO61 Fc  B domain of Protein G 
1FCC_A_C  KC28A  COR  1.256154  10452608  IgG1 MO61 Fc  B domain of Protein G 
1FCC_A_C  KC31A  COR  3.477555  10452608  IgG1 MO61 Fc  B domain of Protein G 
1FCC_A_C  NC35A  COR  2.365107  10452608  IgG1 MO61 Fc  B domain of Protein G 
1FCC_A_C  DC40A  RIM  0.272251  10452608  IgG1 MO61 Fc  B domain of Protein G 
1FCC_A_C  EC42A  RIM  0.385442  10452608  IgG1 MO61 Fc  B domain of Protein G 
1FCC_A_C  WC43A  COR  3.773184  10452608  IgG1 MO61 Fc  B domain of Protein G 
1FFW_A_B  EB171A  SUP  0.716771  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1FFW_A_B  EB178A  COR  0.639143  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1FFW_A_B  HB181A  RIM  0.033864  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1FFW_A_B  DB202A  RIM  -0.07415  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1FFW_A_B  DB207A  RIM  0.096285  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1FFW_A_B  CB213A  RIM  0.204301  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1FFW_A_B  FB214A  COR  3.64594  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1FFW_A_B  IB216A  SUP  0.42783  21642453  Chemotaxis protein CheY  Chemotaxis protein CheA 
1GC1_G_C  SC23A  RIM  0.292682  2402498  gp120  CD4 
 
1GC1_G_C  QC25A  COR  0.032032  2402498  gp120  CD4 
 
1GC1_G_C  HC27A  COR  0.282555  2402498  gp120  CD4 
 
1GC1_G_C  KC29A  SUP  0.536239  2402498  gp120  CD4 
 
1GC1_G_C  NC32A  RIM  0.182654  2402498  gp120  CD4 
 
1GC1_G_C  QC33A  RIM  0.105268  2402498  gp120  CD4 
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1GC1_G_C  KC35A  COR  0.322066  2402498  gp120  CD4 
 
1GC1_G_C  QC40A  COR  -0.41066  2402498  gp120  CD4 
 
1GC1_G_C  SC42A  COR  0  2402498  gp120  CD4 
 
1GC1_G_C  LC44A  SUP  1.05602  2402498  gp120  CD4 
 
1GC1_G_C  TC45A  COR  -0.14889  2402498  gp120  CD4 
 
1GC1_G_C  KC46A  COR  1.431019  2402498  gp120  CD4 
 
1GC1_G_C  NC52A  COR  0.708338  2402498  gp120  CD4 
 
1GC1_G_C  RC59A  COR  1.175914  2402498  gp120  CD4 
 
1GC1_G_C  SC60A  RIM  -0.08859  2402498  gp120  CD4 
 
1GC1_G_C  DC63A  RIM  -0.31933  2402498  gp120  CD4 
 
1GC1_G_C  QC64A  RIM  0.442689  2402498  gp120  CD4 
 
1GC1_G_C  EC85A  SUP  1.323296  2402498  gp120  CD4 
 
1GCQ_AB_C  PC595A  COR  0.767836  11406576 
Growth factor receptor-bound 
protein 2  VavS 
 
1GCQ_AB_C  PC657A  COR  1.316456  11406576 
Growth factor receptor-bound 
protein 2  VavS 
 
1GCQ_AB_C  PC608A  COR  0.120808  11406576 
Growth factor receptor-bound 
protein 2  VavS 
 
1GCQ_AB_C  PC609A  SUP  0.08525  11406576 
Growth factor receptor-bound 
protein 2  VavS 
 
1H9D_A_B  RB3A  RIM  1.162188  10984496  AML1 Runx1 Runt domain  Core-binding factor beta 
1H9D_A_B  VB4A  SUP  1.402407  10984496  AML1 Runx1 Runt domain  Core-binding factor beta 
1H9D_A_B  GB61A  COR  2.077467  10984496  AML1 Runx1 Runt domain  Core-binding factor beta 
1H9D_A_B  QB67A  COR  1.364171  10984496  AML1 Runx1 Runt domain  Core-binding factor beta 
1H9D_A_B  LB103A  SUP  0.940201  10984496  AML1 Runx1 Runt domain  Core-binding factor beta 
1H9D_A_B  NB104A  COR  2.304372  10984496  AML1 Runx1 Runt domain  Core-binding factor beta 
1IAR_A_B  IA5A  COR  1.171374  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  TA6A  SUP  -0.10364  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  QA8A  RIM  -0.02236  9050834  Interleukin-4  Interleukin-4 receptor Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1IAR_A_B  TA13A  SUP  0.978577  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  QA78A  COR  0.124842  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA81A  RIM  0.479624  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  FA82A  SUP  -0.08647  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  KA84A  COR  0.344976  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA85A  COR  0.426889  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  RA88A  COR  3.754718  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  NA89A  SUP  1.558794  9050834  Interleukin-4  Interleukin-4 receptor 
1IAR_A_B  WA91A  COR  0.729529  9050834  Interleukin-4  Interleukin-4 receptor 
1JCK_A_B  TB20A  COR  1.654842  9500785  Beta-chain of 14.3.d  Staphylococcal enterotoxin C3 
1JCK_A_B  YB26A  COR  1.774828  9500785  Beta-chain of 14.3.d  Staphylococcal enterotoxin C3 
1JCK_A_B  NB60A  COR  1.642626  9500785  Beta-chain of 14.3.d  Staphylococcal enterotoxin C3 
1JCK_A_B  YB90A  SUP  2.59614  9500785  Beta-chain of 14.3.d  Staphylococcal enterotoxin C3 
1JCK_A_B  VB91A  COR  2.232905  9500785  Beta-chain of 14.3.d  Staphylococcal enterotoxin C3 
1JCK_A_B  KB103A  SUP  0.676638  9500785  Beta-chain of 14.3.d  Staphylococcal enterotoxin C3 
1JCK_A_B  FB176A  RIM  2.133934  9500785  Beta-chain of 14.3.d  Staphylococcal enterotoxin C3 
1JRH_LH_I  EL27A  RIM  0.542858  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  DL28A  COR  0.434841  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  YL30A  COR  1.108953  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  YL91A  COR  0.581094  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  WL92A  COR  2.819669  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  SL93A  COR  -0.65088  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  TL94A  COR  0.385442  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  WL96A  COR  1.666811  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  YH32A  RIM  1.433952  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  WH52A  SUP  2.687467  11123892  mAbs A6  Interferon gamma receptor Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1JRH_LH_I  WH53A  COR  2.422402  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  DH54A  RIM  1.886944  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  DH56A  RIM  1.855479  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  YH58A  COR  1.256154  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  RH95A  SUP  0.542858  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  YH99A  RIM  1.061531  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  HH100bA  COR  1.698531  11123892  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  KI47A  SUP  3.578757  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  NI48A  SUP  -0.29312  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  YI49A  COR  3.400763  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  GI50A  COR  4.527355  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  VI51A  COR  1.88353  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  KI52A  COR  2.984793  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  NI53A  COR  3.893992  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  SI54A  COR  0.297682  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  EI55A  RIM  -0.43501  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  WI82A  COR  4.529326  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  RI84A  SUP  -0.24642  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  KI98A  RIM  -0.04264  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  KI47A  SUP  3.852295  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  NI48A  SUP  0.634185  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  YI49A  COR  3.656642  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  GI50A  COR  4.377107  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  VI51A  COR  1.476288  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  KI52A  COR  3.789874  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  NI53A  COR  4.709525  9878445  mAbs A6  Interferon gamma receptor Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1JRH_LH_I  SI54A  COR  0.458078  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  EI55A  RIM  -0.69706  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  WI82A  COR  4.332732  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  RI84A  SUP  1.032008  9878445  mAbs A6  Interferon gamma receptor 
1JRH_LH_I  KI98A  RIM  0.667108  9878445  mAbs A6  Interferon gamma receptor 
1JTG_A_B  DB49A  COR  2.561484  9891008  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  FB142A  COR  3.379217  9891008  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  DB49A  COR  1.814255  10772866  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  SA235A  SUP  1.239083  10772866  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  SA130A  SUP  0.791973  10772866  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  RA243A  SUP  1.339371  10772866  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  DB49A  COR  1.791966  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  KB74A  SUP  3.559509  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  FB142A  COR  2.102992  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  YB143A  COR  0.38203  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  EA104A  COR  1.552953  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  YA105A  COR  -0.16837  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  RA243A  SUP  1.265764  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  SA130A  SUP  0.333848  15618400  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  QA99A  COR  0.429602  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  NA100A  RIM  -0.45581  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  VA103A  SUP  1.910744  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  EA104A  COR  1.767957  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  PA107A  COR  -0.38276  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  EA110A  COR  4.061928  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  MA129A  COR  0.738821  17070843  TEM-1 beta-lactamase  BLIP 
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1JTG_A_B  EA168A  RIM  -0.07258  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  VA216A  COR  -0.40694  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  FB36A  COR  3.20142  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  HB41A  SUP  3.2497  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  DB49A  COR  1.672743  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  YB50A  COR  -0.40694  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  YB53A  SUP  2.077467  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  SB71A  SUP  0.358089  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  KB74A  SUP  3.823668  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  WB112A  COR  3.010511  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  SB113A  COR  -0.16837  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  FB142A  COR  2.508271  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  HB148A  SUP  2.747889  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  WB150A  COR  4.253562  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  RB160A  RIM  2.222204  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  WB162A  COR  2.340827  17070843  TEM-1 beta-lactamase  BLIP 
 
1JTG_A_B  DB163A  RIM  -1.34093  10876236  TEM-1 beta-lactamase  BLIP 
 
1KTZ_A_B  RA25A  RIM  1.481581  19161338  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  RA94A  RIM  2.884404  19161338  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  LB27A  COR  2.271497  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  FB30A  COR  3.426639  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  DB32A  RIM  1.96819  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  SB49A  RIM  0.773119  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  IB50A  COR  2.343055  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  TB51A  COR  1.96012  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  SB52A  SUP  0.663091  16300789  Transforming growth factor beta 3  TGF-beta type II receptor Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1KTZ_A_B  IB53A  COR  1.816812  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  EB55A  RIM  1.663096  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  VB77A  SUP  0.86157  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  DB118A  RIM  1.261316  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1KTZ_A_B  EB119A  COR  1.940852  16300789  Transforming growth factor beta 3  TGF-beta type II receptor 
1LFD_A_B  RA20A  RIM  1.136044  15197281  RalGSD-RBD  H-Ras1 
 
1LFD_A_B  KA32A  COR  1.326342  15197281  RalGSD-RBD  H-Ras1 
 
1LFD_A_B  DA51A  RIM  -0.57906  15197281  RalGSD-RBD  H-Ras1 
 
1LFD_A_B  KA52A  COR  1.179308  15197281  RalGSD-RBD  H-Ras1 
 
1LFD_A_B  DA56A  RIM  -0.27968  15197281  RalGSD-RBD  H-Ras1 
 
1NMB_N_LH  YH99A  RIM  2.141579  9579662  Subtype N9 neuraminidase  Antibody NC10 
1PPF_E_I  LI18A  COR  1.071087  9047374  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  TI17A  COR  3.484821  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  EI19A  COR  1.203289  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  YI20A  COR  3.210383  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  RI21A  RIM  0.208053  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  PI14A  RIM  -0.12413  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  KI13A  RIM  0.756479  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  GI32A  COR  0.235382  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  NI36A  RIM  -1.64552  11171964  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  GI32A  COR  0.279808 
Stephen 
Ming-teh Lu, 
PhD Thesis, 
Purdue 
University, 
2000  Human leukocyte elastase  Turkey ovomucoid third domain 
1PPF_E_I  TI17A  COR  2.894247 
Stephen 
Ming-teh Lu, 
PhD Thesis, 
Purdue  Human leukocyte elastase  Turkey ovomucoid third domain Appendices: SKEMPI Hotspot ΔΔG Dataset 
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  University, 
2000 
1PPF_E_I  LI18A  COR  0.962834 
Stephen 
Ming-teh Lu, 
PhD Thesis, 
Purdue 
University, 
2000  Human leukocyte elastase  Turkey ovomucoid third domain 
1R0R_E_I  LI18A  COR  0.314609  9047374  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  TI17A  COR  1.173231  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  EI19A  COR  2.089436  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  YI20A  COR  5.474549  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  RI21A  RIM  -0.09605  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  PI14A  RIM  -0.63891  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  KI13A  RIM  -0.61  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  GI32A  SUP  1.298157  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  NI36A  RIM  -0.03315  11171964  Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  GI32A  SUP  1.331018 
 
Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  TI17A  COR  0.787094 
 
Subtilisin Carlsberg  Turkey ovomucoid third domain 
1R0R_E_I  LI18A  COR  0.525685 
 
Subtilisin Carlsberg  Turkey ovomucoid third domain 
1REW_AB_C  QC86A  COR  2.658561  15064755  Bone morphogenetic protein-2  BMPR-IA receptor 
1S1Q_A_B  VA43A  COR  0.670753  12006492 
Tumor susceptibility gene 101 
protein  Ubiquitin 
 
1S1Q_A_B  FA44A  RIM  0.199344  12006492 
Tumor susceptibility gene 101 
protein  Ubiquitin 
 
1S1Q_A_B  NA45A  RIM  1.231969  12006492 
Tumor susceptibility gene 101 
protein  Ubiquitin 
 
1S1Q_A_B  DA46A  RIM  0.965521  12006492 
Tumor susceptibility gene 101 
protein  Ubiquitin 
 
1S1Q_A_B  WA75A  SUP  0.280782  12006492 
Tumor susceptibility gene 101 
protein  Ubiquitin 
 
1S1Q_A_B  FA88A  SUP  0.77525  12006492 
Tumor susceptibility gene 101 
protein  Ubiquitin 
 
1SMF_E_I  EI16A  RIM  1.012809  20656696  Bovine trypsin  Mung bean inhibitor peptide Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1SMF_E_I  SI12A  COR  1.899972  20656696  Bovine trypsin  Mung bean inhibitor peptide 
1SMF_E_I  TI10A  COR  2.046052  20656696  Bovine trypsin  Mung bean inhibitor peptide 
1SMF_E_I  II13A  COR  3.511419  20656696  Bovine trypsin  Mung bean inhibitor peptide 
1TM1_E_I  YI61A  COR  2.17953  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI65A  SUP  3.07986  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI67A  SUP  2.923439  10065709  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  TI58A  COR  2.572396  7947796  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  EI60A  COR  2.924655  7947796  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  TI58A  COR  2.728342  15865427  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  EI60A  COR  3.054218  15865427  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI62A  RIM  1.256154  15865427  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI65A  SUP  3.75601  15865427  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  RI67A  SUP  3.098124  15865427  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  MI59A  COR  1.027668  15504027  Subtilisin BPN  Chymotrypsin inhibitor 2 
1TM1_E_I  YI61A  COR  2.981582  15504027  Subtilisin BPN  Chymotrypsin inhibitor 2 
1UUZ_A_D  HA62A  RIM  1.774828  17405861  Inhibitor of vertebrate lysozyme  HEW Lysozyme 
1UUZ_A_D  CA64A  COR  0.650875  17405861  Inhibitor of vertebrate lysozyme  HEW Lysozyme 
1VFB_AB_C  HA30A  COR  0.845261  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YA32A  COR  1.339986  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YA49A  COR  0.797899  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YA50A  COR  0.388012  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  WA92A  COR  2.728342  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  SA93A  RIM  0.343278  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  TB30A  RIM  -0.05587  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YB32A  COR  0.460352  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  WB52A  COR  0.364468  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1VFB_AB_C  DB54A  RIM  0.638906  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  DB58A  RIM  -0.2071  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  EB98A  SUP  1.157075  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  RB99A  RIM  -0.09978  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  DB100A  COR  3.07162  8703938  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  DC18A  COR  0.340283  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  NC19A  COR  0.396264  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YC23A  SUP  0.410656  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  SC24A  COR  0.851346  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  KC116A  COR  0.71377  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  TC118A  COR  0.765438  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  DC119A  RIM  0.953515  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  VC120A  SUP  0.91736  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  QC121A  COR  2.878286  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  IC124A  SUP  1.231969  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  RC125A  RIM  1.837722  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  LC129A  RIM  0.171622  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YA32A  COR  1.717649  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YA50A  COR  0.524568  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  WA92A  COR  3.350074  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  YB32A  COR  1.123715  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  WB52A  COR  0.91736  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  DB54A  RIM  0.992047  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1VFB_AB_C  DB100A  COR  2.941075  9609690  IgG1-kappa D1.3 Fv  HEW Lysozyme 
1XD3_A_B  KB6A  RIM  1.344086  10518943  UCH-L3  Ubiquitin 
 
1XD3_A_B  KB27A  SUP  -0.06242  10518943  UCH-L3  Ubiquitin 
 Appendices: SKEMPI Hotspot ΔΔG Dataset 
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1XD3_A_B  DB39A  RIM  -0.41066  10518943  UCH-L3  Ubiquitin 
 
1XD3_A_B  LB8A  COR  2.676792  10518943  UCH-L3  Ubiquitin 
 
1XD3_A_B  IB44A  SUP  0.265981  10518943  UCH-L3  Ubiquitin 
 
1Z7X_W_X  YW434A  COR  5.955931  9050852  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  DW435A  COR  3.662431  9050852  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  YW437A  COR  2.624135  9050852  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  RW457A  RIM  0.848247  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  IW459A  SUP  0.337421  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  EW206A  SUP  1.018685  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  WW261A  COR  1.335954  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  WW263A  SUP  2.212418  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  EW287A  RIM  1.321325  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  SW289A  SUP  0.814384  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  WW318A  SUP  0.99347  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  KW320A  COR  1.321325  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  EW344A  SUP  1.561543  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  WW375A  COR  1.66956  10970748  Ribonuclease inhibitor  RNase A 
 
1Z7X_W_X  EW401A  RIM  1.306325  10970748  Ribonuclease inhibitor  RNase A 
 
2B42_A_B  HA374A  COR  1.638458  16279951  TAXI-I  B. subtilis endoxylanase 
2BTF_A_P  FP59A  COR  1.595741  9788869  Bovine beta-actin  Bovine profilin 
2BTF_A_P  KP125A  COR  0.460056  9788869  Bovine beta-actin  Bovine profilin 
2FTL_E_I  GI12A  COR  4.392778  8784199  Bovine trypsin  BPTI 
 
2FTL_E_I  KI15A  COR  10.1592  8784199  Bovine trypsin  BPTI 
 
2FTL_E_I  II18A  COR  5.021843  8784199  Bovine trypsin  BPTI 
 
2FTL_E_I  GI36A  SUP  2.21439  8784199  Bovine trypsin  BPTI 
 
2FTL_E_I  KI15A  COR  10.63893  10339415  Bovine trypsin  BPTI 
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2G2U_A_B  EB31A  RIM  0.650875  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  SB35A  RIM  -0.9509  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  FB36A  COR  2.763951  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  SB39A  SUP  -0.95614  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  HB41A  SUP  1.717049  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  GB48A  COR  -0.4266  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  YB50A  COR  -2.07572  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  YB51A  COR  -0.62875  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  YB53A  SUP  2.301744  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  SB71A  SUP  -0.51221  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  EB73A  COR  -1.97944  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  KB74A  SUP  -0.21734  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  WB112A  COR  0.958735  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  SB113A  SUP  -0.61231  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  GB141A  SUP  -0.41381  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  FB142A  COR  0.275827  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  YB143A  COR  -1.84724  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  RB144A  RIM  -0.34239  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  HB148A  SUP  1.118951  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  WB150A  COR  1.785222  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  RB160A  RIM  0.669794  15284234  SHV-1 beta-lactamase  BLIP 
 
2G2U_A_B  WB162A  COR  0.53121  15284234  SHV-1 beta-lactamase  BLIP 
 
2GOX_A_B  RB131A  COR  2.24674  18687868  Complement C3d  Fibrinogen-binding protein Efb-C 
2GOX_A_B  NB138A  COR  1.56953  18687868  Complement C3d  Fibrinogen-binding protein Efb-C 
2GOX_A_B  RB131A  COR  1.519609  18687868  Complement C3d  Fibrinogen-binding protein Efb-C 
2GOX_A_B  NB138A  COR  1.333782  18687868  Complement C3d  Fibrinogen-binding protein Efb-C Appendices: SKEMPI Hotspot ΔΔG Dataset 
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2HRK_A_B  KA159A  RIM  0.953515  17976650  GluRS  Arc1p 
 
2I9B_A_E  RE137A  RIM  -0.28764  10864923 
Urokinase-type plasminogen 
activator 
Urokinase plasminogen activator 
receptor 
2I9B_A_E  KE139A  RIM  0.674278  10864923 
Urokinase-type plasminogen 
activator 
Urokinase plasminogen activator 
receptor 
2J0T_A_D  VD4A  RIM  0  12515831  MMP1 Interstitial collagenase  Metalloproteinase inhibitor 1 
2J0T_A_D  SD68A  COR  2.106373  12515831  MMP1 Interstitial collagenase  Metalloproteinase inhibitor 1 
2J0T_A_D  TD2A  COR  4.289029  9268350  MMP1 Interstitial collagenase  Metalloproteinase inhibitor 1 
2J0T_A_D  MD66A  RIM  1.642626  9268350  MMP1 Interstitial collagenase  Metalloproteinase inhibitor 1 
2J1K_C_T  RC384A  COR  0.764846  16923808  CAV-2  CAR D1 domain 
2JEL_LH_P  TP62A  SUP  0  1711212  Jel42 antibody  Histadine-containing protein HPr 
2JEL_LH_P  EP68A  RIM  0.410656  1711212  Jel42 antibody  Histadine-containing protein HPr 
2JEL_LH_P  EP70A  SUP  2.728342  1711212  Jel42 antibody  Histadine-containing protein HPr 
2JEL_LH_P  HP76A  RIM  -0.41066  1711212  Jel42 antibody  Histadine-containing protein HPr 
2O3B_A_B  EB24A  COR  5.474915  17138564  NucA nuclease  NuiA nuclease inhibitor 
2O3B_A_B  QB74A  RIM  3.232964  17138564  NucA nuclease  NuiA nuclease inhibitor 
2O3B_A_B  WB76A  COR  4.073704  17138564  NucA nuclease  NuiA nuclease inhibitor 
2PCC_A_B  DA34A  COR  -0.89705  11148036  Cytochrome C peroxidase  Cytochrome C 
2PCC_A_B  VA197A  COR  2.102682  11148036  Cytochrome C peroxidase  Cytochrome C 
2PCC_A_B  EA290A  RIM  6.202555  11148036  Cytochrome C peroxidase  Cytochrome C 
2PCC_A_B  KB87A  RIM  0.901871  11148036  Cytochrome C peroxidase  Cytochrome C 
2PCC_A_B  KB72A  RIM  0.303669  11148036  Cytochrome C peroxidase  Cytochrome C 
2SIC_E_I  MI73A  COR  0.217859  8276767  Subtilisin BPN  Streptomyces subtilisin inhibitor 
2VLJ_ABC_DE  DE32A  COR  1.573201  18275829  HL-A2-flu  JM22 
 
2VLJ_ABC_DE  NE55A  RIM  1.129622  18275829  HL-A2-flu  JM22 
 
2VLJ_ABC_DE  DE56A  COR  0.132202  18275829  HL-A2-flu  JM22 
 
2VLJ_ABC_DE  QE58A  COR  0.495437  18275829  HL-A2-flu  JM22 
 
2VLJ_ABC_DE  SE99A  SUP  -0.03521  18275829  HL-A2-flu  JM22 
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2VLJ_ABC_DE  YE101A  COR  0.232574  18275829  HL-A2-flu  JM22 
 
2VLJ_ABC_DE  SD31A  COR  0.627639  18275829  HL-A2-flu  JM22 
 
2VLJ_ABC_DE  SD32A  COR  1.038295  18275829  HL-A2-flu  JM22 
 
2VLJ_ABC_DE  QD34A  SUP  0.975874  18275829  HL-A2-flu  JM22 
 
2WPT_A_B  EA30A  RIM  1.733953  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  DA33A  SUP  -0.1322  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  NA34A  COR  -0.37987  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  VA37A  SUP  3.8093  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  RA38A  RIM  -1.11093  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  EA41A  COR  4.50317  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SA50A  COR  2.425703  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  PA56A  SUP  2.927686  9718299  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  RB54A  COR  1.134343  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  NB72A  COR  0.917825  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SB74A  COR  -0.84931  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  NB75A  SUP  1.237639  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SB77A  COR  -0.61164  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SB78A  SUP  -0.14954  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SB84A  SUP  -0.09361  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  FB86A  COR  1.170181  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  TB87A  SUP  0.52622  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  QB92A  SUP  0.900139  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  KB97A  COR  0.497408  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  VB98A  SUP  0.119302  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  RB54A  COR  0.61  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  NB72A  COR  0.48481  18471830  Colicin E2 immunity protein  Colicin E9 DNase Appendices: SKEMPI Hotspot ΔΔG Dataset 
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2WPT_A_B  SB74A  COR  0.581094  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  NB75A  SUP  1.265559  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SB77A  COR  -0.30264  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SB78A  SUP  -0.04087  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  SB84A  SUP  -0.04087  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  FB86A  COR  0.945562  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  TB87A  SUP  0.226905  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  QB92A  SUP  -0.1322  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  KB97A  COR  0.801228  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
2WPT_A_B  VB98A  SUP  0.410656  18471830  Colicin E2 immunity protein  Colicin E9 DNase 
3BK3_A_C  LC1A  RIM  0  18477456  Bone morphogenetic protein-2  Crossveinless 2 
3BK3_A_C  IC2A  RIM  1.038654  18477456  Bone morphogenetic protein-2  Crossveinless 2 
3BK3_A_C  IC18A  COR  0.486392  18477456  Bone morphogenetic protein-2  Crossveinless 2 
3BK3_A_C  IC21A  COR  1.307704  18477456  Bone morphogenetic protein-2  Crossveinless 2 
3BK3_A_C  IC27A  COR  1.261516  18477456  Bone morphogenetic protein-2  Crossveinless 2 
3BN9_B_CD  IB41A  COR  0  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  IB60A  COR  0.835589  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  DB60aA  RIM  0.422577  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  DB60bA  RIM  0.311247  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  RB60cA  RIM  -0.04502  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  FB94A  SUP  0.639528  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  NB95A  COR  0.773691  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  TB98A  COR  1.13256  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  HB143A  COR  0.085101  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  YB146A  RIM  1.085138  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  QB174A  RIM  -0.03471  17475279  Membrane-type serine protease 1  E2 Fab 
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3BN9_B_CD  QB175A  COR  2.510108  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  DB217A  COR  0.566465  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  QB221aA  RIM  0.706027  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BN9_B_CD  KB224A  COR  0.78532  17475279  Membrane-type serine protease 1  E2 Fab 
 
3BP8_A_C  FA136A  SUP  0.708987  18319344  Mlc transcription regulator  PTS glucose-specific enzyme EIICB 
3HFM_HL_Y  YY20A  COR  4.878217  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  NL32A  SUP  5.109633  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  KY96A  SUP  6.991293  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  NL31A  COR  5.216466  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YL50A  COR  4.559636  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  KY97A  COR  6.169981  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YH33A  COR  6.037779  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  WH98A  COR  5.513151  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DH32A  COR  1.899077  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21A  COR  1.027668  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  SH31A  COR  0.170438  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YH50A  SUP  7.322839  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  QL53A  COR  0.953515  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YL96A  COR  2.708257  10338006  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YH53A  COR  3.198175  7629185  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  YH58A  COR  1.649124  7629185  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101A  COR  1.208733  7683415  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21A  COR  0.821313  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  KY97A  COR  5.558082  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101A  COR  1.52264  9761467  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  HY15A  SUP  -0.44552  9761468  HyHEL-10  HEW Lysozyme Appendices: SKEMPI Hotspot ΔΔG Dataset 
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3HFM_HL_Y  YY20A  COR  4.273437  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY21A  COR  0.862188  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  WY63A  SUP  0.31933  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  RY73A  RIM  -0.33155  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  LY75A  COR  0.704771  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  TY89A  RIM  0  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  NY93A  COR  0.211313  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  IY98A  SUP  0  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  SY100A  COR  0.267779  9761468  HyHEL-10  HEW Lysozyme 
3HFM_HL_Y  DY101A  COR  0.953515  9761468  HyHEL-10  HEW Lysozyme 
3NPS_A_BC  IA41A  COR  0.64183  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  DA60aA  RIM  0.340139  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  DA60bA  RIM  1.067948  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  RA60cA  RIM  -1.06322  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  DA96A  RIM  1.507709  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  FA97A  COR  0.463747  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  TA98A  RIM  0.724136  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  HA143A  COR  1.875931  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  YA146A  COR  1.775668  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  TA150A  RIM  0.175048  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  QA174A  RIM  -0.05925  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  QA175A  COR  0.741239  17475279  Membrane-type serine protease 1  S4 Fab 
 
3NPS_A_BC  QA221aA  COR  -0.04094  17475279  Membrane-type serine protease 1  S4 Fab 
 
3SGB_E_I  LI18A  COR  2.98916  9047374  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  TI17A  COR  3.591963  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  EI19A  RIM  1.019236  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain Appendices: SKEMPI Hotspot ΔΔG Dataset 
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3SGB_E_I  YI20A  COR  1.943608  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  RI21A  RIM  0.053752  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  PI14A  RIM  -0.1895  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  KI13A  COR  -2.57214  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  GI32A  COR  1.222797  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  NI36A  RIM  0.331072  11171964  Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  GI32A  COR  1.364171 
 
Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  TI17A  COR  3.229379 
 
Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
3SGB_E_I  LI18A  COR  2.956299 
 
Streptomyces griseus proteinase B  Turkey ovomucoid third domain 
4CPA_A_I  VI38A  COR  2.325533  8063780  Carboxypeptidase A  Potato carboxypeptidase inhibitor 
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